data_2mt8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mt8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.251 1.177 0 CA-C-O 121.523 0.678 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.05 135.06 33.59 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 155.59 38.07 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mt -103.97 -40.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 O-C-N 123.672 0.608 . . . . 0.0 110.798 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -89.39 -40.53 12.68 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.406 0.622 . . . . 0.0 110.501 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.47 49.53 1.2 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.389 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.67 122.87 86.4 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.387 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.43 120.32 5.88 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.047 1.831 . . . . 0.0 109.81 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.4 pttt -76.08 158.94 31.27 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.885 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.8 p -120.22 150.49 40.58 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.207 0.527 . . . . 0.0 111.823 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.411 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 73.5 mtm180 -110.92 -47.57 3.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.1 159.24 42.63 Favored 'General case' 0 CA--C 1.477 -1.857 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.085 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.63 -36.92 70.04 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.216 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 p -67.04 -27.65 67.57 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.539 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 11' ' ' ARG 0.281 1.7 p30 -86.46 10.31 15.57 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.618 178.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.2 m -93.63 136.68 23.81 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.541 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.43 152.7 71.16 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.621 2.881 . . . . 0.0 113.521 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 -114.52 6.93 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.507 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.96 15.27 7.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.04 153.87 20.53 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 pt -113.2 172.18 3.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.9 t -89.68 103.39 16.05 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -74.08 166.21 23.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.256 0.55 . . . . 0.0 111.512 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.94 -2.56 47.06 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.845 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -89.89 -17.05 28.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.79 31.42 Favored Glycine 0 CA--C 1.498 -0.991 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 85.4 m-85 -128.43 160.72 31.37 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.443 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.9 m -80.27 140.88 36.0 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.305 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.01 161.44 35.03 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 39' ' ' ARG . 9.2 tp10 -64.63 162.1 16.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.256 0.528 . . . . 0.0 109.846 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.79 -49.56 17.74 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mm -116.12 122.69 70.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -73.45 -29.97 62.89 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.26 0.552 . . . . 0.0 110.818 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.0 -28.15 65.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.577 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.67 111.16 23.64 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.392 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 5.4 Cg_exo -79.66 99.47 1.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.333 0 C-N-CA 121.077 1.184 . . . . 0.0 110.365 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -134.46 -75.73 0.47 Allowed 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 86.94 2.05 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.334 0.588 . . . . 0.0 110.82 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 84.1 mtp180 . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.927 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.631 -1.618 . . . . 64.129999999999995 106.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.07 139.87 30.35 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 113.72 -1.582 . . . . 74.420000000000002 109.041 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.52 130.18 6.61 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.63 -1.248 . . . . 73.099999999999994 107.63 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.64 -27.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 112.529 0.566 . . . . 74.010000000000005 112.529 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.63 -44.28 10.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.249 -0.907 . . . . 72.5 109.195 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.7 86.81 2.24 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.481 -0.781 . . . . 64.420000000000002 110.376 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.0 123.94 90.18 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.552 -0.749 . . . . 74.049999999999997 109.407 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.63 110.1 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 112.105 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 20.6 pttp -80.82 153.51 27.67 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 110.772 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 19.2 p -135.8 151.34 49.98 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.265 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -105.97 -36.64 6.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.249 -1.759 . . . . 75.109999999999999 106.249 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -136.5 161.41 35.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.659 -1.61 . . . . 74.400000000000006 109.916 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.46 -30.75 71.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.958 0.903 . . . . 65.409999999999997 111.494 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -69.18 -15.08 63.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.335 -0.848 . . . . 74.420000000000002 112.697 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -73.34 -16.0 61.37 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.59 123.62 47.33 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 109.015 -0.735 . . . . 70.010000000000005 109.015 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.8 -174.69 0.73 Allowed 'Trans proline' 0 C--O 1.258 1.475 0 C-N-CA 122.692 2.261 . . . . 75.319999999999993 112.716 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.89 -102.21 0.68 Allowed Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.34 -0.845 . . . . 75.310000000000002 112.411 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.74 11.72 2.69 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.242 0.544 . . . . 60.020000000000003 109.692 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.8 m -84.36 151.67 24.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.856 -0.611 . . . . 73.310000000000002 110.542 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.9 pt -118.09 171.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.219 -1.03 . . . . 72.109999999999999 108.219 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.1 t -94.52 107.63 19.61 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.424 -0.954 . . . . 71.319999999999993 108.424 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -73.32 166.44 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.65 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.21 -8.72 45.37 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 114.48 0.552 . . . . 62.439999999999998 114.48 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -89.25 -19.09 25.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.047 0.451 . . . . 73.329999999999998 109.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.77 23.41 10.88 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.078 -0.809 . . . . 74.409999999999997 111.078 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 74.6 m-85 -127.18 151.46 48.64 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 122.841 0.457 . . . . 74.409999999999997 110.768 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.4 m -79.53 128.37 33.29 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.58 -0.737 . . . . 73.209999999999994 111.434 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.25 168.64 35.26 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.598 -1.401 . . . . 71.299999999999997 109.598 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 8.9 tp10 -78.52 167.31 21.47 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.634 -0.876 . . . . 75.030000000000001 108.634 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.908 0.861 . . . . 73.019999999999996 109.166 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 57.6 mt -96.48 150.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 105.615 -1.994 . . . . 74.329999999999998 105.615 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -59.93 -59.32 5.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 111.32 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 123.05 41.08 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.959 -1.497 . . . . 72.209999999999994 106.959 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 39' ' ' ARG . . . -73.16 132.39 82.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 109.848 -0.427 . . . . 74.120000000000005 109.848 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.81 -45.09 41.52 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.419 2.746 . . . . 73.510000000000005 114.355 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -150.05 -50.81 0.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.996 -0.372 . . . . 73.209999999999994 109.996 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.68 70.76 6.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.722 0.772 . . . . 74.030000000000001 109.532 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.449 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 66.7 mtp180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-N 114.476 -1.238 . . . . 75.319999999999993 109.518 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.41 -2.474 0 N-CA-C 103.944 -2.613 . . . . 64.430000000000007 103.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -88.08 143.95 26.78 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 120.901 0.381 . . . . 74.230000000000004 109.996 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.59 36.33 3.56 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.404 -0.816 . . . . 74.349999999999994 110.109 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.11 -50.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.612 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.28 -34.82 12.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.798 0.809 . . . . 65.439999999999998 109.079 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.0 104.73 3.72 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.997 -1.456 . . . . 51.340000000000003 109.152 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.2 116.12 56.33 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 110.649 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.47 114.97 2.93 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.637 2.225 . . . . 73.530000000000001 111.859 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -89.68 159.62 17.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.357 -0.979 . . . . 71.340000000000003 108.357 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 18.7 p -152.26 158.78 43.3 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.266 0.555 . . . . 62.32 111.685 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -119.78 -35.83 3.43 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.311 -1.366 . . . . 74.010000000000005 107.311 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -125.75 156.82 38.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.585 -1.189 . . . . 73.450000000000003 109.287 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -63.16 -32.24 73.58 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.027 0.931 . . . . 74.030000000000001 110.971 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -65.83 -16.31 63.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.655 -1.157 . . . . 62.130000000000003 113.182 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.79 -14.51 59.56 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.137 0.494 . . . . 62.409999999999997 109.831 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.1 m -89.75 130.36 43.26 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.884 -0.598 . . . . 61.450000000000003 112.136 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.92 -179.75 5.5 Favored 'Trans proline' 0 C--O 1.27 2.123 0 C-N-CA 122.503 2.135 . . . . 74.400000000000006 112.112 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 -116.8 9.3 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.098 -0.956 . . . . 64.230000000000004 111.501 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.73 19.67 3.55 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.519 -0.919 . . . . 73.409999999999997 108.519 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.8 m -77.59 150.81 34.65 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.09 -0.959 . . . . 64.439999999999998 110.267 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -109.05 174.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.966 -0.753 . . . . 74.129999999999995 108.966 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.16 118.65 30.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.738 -0.838 . . . . 75.400000000000006 108.738 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -87.66 170.5 11.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.737 -0.21 . . . . 73.140000000000001 110.72 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.64 -6.59 50.88 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 114.347 0.499 . . . . 72.030000000000001 114.347 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -89.47 -17.71 28.16 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.935 0.398 . . . . 74.349999999999994 110.541 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 22.86 21.41 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.567 -1.013 . . . . 61.039999999999999 110.567 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.18 147.21 48.16 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 124.571 1.148 . . . . 75.040000000000006 110.746 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.6 m -81.07 139.44 35.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.855 -1.066 . . . . 73.239999999999995 112.167 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.5 147.24 12.37 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.491 -1.044 . . . . 71.319999999999993 110.491 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.59 161.78 30.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.745 -0.835 . . . . 74.120000000000005 108.745 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.56 74.19 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.615 0.766 . . . . 71.030000000000001 109.995 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.1 mt -118.6 135.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.225 0 N-CA-C 106.965 -1.494 . . . . 74.420000000000002 106.965 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -75.34 -33.78 61.15 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.003 0.43 . . . . 73.450000000000003 110.449 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.96 0.79 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.937 0.717 . . . . 75.209999999999994 112.937 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.47 124.04 87.18 Favored Pre-proline 0 C--O 1.212 -0.894 0 N-CA-C 108.953 -0.758 . . . . 72.420000000000002 108.953 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -50.97 -53.24 7.49 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.429 2.753 . . . . 74.519999999999996 115.138 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 39' ' ' ARG . 89.4 t80 -127.42 -26.14 3.09 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 111.866 0.321 . . . . 74.129999999999995 111.866 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.3 26.19 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.411 0.893 . . . . 73.200000000000003 113.411 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 37' ' ' PHE . 19.3 mtp180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-O 121.939 0.876 . . . . 75.25 112.087 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 121.408 0.623 . . . . 74.400000000000006 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -89.95 149.09 22.74 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.269 -0.878 . . . . 74.129999999999995 111.414 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 93.5 8.88 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.05 -0.977 . . . . 72.319999999999993 109.057 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.75 -63.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.659 -1.608 . . . . 75.010000000000005 106.659 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -99.19 -34.05 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -177.11 148.51 0.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.886 -1.506 . . . . 63.409999999999997 108.447 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 140.73 49.66 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.11 -0.7 . . . . 73.019999999999996 109.11 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.45 131.04 40.37 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 110.767 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.91 147.55 26.2 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.857 -0.424 . . . . 75.409999999999997 109.857 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.8 p -126.27 155.35 42.05 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 75.510000000000005 111.93 -175.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -120.45 -34.48 3.62 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.631 -1.248 . . . . 74.340000000000003 107.631 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -132.82 160.19 37.61 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.879 1.272 . . . . 75.400000000000006 108.803 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.59 -32.54 74.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.425 0.631 . . . . 75.109999999999999 110.717 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -68.38 -13.0 61.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.989 -1.005 . . . . 63.210000000000001 113.182 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.55 -28.41 62.82 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.687 -0.857 . . . . 64.099999999999994 108.687 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.2 m -89.82 132.78 35.52 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.827 -1.079 . . . . 71.099999999999994 109.397 -175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.14 139.9 17.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.302 2.001 . . . . 72.230000000000004 114.405 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.14 -102.68 0.13 Allowed Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 116.087 1.195 . . . . 74.129999999999995 116.087 172.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.79 -5.81 52.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.218 0.451 . . . . 71.099999999999994 112.218 -173.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.27 140.18 36.32 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.231 0.538 . . . . 74.209999999999994 110.2 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -120.61 172.14 8.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.335 -1.357 . . . . 75.209999999999994 107.335 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.6 t -89.62 114.36 25.95 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.782 -0.822 . . . . 72.25 108.782 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 76.2 mtp180 -88.83 164.54 15.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.886 -0.413 . . . . 74.329999999999998 109.886 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.5 45.97 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 114.0 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.9 p-10 -89.62 -14.4 35.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.929 -0.767 . . . . 75.219999999999999 108.929 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.24 16.7 34.13 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.353 -0.84 . . . . 61.0 111.043 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -125.51 152.18 45.34 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.25 0.547 . . . . 75.319999999999993 110.31 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.47 134.97 36.04 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.903 -1.044 . . . . 71.209999999999994 110.296 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.02 145.26 11.5 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.65 -0.98 . . . . 72.239999999999995 110.65 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 31' ' ' ALA . 18.8 tt0 -65.37 146.57 54.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.143 -0.688 . . . . 52.140000000000001 109.143 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' N ' ' HG2' ' A' ' 30' ' ' GLU . . . -80.7 -86.16 0.09 Allowed 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.579 -0.897 . . . . 63.109999999999999 108.579 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 mt -149.62 93.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 105.593 -2.002 . . . . 65.209999999999994 105.593 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -139.13 -168.71 2.49 Favored 'General case' 0 C--N 1.246 -3.916 0 C-N-CA 123.868 0.867 . . . . 74.530000000000001 108.967 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.3 35.83 4.04 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.185 -0.672 . . . . 73.540000000000006 109.185 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.46 117.75 59.97 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.599 -0.728 . . . . 64.230000000000004 111.988 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.47 -35.86 46.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.824 2.349 . . . . 65.319999999999993 113.55 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -129.83 -19.75 3.26 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.697 -0.401 . . . . 74.319999999999993 111.98 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.17 33.92 0.46 Allowed 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.939 -0.476 . . . . 71.439999999999998 112.284 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.398 -0.964 . . . . 73.230000000000004 108.398 173.006 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 30.5 p . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 106.375 -1.713 . . . . 72.439999999999998 106.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.83 152.79 35.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.746 -0.835 . . . . 74.040000000000006 108.746 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.48 58.14 4.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.993 0.901 . . . . 72.409999999999997 112.099 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.82 -55.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.239 -1.023 . . . . 75.129999999999995 108.239 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -89.99 -33.75 16.25 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.527 -0.76 . . . . 75.140000000000001 108.962 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.28 119.67 6.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 109.3 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 107.91 8.51 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 122.915 0.486 . . . . 51.450000000000003 111.83 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 56.5 Cg_endo -96.67 125.91 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.742 2.295 . . . . 74.219999999999999 111.179 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -97.49 149.87 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.321 -0.622 . . . . 75.439999999999998 109.321 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.753 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -130.52 157.07 43.68 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.095 0.474 . . . . 74.099999999999994 111.823 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -117.48 -51.14 2.51 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.193 -2.151 . . . . 74.25 105.193 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -123.05 158.06 31.41 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 113.98 -1.464 . . . . 73.019999999999996 109.564 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.31 -29.85 70.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.174 0.511 . . . . 75.530000000000001 112.134 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.0 p -66.41 -21.27 66.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.327 -0.851 . . . . 75.340000000000003 111.669 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.57 -20.57 63.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.226 0.536 . . . . 71.439999999999998 109.986 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -94.14 119.84 66.23 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 115.303 -0.862 . . . . 73.0 109.78 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.15 141.2 32.18 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.847 2.365 . . . . 72.239999999999995 115.139 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.95 -108.84 2.61 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 114.446 -1.252 . . . . 41.509999999999998 114.235 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' N ' ' HB3' ' A' ' 38' ' ' ALA . . . -102.37 -2.23 29.29 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.598 -0.519 . . . . 73.239999999999995 109.598 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.1 m -73.55 139.95 45.98 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.933 -0.766 . . . . 73.430000000000007 108.933 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.27 169.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 108.031 -1.1 . . . . 70.209999999999994 108.031 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.56 115.94 28.45 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.481 -0.563 . . . . 53.350000000000001 109.481 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -88.92 161.46 16.64 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.277 -0.638 . . . . 72.349999999999994 109.277 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.98 -2.56 47.42 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 113.43 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -89.5 -18.9 25.8 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.638 0.256 . . . . 71.400000000000006 110.87 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.34 4.71 32.74 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.515 -0.634 . . . . 71.340000000000003 111.515 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.77 146.55 36.17 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.584 0.754 . . . . 73.400000000000006 110.874 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.0 m -80.98 148.85 29.58 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.353 -0.84 . . . . 72.219999999999999 109.01 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 1' ' ' CYS . . . -176.3 152.01 12.21 Favored Glycine 0 N--CA 1.416 -2.692 0 C-N-CA 118.971 -1.585 . . . . 73.540000000000006 112.772 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.73 140.67 28.92 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.356 1.062 . . . . 71.340000000000003 109.502 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -85.61 0.11 Allowed 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 114.28 -1.327 . . . . 75.349999999999994 109.9 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.3 mt -153.53 102.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 105.678 -1.971 . . . . 74.540000000000006 105.678 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.5 t80 179.86 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.824 0 O-C-N 124.275 0.985 . . . . 72.230000000000004 108.672 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.73 60.15 1.1 Allowed 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.568 -1.196 . . . . 75.340000000000003 109.881 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.84 123.3 89.41 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.748 -1.114 . . . . 73.319999999999993 110.522 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -43.15 -49.33 7.27 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 124.634 3.556 . . . . 62.409999999999997 115.568 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -107.21 -16.9 14.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.32 0.581 . . . . 75.349999999999994 111.307 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 19' ' ' ALA . . . -94.31 17.21 13.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.095 0.776 . . . . 74.0 113.095 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 . . . . . 0 C--N 1.285 -2.213 0 CA-C-N 115.208 -0.905 . . . . 75.109999999999999 110.973 177.544 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.999 0.904 . . . . 74.530000000000001 109.633 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.61 147.99 24.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.702 -1.135 . . . . 73.030000000000001 108.445 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.94 142.9 12.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.39 -0.967 . . . . 73.439999999999998 108.39 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.46 -23.08 4.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.74 -0.664 . . . . 71.319999999999993 110.384 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -89.23 -42.29 11.71 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.477 -0.489 . . . . 74.420000000000002 110.136 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.02 89.04 1.42 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.145 -0.479 . . . . 65.450000000000003 112.032 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.74 78.11 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.869 -0.605 . . . . 71.340000000000003 109.649 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.09 119.82 6.9 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.709 2.272 . . . . 74.099999999999994 113.125 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 99.4 mttt -83.89 134.26 34.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.978 -0.749 . . . . 75.340000000000003 108.978 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.524 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.5 p -100.07 147.76 25.29 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.986 0.422 . . . . 71.439999999999998 112.033 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -109.2 -31.33 7.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.636 -1.246 . . . . 75.0 107.636 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -148.52 156.6 42.66 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.302 -1.317 . . . . 72.010000000000005 109.246 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 13.2 m-20 -59.53 -37.73 79.13 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.092 0.949 . . . . 73.109999999999999 110.311 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -71.82 -12.15 61.15 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.078 -1.419 . . . . 64.299999999999997 114.018 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.42 0.21 53.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.348 -0.941 . . . . 71.409999999999997 110.905 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 90.0 m -91.13 136.22 27.53 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 109.77 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 179.44 5.95 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.565 2.177 . . . . 75.040000000000006 112.967 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.66 -122.75 31.07 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.359 -0.837 . . . . 72.349999999999994 112.048 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.38 19.47 13.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.704 -0.85 . . . . 52.140000000000001 108.704 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.3 m -81.2 145.78 30.81 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.216 -0.902 . . . . 74.510000000000005 112.511 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' OD1' ' A' ' 13' ' ' ASP . 30.7 pt -119.73 179.15 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.059 -1.46 . . . . 73.420000000000002 107.059 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -90.63 117.93 29.67 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.44 -0.948 . . . . 73.030000000000001 108.44 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -89.02 160.05 17.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.38 -1.12 41.7 Favored Glycine 0 C--N 1.31 -0.892 0 CA-C-N 115.931 -0.577 . . . . 75.239999999999995 113.411 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -89.66 -19.53 24.75 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.694 -0.484 . . . . 75.140000000000001 109.694 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 2.44 34.21 Favored Glycine 0 CA--C 1.499 -0.952 0 N-CA-C 111.486 -0.646 . . . . 74.030000000000001 111.486 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 95.7 m-85 -114.69 161.65 17.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 123.414 0.685 . . . . 72.510000000000005 109.997 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 76.6 m -80.26 142.01 35.0 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.579 -0.526 . . . . 61.32 109.579 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.21 146.84 14.71 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.9 -1.28 . . . . 72.049999999999997 109.9 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.3 tt0 -59.94 148.51 34.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.64 0.733 . . . . 72.239999999999995 110.597 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.39 -151.85 0.09 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.473 -1.239 . . . . 74.329999999999998 107.736 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.5 mm -95.82 136.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 C-N-CA 119.398 -0.921 . . . . 72.25 110.413 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 22.7 t80 -170.82 154.46 4.32 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 102.731 -3.062 . . . . 75.230000000000004 102.731 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.24 3.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 119.061 0.846 . . . . 63.009999999999998 110.341 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.63 155.06 73.78 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.441 -0.8 . . . . 62.409999999999997 109.078 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.92 125.47 11.57 Favored 'Trans proline' 0 C--O 1.241 0.639 0 N-CA-C 108.23 -1.488 . . . . 73.299999999999997 108.23 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -109.65 -46.34 3.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.006 0.432 . . . . 74.420000000000002 110.43 -173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.3 78.58 1.02 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.664 -0.698 . . . . 71.019999999999996 109.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 115.368 -0.833 . . . . 74.409999999999997 108.795 178.601 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 122.39 1.091 . . . . 75.230000000000004 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.67 165.94 10.73 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.621 -1.172 . . . . 74.209999999999994 112.188 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.18 126.17 12.04 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.457 -1.683 . . . . 74.420000000000002 106.457 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.9 mt -93.67 -23.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 120.976 0.417 . . . . 71.109999999999999 111.629 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -87.83 -42.53 12.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.008 -0.677 . . . . 70.230000000000004 109.304 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.19 82.68 1.93 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.02 -0.991 . . . . 72.310000000000002 108.849 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.87 122.45 79.31 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.284 -0.871 . . . . 73.239999999999995 111.494 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.15 127.43 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.492 2.128 . . . . 63.530000000000001 109.923 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.0 pttm -94.49 156.89 16.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.55 -0.167 . . . . 72.299999999999997 110.55 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 15.2 p -142.55 157.68 44.46 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.507 0.194 . . . . 75.129999999999995 110.903 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -111.57 -42.51 3.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.145 -1.428 . . . . 71.510000000000005 107.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -127.5 157.52 39.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.758 -1.564 . . . . 75.219999999999999 108.631 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.89 -34.93 76.92 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.365 -0.834 . . . . 73.25 111.248 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -64.66 -21.62 66.77 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.526 -1.216 . . . . 71.439999999999998 112.584 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.19 -29.5 70.32 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.393 -0.595 . . . . 64.299999999999997 109.393 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 44.3 m -89.97 121.2 69.08 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 115.754 -0.657 . . . . 73.120000000000005 109.333 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.83 -177.55 2.59 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.45 2.1 . . . . 74.430000000000007 112.491 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.73 -132.75 51.42 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.575 -0.739 . . . . 63.310000000000002 111.926 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.33 11.08 33.91 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.606 0.241 . . . . 73.319999999999993 110.823 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.4 m -84.7 149.23 25.94 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.882 0.848 . . . . 73.409999999999997 112.63 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.25 175.71 10.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 113.858 -1.519 . . . . 74.439999999999998 107.683 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.8 t -97.25 110.85 23.32 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.07 -0.715 . . . . 55.219999999999999 109.07 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -74.15 169.36 17.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.862 0.363 . . . . 74.120000000000005 111.649 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.93 -14.53 61.17 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 115.438 -0.801 . . . . 61.119999999999997 112.997 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.32 -16.27 33.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.082 0.468 . . . . 72.209999999999994 111.49 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.46 17.1 32.29 Favored Glycine 0 CA--C 1.485 -1.803 0 C-N-CA 120.233 -0.984 . . . . 75.439999999999998 111.05 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 71.1 m-85 -121.18 147.16 45.98 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.66 -0.77 . . . . 73.420000000000002 109.268 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 71.9 m -70.82 127.92 34.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.065 -0.516 . . . . 64.030000000000001 110.725 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.33 153.82 20.57 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.139 -1.184 . . . . 64.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -79.28 178.11 8.32 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.47 -0.566 . . . . 72.450000000000003 109.47 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.15 -72.69 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.074 0.549 . . . . 62.399999999999999 112.133 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.0 mt -138.78 146.96 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.811 -1.181 . . . . 71.299999999999997 107.811 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.639 -1.245 . . . . 74.510000000000005 107.639 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.56 -81.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.011 -0.737 . . . . 73.319999999999993 109.011 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 36' ' ' PRO 0.27 . . -80.54 -50.89 1.05 Allowed Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 120.471 -0.492 . . . . 75.409999999999997 110.429 170.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 35' ' ' ALA . 20.9 Cg_exo -64.38 142.57 79.46 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.42 2.08 . . . . 71.219999999999999 107.816 167.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -119.95 25.5 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 111.989 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.8 39.19 4.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.806 0.843 . . . . 65.120000000000005 110.199 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-N 114.596 -1.184 . . . . 75.510000000000005 111.31 -174.626 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 108.628 -0.879 . . . . 72.5 108.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.36 170.02 9.8 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.769 -1.105 . . . . 65.519999999999996 109.936 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.78 144.37 4.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.928 -1.508 . . . . 75.510000000000005 106.928 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.4 mt -105.0 -21.48 5.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.093 0.473 . . . . 74.209999999999994 110.367 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -88.23 -43.87 11.28 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.234 -1.024 . . . . 75.310000000000002 108.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.11 77.99 1.36 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.041 -1.096 . . . . 61.200000000000003 108.041 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 116.64 31.82 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 115.289 -0.869 . . . . 61.329999999999998 110.679 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.83 118.36 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.791 2.328 . . . . 74.540000000000006 111.453 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.15 163.22 17.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.981 -0.554 . . . . 74.099999999999994 110.636 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.1 p -139.21 148.68 43.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.933 -0.576 . . . . 75.510000000000005 109.996 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -115.67 -40.32 3.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.452 -1.685 . . . . 73.010000000000005 106.452 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -132.96 160.98 35.52 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.712 1.605 . . . . 74.420000000000002 108.004 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.08 -30.71 71.68 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.537 0.684 . . . . 75.219999999999999 111.47 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -67.41 -17.26 64.65 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.064 -0.971 . . . . 72.25 112.125 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -67.11 -23.92 65.88 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.159 0.504 . . . . 72.400000000000006 109.646 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.77 137.68 26.81 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-N 115.316 -0.856 . . . . 64.310000000000002 110.055 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -86.18 177.61 4.47 Favored 'Trans proline' 0 C--O 1.253 1.272 0 C-N-CA 122.541 2.16 . . . . 75.519999999999996 112.572 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.02 -124.18 35.89 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.036 -0.984 . . . . 50.299999999999997 112.885 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.66 13.12 21.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.787 0.327 . . . . 71.299999999999997 110.167 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.38 155.22 32.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.305 0.574 . . . . 74.319999999999993 112.01 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.86 174.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.623 -0.88 . . . . 74.25 108.623 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.03 115.5 28.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.689 -0.856 . . . . 74.510000000000005 108.689 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -84.85 165.72 17.48 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 111.172 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.15 7.3 37.5 Favored Glycine 0 CA--C 1.51 -0.226 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 112.854 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -95.2 -16.36 22.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.617 -0.512 . . . . 74.299999999999997 109.617 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.01 11.97 41.31 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.729 -0.948 . . . . 74.109999999999999 110.729 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -127.87 160.8 30.71 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.458 -0.871 . . . . 75.239999999999995 110.775 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.3 m -80.0 140.54 36.54 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.602 -0.726 . . . . 75.109999999999999 111.368 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.65 176.6 39.73 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.124 -1.19 . . . . 70.340000000000003 110.124 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 9.3 tp10 -74.68 173.74 10.07 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.821 0.848 . . . . 62.399999999999999 109.414 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.59 -24.64 63.71 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.191 0.996 . . . . 71.530000000000001 108.405 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.532 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 53.3 mt -92.57 149.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 105.853 -1.906 . . . . 74.109999999999999 105.853 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -44.75 -47.08 10.78 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.318 1.047 . . . . 73.129999999999995 113.275 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -119.58 135.45 54.79 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.776 -0.824 . . . . 74.430000000000007 108.776 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.74 110.03 15.6 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.599 0.562 . . . . 74.439999999999998 111.933 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 70.7 Cg_endo -83.57 -38.32 0.14 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.522 2.148 . . . . 63.409999999999997 114.071 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -117.15 -51.42 2.54 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.444 0.64 . . . . 74.430000000000007 109.882 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 56.71 3.57 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.779 0.799 . . . . 60.329999999999998 108.944 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 . . . . . 0 N--CA 1.426 -1.625 0 CA-C-N 115.352 -0.84 . . . . 74.129999999999995 109.237 -179.298 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.296 -1.372 . . . . 73.510000000000005 107.296 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -89.52 123.66 33.82 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.016 0.912 . . . . 73.340000000000003 109.705 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.72 100.82 3.01 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 114.165 -1.38 . . . . 73.439999999999998 108.887 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 mm -91.38 -13.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.362 -0.835 . . . . 75.430000000000007 109.878 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.11 -45.41 9.61 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.416 -0.811 . . . . 73.099999999999994 109.754 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.71 96.13 2.08 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.562 -0.745 . . . . 73.349999999999994 109.316 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.57 126.41 90.83 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 115.91 -0.587 . . . . 74.310000000000002 110.166 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.55 116.41 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.539 2.159 . . . . 72.329999999999998 112.788 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -70.77 148.2 48.16 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.289 -1.004 . . . . 73.150000000000006 108.289 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 29.9 p -117.74 150.58 38.87 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 120.981 -0.288 . . . . 63.030000000000001 110.264 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.73 -43.66 2.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.278 -1.379 . . . . 72.219999999999999 107.278 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -132.18 153.1 50.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.64 -1.164 . . . . 74.530000000000001 108.729 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 6.1 m-20 -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.319 -0.855 . . . . 75.019999999999996 110.606 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -68.02 -19.26 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.64 -1.164 . . . . 74.340000000000003 113.284 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.23 -3.71 59.06 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.067 -1.053 . . . . 71.25 111.004 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -94.22 118.29 67.11 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 109.401 -0.592 . . . . 71.310000000000002 109.401 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.89 -175.44 2.68 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.586 2.19 . . . . 71.299999999999997 111.53 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.1 13.98 60.68 Favored Glycine 0 N--CA 1.465 0.599 0 CA-C-N 116.643 -0.253 . . . . 64.409999999999997 112.829 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.66 8.97 5.64 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.655 1.582 . . . . 75.549999999999997 111.129 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.76 149.17 50.28 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.047 -0.524 . . . . 65.140000000000001 109.629 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 44.9 pt -110.92 174.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.772 -0.825 . . . . 74.219999999999999 108.772 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -95.56 107.32 19.49 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.277 -1.008 . . . . 71.0 108.277 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -84.18 168.55 15.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.397 0.617 . . . . 73.209999999999994 110.857 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.45 2.25 63.14 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.295 -0.866 . . . . 75.340000000000003 112.398 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -88.74 -17.97 28.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.926 . . . . 70.25 108.501 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.8 6.94 42.7 Favored Glycine 0 CA--C 1.487 -1.673 0 N-CA-C 111.274 -0.731 . . . . 73.219999999999999 111.274 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.69 159.34 28.15 Favored 'General case' 0 N--CA 1.414 -2.255 0 C-N-CA 123.331 0.652 . . . . 71.010000000000005 110.39 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.2 m -80.21 131.94 35.78 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.254 -0.885 . . . . 53.409999999999997 108.633 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.47 170.01 30.38 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.633 -1.387 . . . . 65.549999999999997 109.633 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.6 157.74 36.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 117.643 0.722 . . . . 65.409999999999997 110.062 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 -141.83 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.648 -1.242 . . . . 74.209999999999994 107.648 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.2 mt -101.97 130.51 51.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.647 -1.242 . . . . 75.430000000000007 107.647 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 37.1 t80 -165.58 167.89 16.93 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.669 -1.604 . . . . 71.310000000000002 106.669 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.7 -80.26 0.16 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.403 0.547 . . . . 75.019999999999996 112.069 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.5 151.09 71.41 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 109.735 -0.469 . . . . 75.109999999999999 109.735 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -64.77 112.69 2.06 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.706 1.604 . . . . 74.340000000000003 111.271 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -138.17 -39.23 0.54 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.115 0.783 . . . . 75.109999999999999 113.115 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.22 43.49 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.67 -0.863 . . . . 73.450000000000003 108.67 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 114.667 -1.152 . . . . 75.439999999999998 111.433 -178.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.469 0 CA-C-O 122.558 1.17 . . . . 75.420000000000002 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.25 -26.67 22.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.365 -1.743 . . . . 72.340000000000003 107.399 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.04 93.59 9.4 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.865 -1.532 . . . . 63.299999999999997 106.865 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.8 mt -89.62 -16.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.834 -1.075 . . . . 75.329999999999998 111.071 -174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -89.34 -27.34 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.872 -1.159 . . . . 72.420000000000002 107.872 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.61 12.02 34.99 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.938 -1.028 . . . . 73.239999999999995 110.407 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.12 166.19 40.22 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 123.756 0.822 . . . . 72.140000000000001 110.722 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.8 164.54 22.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.786 1.657 . . . . 74.120000000000005 110.716 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.19 162.51 26.54 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.63 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.7 p -151.89 154.49 36.24 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.809 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -114.93 -34.23 5.16 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.221 -1.029 . . . . 75.430000000000007 108.221 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.85 161.71 34.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.512 -1.222 . . . . 74.319999999999993 110.664 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.91 -33.49 68.83 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.802 0.841 . . . . 62.219999999999999 111.57 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -65.03 -25.21 67.74 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.085 -0.961 . . . . 74.310000000000002 112.407 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.72 -26.76 68.8 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.524 0.678 . . . . 64.25 109.261 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -96.79 128.45 35.74 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.13 -0.941 . . . . 45.439999999999998 110.167 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.02 158.6 4.88 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.67 2.246 . . . . 64.510000000000005 114.547 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.36 -111.81 4.34 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.774 -1.103 . . . . 63.039999999999999 114.746 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -105.45 5.54 31.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.437 0.637 . . . . 74.219999999999999 109.844 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.79 136.15 33.36 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.712 -1.218 . . . . 74.430000000000007 107.712 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.73 177.24 4.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.175 -1.046 . . . . 75.209999999999994 108.175 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -89.31 118.82 29.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.233 -0.987 . . . . 65.129999999999995 108.368 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -89.56 166.89 13.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.507 -0.553 . . . . 74.129999999999995 109.507 -177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.53 -8.69 52.88 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 114.221 0.448 . . . . 64.510000000000005 114.221 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -89.07 -17.13 29.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.361 0.6 . . . . 75.109999999999999 109.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.82 19.54 24.19 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 111.277 -0.729 . . . . 63.310000000000002 111.277 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.5 154.59 35.07 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.971 0.908 . . . . 75.439999999999998 109.9 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 93.8 m -80.14 101.59 8.88 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 123.14 0.576 . . . . 72.209999999999994 111.87 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.47 16.79 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.538 -0.839 . . . . 74.409999999999997 111.028 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE2' ' HA ' ' A' ' 33' ' ' TYR . 27.3 tt0 -61.94 159.35 14.27 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.088 0.955 . . . . 62.310000000000002 111.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -71.48 0.16 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.386 -1.279 . . . . 74.420000000000002 110.106 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -133.23 -66.09 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.877 -1.157 . . . . 73.310000000000002 107.877 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.495 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 50.2 t80 -163.75 103.2 0.91 Allowed 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.699 -1.591 . . . . 75.329999999999998 107.562 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.8 167.41 10.31 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.709 -0.678 . . . . 64.530000000000001 111.809 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.2 169.51 19.56 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 114.802 -1.09 . . . . 73.120000000000005 108.301 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.11 92.31 0.21 Allowed 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.303 1.335 . . . . 74.120000000000005 112.389 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -143.76 -55.1 0.37 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 105.735 -1.95 . . . . 71.219999999999999 105.735 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HB1' ' H ' ' A' ' 19' ' ' ALA . . . -149.89 97.54 2.6 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.311 -1.737 . . . . 71.109999999999999 106.311 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 . . . . . 0 C--N 1.288 -2.092 0 CA-C-O 121.466 0.65 . . . . 73.310000000000002 109.381 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.422 -1.855 0 CA-C-O 122.108 0.956 . . . . 65.329999999999998 111.264 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -89.76 -35.3 15.81 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.883 -1.508 . . . . 73.299999999999997 108.974 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.63 89.18 7.08 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.378 -1.342 . . . . 73.430000000000007 107.378 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.23 -15.24 8.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.74 -0.664 . . . . 74.510000000000005 111.03 -175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.05 -31.98 18.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.275 -1.38 . . . . 71.219999999999999 107.275 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 25.01 11.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.604 -1.18 . . . . 72.319999999999993 110.122 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.2 126.66 88.2 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 75.420000000000002 109.401 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.21 143.46 44.05 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.901 1.734 . . . . 63.219999999999999 111.473 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 14.9 ptmm? -82.28 158.79 23.33 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.948 -0.39 . . . . 74.340000000000003 109.948 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -132.57 151.54 51.9 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.295 0.569 . . . . 65.319999999999993 111.963 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -101.34 -44.96 5.48 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.264 -2.124 . . . . 73.540000000000006 105.264 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.45 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 8.5 ptp180 -129.93 163.2 26.91 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 110.18 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.08 -32.12 73.57 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.886 -1.052 . . . . 73.540000000000006 110.815 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -72.72 -4.72 33.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.129 -0.941 . . . . 64.109999999999999 112.969 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 69.5 m-20 -77.71 -23.25 49.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.467 0.651 . . . . 70.510000000000005 109.45 172.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.2 m -104.96 127.37 28.89 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 108.656 -0.868 . . . . 73.219999999999999 108.656 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -100.52 -175.65 0.14 Allowed 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.413 2.076 . . . . 72.450000000000003 113.27 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.64 -108.9 2.63 Favored Glycine 0 CA--C 1.489 -1.545 0 CA-C-N 115.025 -0.989 . . . . 72.549999999999997 113.463 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' GLU . . . -115.23 0.24 13.46 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.174 0.512 . . . . 72.310000000000002 109.969 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 72.2 m -91.99 139.87 30.22 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 122.03 0.919 . . . . 71.140000000000001 111.826 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.79 179.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 113.883 -1.508 . . . . 72.519999999999996 107.065 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.8 t -95.51 104.94 16.86 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.198 -1.038 . . . . 51.229999999999997 108.198 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 74.3 mtp180 -79.96 170.16 16.86 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.453 -0.34 . . . . 74.430000000000007 110.893 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.52 -2.31 27.12 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 115.933 -0.576 . . . . 64.129999999999995 114.011 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' A' ' 27' ' ' TYR . 32.1 p-10 -88.89 -19.19 26.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.826 -0.805 . . . . 71.019999999999996 108.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.07 32.33 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 110.939 -0.864 . . . . 74.540000000000006 110.939 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 73.9 m-85 -129.31 157.59 41.47 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.085 -0.558 . . . . 73.319999999999993 110.808 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.37 133.86 47.33 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.244 -0.889 . . . . 74.340000000000003 109.827 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.57 135.69 4.61 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.403 -1.079 . . . . 72.329999999999998 110.403 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 41.8 tt0 -51.36 139.0 20.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.263 1.03 . . . . 74.409999999999997 112.112 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.28 -62.43 1.66 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.873 -1.512 . . . . 70.420000000000002 110.549 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -131.04 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.016 -2.216 . . . . 64.319999999999993 105.016 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -59.93 107.79 0.67 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 123.888 0.742 . . . . 74.129999999999995 110.674 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 -166.22 1.21 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.933 0.716 . . . . 63.219999999999999 112.933 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.16 147.96 83.63 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-N 115.38 -0.827 . . . . 72.239999999999995 110.122 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.25 121.32 8.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.151 2.568 . . . . 64.510000000000005 114.534 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -150.31 -63.17 0.2 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.877 -2.268 . . . . 75.099999999999994 104.877 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.35 95.7 2.76 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.674 -1.602 . . . . 63.32 106.674 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 106.14 -1.8 . . . . 73.439999999999998 106.14 177.633 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.41 -2.452 0 N-CA-C 107.859 -1.163 . . . . 73.340000000000003 107.859 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.465 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 38.3 mt-10 -141.89 -170.03 3.04 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.644 -2.354 . . . . 70.409999999999997 104.644 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.57 83.47 4.12 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.934 -0.707 . . . . 73.030000000000001 109.396 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.41 -62.38 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.318 -0.993 . . . . 71.519999999999996 108.318 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -88.81 -32.78 17.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.813 -1.18 . . . . 72.209999999999994 107.813 -176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.35 160.02 7.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.245 -1.391 . . . . 73.230000000000004 107.245 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.92 113.43 40.47 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.27 -0.641 . . . . 54.520000000000003 109.27 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -86.8 101.0 0.55 Allowed 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 121.801 1.667 . . . . 74.5 112.112 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -84.09 157.48 21.73 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.246 -0.65 . . . . 65.129999999999995 109.246 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.575 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -140.22 148.04 40.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.319 0.581 . . . . 64.340000000000003 112.063 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -105.42 -40.86 5.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.792 -1.929 . . . . 74.140000000000001 105.792 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -139.11 166.28 24.92 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 114.295 -1.32 . . . . 75.439999999999998 110.987 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.94 -33.85 72.45 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 123.774 0.83 . . . . 74.129999999999995 110.951 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -65.18 -21.44 66.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.868 -1.06 . . . . 64.329999999999998 112.293 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.31 0.576 . . . . 60.409999999999997 110.357 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.49 133.72 30.75 Favored Pre-proline 0 N--CA 1.422 -1.857 0 CA-C-N 115.341 -0.845 . . . . 73.129999999999995 111.008 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.42 177.35 8.63 Favored 'Trans proline' 0 C--O 1.257 1.465 0 C-N-CA 122.804 2.336 . . . . 74.239999999999995 112.76 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.99 -130.58 47.82 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 110.127 -1.189 . . . . 64.030000000000001 110.127 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.97 9.57 22.23 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 109.096 -0.705 . . . . 73.319999999999993 109.096 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.64 148.63 50.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.018 -0.537 . . . . 73.540000000000006 111.208 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -116.9 174.72 3.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 108.951 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.76 121.47 31.94 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 108.021 -1.103 . . . . 75.109999999999999 108.021 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -91.4 158.6 16.42 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.611 -0.885 . . . . 74.109999999999999 108.611 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.73 0.28 28.78 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.744 -0.662 . . . . 71.349999999999994 113.666 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -88.5 -19.68 26.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.12 0.486 . . . . 72.430000000000007 109.709 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.32 25.01 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 111.303 -0.719 . . . . 51.340000000000003 111.303 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -118.71 160.65 21.46 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 123.437 0.695 . . . . 74.200000000000003 111.494 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.8 m -80.39 139.61 36.43 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.989 -1.005 . . . . 74.340000000000003 110.336 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.3 157.41 28.3 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.831 -1.308 . . . . 71.25 109.831 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 10.1 tp10 -73.6 158.81 34.09 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.897 -0.779 . . . . 72.510000000000005 108.897 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.93 -39.01 61.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.945 -1.131 . . . . 72.510000000000005 107.945 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 37.6 mm -82.34 140.2 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.247 -1.761 . . . . 71.109999999999999 106.247 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.32 -37.89 60.52 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.284 0.564 . . . . 71.129999999999995 110.354 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.7 84.65 5.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.025 -0.534 . . . . 73.329999999999998 110.792 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.46 121.08 81.08 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.844 -0.616 . . . . 74.349999999999994 110.213 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.39 -42.04 66.05 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.655 2.903 . . . . 71.329999999999998 114.674 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -150.68 -47.16 0.12 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.775 -0.454 . . . . 73.450000000000003 109.775 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.64 67.09 2.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.848 0.832 . . . . 73.0 110.852 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 2' ' ' GLU . 65.9 mtt180 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-N 114.089 -1.414 . . . . 73.430000000000007 109.916 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.268 -1.382 . . . . 63.140000000000001 107.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 15.9 mt-10 -91.4 176.86 6.41 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 112.877 -1.965 . . . . 73.120000000000005 110.174 -169.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -161.61 150.63 15.98 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 106.777 -1.564 . . . . 73.030000000000001 106.777 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.1 -25.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-O 121.094 0.474 . . . . 70.219999999999999 110.128 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -88.84 -44.49 10.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.896 -0.779 . . . . 65.439999999999998 108.896 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -133.18 88.58 2.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.709 -0.678 . . . . 75.329999999999998 110.338 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 132.83 60.89 Favored Pre-proline 0 C--N 1.297 -1.677 0 CA-C-N 115.894 -0.594 . . . . 72.120000000000005 110.962 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.36 123.27 10.64 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.18 1.92 . . . . 60.229999999999997 109.396 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 62.0 pttt -82.26 163.76 21.62 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.065 -0.654 . . . . 74.219999999999999 111.234 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.1 p -150.99 157.39 42.83 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.197 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 2.8 mmp_? -116.68 -33.91 4.69 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.092 -1.077 . . . . 74.010000000000005 108.092 170.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.79 158.81 32.44 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.074 -0.967 . . . . 75.420000000000002 110.137 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -61.47 -30.87 70.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.118 -0.946 . . . . 70.129999999999995 111.533 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -71.78 -10.92 60.49 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.909 0.707 . . . . 60.119999999999997 112.909 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.24 -12.97 61.05 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.391 0.615 . . . . 71.430000000000007 109.581 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.3 m -110.92 126.71 28.18 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.603 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -84.9 168.85 10.61 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.67 2.247 . . . . 55.310000000000002 113.672 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.58 -126.17 40.47 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.273 -0.876 . . . . 73.140000000000001 113.522 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.12 13.3 29.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.068 -0.566 . . . . 70.219999999999999 110.881 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.87 151.13 25.29 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.898 -0.778 . . . . 75.299999999999997 108.898 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 44.1 pt -129.26 172.83 14.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.357 -1.349 . . . . 74.209999999999994 107.357 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.0 t -92.04 111.08 22.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.274 -1.38 . . . . 72.540000000000006 107.274 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.3 mmm180 -77.95 164.22 25.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.475 -0.565 . . . . 73.219999999999999 109.475 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.32 1.34 20.07 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 116.172 -0.467 . . . . 54.420000000000002 114.129 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.7 p-10 -89.81 -21.38 22.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.084 -0.709 . . . . 74.439999999999998 109.084 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.93 15.17 19.09 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.573 -0.74 . . . . 74.109999999999999 111.381 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 92.9 m-85 -131.59 150.16 52.25 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 122.863 0.465 . . . . 75.549999999999997 110.858 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.67 124.17 22.11 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.688 -0.687 . . . . 75.420000000000002 111.248 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.97 163.88 27.62 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.227 -1.149 . . . . 73.239999999999995 110.227 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 32' ' ' ILE . 42.1 tt0 -62.02 152.91 31.14 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.425 0.631 . . . . 73.409999999999997 110.992 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . . . -77.45 -23.35 50.49 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.341 -0.845 . . . . 73.010000000000005 112.397 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.514 HG21 ' H ' ' A' ' 34' ' ' ALA . 39.2 mt -72.98 148.91 8.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.612 -0.722 . . . . 75.530000000000001 109.165 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -88.27 -10.44 49.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.198 0.523 . . . . 71.540000000000006 111.357 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' H ' HG21 ' A' ' 32' ' ' ILE . . . -76.96 -176.94 4.16 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.616 -0.883 . . . . 72.319999999999993 108.616 174.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.17 119.7 51.51 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.682 -0.488 . . . . 72.0 109.682 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 56.1 Cg_exo -56.14 155.5 23.87 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.467 2.778 . . . . 73.230000000000004 112.909 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.53 -13.38 37.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.878 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' A' ' 2' ' ' GLU . . . 70.13 61.39 0.24 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.332 1.053 . . . . 73.239999999999995 109.439 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 . . . . . 0 CA--C 1.495 -1.15 0 CA-C-N 113.863 -1.517 . . . . 73.129999999999995 111.258 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.7 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -146.76 148.84 32.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.287 -0.635 . . . . 73.319999999999993 109.287 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 6' ' ' ALA . . . -168.56 145.75 3.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.671 -1.974 . . . . 71.099999999999994 105.671 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.4 -30.48 4.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 112.278 0.473 . . . . 73.439999999999998 112.278 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -87.89 -41.22 13.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.617 -0.833 . . . . 74.230000000000004 109.29 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -125.42 83.66 2.19 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 114.969 -1.014 . . . . 72.430000000000007 110.288 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.96 119.36 76.39 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.083 -0.71 . . . . 73.450000000000003 109.083 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.95 104.82 0.87 Allowed 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.908 2.405 . . . . 72.439999999999998 114.275 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -85.06 154.23 22.21 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.191 -0.913 . . . . 74.0 108.547 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.0 p -127.62 148.91 50.38 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.034 0.445 . . . . 65.030000000000001 111.186 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -112.02 -39.33 4.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.119 -1.808 . . . . 72.319999999999993 106.119 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -127.48 157.04 41.13 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.189 -1.369 . . . . 74.140000000000001 109.422 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.73 -29.12 70.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.394 0.678 . . . . 64.310000000000002 111.728 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.8 p -63.68 -23.05 67.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.239 -0.891 . . . . 73.099999999999994 111.866 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.485 0.66 . . . . 75.140000000000001 110.3 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 m -105.39 110.46 64.36 Favored Pre-proline 0 N--CA 1.401 -2.892 0 CA-C-N 115.384 -0.826 . . . . 72.129999999999995 109.879 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.84 178.84 6.52 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.517 2.145 . . . . 73.400000000000006 112.733 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.27 -111.87 4.52 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.989 -0.551 . . . . 70.340000000000003 112.997 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.51 16.18 9.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.845 -0.798 . . . . 74.409999999999997 108.845 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.95 144.4 29.19 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.179 -0.919 . . . . 73.310000000000002 109.867 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.2 pt -122.29 174.12 7.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.945 -1.502 . . . . 74.209999999999994 106.945 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.41 108.47 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.777 -1.194 . . . . 72.310000000000002 107.777 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 70.5 mtp180 -82.17 165.92 20.09 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 116.127 -0.488 . . . . 71.209999999999994 111.128 -177.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.85 -4.24 57.9 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 115.77 -0.65 . . . . 72.129999999999995 112.925 -177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 36.7 p-10 -89.05 -14.8 35.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 15.47 38.88 Favored Glycine 0 CA--C 1.493 -1.3 0 CA-C-N 115.479 -0.782 . . . . 73.400000000000006 111.183 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -124.14 154.38 40.11 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 123.482 0.713 . . . . 71.120000000000005 111.532 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.31 118.71 22.2 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.796 -1.093 . . . . 74.030000000000001 110.211 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.09 160.43 28.33 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.816 -1.183 . . . . 73.25 111.008 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.62 155.51 29.54 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.491 -0.559 . . . . 73.409999999999997 109.491 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.35 26.44 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.189 -0.46 . . . . 72.219999999999999 110.836 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.35 138.01 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 106.685 -1.598 . . . . 74.230000000000004 106.685 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -99.24 82.95 2.77 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 111.446 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.54 -85.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.229 -0.896 . . . . 65.439999999999998 108.966 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.79 117.55 68.7 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.564 -0.902 . . . . 72.239999999999995 108.564 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.44 121.07 6.86 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.581 1.521 . . . . 73.420000000000002 111.023 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -112.68 -54.32 2.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.628 -1.249 . . . . 74.319999999999993 107.628 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.3 87.71 0.91 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.925 -1.034 . . . . 74.120000000000005 109.424 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.301 -1.527 0 CA-C-N 114.966 -1.016 . . . . 75.349999999999994 111.063 178.058 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 18' ' ' GLY . 1.8 p . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 116.055 1.872 . . . . 74.040000000000006 116.055 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.29 178.72 5.89 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.378 -1.341 . . . . 75.409999999999997 107.378 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.86 98.23 0.4 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.559 0.695 . . . . 74.200000000000003 109.165 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.8 mt -111.69 -66.52 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 114.815 -1.084 . . . . 74.430000000000007 108.795 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -88.38 -37.2 16.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.245 -1.343 . . . . 75.120000000000005 108.636 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -145.79 143.39 29.65 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.054 -1.43 . . . . 62.240000000000002 109.037 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.74 104.86 3.05 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 123.833 0.708 . . . . 72.519999999999996 109.196 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 2.8 Cg_endo -83.78 117.04 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.455 2.103 . . . . 74.430000000000007 110.823 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.73 155.23 26.83 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.676 -0.49 . . . . 73.25 109.676 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 14.6 p -144.52 162.86 35.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.169 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -123.07 -41.06 2.35 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.247 -1.39 . . . . 71.019999999999996 107.247 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -119.48 154.23 34.1 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.234 -1.348 . . . . 75.319999999999993 109.514 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.13 -28.16 67.91 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.978 0.894 . . . . 71.219999999999999 111.14 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 p -68.6 -11.95 60.7 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.464 -1.243 . . . . 71.109999999999999 113.19 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -69.06 -24.8 64.21 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.056 -0.72 . . . . 70.5 109.056 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -95.71 121.5 61.19 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 115.443 -0.799 . . . . 74.400000000000006 109.962 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -85.11 -167.27 0.4 Allowed 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.101 2.534 . . . . 62.310000000000002 112.375 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 1' ' ' CYS . . . 64.48 -111.99 4.63 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.237 -0.745 . . . . 64.209999999999994 111.237 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.64 19.43 3.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.584 -1.265 . . . . 64.239999999999995 107.584 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.78 153.62 20.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.952 -1.022 . . . . 75.400000000000006 111.946 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.15 175.13 5.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.214 -0.903 . . . . 71.299999999999997 109.911 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.04 110.71 23.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.853 -0.795 . . . . 64.319999999999993 108.853 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -82.65 169.98 15.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.075 0.464 . . . . 74.299999999999997 111.405 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.62 -1.76 46.89 Favored Glycine 0 N--CA 1.464 0.514 0 CA-C-N 115.734 -0.666 . . . . 73.409999999999997 113.433 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -89.03 -15.19 34.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.786 -0.82 . . . . 75.209999999999994 108.786 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.54 15.54 34.41 Favored Glycine 0 CA--C 1.481 -2.056 0 N-CA-C 111.292 -0.723 . . . . 53.100000000000001 111.292 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.76 156.4 42.5 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.719 -0.741 . . . . 74.549999999999997 110.705 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 72.6 m -79.87 141.18 36.37 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 109.383 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.13 168.55 33.04 Favored Glycine 0 N--CA 1.407 -3.246 0 N-CA-C 109.271 -1.532 . . . . 72.319999999999993 109.271 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.32 162.05 18.32 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.627 -0.508 . . . . 71.299999999999997 109.627 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.64 64.89 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.566 0.698 . . . . 63.350000000000001 109.784 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.53 140.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 106.559 -1.645 . . . . 73.230000000000004 106.559 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -81.22 -32.15 33.55 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.164 0.506 . . . . 74.519999999999996 110.042 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.1 87.48 2.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.962 -1.125 . . . . 73.439999999999998 107.962 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 126.75 84.19 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.372 -0.831 . . . . 71.140000000000001 112.01 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.25 -36.92 79.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.782 2.988 . . . . 74.010000000000005 112.621 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -135.79 -79.92 0.42 Allowed 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.739 -1.208 . . . . 74.129999999999995 107.739 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 168.29 88.95 0.0 OUTLIER 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.87 1.268 . . . . 60.310000000000002 109.534 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 . . . . . 0 C--N 1.308 -1.231 0 CA-C-O 119.316 -0.373 . . . . 75.329999999999998 110.153 170.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.399 -2.985 0 N-CA-C 103.382 -2.822 . . . . 75.219999999999999 103.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.7 -31.39 19.74 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.65 -0.87 . . . . 73.409999999999997 108.65 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.39 93.41 9.31 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.455 -0.942 . . . . 75.519999999999996 108.455 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.19 -33.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 75.099999999999994 109.032 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -88.83 -43.12 11.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.66 -1.237 . . . . 75.120000000000005 107.66 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.19 35.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.196 -1.365 . . . . 74.319999999999993 108.733 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 153.0 84.83 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.17 -1.377 . . . . 71.319999999999993 110.369 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.47 161.9 31.06 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.921 1.747 . . . . 74.219999999999999 109.856 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -80.7 145.09 31.77 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.83 -0.434 . . . . 73.519999999999996 109.83 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.4 p -121.35 148.03 44.91 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.828 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -109.22 -32.46 7.19 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 73.25 107.155 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.95 160.02 42.0 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 125.395 1.478 . . . . 74.329999999999998 108.528 172.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -59.23 -37.43 77.51 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.962 0.887 . . . . 74.129999999999995 110.549 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -68.33 -17.39 64.25 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.348 -1.296 . . . . 60.210000000000001 113.75 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -91.04 6.25 45.61 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.914 -1.114 . . . . 75.299999999999997 111.734 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.0 m -89.23 145.26 33.81 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 120.719 -0.392 . . . . 70.340000000000003 110.74 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.82 132.56 52.47 Favored 'Trans proline' 0 C--O 1.257 1.453 0 C-N-CA 123.373 2.715 . . . . 73.349999999999994 113.019 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.71 -106.94 1.72 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.801 -1.09 . . . . 60.350000000000001 112.563 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.07 16.9 5.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.545 -0.168 . . . . 64.409999999999997 110.545 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.69 150.34 41.29 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.0 pt -104.07 170.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.875 -0.416 . . . . 71.230000000000004 109.875 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.3 t -98.24 122.75 41.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.04 -1.096 . . . . 65.329999999999998 108.04 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mtm-85 -88.72 166.67 13.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.916 -0.401 . . . . 74.540000000000006 109.916 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.5 -7.57 41.0 Favored Glycine 0 N--CA 1.467 0.715 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 113.831 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 33.5 p-10 -89.18 -24.84 22.07 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 122.548 -0.383 . . . . 71.430000000000007 110.057 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.92 9.71 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.609 -0.805 . . . . 74.430000000000007 111.547 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 70.8 m-85 -125.32 155.91 39.49 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.729 -0.841 . . . . 73.409999999999997 108.729 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.3 m -80.26 153.06 28.74 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.816 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.46 -179.7 33.51 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-O 119.189 -0.784 . . . . 72.120000000000005 111.34 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.07 150.12 30.35 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.268 0.627 . . . . 65.040000000000006 110.125 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.14 32.87 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.369 -0.832 . . . . 64.409999999999997 110.333 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.3 mt -139.59 128.63 28.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.087 -1.82 . . . . 72.0 106.087 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -87.72 87.22 7.31 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 121.589 0.709 . . . . 74.439999999999998 111.599 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.67 -92.4 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.383 -1.34 . . . . 75.430000000000007 107.383 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.65 60.18 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.392 -1.336 . . . . 74.420000000000002 107.392 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.12 110.83 2.07 Favored 'Trans proline' 0 C--O 1.249 1.052 0 N-CA-C 108.579 -1.354 . . . . 75.109999999999999 108.579 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -109.15 -65.93 1.1 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.324 0.583 . . . . 75.310000000000002 111.592 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.26 38.63 2.16 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.77 -1.196 . . . . 63.0 107.77 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 CA--C 1.489 -1.38 0 C-N-CA 126.562 1.945 . . . . 64.430000000000007 115.481 -169.499 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 101.683 -3.451 . . . . 64.319999999999993 101.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -137.87 155.16 49.25 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.605 -0.725 . . . . 63.219999999999999 111.996 -163.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.82 132.54 5.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.874 -2.269 . . . . 71.129999999999995 104.874 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 mm -96.48 -20.44 5.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 120.875 0.369 . . . . 73.340000000000003 111.533 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -88.25 -41.41 12.95 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.576 -0.85 . . . . 74.450000000000003 108.9 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.91 102.82 3.01 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.979 -0.749 . . . . 74.099999999999994 108.979 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 134.42 57.53 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 116.601 -0.272 . . . . 73.299999999999997 110.402 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.12 119.4 6.57 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.796 2.331 . . . . 72.209999999999994 112.277 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.77 157.81 17.79 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.45 -0.945 . . . . 75.430000000000007 108.45 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.8 p -136.88 142.01 42.78 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.398 0.618 . . . . 71.430000000000007 111.478 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.9 -32.52 7.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.645 -1.613 . . . . 72.409999999999997 106.645 171.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -140.02 161.5 37.47 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.705 -1.589 . . . . 71.349999999999994 108.651 174.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.54 -29.54 70.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.561 -0.745 . . . . 72.340000000000003 111.864 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -69.54 -15.56 63.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.847 -0.615 . . . . 65.200000000000003 112.57 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.504 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m-20 -68.41 -22.55 64.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.451 0.643 . . . . 64.519999999999996 110.007 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -89.83 123.54 66.03 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-N 115.351 -0.84 . . . . 61.409999999999997 111.513 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.23 -179.81 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.979 2.453 . . . . 74.230000000000004 112.077 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.83 -123.82 34.34 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 112.311 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 31' ' ' ALA . . . -113.04 10.44 18.78 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.005 -0.739 . . . . 64.439999999999998 109.005 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 m -71.08 146.68 49.13 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.675 -0.693 . . . . 73.349999999999994 110.614 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 22.9 pt -127.12 171.41 15.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.901 -0.777 . . . . 71.349999999999994 108.901 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.7 115.02 26.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.077 0.465 . . . . 71.200000000000003 109.781 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -86.3 167.76 14.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 109.899 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.42 -2.23 54.13 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 113.403 -174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -89.96 -17.55 27.72 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.761 0.315 . . . . 72.140000000000001 111.024 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.53 27.16 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.717 -0.953 . . . . 72.510000000000005 110.717 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -126.3 154.99 42.67 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 124.452 1.101 . . . . 75.329999999999998 109.988 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 74.4 m -80.19 126.2 30.81 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 72.230000000000004 109.839 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.46 -178.97 15.57 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.139 -1.185 . . . . 73.430000000000007 110.139 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.0 tp10 -66.17 156.19 34.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.873 0.336 . . . . 72.019999999999996 110.271 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . -80.59 -53.39 6.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.37 0.605 . . . . 73.219999999999999 111.482 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -115.66 150.31 17.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.05 -0.977 . . . . 74.219999999999999 109.704 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -82.41 136.76 34.88 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.489 -0.93 . . . . 74.5 108.489 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 69.82 24.64 5.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.422 1.089 . . . . 75.209999999999994 110.15 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.94 166.49 42.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.444 -0.798 . . . . 61.149999999999999 110.77 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -42.09 -50.21 5.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.97 3.113 . . . . 72.209999999999994 115.2 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -96.87 -38.09 9.98 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.131 -0.628 . . . . 74.400000000000006 109.84 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . . . 72.6 14.99 5.06 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 125.113 1.365 . . . . 73.340000000000003 111.488 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-N 114.324 -1.307 . . . . 73.349999999999994 109.871 -176.407 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 122.019 0.914 . . . . 74.319999999999993 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.42 ' CD ' ' HD2' ' A' ' 39' ' ' ARG . 6.0 pt-20 -97.71 161.64 13.66 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.713 -1.13 . . . . 71.120000000000005 110.503 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.0 120.07 30.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 106.422 -1.696 . . . . 73.25 106.422 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.45 -29.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-N 114.734 -1.121 . . . . 62.530000000000001 112.228 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.8 -42.23 12.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.137 -1.06 . . . . 74.430000000000007 108.137 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.26 78.62 1.77 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.982 -1.008 . . . . 73.099999999999994 108.403 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.98 117.2 12.01 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.253 -0.885 . . . . 71.349999999999994 111.758 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 3' ' ' ALA . 34.0 Cg_endo -89.87 108.79 0.4 Allowed 'Trans proline' 0 N--CA 1.429 -2.289 0 C-N-CA 122.458 2.105 . . . . 74.310000000000002 111.806 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.6 pttm -88.7 145.6 25.55 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.572 -0.529 . . . . 75.400000000000006 109.572 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.6 p -127.38 154.55 44.86 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.826 0.822 . . . . 70.019999999999996 111.598 -173.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -115.22 -35.25 4.73 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.089 -1.448 . . . . 71.349999999999994 107.089 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -130.57 158.45 39.95 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.306 -1.315 . . . . 75.319999999999993 110.103 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.71 -34.33 76.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.626 0.726 . . . . 70.209999999999994 110.679 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -67.01 -6.41 16.9 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.502 -1.226 . . . . 74.540000000000006 113.212 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.7 -40.46 92.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.285 0.564 . . . . 73.510000000000005 109.523 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 79.2 m -131.71 98.34 18.02 Favored Pre-proline 0 N--CA 1.409 -2.479 0 N-CA-C 107.836 -1.172 . . . . 72.310000000000002 107.836 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.75 -166.21 0.39 Allowed 'Trans proline' 0 C--O 1.261 1.667 0 C-N-CA 122.896 2.397 . . . . 72.049999999999997 115.291 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.74 -111.22 4.0 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 113.933 -1.485 . . . . 50.140000000000001 112.762 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 -14.93 36.79 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.15 -0.525 . . . . 70.319999999999993 111.426 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.91 155.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.316 -0.554 . . . . 73.340000000000003 110.951 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.7 pt -131.9 179.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.401 -0.963 . . . . 65.230000000000004 108.401 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.4 t -101.28 126.55 48.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.318 -1.364 . . . . 74.200000000000003 107.318 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 41.4 mtt180 -91.25 165.81 13.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.796 -0.446 . . . . 71.329999999999998 109.796 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -5.92 66.76 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.71 -0.677 . . . . 74.299999999999997 112.491 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.577 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.5 p-10 -88.3 -11.69 45.69 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.908 -0.775 . . . . 72.409999999999997 108.908 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.42 42.49 Favored Glycine 0 CA--C 1.488 -1.601 0 CA-C-N 115.598 -0.728 . . . . 64.519999999999996 111.298 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 60.7 m-85 -125.14 157.03 37.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.496 0.718 . . . . 72.299999999999997 110.285 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.8 m -79.98 166.53 21.5 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.733 0.301 . . . . 62.420000000000002 110.414 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.55 -176.16 44.18 Favored Glycine 0 CA--C 1.486 -1.762 0 C-N-CA 120.172 -1.013 . . . . 52.450000000000003 112.488 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.75 154.92 20.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.347 0.674 . . . . 74.549999999999997 109.95 176.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.92 16.54 1.43 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.961 0.905 . . . . 75.420000000000002 112.356 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.93 129.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.509 -1.663 . . . . 72.209999999999994 106.509 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -90.64 -21.78 21.51 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 115.62 -0.718 . . . . 74.439999999999998 111.483 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.03 -166.54 1.52 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.128 -1.064 . . . . 73.239999999999995 108.128 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.65 114.76 15.74 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 109.893 -0.41 . . . . 71.5 109.893 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.26 -173.99 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.666 2.244 . . . . 74.109999999999999 111.43 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -148.25 -59.93 0.25 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.039 -1.097 . . . . 74.25 108.039 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.53 78.84 7.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.819 -0.628 . . . . 73.329999999999998 109.943 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.42 ' HD2' ' CD ' ' A' ' 2' ' ' GLU . 80.0 mtm180 . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.927 -0.579 . . . . 73.25 109.987 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.388 0.613 . . . . 75.109999999999999 109.775 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.06 175.31 7.45 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.779 -1.101 . . . . 72.129999999999995 109.118 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.91 8.67 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.635 -1.246 . . . . 73.450000000000003 107.635 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.66 -26.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.735 -0.666 . . . . 72.439999999999998 110.596 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -88.06 -40.8 13.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.456 0.646 . . . . 73.519999999999996 109.709 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.63 87.85 1.66 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.044 -0.98 . . . . 73.140000000000001 109.62 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.07 135.45 96.32 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.296 -0.865 . . . . 74.530000000000001 111.459 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.12 122.2 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.465 2.11 . . . . 70.329999999999998 111.348 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 50.9 mtpt -76.58 145.98 38.62 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.845 -0.428 . . . . 73.340000000000003 109.845 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.6 p -117.82 146.85 43.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.645 0.259 . . . . 54.409999999999997 110.764 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.38 -45.08 4.16 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.79 -1.559 . . . . 72.540000000000006 106.79 172.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -136.66 155.26 50.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.04 -1.436 . . . . 74.150000000000006 109.309 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' OD2' ' HB ' ' A' ' 21' ' ' ILE . 2.9 m-20 -58.43 -35.01 71.45 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 123.698 0.799 . . . . 70.420000000000002 111.023 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -67.31 -16.26 64.16 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.29 1.218 . . . . 63.329999999999998 114.29 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -90.25 -4.14 57.37 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.289 -0.964 . . . . 72.25 111.549 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.93 137.41 28.25 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 115.791 -0.64 . . . . 63.049999999999997 110.012 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.0 122.27 6.03 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 124.18 3.254 . . . . 70.340000000000003 114.525 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.61 -119.25 17.57 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.131 -0.94 . . . . 74.219999999999999 112.914 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.93 10.54 36.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.316 -0.442 . . . . 72.150000000000006 110.866 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.54 146.8 52.96 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.125 -0.694 . . . . 71.219999999999999 109.125 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' OD2' ' A' ' 13' ' ' ASP . 36.0 pt -111.67 167.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.007 0.432 . . . . 75.099999999999994 111.0 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.19 105.1 17.39 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.564 -1.273 . . . . 74.140000000000001 107.564 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.96 165.16 22.89 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.01 0.433 . . . . 72.230000000000004 111.546 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.38 48.2 Favored Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.381 -0.827 . . . . 74.040000000000006 113.743 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -88.18 -15.47 35.92 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.987 -0.746 . . . . 74.010000000000005 108.987 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.39 10.83 37.67 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 111.037 -0.825 . . . . 65.310000000000002 111.037 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 71.4 m-85 -124.69 151.75 44.58 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 121.44 0.638 . . . . 73.049999999999997 110.686 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.631 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.7 m -74.19 147.22 42.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.464 -0.789 . . . . 64.430000000000007 109.271 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.15 159.68 32.26 Favored Glycine 0 CA--C 1.472 -2.637 0 N-CA-C 110.321 -1.112 . . . . 72.140000000000001 110.321 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -63.69 161.39 15.1 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.196 0.586 . . . . 74.030000000000001 110.007 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.25 42.69 0.27 Allowed 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.5 1.12 . . . . 71.010000000000005 111.398 -176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -93.13 130.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.98 -1.489 . . . . 64.239999999999995 106.98 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -99.68 -6.95 26.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.904 0.859 . . . . 74.040000000000006 110.334 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.8 -158.02 0.64 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.487 -1.233 . . . . 74.430000000000007 107.871 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.6 93.14 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.554 -0.165 . . . . 75.109999999999999 110.554 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.97 147.72 51.0 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.48 2.787 . . . . 71.140000000000001 112.808 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -109.59 -7.59 15.1 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.477 0.656 . . . . 71.209999999999994 109.391 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 70.91 70.77 0.19 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.707 1.203 . . . . 73.519999999999996 111.241 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 CA--C 1.476 -1.884 0 N-CA-C 106.719 -1.586 . . . . 73.129999999999995 106.719 174.615 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 113.269 0.841 . . . . 62.240000000000002 113.269 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -99.07 -55.39 2.71 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.27 -0.877 . . . . 71.230000000000004 110.277 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.85 142.92 13.95 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 106.394 -1.706 . . . . 61.32 106.394 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.69 -39.76 4.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 116.579 -0.282 . . . . 73.319999999999993 111.68 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -89.25 -41.19 12.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.178 -1.045 . . . . 75.409999999999997 108.178 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.453 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -87.46 136.98 32.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.737 -1.12 . . . . 73.030000000000001 109.463 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 108.66 12.04 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 123.373 0.42 . . . . 74.510000000000005 111.594 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 35.1 Cg_endo -89.4 123.89 1.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.332 2.021 . . . . 73.030000000000001 109.914 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.9 pttt -100.07 145.69 27.64 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.995 -0.682 . . . . 75.430000000000007 111.416 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.4 p -124.1 152.07 43.16 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.631 0.253 . . . . 74.519999999999996 110.876 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -110.2 -36.13 5.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.524 -1.658 . . . . 73.109999999999999 106.524 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -132.38 151.89 51.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.36 -1.291 . . . . 74.439999999999998 109.184 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.45 -40.9 88.35 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.951 0.881 . . . . 73.230000000000004 109.343 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 p -63.33 -18.46 63.65 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.649 -1.614 . . . . 55.229999999999997 114.47 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.305 2.6 p30 -78.91 -9.1 59.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 118.668 -1.213 . . . . 75.099999999999994 112.051 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -125.99 106.77 25.36 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.06 -168.2 0.49 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 123.412 2.741 . . . . 75.219999999999999 115.792 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.47 -128.32 32.78 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 113.85 -1.523 . . . . 70.120000000000005 112.167 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.65 6.58 46.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.417 -0.392 . . . . 75.400000000000006 110.87 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.5 m -93.72 147.85 22.65 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 111.98 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 pt -138.0 177.06 5.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 114.052 -1.431 . . . . 71.109999999999999 107.97 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -97.9 124.63 42.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.565 -0.902 . . . . 71.340000000000003 108.565 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 1.6 mmp_? -98.01 167.77 10.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 O-C-N 122.193 -0.317 . . . . 73.510000000000005 110.765 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.26 -9.14 56.98 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 114.424 0.53 . . . . 75.439999999999998 114.424 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -88.84 -17.57 29.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.45 0.643 . . . . 71.329999999999998 109.398 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.26 17.83 23.5 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.888 -0.885 . . . . 52.450000000000003 110.888 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 70.9 m-85 -121.08 151.98 39.21 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.165 0.507 . . . . 71.329999999999998 111.938 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.5 m -79.49 109.76 14.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.169 -0.923 . . . . 71.319999999999993 109.674 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.79 163.63 12.78 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 109.112 -1.595 . . . . 61.049999999999997 109.112 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -80.27 166.36 21.44 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.744 -1.576 . . . . 63.340000000000003 106.744 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.38 74.07 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.864 0.364 . . . . 64.25 110.259 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.73 -62.01 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-O 121.319 0.58 . . . . 75.129999999999995 110.912 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -87.38 95.62 10.07 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 115.261 -0.882 . . . . 74.439999999999998 112.848 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.15 -22.6 18.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.358 -0.837 . . . . 72.450000000000003 110.939 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.95 156.09 84.44 Favored Pre-proline 0 C--O 1.254 1.298 0 CA-C-N 115.651 -0.704 . . . . 71.219999999999999 109.259 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.12 84.56 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.108 1.872 . . . . 71.109999999999999 111.321 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.4 -50.94 0.13 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 108.954 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.12 72.44 1.21 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.67 . . . . 71.510000000000005 112.274 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 28' ' ' CYS . 37.5 mtm180 . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 107.209 -1.404 . . . . 74.540000000000006 107.209 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.251 1.177 0 CA-C-O 121.523 0.678 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.05 135.06 33.59 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 155.59 38.07 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mt -103.97 -40.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 O-C-N 123.672 0.608 . . . . 0.0 110.798 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -89.39 -40.53 12.68 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.406 0.622 . . . . 0.0 110.501 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.47 49.53 1.2 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.389 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.67 122.87 86.4 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.387 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.43 120.32 5.88 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.047 1.831 . . . . 0.0 109.81 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.4 pttt -76.08 158.94 31.27 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.885 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.8 p -120.22 150.49 40.58 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.207 0.527 . . . . 0.0 111.823 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.411 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 73.5 mtm180 -110.92 -47.57 3.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.1 159.24 42.63 Favored 'General case' 0 CA--C 1.477 -1.857 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.085 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.63 -36.92 70.04 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.216 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 p -67.04 -27.65 67.57 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.539 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 11' ' ' ARG 0.281 1.7 p30 -86.46 10.31 15.57 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.618 178.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.2 m -93.63 136.68 23.81 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.541 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.43 152.7 71.16 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.621 2.881 . . . . 0.0 113.521 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 -114.52 6.93 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.507 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.96 15.27 7.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.04 153.87 20.53 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 pt -113.2 172.18 3.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.9 t -89.68 103.39 16.05 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -74.08 166.21 23.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.256 0.55 . . . . 0.0 111.512 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.94 -2.56 47.06 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.845 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -89.89 -17.05 28.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.79 31.42 Favored Glycine 0 CA--C 1.498 -0.991 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 85.4 m-85 -128.43 160.72 31.37 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.443 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.9 m -80.27 140.88 36.0 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.305 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.01 161.44 35.03 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 39' ' ' ARG . 9.2 tp10 -64.63 162.1 16.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.256 0.528 . . . . 0.0 109.846 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.79 -49.56 17.74 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mm -116.12 122.69 70.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -73.45 -29.97 62.89 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.26 0.552 . . . . 0.0 110.818 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.0 -28.15 65.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.577 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.67 111.16 23.64 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.392 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 5.4 Cg_exo -79.66 99.47 1.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.333 0 C-N-CA 121.077 1.184 . . . . 0.0 110.365 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -134.46 -75.73 0.47 Allowed 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 86.94 2.05 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.334 0.588 . . . . 0.0 110.82 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 84.1 mtp180 . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.927 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.631 -1.618 . . . . 64.129999999999995 106.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.07 139.87 30.35 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 113.72 -1.582 . . . . 74.420000000000002 109.041 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.52 130.18 6.61 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.63 -1.248 . . . . 73.099999999999994 107.63 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.64 -27.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 112.529 0.566 . . . . 74.010000000000005 112.529 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.63 -44.28 10.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.249 -0.907 . . . . 72.5 109.195 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.7 86.81 2.24 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.481 -0.781 . . . . 64.420000000000002 110.376 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.0 123.94 90.18 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.552 -0.749 . . . . 74.049999999999997 109.407 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.63 110.1 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 112.105 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 20.6 pttp -80.82 153.51 27.67 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 110.772 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 19.2 p -135.8 151.34 49.98 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.265 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -105.97 -36.64 6.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.249 -1.759 . . . . 75.109999999999999 106.249 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -136.5 161.41 35.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.659 -1.61 . . . . 74.400000000000006 109.916 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.46 -30.75 71.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.958 0.903 . . . . 65.409999999999997 111.494 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -69.18 -15.08 63.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.335 -0.848 . . . . 74.420000000000002 112.697 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -73.34 -16.0 61.37 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.358 -0.608 . . . . 72.140000000000001 109.358 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.59 123.62 47.33 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 109.015 -0.735 . . . . 70.010000000000005 109.015 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.8 -174.69 0.73 Allowed 'Trans proline' 0 C--O 1.258 1.475 0 C-N-CA 122.692 2.261 . . . . 75.319999999999993 112.716 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.89 -102.21 0.68 Allowed Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.34 -0.845 . . . . 75.310000000000002 112.411 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.74 11.72 2.69 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.242 0.544 . . . . 60.020000000000003 109.692 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.8 m -84.36 151.67 24.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.856 -0.611 . . . . 73.310000000000002 110.542 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.9 pt -118.09 171.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.219 -1.03 . . . . 72.109999999999999 108.219 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.1 t -94.52 107.63 19.61 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.424 -0.954 . . . . 71.319999999999993 108.424 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -73.32 166.44 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.166 -0.47 . . . . 73.439999999999998 110.65 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.21 -8.72 45.37 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 114.48 0.552 . . . . 62.439999999999998 114.48 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -89.25 -19.09 25.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.047 0.451 . . . . 73.329999999999998 109.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.77 23.41 10.88 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.078 -0.809 . . . . 74.409999999999997 111.078 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 74.6 m-85 -127.18 151.46 48.64 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 122.841 0.457 . . . . 74.409999999999997 110.768 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.4 m -79.53 128.37 33.29 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.58 -0.737 . . . . 73.209999999999994 111.434 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.25 168.64 35.26 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.598 -1.401 . . . . 71.299999999999997 109.598 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 8.9 tp10 -78.52 167.31 21.47 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.634 -0.876 . . . . 75.030000000000001 108.634 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.908 0.861 . . . . 73.019999999999996 109.166 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 57.6 mt -96.48 150.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 105.615 -1.994 . . . . 74.329999999999998 105.615 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -59.93 -59.32 5.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 111.32 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 123.05 41.08 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.959 -1.497 . . . . 72.209999999999994 106.959 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 39' ' ' ARG . . . -73.16 132.39 82.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 109.848 -0.427 . . . . 74.120000000000005 109.848 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.81 -45.09 41.52 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.419 2.746 . . . . 73.510000000000005 114.355 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -150.05 -50.81 0.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.996 -0.372 . . . . 73.209999999999994 109.996 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.68 70.76 6.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.722 0.772 . . . . 74.030000000000001 109.532 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.449 ' HG2' ' HB1' ' A' ' 35' ' ' ALA . 66.7 mtp180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-N 114.476 -1.238 . . . . 75.319999999999993 109.518 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.41 -2.474 0 N-CA-C 103.944 -2.613 . . . . 64.430000000000007 103.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -88.08 143.95 26.78 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 120.901 0.381 . . . . 74.230000000000004 109.996 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.59 36.33 3.56 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.404 -0.816 . . . . 74.349999999999994 110.109 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.11 -50.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.612 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.28 -34.82 12.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.798 0.809 . . . . 65.439999999999998 109.079 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.0 104.73 3.72 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.997 -1.456 . . . . 51.340000000000003 109.152 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.2 116.12 56.33 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 110.649 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.47 114.97 2.93 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.637 2.225 . . . . 73.530000000000001 111.859 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -89.68 159.62 17.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.357 -0.979 . . . . 71.340000000000003 108.357 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 18.7 p -152.26 158.78 43.3 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.266 0.555 . . . . 62.32 111.685 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -119.78 -35.83 3.43 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.311 -1.366 . . . . 74.010000000000005 107.311 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -125.75 156.82 38.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.585 -1.189 . . . . 73.450000000000003 109.287 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -63.16 -32.24 73.58 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.027 0.931 . . . . 74.030000000000001 110.971 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -65.83 -16.31 63.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.655 -1.157 . . . . 62.130000000000003 113.182 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.79 -14.51 59.56 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.137 0.494 . . . . 62.409999999999997 109.831 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.1 m -89.75 130.36 43.26 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.884 -0.598 . . . . 61.450000000000003 112.136 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.92 -179.75 5.5 Favored 'Trans proline' 0 C--O 1.27 2.123 0 C-N-CA 122.503 2.135 . . . . 74.400000000000006 112.112 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 -116.8 9.3 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.098 -0.956 . . . . 64.230000000000004 111.501 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.73 19.67 3.55 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.519 -0.919 . . . . 73.409999999999997 108.519 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.8 m -77.59 150.81 34.65 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.09 -0.959 . . . . 64.439999999999998 110.267 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -109.05 174.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.966 -0.753 . . . . 74.129999999999995 108.966 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.16 118.65 30.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.738 -0.838 . . . . 75.400000000000006 108.738 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -87.66 170.5 11.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.737 -0.21 . . . . 73.140000000000001 110.72 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.64 -6.59 50.88 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 114.347 0.499 . . . . 72.030000000000001 114.347 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -89.47 -17.71 28.16 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.935 0.398 . . . . 74.349999999999994 110.541 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 22.86 21.41 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.567 -1.013 . . . . 61.039999999999999 110.567 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.18 147.21 48.16 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 124.571 1.148 . . . . 75.040000000000006 110.746 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.6 m -81.07 139.44 35.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.855 -1.066 . . . . 73.239999999999995 112.167 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.5 147.24 12.37 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.491 -1.044 . . . . 71.319999999999993 110.491 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -72.59 161.78 30.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.745 -0.835 . . . . 74.120000000000005 108.745 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.56 74.19 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.615 0.766 . . . . 71.030000000000001 109.995 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.1 mt -118.6 135.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.225 0 N-CA-C 106.965 -1.494 . . . . 74.420000000000002 106.965 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -75.34 -33.78 61.15 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.003 0.43 . . . . 73.450000000000003 110.449 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.96 0.79 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.937 0.717 . . . . 75.209999999999994 112.937 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.47 124.04 87.18 Favored Pre-proline 0 C--O 1.212 -0.894 0 N-CA-C 108.953 -0.758 . . . . 72.420000000000002 108.953 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -50.97 -53.24 7.49 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.429 2.753 . . . . 74.519999999999996 115.138 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 39' ' ' ARG . 89.4 t80 -127.42 -26.14 3.09 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 111.866 0.321 . . . . 74.129999999999995 111.866 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.3 26.19 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.411 0.893 . . . . 73.200000000000003 113.411 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 37' ' ' PHE . 19.3 mtp180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-O 121.939 0.876 . . . . 75.25 112.087 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 121.408 0.623 . . . . 74.400000000000006 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -89.95 149.09 22.74 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.269 -0.878 . . . . 74.129999999999995 111.414 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 93.5 8.88 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.05 -0.977 . . . . 72.319999999999993 109.057 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.75 -63.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.659 -1.608 . . . . 75.010000000000005 106.659 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -99.19 -34.05 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -177.11 148.51 0.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.886 -1.506 . . . . 63.409999999999997 108.447 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 140.73 49.66 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.11 -0.7 . . . . 73.019999999999996 109.11 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.45 131.04 40.37 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 110.767 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.91 147.55 26.2 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.857 -0.424 . . . . 75.409999999999997 109.857 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.636 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.8 p -126.27 155.35 42.05 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 75.510000000000005 111.93 -175.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -120.45 -34.48 3.62 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.631 -1.248 . . . . 74.340000000000003 107.631 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -132.82 160.19 37.61 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.879 1.272 . . . . 75.400000000000006 108.803 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.59 -32.54 74.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.425 0.631 . . . . 75.109999999999999 110.717 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -68.38 -13.0 61.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.989 -1.005 . . . . 63.210000000000001 113.182 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.55 -28.41 62.82 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.687 -0.857 . . . . 64.099999999999994 108.687 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.2 m -89.82 132.78 35.52 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.827 -1.079 . . . . 71.099999999999994 109.397 -175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.14 139.9 17.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.302 2.001 . . . . 72.230000000000004 114.405 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.14 -102.68 0.13 Allowed Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 116.087 1.195 . . . . 74.129999999999995 116.087 172.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.79 -5.81 52.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.218 0.451 . . . . 71.099999999999994 112.218 -173.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.27 140.18 36.32 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.231 0.538 . . . . 74.209999999999994 110.2 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -120.61 172.14 8.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.335 -1.357 . . . . 75.209999999999994 107.335 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.6 t -89.62 114.36 25.95 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.782 -0.822 . . . . 72.25 108.782 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 76.2 mtp180 -88.83 164.54 15.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.886 -0.413 . . . . 74.329999999999998 109.886 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.5 45.97 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 114.0 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.9 p-10 -89.62 -14.4 35.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.929 -0.767 . . . . 75.219999999999999 108.929 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.24 16.7 34.13 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.353 -0.84 . . . . 61.0 111.043 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -125.51 152.18 45.34 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.25 0.547 . . . . 75.319999999999993 110.31 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.47 134.97 36.04 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.903 -1.044 . . . . 71.209999999999994 110.296 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.02 145.26 11.5 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.65 -0.98 . . . . 72.239999999999995 110.65 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 31' ' ' ALA . 18.8 tt0 -65.37 146.57 54.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.143 -0.688 . . . . 52.140000000000001 109.143 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' N ' ' HG2' ' A' ' 30' ' ' GLU . . . -80.7 -86.16 0.09 Allowed 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.579 -0.897 . . . . 63.109999999999999 108.579 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 mt -149.62 93.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 105.593 -2.002 . . . . 65.209999999999994 105.593 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -139.13 -168.71 2.49 Favored 'General case' 0 C--N 1.246 -3.916 0 C-N-CA 123.868 0.867 . . . . 74.530000000000001 108.967 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.3 35.83 4.04 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.185 -0.672 . . . . 73.540000000000006 109.185 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.46 117.75 59.97 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.599 -0.728 . . . . 64.230000000000004 111.988 -176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.47 -35.86 46.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.824 2.349 . . . . 65.319999999999993 113.55 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -129.83 -19.75 3.26 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.697 -0.401 . . . . 74.319999999999993 111.98 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.17 33.92 0.46 Allowed 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.939 -0.476 . . . . 71.439999999999998 112.284 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.398 -0.964 . . . . 73.230000000000004 108.398 173.006 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 30.5 p . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 106.375 -1.713 . . . . 72.439999999999998 106.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.83 152.79 35.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.746 -0.835 . . . . 74.040000000000006 108.746 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.48 58.14 4.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.993 0.901 . . . . 72.409999999999997 112.099 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.82 -55.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.239 -1.023 . . . . 75.129999999999995 108.239 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -89.99 -33.75 16.25 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.527 -0.76 . . . . 75.140000000000001 108.962 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.28 119.67 6.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.125 -0.943 . . . . 74.239999999999995 109.3 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 107.91 8.51 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 122.915 0.486 . . . . 51.450000000000003 111.83 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 56.5 Cg_endo -96.67 125.91 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.742 2.295 . . . . 74.219999999999999 111.179 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -97.49 149.87 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.321 -0.622 . . . . 75.439999999999998 109.321 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.753 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -130.52 157.07 43.68 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.095 0.474 . . . . 74.099999999999994 111.823 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -117.48 -51.14 2.51 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.193 -2.151 . . . . 74.25 105.193 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -123.05 158.06 31.41 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 113.98 -1.464 . . . . 73.019999999999996 109.564 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.31 -29.85 70.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.174 0.511 . . . . 75.530000000000001 112.134 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.0 p -66.41 -21.27 66.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.327 -0.851 . . . . 75.340000000000003 111.669 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.57 -20.57 63.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.226 0.536 . . . . 71.439999999999998 109.986 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -94.14 119.84 66.23 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 115.303 -0.862 . . . . 73.0 109.78 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.15 141.2 32.18 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.847 2.365 . . . . 72.239999999999995 115.139 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.95 -108.84 2.61 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 114.446 -1.252 . . . . 41.509999999999998 114.235 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' N ' ' HB3' ' A' ' 38' ' ' ALA . . . -102.37 -2.23 29.29 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.598 -0.519 . . . . 73.239999999999995 109.598 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.1 m -73.55 139.95 45.98 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.933 -0.766 . . . . 73.430000000000007 108.933 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.27 169.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 108.031 -1.1 . . . . 70.209999999999994 108.031 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.56 115.94 28.45 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.481 -0.563 . . . . 53.350000000000001 109.481 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -88.92 161.46 16.64 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.277 -0.638 . . . . 72.349999999999994 109.277 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.98 -2.56 47.42 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 113.43 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -89.5 -18.9 25.8 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.638 0.256 . . . . 71.400000000000006 110.87 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.34 4.71 32.74 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.515 -0.634 . . . . 71.340000000000003 111.515 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.77 146.55 36.17 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.584 0.754 . . . . 73.400000000000006 110.874 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.0 m -80.98 148.85 29.58 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.353 -0.84 . . . . 72.219999999999999 109.01 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 1' ' ' CYS . . . -176.3 152.01 12.21 Favored Glycine 0 N--CA 1.416 -2.692 0 C-N-CA 118.971 -1.585 . . . . 73.540000000000006 112.772 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.73 140.67 28.92 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.356 1.062 . . . . 71.340000000000003 109.502 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -85.61 0.11 Allowed 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 114.28 -1.327 . . . . 75.349999999999994 109.9 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.3 mt -153.53 102.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 105.678 -1.971 . . . . 74.540000000000006 105.678 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.5 t80 179.86 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.824 0 O-C-N 124.275 0.985 . . . . 72.230000000000004 108.672 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.73 60.15 1.1 Allowed 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.568 -1.196 . . . . 75.340000000000003 109.881 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.84 123.3 89.41 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.748 -1.114 . . . . 73.319999999999993 110.522 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -43.15 -49.33 7.27 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 124.634 3.556 . . . . 62.409999999999997 115.568 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -107.21 -16.9 14.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.32 0.581 . . . . 75.349999999999994 111.307 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 19' ' ' ALA . . . -94.31 17.21 13.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.095 0.776 . . . . 74.0 113.095 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 . . . . . 0 C--N 1.285 -2.213 0 CA-C-N 115.208 -0.905 . . . . 75.109999999999999 110.973 177.544 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.999 0.904 . . . . 74.530000000000001 109.633 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.61 147.99 24.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.702 -1.135 . . . . 73.030000000000001 108.445 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.94 142.9 12.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.39 -0.967 . . . . 73.439999999999998 108.39 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.46 -23.08 4.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.74 -0.664 . . . . 71.319999999999993 110.384 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -89.23 -42.29 11.71 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.477 -0.489 . . . . 74.420000000000002 110.136 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.02 89.04 1.42 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.145 -0.479 . . . . 65.450000000000003 112.032 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.39 126.74 78.11 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.869 -0.605 . . . . 71.340000000000003 109.649 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.09 119.82 6.9 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.709 2.272 . . . . 74.099999999999994 113.125 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 99.4 mttt -83.89 134.26 34.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.978 -0.749 . . . . 75.340000000000003 108.978 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.5 p -100.07 147.76 25.29 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.986 0.422 . . . . 71.439999999999998 112.033 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -109.2 -31.33 7.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.636 -1.246 . . . . 75.0 107.636 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -148.52 156.6 42.66 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.302 -1.317 . . . . 72.010000000000005 109.246 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 13.2 m-20 -59.53 -37.73 79.13 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.092 0.949 . . . . 73.109999999999999 110.311 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -71.82 -12.15 61.15 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.078 -1.419 . . . . 64.299999999999997 114.018 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.42 0.21 53.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.348 -0.941 . . . . 71.409999999999997 110.905 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 90.0 m -91.13 136.22 27.53 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 109.77 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 179.44 5.95 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.565 2.177 . . . . 75.040000000000006 112.967 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.66 -122.75 31.07 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.359 -0.837 . . . . 72.349999999999994 112.048 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.38 19.47 13.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.704 -0.85 . . . . 52.140000000000001 108.704 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.3 m -81.2 145.78 30.81 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.216 -0.902 . . . . 74.510000000000005 112.511 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' OD1' ' A' ' 13' ' ' ASP . 30.7 pt -119.73 179.15 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.059 -1.46 . . . . 73.420000000000002 107.059 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -90.63 117.93 29.67 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.44 -0.948 . . . . 73.030000000000001 108.44 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -89.02 160.05 17.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.38 -1.12 41.7 Favored Glycine 0 C--N 1.31 -0.892 0 CA-C-N 115.931 -0.577 . . . . 75.239999999999995 113.411 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -89.66 -19.53 24.75 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.694 -0.484 . . . . 75.140000000000001 109.694 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 2.44 34.21 Favored Glycine 0 CA--C 1.499 -0.952 0 N-CA-C 111.486 -0.646 . . . . 74.030000000000001 111.486 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 95.7 m-85 -114.69 161.65 17.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 123.414 0.685 . . . . 72.510000000000005 109.997 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 76.6 m -80.26 142.01 35.0 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.579 -0.526 . . . . 61.32 109.579 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.21 146.84 14.71 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.9 -1.28 . . . . 72.049999999999997 109.9 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.3 tt0 -59.94 148.51 34.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.64 0.733 . . . . 72.239999999999995 110.597 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.39 -151.85 0.09 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.473 -1.239 . . . . 74.329999999999998 107.736 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.5 mm -95.82 136.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 C-N-CA 119.398 -0.921 . . . . 72.25 110.413 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 22.7 t80 -170.82 154.46 4.32 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 102.731 -3.062 . . . . 75.230000000000004 102.731 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.24 3.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 119.061 0.846 . . . . 63.009999999999998 110.341 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.63 155.06 73.78 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.441 -0.8 . . . . 62.409999999999997 109.078 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.92 125.47 11.57 Favored 'Trans proline' 0 C--O 1.241 0.639 0 N-CA-C 108.23 -1.488 . . . . 73.299999999999997 108.23 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -109.65 -46.34 3.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.006 0.432 . . . . 74.420000000000002 110.43 -173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.3 78.58 1.02 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.664 -0.698 . . . . 71.019999999999996 109.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 115.368 -0.833 . . . . 74.409999999999997 108.795 178.601 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 122.39 1.091 . . . . 75.230000000000004 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.67 165.94 10.73 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.621 -1.172 . . . . 74.209999999999994 112.188 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.18 126.17 12.04 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.457 -1.683 . . . . 74.420000000000002 106.457 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.9 mt -93.67 -23.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 120.976 0.417 . . . . 71.109999999999999 111.629 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -87.83 -42.53 12.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.008 -0.677 . . . . 70.230000000000004 109.304 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.19 82.68 1.93 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.02 -0.991 . . . . 72.310000000000002 108.849 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.87 122.45 79.31 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.284 -0.871 . . . . 73.239999999999995 111.494 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.15 127.43 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.492 2.128 . . . . 63.530000000000001 109.923 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.0 pttm -94.49 156.89 16.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.55 -0.167 . . . . 72.299999999999997 110.55 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 15.2 p -142.55 157.68 44.46 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.507 0.194 . . . . 75.129999999999995 110.903 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -111.57 -42.51 3.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.145 -1.428 . . . . 71.510000000000005 107.145 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -127.5 157.52 39.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.758 -1.564 . . . . 75.219999999999999 108.631 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.89 -34.93 76.92 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.365 -0.834 . . . . 73.25 111.248 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -64.66 -21.62 66.77 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.526 -1.216 . . . . 71.439999999999998 112.584 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.19 -29.5 70.32 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.393 -0.595 . . . . 64.299999999999997 109.393 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 44.3 m -89.97 121.2 69.08 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 115.754 -0.657 . . . . 73.120000000000005 109.333 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.83 -177.55 2.59 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.45 2.1 . . . . 74.430000000000007 112.491 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.73 -132.75 51.42 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.575 -0.739 . . . . 63.310000000000002 111.926 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.33 11.08 33.91 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.606 0.241 . . . . 73.319999999999993 110.823 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.4 m -84.7 149.23 25.94 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.882 0.848 . . . . 73.409999999999997 112.63 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.25 175.71 10.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 113.858 -1.519 . . . . 74.439999999999998 107.683 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.8 t -97.25 110.85 23.32 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.07 -0.715 . . . . 55.219999999999999 109.07 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -74.15 169.36 17.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.862 0.363 . . . . 74.120000000000005 111.649 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.93 -14.53 61.17 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 115.438 -0.801 . . . . 61.119999999999997 112.997 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.32 -16.27 33.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.082 0.468 . . . . 72.209999999999994 111.49 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.46 17.1 32.29 Favored Glycine 0 CA--C 1.485 -1.803 0 C-N-CA 120.233 -0.984 . . . . 75.439999999999998 111.05 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 71.1 m-85 -121.18 147.16 45.98 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.66 -0.77 . . . . 73.420000000000002 109.268 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 71.9 m -70.82 127.92 34.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.065 -0.516 . . . . 64.030000000000001 110.725 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.33 153.82 20.57 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.139 -1.184 . . . . 64.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -79.28 178.11 8.32 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.47 -0.566 . . . . 72.450000000000003 109.47 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.15 -72.69 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.074 0.549 . . . . 62.399999999999999 112.133 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.0 mt -138.78 146.96 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.811 -1.181 . . . . 71.299999999999997 107.811 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.639 -1.245 . . . . 74.510000000000005 107.639 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.56 -81.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.011 -0.737 . . . . 73.319999999999993 109.011 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 36' ' ' PRO 0.27 . . -80.54 -50.89 1.05 Allowed Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 120.471 -0.492 . . . . 75.409999999999997 110.429 170.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 35' ' ' ALA . 20.9 Cg_exo -64.38 142.57 79.46 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.42 2.08 . . . . 71.219999999999999 107.816 167.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -119.95 25.5 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 111.989 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.8 39.19 4.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.806 0.843 . . . . 65.120000000000005 110.199 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-N 114.596 -1.184 . . . . 75.510000000000005 111.31 -174.626 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 108.628 -0.879 . . . . 72.5 108.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.36 170.02 9.8 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.769 -1.105 . . . . 65.519999999999996 109.936 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.78 144.37 4.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.928 -1.508 . . . . 75.510000000000005 106.928 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.4 mt -105.0 -21.48 5.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.093 0.473 . . . . 74.209999999999994 110.367 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -88.23 -43.87 11.28 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.234 -1.024 . . . . 75.310000000000002 108.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.11 77.99 1.36 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.041 -1.096 . . . . 61.200000000000003 108.041 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 116.64 31.82 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 115.289 -0.869 . . . . 61.329999999999998 110.679 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.83 118.36 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.791 2.328 . . . . 74.540000000000006 111.453 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -86.15 163.22 17.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.981 -0.554 . . . . 74.099999999999994 110.636 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.1 p -139.21 148.68 43.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.933 -0.576 . . . . 75.510000000000005 109.996 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -115.67 -40.32 3.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.452 -1.685 . . . . 73.010000000000005 106.452 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -132.96 160.98 35.52 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.712 1.605 . . . . 74.420000000000002 108.004 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.08 -30.71 71.68 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.537 0.684 . . . . 75.219999999999999 111.47 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -67.41 -17.26 64.65 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.064 -0.971 . . . . 72.25 112.125 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -67.11 -23.92 65.88 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.159 0.504 . . . . 72.400000000000006 109.646 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.77 137.68 26.81 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-N 115.316 -0.856 . . . . 64.310000000000002 110.055 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -86.18 177.61 4.47 Favored 'Trans proline' 0 C--O 1.253 1.272 0 C-N-CA 122.541 2.16 . . . . 75.519999999999996 112.572 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.02 -124.18 35.89 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.036 -0.984 . . . . 50.299999999999997 112.885 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.66 13.12 21.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.787 0.327 . . . . 71.299999999999997 110.167 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.38 155.22 32.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.305 0.574 . . . . 74.319999999999993 112.01 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.86 174.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.623 -0.88 . . . . 74.25 108.623 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.03 115.5 28.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.689 -0.856 . . . . 74.510000000000005 108.689 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -84.85 165.72 17.48 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 111.172 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.15 7.3 37.5 Favored Glycine 0 CA--C 1.51 -0.226 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 112.854 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -95.2 -16.36 22.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.617 -0.512 . . . . 74.299999999999997 109.617 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.01 11.97 41.31 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.729 -0.948 . . . . 74.109999999999999 110.729 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -127.87 160.8 30.71 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.458 -0.871 . . . . 75.239999999999995 110.775 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.3 m -80.0 140.54 36.54 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.602 -0.726 . . . . 75.109999999999999 111.368 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.65 176.6 39.73 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.124 -1.19 . . . . 70.340000000000003 110.124 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 9.3 tp10 -74.68 173.74 10.07 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.821 0.848 . . . . 62.399999999999999 109.414 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.59 -24.64 63.71 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.191 0.996 . . . . 71.530000000000001 108.405 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.532 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 53.3 mt -92.57 149.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 105.853 -1.906 . . . . 74.109999999999999 105.853 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -44.75 -47.08 10.78 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.318 1.047 . . . . 73.129999999999995 113.275 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -119.58 135.45 54.79 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.776 -0.824 . . . . 74.430000000000007 108.776 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.74 110.03 15.6 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.599 0.562 . . . . 74.439999999999998 111.933 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 70.7 Cg_endo -83.57 -38.32 0.14 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.522 2.148 . . . . 63.409999999999997 114.071 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -117.15 -51.42 2.54 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.444 0.64 . . . . 74.430000000000007 109.882 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 56.71 3.57 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.779 0.799 . . . . 60.329999999999998 108.944 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 . . . . . 0 N--CA 1.426 -1.625 0 CA-C-N 115.352 -0.84 . . . . 74.129999999999995 109.237 -179.298 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.296 -1.372 . . . . 73.510000000000005 107.296 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -89.52 123.66 33.82 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.016 0.912 . . . . 73.340000000000003 109.705 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.72 100.82 3.01 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 114.165 -1.38 . . . . 73.439999999999998 108.887 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 mm -91.38 -13.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.362 -0.835 . . . . 75.430000000000007 109.878 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.11 -45.41 9.61 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.416 -0.811 . . . . 73.099999999999994 109.754 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.71 96.13 2.08 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.562 -0.745 . . . . 73.349999999999994 109.316 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.57 126.41 90.83 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 115.91 -0.587 . . . . 74.310000000000002 110.166 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.55 116.41 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.539 2.159 . . . . 72.329999999999998 112.788 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -70.77 148.2 48.16 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.289 -1.004 . . . . 73.150000000000006 108.289 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 29.9 p -117.74 150.58 38.87 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 120.981 -0.288 . . . . 63.030000000000001 110.264 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.73 -43.66 2.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.278 -1.379 . . . . 72.219999999999999 107.278 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -132.18 153.1 50.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.64 -1.164 . . . . 74.530000000000001 108.729 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 6.1 m-20 -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.319 -0.855 . . . . 75.019999999999996 110.606 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -68.02 -19.26 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.64 -1.164 . . . . 74.340000000000003 113.284 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.23 -3.71 59.06 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.067 -1.053 . . . . 71.25 111.004 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -94.22 118.29 67.11 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 109.401 -0.592 . . . . 71.310000000000002 109.401 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.89 -175.44 2.68 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.586 2.19 . . . . 71.299999999999997 111.53 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.1 13.98 60.68 Favored Glycine 0 N--CA 1.465 0.599 0 CA-C-N 116.643 -0.253 . . . . 64.409999999999997 112.829 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.66 8.97 5.64 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.655 1.582 . . . . 75.549999999999997 111.129 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.76 149.17 50.28 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.047 -0.524 . . . . 65.140000000000001 109.629 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 44.9 pt -110.92 174.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.772 -0.825 . . . . 74.219999999999999 108.772 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -95.56 107.32 19.49 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.277 -1.008 . . . . 71.0 108.277 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -84.18 168.55 15.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.397 0.617 . . . . 73.209999999999994 110.857 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.45 2.25 63.14 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.295 -0.866 . . . . 75.340000000000003 112.398 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -88.74 -17.97 28.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.926 . . . . 70.25 108.501 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.8 6.94 42.7 Favored Glycine 0 CA--C 1.487 -1.673 0 N-CA-C 111.274 -0.731 . . . . 73.219999999999999 111.274 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.69 159.34 28.15 Favored 'General case' 0 N--CA 1.414 -2.255 0 C-N-CA 123.331 0.652 . . . . 71.010000000000005 110.39 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.2 m -80.21 131.94 35.78 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.254 -0.885 . . . . 53.409999999999997 108.633 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.47 170.01 30.38 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.633 -1.387 . . . . 65.549999999999997 109.633 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.6 157.74 36.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 117.643 0.722 . . . . 65.409999999999997 110.062 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 -141.83 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.648 -1.242 . . . . 74.209999999999994 107.648 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.2 mt -101.97 130.51 51.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.647 -1.242 . . . . 75.430000000000007 107.647 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 37.1 t80 -165.58 167.89 16.93 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.669 -1.604 . . . . 71.310000000000002 106.669 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.7 -80.26 0.16 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.403 0.547 . . . . 75.019999999999996 112.069 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.5 151.09 71.41 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 109.735 -0.469 . . . . 75.109999999999999 109.735 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -64.77 112.69 2.06 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.706 1.604 . . . . 74.340000000000003 111.271 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -138.17 -39.23 0.54 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.115 0.783 . . . . 75.109999999999999 113.115 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.22 43.49 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.67 -0.863 . . . . 73.450000000000003 108.67 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 114.667 -1.152 . . . . 75.439999999999998 111.433 -178.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.469 0 CA-C-O 122.558 1.17 . . . . 75.420000000000002 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.25 -26.67 22.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.365 -1.743 . . . . 72.340000000000003 107.399 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.04 93.59 9.4 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.865 -1.532 . . . . 63.299999999999997 106.865 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.8 mt -89.62 -16.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.834 -1.075 . . . . 75.329999999999998 111.071 -174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -89.34 -27.34 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.872 -1.159 . . . . 72.420000000000002 107.872 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.61 12.02 34.99 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.938 -1.028 . . . . 73.239999999999995 110.407 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.12 166.19 40.22 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 123.756 0.822 . . . . 72.140000000000001 110.722 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.8 164.54 22.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.786 1.657 . . . . 74.120000000000005 110.716 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.19 162.51 26.54 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.743 0.306 . . . . 73.010000000000005 111.63 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.7 p -151.89 154.49 36.24 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.809 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -114.93 -34.23 5.16 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.221 -1.029 . . . . 75.430000000000007 108.221 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.85 161.71 34.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.512 -1.222 . . . . 74.319999999999993 110.664 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.91 -33.49 68.83 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.802 0.841 . . . . 62.219999999999999 111.57 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -65.03 -25.21 67.74 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.085 -0.961 . . . . 74.310000000000002 112.407 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.72 -26.76 68.8 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.524 0.678 . . . . 64.25 109.261 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -96.79 128.45 35.74 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.13 -0.941 . . . . 45.439999999999998 110.167 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.02 158.6 4.88 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.67 2.246 . . . . 64.510000000000005 114.547 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.36 -111.81 4.34 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.774 -1.103 . . . . 63.039999999999999 114.746 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -105.45 5.54 31.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.437 0.637 . . . . 74.219999999999999 109.844 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.79 136.15 33.36 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.712 -1.218 . . . . 74.430000000000007 107.712 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.73 177.24 4.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.175 -1.046 . . . . 75.209999999999994 108.175 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -89.31 118.82 29.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.233 -0.987 . . . . 65.129999999999995 108.368 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -89.56 166.89 13.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.507 -0.553 . . . . 74.129999999999995 109.507 -177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.53 -8.69 52.88 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 114.221 0.448 . . . . 64.510000000000005 114.221 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -89.07 -17.13 29.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.361 0.6 . . . . 75.109999999999999 109.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.82 19.54 24.19 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 111.277 -0.729 . . . . 63.310000000000002 111.277 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.5 154.59 35.07 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.971 0.908 . . . . 75.439999999999998 109.9 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 93.8 m -80.14 101.59 8.88 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 123.14 0.576 . . . . 72.209999999999994 111.87 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.47 16.79 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.538 -0.839 . . . . 74.409999999999997 111.028 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' OE2' ' HA ' ' A' ' 33' ' ' TYR . 27.3 tt0 -61.94 159.35 14.27 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.088 0.955 . . . . 62.310000000000002 111.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -71.48 0.16 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.386 -1.279 . . . . 74.420000000000002 110.106 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -133.23 -66.09 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.877 -1.157 . . . . 73.310000000000002 107.877 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.495 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 50.2 t80 -163.75 103.2 0.91 Allowed 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.699 -1.591 . . . . 75.329999999999998 107.562 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.8 167.41 10.31 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.709 -0.678 . . . . 64.530000000000001 111.809 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.2 169.51 19.56 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 114.802 -1.09 . . . . 73.120000000000005 108.301 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -65.11 92.31 0.21 Allowed 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.303 1.335 . . . . 74.120000000000005 112.389 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -143.76 -55.1 0.37 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 105.735 -1.95 . . . . 71.219999999999999 105.735 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HB1' ' H ' ' A' ' 19' ' ' ALA . . . -149.89 97.54 2.6 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.311 -1.737 . . . . 71.109999999999999 106.311 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 . . . . . 0 C--N 1.288 -2.092 0 CA-C-O 121.466 0.65 . . . . 73.310000000000002 109.381 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.422 -1.855 0 CA-C-O 122.108 0.956 . . . . 65.329999999999998 111.264 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -89.76 -35.3 15.81 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.883 -1.508 . . . . 73.299999999999997 108.974 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.63 89.18 7.08 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.378 -1.342 . . . . 73.430000000000007 107.378 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.23 -15.24 8.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.74 -0.664 . . . . 74.510000000000005 111.03 -175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.05 -31.98 18.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.275 -1.38 . . . . 71.219999999999999 107.275 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 25.01 11.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.604 -1.18 . . . . 72.319999999999993 110.122 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.2 126.66 88.2 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 75.420000000000002 109.401 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.21 143.46 44.05 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.901 1.734 . . . . 63.219999999999999 111.473 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 14.9 ptmm? -82.28 158.79 23.33 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.948 -0.39 . . . . 74.340000000000003 109.948 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -132.57 151.54 51.9 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.295 0.569 . . . . 65.319999999999993 111.963 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -101.34 -44.96 5.48 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.264 -2.124 . . . . 73.540000000000006 105.264 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.45 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 8.5 ptp180 -129.93 163.2 26.91 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 110.18 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.08 -32.12 73.57 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.886 -1.052 . . . . 73.540000000000006 110.815 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -72.72 -4.72 33.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.129 -0.941 . . . . 64.109999999999999 112.969 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 69.5 m-20 -77.71 -23.25 49.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.467 0.651 . . . . 70.510000000000005 109.45 172.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.2 m -104.96 127.37 28.89 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 108.656 -0.868 . . . . 73.219999999999999 108.656 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -100.52 -175.65 0.14 Allowed 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.413 2.076 . . . . 72.450000000000003 113.27 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.64 -108.9 2.63 Favored Glycine 0 CA--C 1.489 -1.545 0 CA-C-N 115.025 -0.989 . . . . 72.549999999999997 113.463 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' GLU . . . -115.23 0.24 13.46 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.174 0.512 . . . . 72.310000000000002 109.969 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 72.2 m -91.99 139.87 30.22 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 122.03 0.919 . . . . 71.140000000000001 111.826 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.79 179.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 113.883 -1.508 . . . . 72.519999999999996 107.065 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.8 t -95.51 104.94 16.86 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.198 -1.038 . . . . 51.229999999999997 108.198 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 74.3 mtp180 -79.96 170.16 16.86 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.453 -0.34 . . . . 74.430000000000007 110.893 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.52 -2.31 27.12 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 115.933 -0.576 . . . . 64.129999999999995 114.011 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' A' ' 27' ' ' TYR . 32.1 p-10 -88.89 -19.19 26.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.826 -0.805 . . . . 71.019999999999996 108.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.07 32.33 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 110.939 -0.864 . . . . 74.540000000000006 110.939 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 73.9 m-85 -129.31 157.59 41.47 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.085 -0.558 . . . . 73.319999999999993 110.808 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.37 133.86 47.33 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.244 -0.889 . . . . 74.340000000000003 109.827 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.57 135.69 4.61 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.403 -1.079 . . . . 72.329999999999998 110.403 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 41.8 tt0 -51.36 139.0 20.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.263 1.03 . . . . 74.409999999999997 112.112 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.28 -62.43 1.66 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.873 -1.512 . . . . 70.420000000000002 110.549 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -131.04 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.016 -2.216 . . . . 64.319999999999993 105.016 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -59.93 107.79 0.67 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 123.888 0.742 . . . . 74.129999999999995 110.674 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 -166.22 1.21 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.933 0.716 . . . . 63.219999999999999 112.933 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.16 147.96 83.63 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-N 115.38 -0.827 . . . . 72.239999999999995 110.122 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.25 121.32 8.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.151 2.568 . . . . 64.510000000000005 114.534 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -150.31 -63.17 0.2 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.877 -2.268 . . . . 75.099999999999994 104.877 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.35 95.7 2.76 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.674 -1.602 . . . . 63.32 106.674 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 106.14 -1.8 . . . . 73.439999999999998 106.14 177.633 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.41 -2.452 0 N-CA-C 107.859 -1.163 . . . . 73.340000000000003 107.859 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.465 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 38.3 mt-10 -141.89 -170.03 3.04 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.644 -2.354 . . . . 70.409999999999997 104.644 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.57 83.47 4.12 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.934 -0.707 . . . . 73.030000000000001 109.396 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.41 -62.38 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.318 -0.993 . . . . 71.519999999999996 108.318 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -88.81 -32.78 17.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.813 -1.18 . . . . 72.209999999999994 107.813 -176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.35 160.02 7.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.245 -1.391 . . . . 73.230000000000004 107.245 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.92 113.43 40.47 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.27 -0.641 . . . . 54.520000000000003 109.27 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -86.8 101.0 0.55 Allowed 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 121.801 1.667 . . . . 74.5 112.112 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -84.09 157.48 21.73 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.246 -0.65 . . . . 65.129999999999995 109.246 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.575 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -140.22 148.04 40.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.319 0.581 . . . . 64.340000000000003 112.063 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -105.42 -40.86 5.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.792 -1.929 . . . . 74.140000000000001 105.792 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -139.11 166.28 24.92 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 114.295 -1.32 . . . . 75.439999999999998 110.987 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.94 -33.85 72.45 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 123.774 0.83 . . . . 74.129999999999995 110.951 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -65.18 -21.44 66.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.868 -1.06 . . . . 64.329999999999998 112.293 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.31 0.576 . . . . 60.409999999999997 110.357 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.49 133.72 30.75 Favored Pre-proline 0 N--CA 1.422 -1.857 0 CA-C-N 115.341 -0.845 . . . . 73.129999999999995 111.008 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.42 177.35 8.63 Favored 'Trans proline' 0 C--O 1.257 1.465 0 C-N-CA 122.804 2.336 . . . . 74.239999999999995 112.76 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.99 -130.58 47.82 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 110.127 -1.189 . . . . 64.030000000000001 110.127 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.97 9.57 22.23 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 109.096 -0.705 . . . . 73.319999999999993 109.096 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.64 148.63 50.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.018 -0.537 . . . . 73.540000000000006 111.208 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -116.9 174.72 3.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 108.951 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.76 121.47 31.94 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 108.021 -1.103 . . . . 75.109999999999999 108.021 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -91.4 158.6 16.42 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.611 -0.885 . . . . 74.109999999999999 108.611 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.73 0.28 28.78 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.744 -0.662 . . . . 71.349999999999994 113.666 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -88.5 -19.68 26.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.12 0.486 . . . . 72.430000000000007 109.709 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.32 25.01 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 111.303 -0.719 . . . . 51.340000000000003 111.303 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -118.71 160.65 21.46 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 123.437 0.695 . . . . 74.200000000000003 111.494 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.8 m -80.39 139.61 36.43 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.989 -1.005 . . . . 74.340000000000003 110.336 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.3 157.41 28.3 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.831 -1.308 . . . . 71.25 109.831 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 10.1 tp10 -73.6 158.81 34.09 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.897 -0.779 . . . . 72.510000000000005 108.897 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.93 -39.01 61.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.945 -1.131 . . . . 72.510000000000005 107.945 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 37.6 mm -82.34 140.2 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.247 -1.761 . . . . 71.109999999999999 106.247 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.32 -37.89 60.52 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.284 0.564 . . . . 71.129999999999995 110.354 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.7 84.65 5.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.025 -0.534 . . . . 73.329999999999998 110.792 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.46 121.08 81.08 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.844 -0.616 . . . . 74.349999999999994 110.213 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.39 -42.04 66.05 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.655 2.903 . . . . 71.329999999999998 114.674 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -150.68 -47.16 0.12 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.775 -0.454 . . . . 73.450000000000003 109.775 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.64 67.09 2.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.848 0.832 . . . . 73.0 110.852 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 2' ' ' GLU . 65.9 mtt180 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-N 114.089 -1.414 . . . . 73.430000000000007 109.916 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.268 -1.382 . . . . 63.140000000000001 107.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 15.9 mt-10 -91.4 176.86 6.41 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 112.877 -1.965 . . . . 73.120000000000005 110.174 -169.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -161.61 150.63 15.98 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 106.777 -1.564 . . . . 73.030000000000001 106.777 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.1 -25.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-O 121.094 0.474 . . . . 70.219999999999999 110.128 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -88.84 -44.49 10.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.896 -0.779 . . . . 65.439999999999998 108.896 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -133.18 88.58 2.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.709 -0.678 . . . . 75.329999999999998 110.338 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.49 132.83 60.89 Favored Pre-proline 0 C--N 1.297 -1.677 0 CA-C-N 115.894 -0.594 . . . . 72.120000000000005 110.962 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.36 123.27 10.64 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.18 1.92 . . . . 60.229999999999997 109.396 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 62.0 pttt -82.26 163.76 21.62 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.065 -0.654 . . . . 74.219999999999999 111.234 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.1 p -150.99 157.39 42.83 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.197 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 2.8 mmp_? -116.68 -33.91 4.69 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.092 -1.077 . . . . 74.010000000000005 108.092 170.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.79 158.81 32.44 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.074 -0.967 . . . . 75.420000000000002 110.137 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -61.47 -30.87 70.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.118 -0.946 . . . . 70.129999999999995 111.533 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -71.78 -10.92 60.49 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.909 0.707 . . . . 60.119999999999997 112.909 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.24 -12.97 61.05 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.391 0.615 . . . . 71.430000000000007 109.581 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.3 m -110.92 126.71 28.18 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.603 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -84.9 168.85 10.61 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.67 2.247 . . . . 55.310000000000002 113.672 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.58 -126.17 40.47 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.273 -0.876 . . . . 73.140000000000001 113.522 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.12 13.3 29.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.068 -0.566 . . . . 70.219999999999999 110.881 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.87 151.13 25.29 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.898 -0.778 . . . . 75.299999999999997 108.898 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 44.1 pt -129.26 172.83 14.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.357 -1.349 . . . . 74.209999999999994 107.357 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.0 t -92.04 111.08 22.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.274 -1.38 . . . . 72.540000000000006 107.274 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.3 mmm180 -77.95 164.22 25.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.475 -0.565 . . . . 73.219999999999999 109.475 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.32 1.34 20.07 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 116.172 -0.467 . . . . 54.420000000000002 114.129 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.7 p-10 -89.81 -21.38 22.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.084 -0.709 . . . . 74.439999999999998 109.084 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.93 15.17 19.09 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.573 -0.74 . . . . 74.109999999999999 111.381 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 92.9 m-85 -131.59 150.16 52.25 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 122.863 0.465 . . . . 75.549999999999997 110.858 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.67 124.17 22.11 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.688 -0.687 . . . . 75.420000000000002 111.248 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.97 163.88 27.62 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.227 -1.149 . . . . 73.239999999999995 110.227 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 32' ' ' ILE . 42.1 tt0 -62.02 152.91 31.14 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.425 0.631 . . . . 73.409999999999997 110.992 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . . . -77.45 -23.35 50.49 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.341 -0.845 . . . . 73.010000000000005 112.397 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.514 HG21 ' H ' ' A' ' 34' ' ' ALA . 39.2 mt -72.98 148.91 8.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.612 -0.722 . . . . 75.530000000000001 109.165 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -88.27 -10.44 49.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.198 0.523 . . . . 71.540000000000006 111.357 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' H ' HG21 ' A' ' 32' ' ' ILE . . . -76.96 -176.94 4.16 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.616 -0.883 . . . . 72.319999999999993 108.616 174.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.17 119.7 51.51 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.682 -0.488 . . . . 72.0 109.682 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 56.1 Cg_exo -56.14 155.5 23.87 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.467 2.778 . . . . 73.230000000000004 112.909 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.53 -13.38 37.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.878 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' A' ' 2' ' ' GLU . . . 70.13 61.39 0.24 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.332 1.053 . . . . 73.239999999999995 109.439 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 . . . . . 0 CA--C 1.495 -1.15 0 CA-C-N 113.863 -1.517 . . . . 73.129999999999995 111.258 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.7 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -146.76 148.84 32.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.287 -0.635 . . . . 73.319999999999993 109.287 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 6' ' ' ALA . . . -168.56 145.75 3.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.671 -1.974 . . . . 71.099999999999994 105.671 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.4 -30.48 4.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 112.278 0.473 . . . . 73.439999999999998 112.278 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -87.89 -41.22 13.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.617 -0.833 . . . . 74.230000000000004 109.29 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -125.42 83.66 2.19 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 114.969 -1.014 . . . . 72.430000000000007 110.288 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.96 119.36 76.39 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.083 -0.71 . . . . 73.450000000000003 109.083 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.95 104.82 0.87 Allowed 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.908 2.405 . . . . 72.439999999999998 114.275 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -85.06 154.23 22.21 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.191 -0.913 . . . . 74.0 108.547 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.628 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.0 p -127.62 148.91 50.38 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.034 0.445 . . . . 65.030000000000001 111.186 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -112.02 -39.33 4.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.119 -1.808 . . . . 72.319999999999993 106.119 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -127.48 157.04 41.13 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.189 -1.369 . . . . 74.140000000000001 109.422 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.73 -29.12 70.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.394 0.678 . . . . 64.310000000000002 111.728 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.8 p -63.68 -23.05 67.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.239 -0.891 . . . . 73.099999999999994 111.866 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.485 0.66 . . . . 75.140000000000001 110.3 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.5 m -105.39 110.46 64.36 Favored Pre-proline 0 N--CA 1.401 -2.892 0 CA-C-N 115.384 -0.826 . . . . 72.129999999999995 109.879 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.84 178.84 6.52 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.517 2.145 . . . . 73.400000000000006 112.733 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.27 -111.87 4.52 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.989 -0.551 . . . . 70.340000000000003 112.997 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.51 16.18 9.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.845 -0.798 . . . . 74.409999999999997 108.845 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.95 144.4 29.19 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.179 -0.919 . . . . 73.310000000000002 109.867 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.2 pt -122.29 174.12 7.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.945 -1.502 . . . . 74.209999999999994 106.945 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.41 108.47 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.777 -1.194 . . . . 72.310000000000002 107.777 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 70.5 mtp180 -82.17 165.92 20.09 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 116.127 -0.488 . . . . 71.209999999999994 111.128 -177.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.85 -4.24 57.9 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 115.77 -0.65 . . . . 72.129999999999995 112.925 -177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 36.7 p-10 -89.05 -14.8 35.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 15.47 38.88 Favored Glycine 0 CA--C 1.493 -1.3 0 CA-C-N 115.479 -0.782 . . . . 73.400000000000006 111.183 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -124.14 154.38 40.11 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 123.482 0.713 . . . . 71.120000000000005 111.532 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.31 118.71 22.2 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.796 -1.093 . . . . 74.030000000000001 110.211 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.09 160.43 28.33 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.816 -1.183 . . . . 73.25 111.008 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.62 155.51 29.54 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.491 -0.559 . . . . 73.409999999999997 109.491 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.35 26.44 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.189 -0.46 . . . . 72.219999999999999 110.836 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.35 138.01 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 106.685 -1.598 . . . . 74.230000000000004 106.685 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -99.24 82.95 2.77 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 111.446 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.54 -85.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.229 -0.896 . . . . 65.439999999999998 108.966 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.79 117.55 68.7 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.564 -0.902 . . . . 72.239999999999995 108.564 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.44 121.07 6.86 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.581 1.521 . . . . 73.420000000000002 111.023 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -112.68 -54.32 2.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.628 -1.249 . . . . 74.319999999999993 107.628 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.3 87.71 0.91 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.925 -1.034 . . . . 74.120000000000005 109.424 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.301 -1.527 0 CA-C-N 114.966 -1.016 . . . . 75.349999999999994 111.063 178.058 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 18' ' ' GLY . 1.8 p . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 116.055 1.872 . . . . 74.040000000000006 116.055 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -91.29 178.72 5.89 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.378 -1.341 . . . . 75.409999999999997 107.378 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.86 98.23 0.4 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.559 0.695 . . . . 74.200000000000003 109.165 174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.8 mt -111.69 -66.52 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 114.815 -1.084 . . . . 74.430000000000007 108.795 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -88.38 -37.2 16.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.245 -1.343 . . . . 75.120000000000005 108.636 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -145.79 143.39 29.65 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.054 -1.43 . . . . 62.240000000000002 109.037 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.74 104.86 3.05 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 123.833 0.708 . . . . 72.519999999999996 109.196 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 2.8 Cg_endo -83.78 117.04 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.455 2.103 . . . . 74.430000000000007 110.823 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.73 155.23 26.83 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.676 -0.49 . . . . 73.25 109.676 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 14.6 p -144.52 162.86 35.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.169 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -123.07 -41.06 2.35 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.247 -1.39 . . . . 71.019999999999996 107.247 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -119.48 154.23 34.1 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.234 -1.348 . . . . 75.319999999999993 109.514 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.13 -28.16 67.91 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.978 0.894 . . . . 71.219999999999999 111.14 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 p -68.6 -11.95 60.7 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.464 -1.243 . . . . 71.109999999999999 113.19 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -69.06 -24.8 64.21 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.056 -0.72 . . . . 70.5 109.056 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -95.71 121.5 61.19 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 115.443 -0.799 . . . . 74.400000000000006 109.962 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -85.11 -167.27 0.4 Allowed 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.101 2.534 . . . . 62.310000000000002 112.375 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 1' ' ' CYS . . . 64.48 -111.99 4.63 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.237 -0.745 . . . . 64.209999999999994 111.237 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.64 19.43 3.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.584 -1.265 . . . . 64.239999999999995 107.584 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.78 153.62 20.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.952 -1.022 . . . . 75.400000000000006 111.946 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.15 175.13 5.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.214 -0.903 . . . . 71.299999999999997 109.911 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.04 110.71 23.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.853 -0.795 . . . . 64.319999999999993 108.853 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -82.65 169.98 15.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.075 0.464 . . . . 74.299999999999997 111.405 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.62 -1.76 46.89 Favored Glycine 0 N--CA 1.464 0.514 0 CA-C-N 115.734 -0.666 . . . . 73.409999999999997 113.433 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -89.03 -15.19 34.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.786 -0.82 . . . . 75.209999999999994 108.786 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.54 15.54 34.41 Favored Glycine 0 CA--C 1.481 -2.056 0 N-CA-C 111.292 -0.723 . . . . 53.100000000000001 111.292 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.76 156.4 42.5 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.719 -0.741 . . . . 74.549999999999997 110.705 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 72.6 m -79.87 141.18 36.37 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 109.383 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.13 168.55 33.04 Favored Glycine 0 N--CA 1.407 -3.246 0 N-CA-C 109.271 -1.532 . . . . 72.319999999999993 109.271 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.32 162.05 18.32 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.627 -0.508 . . . . 71.299999999999997 109.627 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.64 64.89 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.566 0.698 . . . . 63.350000000000001 109.784 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.53 140.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 106.559 -1.645 . . . . 73.230000000000004 106.559 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -81.22 -32.15 33.55 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.164 0.506 . . . . 74.519999999999996 110.042 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.1 87.48 2.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.962 -1.125 . . . . 73.439999999999998 107.962 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 126.75 84.19 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.372 -0.831 . . . . 71.140000000000001 112.01 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.25 -36.92 79.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.782 2.988 . . . . 74.010000000000005 112.621 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -135.79 -79.92 0.42 Allowed 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.739 -1.208 . . . . 74.129999999999995 107.739 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 168.29 88.95 0.0 OUTLIER 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.87 1.268 . . . . 60.310000000000002 109.534 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 . . . . . 0 C--N 1.308 -1.231 0 CA-C-O 119.316 -0.373 . . . . 75.329999999999998 110.153 170.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.399 -2.985 0 N-CA-C 103.382 -2.822 . . . . 75.219999999999999 103.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.7 -31.39 19.74 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.65 -0.87 . . . . 73.409999999999997 108.65 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.39 93.41 9.31 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.455 -0.942 . . . . 75.519999999999996 108.455 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.19 -33.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 75.099999999999994 109.032 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -88.83 -43.12 11.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.66 -1.237 . . . . 75.120000000000005 107.66 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.19 35.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.196 -1.365 . . . . 74.319999999999993 108.733 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 153.0 84.83 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.17 -1.377 . . . . 71.319999999999993 110.369 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.47 161.9 31.06 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.921 1.747 . . . . 74.219999999999999 109.856 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -80.7 145.09 31.77 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.83 -0.434 . . . . 73.519999999999996 109.83 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.4 p -121.35 148.03 44.91 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.828 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -109.22 -32.46 7.19 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 73.25 107.155 174.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.95 160.02 42.0 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 125.395 1.478 . . . . 74.329999999999998 108.528 172.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -59.23 -37.43 77.51 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.962 0.887 . . . . 74.129999999999995 110.549 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -68.33 -17.39 64.25 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.348 -1.296 . . . . 60.210000000000001 113.75 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -91.04 6.25 45.61 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.914 -1.114 . . . . 75.299999999999997 111.734 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.0 m -89.23 145.26 33.81 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 120.719 -0.392 . . . . 70.340000000000003 110.74 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.82 132.56 52.47 Favored 'Trans proline' 0 C--O 1.257 1.453 0 C-N-CA 123.373 2.715 . . . . 73.349999999999994 113.019 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.71 -106.94 1.72 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.801 -1.09 . . . . 60.350000000000001 112.563 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.07 16.9 5.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.545 -0.168 . . . . 64.409999999999997 110.545 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.69 150.34 41.29 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.0 pt -104.07 170.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.875 -0.416 . . . . 71.230000000000004 109.875 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.3 t -98.24 122.75 41.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.04 -1.096 . . . . 65.329999999999998 108.04 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mtm-85 -88.72 166.67 13.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.916 -0.401 . . . . 74.540000000000006 109.916 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.5 -7.57 41.0 Favored Glycine 0 N--CA 1.467 0.715 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 113.831 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 33.5 p-10 -89.18 -24.84 22.07 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 122.548 -0.383 . . . . 71.430000000000007 110.057 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.92 9.71 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.609 -0.805 . . . . 74.430000000000007 111.547 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 70.8 m-85 -125.32 155.91 39.49 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.729 -0.841 . . . . 73.409999999999997 108.729 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.3 m -80.26 153.06 28.74 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.816 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.46 -179.7 33.51 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-O 119.189 -0.784 . . . . 72.120000000000005 111.34 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.07 150.12 30.35 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.268 0.627 . . . . 65.040000000000006 110.125 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.14 32.87 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.369 -0.832 . . . . 64.409999999999997 110.333 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.3 mt -139.59 128.63 28.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.087 -1.82 . . . . 72.0 106.087 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -87.72 87.22 7.31 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 121.589 0.709 . . . . 74.439999999999998 111.599 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.67 -92.4 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.383 -1.34 . . . . 75.430000000000007 107.383 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.65 60.18 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.392 -1.336 . . . . 74.420000000000002 107.392 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.12 110.83 2.07 Favored 'Trans proline' 0 C--O 1.249 1.052 0 N-CA-C 108.579 -1.354 . . . . 75.109999999999999 108.579 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -109.15 -65.93 1.1 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.324 0.583 . . . . 75.310000000000002 111.592 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.26 38.63 2.16 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.77 -1.196 . . . . 63.0 107.77 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 CA--C 1.489 -1.38 0 C-N-CA 126.562 1.945 . . . . 64.430000000000007 115.481 -169.499 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 101.683 -3.451 . . . . 64.319999999999993 101.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -137.87 155.16 49.25 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.605 -0.725 . . . . 63.219999999999999 111.996 -163.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.82 132.54 5.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.874 -2.269 . . . . 71.129999999999995 104.874 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 mm -96.48 -20.44 5.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 120.875 0.369 . . . . 73.340000000000003 111.533 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -88.25 -41.41 12.95 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.576 -0.85 . . . . 74.450000000000003 108.9 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.91 102.82 3.01 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.979 -0.749 . . . . 74.099999999999994 108.979 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 134.42 57.53 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 116.601 -0.272 . . . . 73.299999999999997 110.402 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.12 119.4 6.57 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.796 2.331 . . . . 72.209999999999994 112.277 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.77 157.81 17.79 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.45 -0.945 . . . . 75.430000000000007 108.45 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.8 p -136.88 142.01 42.78 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.398 0.618 . . . . 71.430000000000007 111.478 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.9 -32.52 7.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.645 -1.613 . . . . 72.409999999999997 106.645 171.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -140.02 161.5 37.47 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.705 -1.589 . . . . 71.349999999999994 108.651 174.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.54 -29.54 70.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.561 -0.745 . . . . 72.340000000000003 111.864 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -69.54 -15.56 63.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.847 -0.615 . . . . 65.200000000000003 112.57 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.504 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m-20 -68.41 -22.55 64.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.451 0.643 . . . . 64.519999999999996 110.007 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -89.83 123.54 66.03 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-N 115.351 -0.84 . . . . 61.409999999999997 111.513 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.23 -179.81 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.979 2.453 . . . . 74.230000000000004 112.077 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.83 -123.82 34.34 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 112.311 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 31' ' ' ALA . . . -113.04 10.44 18.78 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.005 -0.739 . . . . 64.439999999999998 109.005 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 m -71.08 146.68 49.13 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.675 -0.693 . . . . 73.349999999999994 110.614 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 22.9 pt -127.12 171.41 15.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.901 -0.777 . . . . 71.349999999999994 108.901 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.7 115.02 26.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.077 0.465 . . . . 71.200000000000003 109.781 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -86.3 167.76 14.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 109.899 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.42 -2.23 54.13 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 113.403 -174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -89.96 -17.55 27.72 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.761 0.315 . . . . 72.140000000000001 111.024 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.53 27.16 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.717 -0.953 . . . . 72.510000000000005 110.717 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -126.3 154.99 42.67 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 124.452 1.101 . . . . 75.329999999999998 109.988 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 74.4 m -80.19 126.2 30.81 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 72.230000000000004 109.839 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.46 -178.97 15.57 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.139 -1.185 . . . . 73.430000000000007 110.139 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.0 tp10 -66.17 156.19 34.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.873 0.336 . . . . 72.019999999999996 110.271 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . -80.59 -53.39 6.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.37 0.605 . . . . 73.219999999999999 111.482 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -115.66 150.31 17.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.05 -0.977 . . . . 74.219999999999999 109.704 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -82.41 136.76 34.88 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.489 -0.93 . . . . 74.5 108.489 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 69.82 24.64 5.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.422 1.089 . . . . 75.209999999999994 110.15 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.94 166.49 42.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.444 -0.798 . . . . 61.149999999999999 110.77 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -42.09 -50.21 5.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.97 3.113 . . . . 72.209999999999994 115.2 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -96.87 -38.09 9.98 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.131 -0.628 . . . . 74.400000000000006 109.84 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . . . 72.6 14.99 5.06 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 125.113 1.365 . . . . 73.340000000000003 111.488 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-N 114.324 -1.307 . . . . 73.349999999999994 109.871 -176.407 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 122.019 0.914 . . . . 74.319999999999993 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' CD ' ' HD2' ' A' ' 39' ' ' ARG . 6.0 pt-20 -97.71 161.64 13.66 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.713 -1.13 . . . . 71.120000000000005 110.503 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.48 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.0 120.07 30.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 106.422 -1.696 . . . . 73.25 106.422 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.45 -29.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-N 114.734 -1.121 . . . . 62.530000000000001 112.228 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.8 -42.23 12.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.137 -1.06 . . . . 74.430000000000007 108.137 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.26 78.62 1.77 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.982 -1.008 . . . . 73.099999999999994 108.403 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.98 117.2 12.01 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.253 -0.885 . . . . 71.349999999999994 111.758 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 3' ' ' ALA . 34.0 Cg_endo -89.87 108.79 0.4 Allowed 'Trans proline' 0 N--CA 1.429 -2.289 0 C-N-CA 122.458 2.105 . . . . 74.310000000000002 111.806 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.6 pttm -88.7 145.6 25.55 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.572 -0.529 . . . . 75.400000000000006 109.572 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.6 p -127.38 154.55 44.86 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.826 0.822 . . . . 70.019999999999996 111.598 -173.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -115.22 -35.25 4.73 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.089 -1.448 . . . . 71.349999999999994 107.089 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -130.57 158.45 39.95 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.306 -1.315 . . . . 75.319999999999993 110.103 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.71 -34.33 76.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.626 0.726 . . . . 70.209999999999994 110.679 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -67.01 -6.41 16.9 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.502 -1.226 . . . . 74.540000000000006 113.212 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.7 -40.46 92.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.285 0.564 . . . . 73.510000000000005 109.523 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 79.2 m -131.71 98.34 18.02 Favored Pre-proline 0 N--CA 1.409 -2.479 0 N-CA-C 107.836 -1.172 . . . . 72.310000000000002 107.836 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.75 -166.21 0.39 Allowed 'Trans proline' 0 C--O 1.261 1.667 0 C-N-CA 122.896 2.397 . . . . 72.049999999999997 115.291 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.74 -111.22 4.0 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 113.933 -1.485 . . . . 50.140000000000001 112.762 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 -14.93 36.79 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.15 -0.525 . . . . 70.319999999999993 111.426 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.91 155.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.316 -0.554 . . . . 73.340000000000003 110.951 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.7 pt -131.9 179.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.401 -0.963 . . . . 65.230000000000004 108.401 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.4 t -101.28 126.55 48.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.318 -1.364 . . . . 74.200000000000003 107.318 175.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 41.4 mtt180 -91.25 165.81 13.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.796 -0.446 . . . . 71.329999999999998 109.796 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -5.92 66.76 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.71 -0.677 . . . . 74.299999999999997 112.491 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.577 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.5 p-10 -88.3 -11.69 45.69 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.908 -0.775 . . . . 72.409999999999997 108.908 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.42 42.49 Favored Glycine 0 CA--C 1.488 -1.601 0 CA-C-N 115.598 -0.728 . . . . 64.519999999999996 111.298 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 60.7 m-85 -125.14 157.03 37.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.496 0.718 . . . . 72.299999999999997 110.285 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.8 m -79.98 166.53 21.5 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.733 0.301 . . . . 62.420000000000002 110.414 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.55 -176.16 44.18 Favored Glycine 0 CA--C 1.486 -1.762 0 C-N-CA 120.172 -1.013 . . . . 52.450000000000003 112.488 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.75 154.92 20.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.347 0.674 . . . . 74.549999999999997 109.95 176.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.92 16.54 1.43 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.961 0.905 . . . . 75.420000000000002 112.356 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.93 129.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.509 -1.663 . . . . 72.209999999999994 106.509 174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -90.64 -21.78 21.51 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 115.62 -0.718 . . . . 74.439999999999998 111.483 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.03 -166.54 1.52 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.128 -1.064 . . . . 73.239999999999995 108.128 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.65 114.76 15.74 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 109.893 -0.41 . . . . 71.5 109.893 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.26 -173.99 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.666 2.244 . . . . 74.109999999999999 111.43 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -148.25 -59.93 0.25 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.039 -1.097 . . . . 74.25 108.039 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.53 78.84 7.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.819 -0.628 . . . . 73.329999999999998 109.943 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.42 ' HD2' ' CD ' ' A' ' 2' ' ' GLU . 80.0 mtm180 . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.927 -0.579 . . . . 73.25 109.987 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.388 0.613 . . . . 75.109999999999999 109.775 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.06 175.31 7.45 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.779 -1.101 . . . . 72.129999999999995 109.118 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.91 8.67 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.635 -1.246 . . . . 73.450000000000003 107.635 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.66 -26.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.735 -0.666 . . . . 72.439999999999998 110.596 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -88.06 -40.8 13.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.456 0.646 . . . . 73.519999999999996 109.709 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.63 87.85 1.66 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.044 -0.98 . . . . 73.140000000000001 109.62 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.07 135.45 96.32 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.296 -0.865 . . . . 74.530000000000001 111.459 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.12 122.2 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.465 2.11 . . . . 70.329999999999998 111.348 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 50.9 mtpt -76.58 145.98 38.62 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.845 -0.428 . . . . 73.340000000000003 109.845 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.631 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.6 p -117.82 146.85 43.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.645 0.259 . . . . 54.409999999999997 110.764 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.38 -45.08 4.16 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.79 -1.559 . . . . 72.540000000000006 106.79 172.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -136.66 155.26 50.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.04 -1.436 . . . . 74.150000000000006 109.309 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' OD2' ' HB ' ' A' ' 21' ' ' ILE . 2.9 m-20 -58.43 -35.01 71.45 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 123.698 0.799 . . . . 70.420000000000002 111.023 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -67.31 -16.26 64.16 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.29 1.218 . . . . 63.329999999999998 114.29 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -90.25 -4.14 57.37 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.289 -0.964 . . . . 72.25 111.549 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.93 137.41 28.25 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 115.791 -0.64 . . . . 63.049999999999997 110.012 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.0 122.27 6.03 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 124.18 3.254 . . . . 70.340000000000003 114.525 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.61 -119.25 17.57 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.131 -0.94 . . . . 74.219999999999999 112.914 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.93 10.54 36.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.316 -0.442 . . . . 72.150000000000006 110.866 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.54 146.8 52.96 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.125 -0.694 . . . . 71.219999999999999 109.125 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.428 ' HB ' ' OD2' ' A' ' 13' ' ' ASP . 36.0 pt -111.67 167.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.007 0.432 . . . . 75.099999999999994 111.0 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.19 105.1 17.39 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.564 -1.273 . . . . 74.140000000000001 107.564 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.96 165.16 22.89 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.01 0.433 . . . . 72.230000000000004 111.546 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.38 48.2 Favored Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.381 -0.827 . . . . 74.040000000000006 113.743 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -88.18 -15.47 35.92 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.987 -0.746 . . . . 74.010000000000005 108.987 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.39 10.83 37.67 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 111.037 -0.825 . . . . 65.310000000000002 111.037 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 71.4 m-85 -124.69 151.75 44.58 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 121.44 0.638 . . . . 73.049999999999997 110.686 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.631 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.7 m -74.19 147.22 42.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.464 -0.789 . . . . 64.430000000000007 109.271 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.15 159.68 32.26 Favored Glycine 0 CA--C 1.472 -2.637 0 N-CA-C 110.321 -1.112 . . . . 72.140000000000001 110.321 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -63.69 161.39 15.1 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.196 0.586 . . . . 74.030000000000001 110.007 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.25 42.69 0.27 Allowed 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.5 1.12 . . . . 71.010000000000005 111.398 -176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -93.13 130.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.98 -1.489 . . . . 64.239999999999995 106.98 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -99.68 -6.95 26.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.904 0.859 . . . . 74.040000000000006 110.334 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.8 -158.02 0.64 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.487 -1.233 . . . . 74.430000000000007 107.871 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.6 93.14 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.554 -0.165 . . . . 75.109999999999999 110.554 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.97 147.72 51.0 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.48 2.787 . . . . 71.140000000000001 112.808 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -109.59 -7.59 15.1 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.477 0.656 . . . . 71.209999999999994 109.391 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 70.91 70.77 0.19 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.707 1.203 . . . . 73.519999999999996 111.241 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 CA--C 1.476 -1.884 0 N-CA-C 106.719 -1.586 . . . . 73.129999999999995 106.719 174.615 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 113.269 0.841 . . . . 62.240000000000002 113.269 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -99.07 -55.39 2.71 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.27 -0.877 . . . . 71.230000000000004 110.277 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.85 142.92 13.95 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 106.394 -1.706 . . . . 61.32 106.394 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.69 -39.76 4.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 116.579 -0.282 . . . . 73.319999999999993 111.68 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -89.25 -41.19 12.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.178 -1.045 . . . . 75.409999999999997 108.178 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -87.46 136.98 32.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.737 -1.12 . . . . 73.030000000000001 109.463 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 108.66 12.04 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 123.373 0.42 . . . . 74.510000000000005 111.594 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 35.1 Cg_endo -89.4 123.89 1.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.332 2.021 . . . . 73.030000000000001 109.914 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.9 pttt -100.07 145.69 27.64 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.995 -0.682 . . . . 75.430000000000007 111.416 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.4 p -124.1 152.07 43.16 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.631 0.253 . . . . 74.519999999999996 110.876 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -110.2 -36.13 5.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.524 -1.658 . . . . 73.109999999999999 106.524 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -132.38 151.89 51.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.36 -1.291 . . . . 74.439999999999998 109.184 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.45 -40.9 88.35 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.951 0.881 . . . . 73.230000000000004 109.343 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 p -63.33 -18.46 63.65 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.649 -1.614 . . . . 55.229999999999997 114.47 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.305 2.6 p30 -78.91 -9.1 59.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 118.668 -1.213 . . . . 75.099999999999994 112.051 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -125.99 106.77 25.36 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.230000000000004 109.347 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.06 -168.2 0.49 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 123.412 2.741 . . . . 75.219999999999999 115.792 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.47 -128.32 32.78 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 113.85 -1.523 . . . . 70.120000000000005 112.167 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.65 6.58 46.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.417 -0.392 . . . . 75.400000000000006 110.87 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.5 m -93.72 147.85 22.65 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 111.98 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 pt -138.0 177.06 5.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 114.052 -1.431 . . . . 71.109999999999999 107.97 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -97.9 124.63 42.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.565 -0.902 . . . . 71.340000000000003 108.565 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 1.6 mmp_? -98.01 167.77 10.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 O-C-N 122.193 -0.317 . . . . 73.510000000000005 110.765 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.26 -9.14 56.98 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 114.424 0.53 . . . . 75.439999999999998 114.424 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -88.84 -17.57 29.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.45 0.643 . . . . 71.329999999999998 109.398 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.26 17.83 23.5 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.888 -0.885 . . . . 52.450000000000003 110.888 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 70.9 m-85 -121.08 151.98 39.21 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.165 0.507 . . . . 71.329999999999998 111.938 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.5 m -79.49 109.76 14.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.169 -0.923 . . . . 71.319999999999993 109.674 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.79 163.63 12.78 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 109.112 -1.595 . . . . 61.049999999999997 109.112 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -80.27 166.36 21.44 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.744 -1.576 . . . . 63.340000000000003 106.744 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.38 74.07 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.864 0.364 . . . . 64.25 110.259 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.73 -62.01 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-O 121.319 0.58 . . . . 75.129999999999995 110.912 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -87.38 95.62 10.07 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 115.261 -0.882 . . . . 74.439999999999998 112.848 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.15 -22.6 18.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.358 -0.837 . . . . 72.450000000000003 110.939 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.95 156.09 84.44 Favored Pre-proline 0 C--O 1.254 1.298 0 CA-C-N 115.651 -0.704 . . . . 71.219999999999999 109.259 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.12 84.56 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.108 1.872 . . . . 71.109999999999999 111.321 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.4 -50.94 0.13 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 108.954 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.12 72.44 1.21 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.67 . . . . 71.510000000000005 112.274 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 28' ' ' CYS . 37.5 mtm180 . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 107.209 -1.404 . . . . 74.540000000000006 107.209 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.251 1.177 0 CA-C-O 121.523 0.678 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.05 135.06 33.59 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 155.59 38.07 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mt -103.97 -40.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 O-C-N 123.672 0.608 . . . . 0.0 110.798 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -89.39 -40.53 12.68 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.406 0.622 . . . . 0.0 110.501 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.47 49.53 1.2 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.389 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.67 122.87 86.4 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.387 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.43 120.32 5.88 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.047 1.831 . . . . 0.0 109.81 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.4 pttt -76.08 158.94 31.27 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.885 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.8 p -120.22 150.49 40.58 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.207 0.527 . . . . 0.0 111.823 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 73.5 mtm180 -110.92 -47.57 3.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 13.5 ptm180 -141.1 159.24 42.63 Favored 'General case' 0 CA--C 1.477 -1.857 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.085 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.63 -36.92 70.04 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.216 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 p -67.04 -27.65 67.57 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.539 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 11' ' ' ARG 0.281 1.7 p30 -86.46 10.31 15.57 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.618 178.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.2 m -93.63 136.68 23.81 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.541 173.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.43 152.7 71.16 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.621 2.881 . . . . 0.0 113.521 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 -114.52 6.93 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.507 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.96 15.27 7.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.04 153.87 20.53 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 pt -113.2 172.18 3.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.9 t -89.68 103.39 16.05 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -74.08 166.21 23.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.256 0.55 . . . . 0.0 111.512 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.94 -2.56 47.06 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.845 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.427 HD21 ' HB2' ' A' ' 27' ' ' TYR . 32.4 p-10 -89.89 -17.05 28.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.79 31.42 Favored Glycine 0 CA--C 1.498 -0.991 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 85.4 m-85 -128.43 160.72 31.37 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.443 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.9 m -80.27 140.88 36.0 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.305 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.01 161.44 35.03 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 39' ' ' ARG . 9.2 tp10 -64.63 162.1 16.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.256 0.528 . . . . 0.0 109.846 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.79 -49.56 17.74 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mm -116.12 122.69 70.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -73.45 -29.97 62.89 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.26 0.552 . . . . 0.0 110.818 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.0 -28.15 65.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.577 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.67 111.16 23.64 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.392 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 5.4 Cg_exo -79.66 99.47 1.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.333 0 C-N-CA 121.077 1.184 . . . . 0.0 110.365 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -134.46 -75.73 0.47 Allowed 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 86.94 2.05 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.334 0.588 . . . . 0.0 110.82 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.549 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 84.1 mtp180 . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.927 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.631 -1.618 . . . . 64.129999999999995 106.631 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.07 139.87 30.35 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 113.72 -1.582 . . . . 74.420000000000002 109.041 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.52 130.18 6.61 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.63 -1.248 . . . . 64.219999999999999 107.63 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.64 -27.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 112.529 0.566 . . . . 70.450000000000003 112.529 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.63 -44.28 10.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.249 -0.907 . . . . 62.009999999999998 109.195 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.7 86.81 2.24 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.481 -0.781 . . . . 64.420000000000002 110.376 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.0 123.94 90.18 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.552 -0.749 . . . . 74.049999999999997 109.407 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.63 110.1 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 112.105 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 20.6 pttp -80.82 153.51 27.67 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 110.772 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 19.2 p -135.8 151.34 49.98 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.265 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -105.97 -36.64 6.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.249 -1.759 . . . . 74.129999999999995 106.249 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -136.5 161.41 35.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.659 -1.61 . . . . 72.540000000000006 109.916 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 4.8 m-20 -63.46 -30.75 71.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.958 0.903 . . . . 65.409999999999997 111.494 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -69.18 -15.08 63.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.335 -0.848 . . . . 74.420000000000002 112.697 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -73.34 -16.0 61.37 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.358 -0.608 . . . . 65.319999999999993 109.358 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.59 123.62 47.33 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 109.015 -0.735 . . . . 70.010000000000005 109.015 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.8 -174.69 0.73 Allowed 'Trans proline' 0 C--O 1.258 1.475 0 C-N-CA 122.692 2.261 . . . . 75.319999999999993 112.716 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.89 -102.21 0.68 Allowed Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.34 -0.845 . . . . 75.310000000000002 112.411 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.74 11.72 2.69 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.242 0.544 . . . . 50.140000000000001 109.692 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.8 m -84.36 151.67 24.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 110.542 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.9 pt -118.09 171.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.219 -1.03 . . . . 72.109999999999999 108.219 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 46.1 t -94.52 107.63 19.61 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.424 -0.954 . . . . 71.319999999999993 108.424 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -73.32 166.44 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.65 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.21 -8.72 45.37 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 114.48 0.552 . . . . 52.219999999999999 114.48 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -89.25 -19.09 25.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.047 0.451 . . . . 63.030000000000001 109.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.77 23.41 10.88 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.078 -0.809 . . . . 63.409999999999997 111.078 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 74.6 m-85 -127.18 151.46 48.64 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 122.841 0.457 . . . . 74.200000000000003 110.768 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.4 m -79.53 128.37 33.29 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.58 -0.737 . . . . 73.209999999999994 111.434 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.25 168.64 35.26 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.598 -1.401 . . . . 60.140000000000001 109.598 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 8.9 tp10 -78.52 167.31 21.47 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.634 -0.876 . . . . 75.030000000000001 108.634 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.908 0.861 . . . . 73.019999999999996 109.166 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.628 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 57.6 mt -96.48 150.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 105.615 -1.994 . . . . 72.439999999999998 105.615 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -59.93 -59.32 5.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 111.32 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 123.05 41.08 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.959 -1.497 . . . . 71.0 106.959 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -73.16 132.39 82.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 109.848 -0.427 . . . . 74.120000000000005 109.848 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 52.7 Cg_exo -55.81 -45.09 41.52 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.419 2.746 . . . . 73.510000000000005 114.355 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -150.05 -50.81 0.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.996 -0.372 . . . . 64.049999999999997 109.996 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.68 70.76 6.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.722 0.772 . . . . 72.230000000000004 109.532 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HG2' ' HB3' ' A' ' 35' ' ' ALA . 66.7 mtp180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-N 114.476 -1.238 . . . . 75.319999999999993 109.518 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.41 -2.474 0 N-CA-C 103.944 -2.613 . . . . 64.430000000000007 103.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -88.08 143.95 26.78 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 120.901 0.381 . . . . 62.109999999999999 109.996 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.59 36.33 3.56 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.404 -0.816 . . . . 74.349999999999994 110.109 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.11 -50.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.612 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.28 -34.82 12.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.798 0.809 . . . . 55.520000000000003 109.079 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.0 104.73 3.72 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.997 -1.456 . . . . 51.229999999999997 109.152 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.2 116.12 56.33 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 110.649 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.47 114.97 2.93 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.637 2.225 . . . . 73.530000000000001 111.859 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -89.68 159.62 17.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.357 -0.979 . . . . 63.219999999999999 108.357 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 18.7 p -152.26 158.78 43.3 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.266 0.555 . . . . 44.350000000000001 111.685 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -119.78 -35.83 3.43 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.311 -1.366 . . . . 73.349999999999994 107.311 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -125.75 156.82 38.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.585 -1.189 . . . . 73.450000000000003 109.287 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -63.16 -32.24 73.58 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.027 0.931 . . . . 74.030000000000001 110.971 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -65.83 -16.31 63.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.655 -1.157 . . . . 62.130000000000003 113.182 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.79 -14.51 59.56 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.137 0.494 . . . . 62.409999999999997 109.831 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.1 m -89.75 130.36 43.26 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.884 -0.598 . . . . 61.450000000000003 112.136 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.92 -179.75 5.5 Favored 'Trans proline' 0 C--O 1.27 2.123 0 C-N-CA 122.503 2.135 . . . . 74.340000000000003 112.112 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 -116.8 9.3 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.098 -0.956 . . . . 34.43 111.501 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.73 19.67 3.55 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.519 -0.919 . . . . 73.409999999999997 108.519 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.8 m -77.59 150.81 34.65 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.09 -0.959 . . . . 64.439999999999998 110.267 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -109.05 174.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.966 -0.753 . . . . 74.129999999999995 108.966 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.16 118.65 30.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.738 -0.838 . . . . 75.400000000000006 108.738 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -87.66 170.5 11.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.737 -0.21 . . . . 73.140000000000001 110.72 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.64 -6.59 50.88 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 114.347 0.499 . . . . 72.030000000000001 114.347 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -89.47 -17.71 28.16 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.935 0.398 . . . . 74.319999999999993 110.541 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 22.86 21.41 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.567 -1.013 . . . . 61.039999999999999 110.567 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.18 147.21 48.16 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 124.571 1.148 . . . . 63.439999999999998 110.746 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.6 m -81.07 139.44 35.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.855 -1.066 . . . . 65.230000000000004 112.167 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.5 147.24 12.37 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.491 -1.044 . . . . 61.119999999999997 110.491 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 7.9 tp10 -72.59 161.78 30.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.745 -0.835 . . . . 70.030000000000001 108.745 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.56 74.19 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.615 0.766 . . . . 65.439999999999998 109.995 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 40.1 mt -118.6 135.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.225 0 N-CA-C 106.965 -1.494 . . . . 74.120000000000005 106.965 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -75.34 -33.78 61.15 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.003 0.43 . . . . 64.319999999999993 110.449 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.96 0.79 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.937 0.717 . . . . 75.209999999999994 112.937 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.47 124.04 87.18 Favored Pre-proline 0 C--O 1.212 -0.894 0 N-CA-C 108.953 -0.758 . . . . 72.420000000000002 108.953 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -50.97 -53.24 7.49 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.429 2.753 . . . . 71.430000000000007 115.138 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -127.42 -26.14 3.09 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 111.866 0.321 . . . . 74.129999999999995 111.866 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.3 26.19 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.411 0.893 . . . . 63.439999999999998 113.411 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-O 121.939 0.876 . . . . 75.25 112.087 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 121.408 0.623 . . . . 74.400000000000006 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -89.95 149.09 22.74 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.269 -0.878 . . . . 74.129999999999995 111.414 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 93.5 8.88 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.05 -0.977 . . . . 72.319999999999993 109.057 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.75 -63.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.659 -1.608 . . . . 75.010000000000005 106.659 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -99.19 -34.05 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -177.11 148.51 0.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.886 -1.506 . . . . 63.409999999999997 108.447 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 140.73 49.66 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.11 -0.7 . . . . 63.509999999999998 109.11 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.45 131.04 40.37 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 110.767 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.91 147.55 26.2 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.857 -0.424 . . . . 74.409999999999997 109.857 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.8 p -126.27 155.35 42.05 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 75.510000000000005 111.93 -175.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -120.45 -34.48 3.62 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.631 -1.248 . . . . 74.239999999999995 107.631 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -132.82 160.19 37.61 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.879 1.272 . . . . 75.400000000000006 108.803 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.59 -32.54 74.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.425 0.631 . . . . 75.109999999999999 110.717 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -68.38 -13.0 61.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.989 -1.005 . . . . 61.310000000000002 113.182 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.55 -28.41 62.82 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.687 -0.857 . . . . 64.099999999999994 108.687 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.2 m -89.82 132.78 35.52 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.827 -1.079 . . . . 71.099999999999994 109.397 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.14 139.9 17.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.302 2.001 . . . . 71.230000000000004 114.405 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.14 -102.68 0.13 Allowed Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 116.087 1.195 . . . . 74.129999999999995 116.087 172.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -91.79 -5.81 52.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.218 0.451 . . . . 62.210000000000001 112.218 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.27 140.18 36.32 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.231 0.538 . . . . 74.209999999999994 110.2 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -120.61 172.14 8.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.335 -1.357 . . . . 62.329999999999998 107.335 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.6 t -89.62 114.36 25.95 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.782 -0.822 . . . . 72.25 108.782 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 76.2 mtp180 -88.83 164.54 15.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.886 -0.413 . . . . 74.329999999999998 109.886 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.5 45.97 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 114.0 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.9 p-10 -89.62 -14.4 35.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.929 -0.767 . . . . 75.219999999999999 108.929 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.24 16.7 34.13 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.353 -0.84 . . . . 33.32 111.043 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -125.51 152.18 45.34 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.25 0.547 . . . . 75.319999999999993 110.31 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.47 134.97 36.04 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.903 -1.044 . . . . 51.329999999999998 110.296 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.02 145.26 11.5 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.65 -0.98 . . . . 72.239999999999995 110.65 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 31' ' ' ALA . 18.8 tt0 -65.37 146.57 54.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.143 -0.688 . . . . 34.149999999999999 109.143 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 30' ' ' GLU . . . -80.7 -86.16 0.09 Allowed 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.579 -0.897 . . . . 52.549999999999997 108.579 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 mt -149.62 93.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 105.593 -2.002 . . . . 65.209999999999994 105.593 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -139.13 -168.71 2.49 Favored 'General case' 0 C--N 1.246 -3.916 0 C-N-CA 123.868 0.867 . . . . 74.530000000000001 108.967 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.3 35.83 4.04 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.185 -0.672 . . . . 73.540000000000006 109.185 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 38' ' ' ALA . . . -71.46 117.75 59.97 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.599 -0.728 . . . . 44.340000000000003 111.988 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 Cg_exo -64.47 -35.86 46.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 113.55 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -129.83 -19.75 3.26 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.697 -0.401 . . . . 73.219999999999999 111.98 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . . . -83.17 33.92 0.46 Allowed 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.939 -0.476 . . . . 70.219999999999999 112.284 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.398 -0.964 . . . . 73.230000000000004 108.398 173.006 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.52 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 30.5 p . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 106.375 -1.713 . . . . 72.439999999999998 106.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.83 152.79 35.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.746 -0.835 . . . . 71.120000000000005 108.746 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.48 58.14 4.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.993 0.901 . . . . 71.5 112.099 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.82 -55.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.239 -1.023 . . . . 75.129999999999995 108.239 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -89.99 -33.75 16.25 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.527 -0.76 . . . . 75.140000000000001 108.962 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.28 119.67 6.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.125 -0.943 . . . . 72.030000000000001 109.3 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 107.91 8.51 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 122.915 0.486 . . . . 34.130000000000003 111.83 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 56.5 Cg_endo -96.67 125.91 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.742 2.295 . . . . 74.219999999999999 111.179 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -97.49 149.87 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.321 -0.622 . . . . 70.219999999999999 109.321 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -130.52 157.07 43.68 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.095 0.474 . . . . 74.099999999999994 111.823 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -117.48 -51.14 2.51 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.193 -2.151 . . . . 74.25 105.193 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -123.05 158.06 31.41 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 113.98 -1.464 . . . . 73.019999999999996 109.564 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.31 -29.85 70.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.174 0.511 . . . . 75.530000000000001 112.134 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.0 p -66.41 -21.27 66.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.327 -0.851 . . . . 74.340000000000003 111.669 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.57 -20.57 63.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.226 0.536 . . . . 63.530000000000001 109.986 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -94.14 119.84 66.23 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 115.303 -0.862 . . . . 71.409999999999997 109.78 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.15 141.2 32.18 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.847 2.365 . . . . 72.239999999999995 115.139 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.95 -108.84 2.61 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 114.446 -1.252 . . . . 41.509999999999998 114.235 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -102.37 -2.23 29.29 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.598 -0.519 . . . . 73.239999999999995 109.598 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.1 m -73.55 139.95 45.98 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.933 -0.766 . . . . 71.030000000000001 108.933 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.27 169.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 108.031 -1.1 . . . . 54.130000000000003 108.031 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.56 115.94 28.45 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.481 -0.563 . . . . 53.350000000000001 109.481 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -88.92 161.46 16.64 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.277 -0.638 . . . . 72.349999999999994 109.277 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.98 -2.56 47.42 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 113.43 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -89.5 -18.9 25.8 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.638 0.256 . . . . 71.400000000000006 110.87 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.34 4.71 32.74 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.515 -0.634 . . . . 71.340000000000003 111.515 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.77 146.55 36.17 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.584 0.754 . . . . 73.400000000000006 110.874 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.0 m -80.98 148.85 29.58 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.353 -0.84 . . . . 64.230000000000004 109.01 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 1' ' ' CYS . . . -176.3 152.01 12.21 Favored Glycine 0 N--CA 1.416 -2.692 0 C-N-CA 118.971 -1.585 . . . . 63.119999999999997 112.772 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.73 140.67 28.92 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.356 1.062 . . . . 71.340000000000003 109.502 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -85.61 0.11 Allowed 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 114.28 -1.327 . . . . 75.349999999999994 109.9 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.3 mt -153.53 102.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 105.678 -1.971 . . . . 72.109999999999999 105.678 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.5 t80 179.86 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.824 0 O-C-N 124.275 0.985 . . . . 60.520000000000003 108.672 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.73 60.15 1.1 Allowed 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.568 -1.196 . . . . 75.340000000000003 109.881 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . . . -72.84 123.3 89.41 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.748 -1.114 . . . . 70.209999999999994 110.522 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -43.15 -49.33 7.27 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 124.634 3.556 . . . . 62.409999999999997 115.568 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -107.21 -16.9 14.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.32 0.581 . . . . 65.150000000000006 111.307 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' H ' ' A' ' 19' ' ' ALA . . . -94.31 17.21 13.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.095 0.776 . . . . 64.439999999999998 113.095 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 . . . . . 0 C--N 1.285 -2.213 0 CA-C-N 115.208 -0.905 . . . . 65.5 110.973 177.544 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.999 0.904 . . . . 74.329999999999998 109.633 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.61 147.99 24.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.702 -1.135 . . . . 71.510000000000005 108.445 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.94 142.9 12.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.39 -0.967 . . . . 61.240000000000002 108.39 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.46 -23.08 4.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.74 -0.664 . . . . 64.510000000000005 110.384 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -89.23 -42.29 11.71 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.477 -0.489 . . . . 74.420000000000002 110.136 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.02 89.04 1.42 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.145 -0.479 . . . . 65.450000000000003 112.032 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -80.39 126.74 78.11 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.869 -0.605 . . . . 51.350000000000001 109.649 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.0 Cg_exo -66.09 119.82 6.9 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.709 2.272 . . . . 74.099999999999994 113.125 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 99.4 mttt -83.89 134.26 34.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.978 -0.749 . . . . 75.340000000000003 108.978 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.5 p -100.07 147.76 25.29 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.986 0.422 . . . . 71.439999999999998 112.033 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -109.2 -31.33 7.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.636 -1.246 . . . . 72.319999999999993 107.636 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -148.52 156.6 42.66 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.302 -1.317 . . . . 55.439999999999998 109.246 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 13.2 m-20 -59.53 -37.73 79.13 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.092 0.949 . . . . 73.109999999999999 110.311 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -71.82 -12.15 61.15 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.078 -1.419 . . . . 60.43 114.018 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.42 0.21 53.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.348 -0.941 . . . . 71.409999999999997 110.905 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 90.0 m -91.13 136.22 27.53 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 109.77 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 179.44 5.95 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.565 2.177 . . . . 63.539999999999999 112.967 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.66 -122.75 31.07 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.359 -0.837 . . . . 72.349999999999994 112.048 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.38 19.47 13.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.704 -0.85 . . . . 44.32 108.704 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.3 m -81.2 145.78 30.81 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.216 -0.902 . . . . 74.510000000000005 112.511 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 13' ' ' ASP . 30.7 pt -119.73 179.15 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.059 -1.46 . . . . 70.510000000000005 107.059 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -90.63 117.93 29.67 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.44 -0.948 . . . . 73.030000000000001 108.44 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -89.02 160.05 17.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.38 -1.12 41.7 Favored Glycine 0 C--N 1.31 -0.892 0 CA-C-N 115.931 -0.577 . . . . 75.239999999999995 113.411 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -89.66 -19.53 24.75 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.694 -0.484 . . . . 73.439999999999998 109.694 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 2.44 34.21 Favored Glycine 0 CA--C 1.499 -0.952 0 N-CA-C 111.486 -0.646 . . . . 74.030000000000001 111.486 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 95.7 m-85 -114.69 161.65 17.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 123.414 0.685 . . . . 72.510000000000005 109.997 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 76.6 m -80.26 142.01 35.0 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.579 -0.526 . . . . 61.32 109.579 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.21 146.84 14.71 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.9 -1.28 . . . . 72.049999999999997 109.9 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.3 tt0 -59.94 148.51 34.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.64 0.733 . . . . 72.239999999999995 110.597 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.39 -151.85 0.09 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.473 -1.239 . . . . 63.539999999999999 107.736 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.5 mm -95.82 136.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 C-N-CA 119.398 -0.921 . . . . 72.25 110.413 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.583 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 22.7 t80 -170.82 154.46 4.32 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 102.731 -3.062 . . . . 73.219999999999999 102.731 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.24 3.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 119.061 0.846 . . . . 63.009999999999998 110.341 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.63 155.06 73.78 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.441 -0.8 . . . . 62.409999999999997 109.078 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.92 125.47 11.57 Favored 'Trans proline' 0 C--O 1.241 0.639 0 N-CA-C 108.23 -1.488 . . . . 71.140000000000001 108.23 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -109.65 -46.34 3.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.006 0.432 . . . . 63.409999999999997 110.43 -173.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.3 78.58 1.02 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.664 -0.698 . . . . 63.409999999999997 109.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 115.368 -0.833 . . . . 74.409999999999997 108.795 178.601 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 122.39 1.091 . . . . 60.549999999999997 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.67 165.94 10.73 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.621 -1.172 . . . . 74.209999999999994 112.188 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.18 126.17 12.04 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.457 -1.683 . . . . 74.420000000000002 106.457 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.9 mt -93.67 -23.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 120.976 0.417 . . . . 62.140000000000001 111.629 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -87.83 -42.53 12.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.008 -0.677 . . . . 63.030000000000001 109.304 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.19 82.68 1.93 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.02 -0.991 . . . . 65.340000000000003 108.849 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -64.87 122.45 79.31 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.284 -0.871 . . . . 62.219999999999999 111.494 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -74.15 127.43 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.492 2.128 . . . . 63.530000000000001 109.923 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.0 pttm -94.49 156.89 16.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.55 -0.167 . . . . 64.120000000000005 110.55 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 15.2 p -142.55 157.68 44.46 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.507 0.194 . . . . 75.129999999999995 110.903 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 11' ' ' ARG . 71.6 mtt180 -111.57 -42.51 3.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.145 -1.428 . . . . 71.510000000000005 107.145 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -127.5 157.52 39.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.758 -1.564 . . . . 71.400000000000006 108.631 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 9.2 m-20 -61.89 -34.93 76.92 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.365 -0.834 . . . . 64.340000000000003 111.248 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -64.66 -21.62 66.77 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.526 -1.216 . . . . 71.439999999999998 112.584 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.19 -29.5 70.32 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.393 -0.595 . . . . 63.340000000000003 109.393 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 44.3 m -89.97 121.2 69.08 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 115.754 -0.657 . . . . 73.120000000000005 109.333 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.83 -177.55 2.59 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.45 2.1 . . . . 74.430000000000007 112.491 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.73 -132.75 51.42 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.575 -0.739 . . . . 63.310000000000002 111.926 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.33 11.08 33.91 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.606 0.241 . . . . 73.129999999999995 110.823 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.4 m -84.7 149.23 25.94 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.882 0.848 . . . . 73.219999999999999 112.63 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.25 175.71 10.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 113.858 -1.519 . . . . 74.439999999999998 107.683 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 37.8 t -97.25 110.85 23.32 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.07 -0.715 . . . . 41.030000000000001 109.07 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -74.15 169.36 17.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 111.649 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.93 -14.53 61.17 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 115.438 -0.801 . . . . 61.119999999999997 112.997 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.32 -16.27 33.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.082 0.468 . . . . 72.209999999999994 111.49 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.46 17.1 32.29 Favored Glycine 0 CA--C 1.485 -1.803 0 C-N-CA 120.233 -0.984 . . . . 40.399999999999999 111.05 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 71.1 m-85 -121.18 147.16 45.98 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.66 -0.77 . . . . 73.420000000000002 109.268 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 71.9 m -70.82 127.92 34.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.065 -0.516 . . . . 53.310000000000002 110.725 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.33 153.82 20.57 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.139 -1.184 . . . . 64.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -79.28 178.11 8.32 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.47 -0.566 . . . . 72.450000000000003 109.47 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.15 -72.69 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.074 0.549 . . . . 62.399999999999999 112.133 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.0 mt -138.78 146.96 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.811 -1.181 . . . . 71.299999999999997 107.811 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.639 -1.245 . . . . 51.119999999999997 107.639 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.56 -81.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.011 -0.737 . . . . 73.319999999999993 109.011 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 36' ' ' PRO 0.27 . . -80.54 -50.89 1.05 Allowed Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 120.471 -0.492 . . . . 75.409999999999997 110.429 170.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 20.9 Cg_exo -64.38 142.57 79.46 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.42 2.08 . . . . 71.040000000000006 107.816 167.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -119.95 25.5 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.204 0.526 . . . . 72.129999999999995 111.989 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.8 39.19 4.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.806 0.843 . . . . 50.030000000000001 110.199 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-N 114.596 -1.184 . . . . 75.510000000000005 111.31 -174.626 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 108.628 -0.879 . . . . 63.439999999999998 108.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.36 170.02 9.8 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.769 -1.105 . . . . 52.109999999999999 109.936 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.78 144.37 4.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.928 -1.508 . . . . 75.510000000000005 106.928 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.4 mt -105.0 -21.48 5.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.093 0.473 . . . . 64.409999999999997 110.367 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -88.23 -43.87 11.28 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.234 -1.024 . . . . 75.310000000000002 108.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.11 77.99 1.36 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.041 -1.096 . . . . 61.200000000000003 108.041 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 116.64 31.82 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 115.289 -0.869 . . . . 54.140000000000001 110.679 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.83 118.36 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.791 2.328 . . . . 64.310000000000002 111.453 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 96.8 mttt -86.15 163.22 17.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.981 -0.554 . . . . 65.450000000000003 110.636 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.1 p -139.21 148.68 43.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.933 -0.576 . . . . 75.510000000000005 109.996 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -115.67 -40.32 3.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.452 -1.685 . . . . 73.010000000000005 106.452 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -132.96 160.98 35.52 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.712 1.605 . . . . 65.349999999999994 108.004 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.08 -30.71 71.68 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.537 0.684 . . . . 31.23 111.47 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -67.41 -17.26 64.65 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.064 -0.971 . . . . 65.409999999999997 112.125 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -67.11 -23.92 65.88 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.159 0.504 . . . . 62.100000000000001 109.646 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.77 137.68 26.81 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-N 115.316 -0.856 . . . . 64.030000000000001 110.055 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -86.18 177.61 4.47 Favored 'Trans proline' 0 C--O 1.253 1.272 0 C-N-CA 122.541 2.16 . . . . 71.010000000000005 112.572 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.02 -124.18 35.89 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.036 -0.984 . . . . 43.049999999999997 112.885 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.66 13.12 21.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.787 0.327 . . . . 53.020000000000003 110.167 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.38 155.22 32.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.305 0.574 . . . . 74.319999999999993 112.01 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.86 174.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.623 -0.88 . . . . 74.230000000000004 108.623 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.03 115.5 28.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.689 -0.856 . . . . 74.510000000000005 108.689 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -84.85 165.72 17.48 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.108 0.48 . . . . 65.540000000000006 111.172 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.15 7.3 37.5 Favored Glycine 0 CA--C 1.51 -0.226 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 112.854 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -95.2 -16.36 22.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.617 -0.512 . . . . 74.299999999999997 109.617 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.01 11.97 41.31 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.729 -0.948 . . . . 74.109999999999999 110.729 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 89.9 m-85 -127.87 160.8 30.71 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.458 -0.871 . . . . 70.319999999999993 110.775 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.3 m -80.0 140.54 36.54 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.602 -0.726 . . . . 73.310000000000002 111.368 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.65 176.6 39.73 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.124 -1.19 . . . . 51.210000000000001 110.124 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 9.3 tp10 -74.68 173.74 10.07 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.821 0.848 . . . . 54.100000000000001 109.414 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.59 -24.64 63.71 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.191 0.996 . . . . 45.25 108.405 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.62 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 53.3 mt -92.57 149.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 105.853 -1.906 . . . . 64.310000000000002 105.853 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -44.75 -47.08 10.78 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.318 1.047 . . . . 71.549999999999997 113.275 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -119.58 135.45 54.79 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.776 -0.824 . . . . 72.540000000000006 108.776 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.74 110.03 15.6 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.599 0.562 . . . . 74.439999999999998 111.933 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 70.7 Cg_endo -83.57 -38.32 0.14 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.522 2.148 . . . . 63.409999999999997 114.071 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -117.15 -51.42 2.54 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.444 0.64 . . . . 73.25 109.882 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 56.71 3.57 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.779 0.799 . . . . 45.140000000000001 108.944 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 . . . . . 0 N--CA 1.426 -1.625 0 CA-C-N 115.352 -0.84 . . . . 62.32 109.237 -179.298 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.296 -1.372 . . . . 54.539999999999999 107.296 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -89.52 123.66 33.82 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.016 0.912 . . . . 73.340000000000003 109.705 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -149.72 100.82 3.01 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 114.165 -1.38 . . . . 55.509999999999998 108.887 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 mm -91.38 -13.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.362 -0.835 . . . . 74.109999999999999 109.878 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.11 -45.41 9.61 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.416 -0.811 . . . . 63.530000000000001 109.754 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.71 96.13 2.08 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.562 -0.745 . . . . 73.349999999999994 109.316 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 3' ' ' ALA . . . -72.57 126.41 90.83 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 115.91 -0.587 . . . . 64.219999999999999 110.166 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.55 116.41 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.539 2.159 . . . . 64.219999999999999 112.788 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -70.77 148.2 48.16 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.289 -1.004 . . . . 44.420000000000002 108.289 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 29.9 p -117.74 150.58 38.87 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 120.981 -0.288 . . . . 52.229999999999997 110.264 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.73 -43.66 2.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.278 -1.379 . . . . 72.219999999999999 107.278 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -132.18 153.1 50.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.64 -1.164 . . . . 53.520000000000003 108.729 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 6.1 m-20 -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.319 -0.855 . . . . 75.019999999999996 110.606 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -68.02 -19.26 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.64 -1.164 . . . . 73.530000000000001 113.284 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.23 -3.71 59.06 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.067 -1.053 . . . . 55.530000000000001 111.004 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -94.22 118.29 67.11 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 109.401 -0.592 . . . . 71.0 109.401 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.89 -175.44 2.68 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.586 2.19 . . . . 71.299999999999997 111.53 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.1 13.98 60.68 Favored Glycine 0 N--CA 1.465 0.599 0 CA-C-N 116.643 -0.253 . . . . 64.409999999999997 112.829 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.66 8.97 5.64 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.655 1.582 . . . . 70.519999999999996 111.129 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.76 149.17 50.28 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.047 -0.524 . . . . 65.140000000000001 109.629 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 44.9 pt -110.92 174.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.772 -0.825 . . . . 73.209999999999994 108.772 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -95.56 107.32 19.49 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.277 -1.008 . . . . 60.299999999999997 108.277 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -84.18 168.55 15.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.397 0.617 . . . . 72.230000000000004 110.857 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.45 2.25 63.14 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.295 -0.866 . . . . 75.340000000000003 112.398 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -88.74 -17.97 28.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.926 . . . . 65.140000000000001 108.501 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.8 6.94 42.7 Favored Glycine 0 CA--C 1.487 -1.673 0 N-CA-C 111.274 -0.731 . . . . 73.219999999999999 111.274 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.69 159.34 28.15 Favored 'General case' 0 N--CA 1.414 -2.255 0 C-N-CA 123.331 0.652 . . . . 71.010000000000005 110.39 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.2 m -80.21 131.94 35.78 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.254 -0.885 . . . . 44.229999999999997 108.633 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.47 170.01 30.38 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.633 -1.387 . . . . 65.549999999999997 109.633 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 42.4 tt0 -69.6 157.74 36.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 117.643 0.722 . . . . 65.239999999999995 110.062 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 -141.83 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.648 -1.242 . . . . 74.209999999999994 107.648 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.2 mt -101.97 130.51 51.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.647 -1.242 . . . . 75.430000000000007 107.647 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 37.1 t80 -165.58 167.89 16.93 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.669 -1.604 . . . . 71.310000000000002 106.669 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.7 -80.26 0.16 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.403 0.547 . . . . 75.019999999999996 112.069 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.5 151.09 71.41 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 109.735 -0.469 . . . . 75.109999999999999 109.735 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -64.77 112.69 2.06 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.706 1.604 . . . . 60.420000000000002 111.271 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -138.17 -39.23 0.54 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.115 0.783 . . . . 71.239999999999995 113.115 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.22 43.49 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.67 -0.863 . . . . 73.120000000000005 108.67 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 26.2 mtp180 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 114.667 -1.152 . . . . 75.439999999999998 111.433 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.469 0 CA-C-O 122.558 1.17 . . . . 63.420000000000002 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.25 -26.67 22.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.365 -1.743 . . . . 72.340000000000003 107.399 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.04 93.59 9.4 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.865 -1.532 . . . . 43.039999999999999 106.865 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.8 mt -89.62 -16.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.834 -1.075 . . . . 54.409999999999997 111.071 -174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -89.34 -27.34 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.872 -1.159 . . . . 72.420000000000002 107.872 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.61 12.02 34.99 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.938 -1.028 . . . . 73.239999999999995 110.407 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.12 166.19 40.22 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 123.756 0.822 . . . . 72.140000000000001 110.722 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.8 164.54 22.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.786 1.657 . . . . 74.120000000000005 110.716 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.19 162.51 26.54 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.743 0.306 . . . . 72.439999999999998 111.63 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.7 p -151.89 154.49 36.24 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.984 -0.553 . . . . 70.200000000000003 110.809 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -114.93 -34.23 5.16 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.221 -1.029 . . . . 75.430000000000007 108.221 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.85 161.71 34.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.512 -1.222 . . . . 74.319999999999993 110.664 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.91 -33.49 68.83 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.802 0.841 . . . . 62.219999999999999 111.57 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -65.03 -25.21 67.74 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.085 -0.961 . . . . 64.409999999999997 112.407 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.72 -26.76 68.8 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.524 0.678 . . . . 64.25 109.261 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -96.79 128.45 35.74 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.13 -0.941 . . . . 31.420000000000002 110.167 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.02 158.6 4.88 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.67 2.246 . . . . 64.099999999999994 114.547 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.36 -111.81 4.34 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.774 -1.103 . . . . 63.039999999999999 114.746 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.569 ' H ' ' HB3' ' A' ' 38' ' ' ALA . . . -105.45 5.54 31.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.437 0.637 . . . . 74.219999999999999 109.844 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.79 136.15 33.36 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.712 -1.218 . . . . 63.210000000000001 107.712 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.73 177.24 4.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.175 -1.046 . . . . 72.230000000000004 108.175 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -89.31 118.82 29.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.233 -0.987 . . . . 52.32 108.368 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -89.56 166.89 13.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.507 -0.553 . . . . 74.129999999999995 109.507 -177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.53 -8.69 52.88 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 114.221 0.448 . . . . 64.510000000000005 114.221 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -89.07 -17.13 29.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.361 0.6 . . . . 74.450000000000003 109.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.82 19.54 24.19 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 111.277 -0.729 . . . . 63.310000000000002 111.277 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.5 154.59 35.07 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.971 0.908 . . . . 75.439999999999998 109.9 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 93.8 m -80.14 101.59 8.88 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 123.14 0.576 . . . . 51.549999999999997 111.87 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.47 16.79 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.538 -0.839 . . . . 61.229999999999997 111.028 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 33' ' ' TYR . 27.3 tt0 -61.94 159.35 14.27 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.088 0.955 . . . . 62.310000000000002 111.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -71.48 0.16 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.386 -1.279 . . . . 71.310000000000002 110.106 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -133.23 -66.09 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.877 -1.157 . . . . 72.319999999999993 107.877 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.47 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 50.2 t80 -163.75 103.2 0.91 Allowed 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.699 -1.591 . . . . 75.329999999999998 107.562 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.8 167.41 10.31 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.709 -0.678 . . . . 64.530000000000001 111.809 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -80.2 169.51 19.56 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 114.802 -1.09 . . . . 73.120000000000005 108.301 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 20.2 Cg_endo -65.11 92.31 0.21 Allowed 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.303 1.335 . . . . 74.120000000000005 112.389 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -143.76 -55.1 0.37 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 105.735 -1.95 . . . . 71.219999999999999 105.735 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.569 ' HB3' ' H ' ' A' ' 19' ' ' ALA . . . -149.89 97.54 2.6 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.311 -1.737 . . . . 55.030000000000001 106.311 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 . . . . . 0 C--N 1.288 -2.092 0 CA-C-O 121.466 0.65 . . . . 64.129999999999995 109.381 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.422 -1.855 0 CA-C-O 122.108 0.956 . . . . 65.329999999999998 111.264 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -89.76 -35.3 15.81 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.883 -1.508 . . . . 73.219999999999999 108.974 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.63 89.18 7.08 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.378 -1.342 . . . . 62.119999999999997 107.378 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.23 -15.24 8.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.74 -0.664 . . . . 55.229999999999997 111.03 -175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.05 -31.98 18.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.275 -1.38 . . . . 71.219999999999999 107.275 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 25.01 11.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.604 -1.18 . . . . 72.319999999999993 110.122 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.2 126.66 88.2 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 75.420000000000002 109.401 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.21 143.46 44.05 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.901 1.734 . . . . 54.210000000000001 111.473 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 14.9 ptmm? -82.28 158.79 23.33 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.948 -0.39 . . . . 74.340000000000003 109.948 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -132.57 151.54 51.9 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.295 0.569 . . . . 62.340000000000003 111.963 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -101.34 -44.96 5.48 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.264 -2.124 . . . . 72.120000000000005 105.264 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 8.5 ptp180 -129.93 163.2 26.91 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.608 -1.633 . . . . 73.129999999999995 110.18 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.08 -32.12 73.57 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.886 -1.052 . . . . 73.540000000000006 110.815 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -72.72 -4.72 33.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.129 -0.941 . . . . 64.109999999999999 112.969 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 69.5 m-20 -77.71 -23.25 49.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.467 0.651 . . . . 70.510000000000005 109.45 172.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 29.2 m -104.96 127.37 28.89 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 108.656 -0.868 . . . . 73.219999999999999 108.656 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 16' ' ' CYS . 73.6 Cg_endo -100.52 -175.65 0.14 Allowed 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.413 2.076 . . . . 70.040000000000006 113.27 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.64 -108.9 2.63 Favored Glycine 0 CA--C 1.489 -1.545 0 CA-C-N 115.025 -0.989 . . . . 72.549999999999997 113.463 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 30' ' ' GLU . . . -115.23 0.24 13.46 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.174 0.512 . . . . 61.549999999999997 109.969 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 72.2 m -91.99 139.87 30.22 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 122.03 0.919 . . . . 71.140000000000001 111.826 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.79 179.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 113.883 -1.508 . . . . 72.239999999999995 107.065 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.8 t -95.51 104.94 16.86 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.198 -1.038 . . . . 51.229999999999997 108.198 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 74.3 mtp180 -79.96 170.16 16.86 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.453 -0.34 . . . . 71.129999999999995 110.893 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.52 -2.31 27.12 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 115.933 -0.576 . . . . 54.149999999999999 114.011 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 27' ' ' TYR . 32.1 p-10 -88.89 -19.19 26.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.826 -0.805 . . . . 71.019999999999996 108.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.07 32.33 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 110.939 -0.864 . . . . 74.540000000000006 110.939 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.532 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 73.9 m-85 -129.31 157.59 41.47 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.085 -0.558 . . . . 61.030000000000001 110.808 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.37 133.86 47.33 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.244 -0.889 . . . . 73.340000000000003 109.827 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.57 135.69 4.61 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.403 -1.079 . . . . 72.329999999999998 110.403 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 41.8 tt0 -51.36 139.0 20.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.263 1.03 . . . . 74.409999999999997 112.112 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.28 -62.43 1.66 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.873 -1.512 . . . . 63.009999999999998 110.549 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -131.04 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.016 -2.216 . . . . 64.319999999999993 105.016 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -59.93 107.79 0.67 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 123.888 0.742 . . . . 74.129999999999995 110.674 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 -166.22 1.21 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.933 0.716 . . . . 45.539999999999999 112.933 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -75.16 147.96 83.63 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-N 115.38 -0.827 . . . . 72.239999999999995 110.122 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 31.4 Cg_exo -65.25 121.32 8.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.151 2.568 . . . . 64.510000000000005 114.534 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -150.31 -63.17 0.2 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.877 -2.268 . . . . 75.099999999999994 104.877 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.35 95.7 2.76 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.674 -1.602 . . . . 63.32 106.674 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 106.14 -1.8 . . . . 60.420000000000002 106.14 177.633 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.41 -2.452 0 N-CA-C 107.859 -1.163 . . . . 73.340000000000003 107.859 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 38.3 mt-10 -141.89 -170.03 3.04 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.644 -2.354 . . . . 64.409999999999997 104.644 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.57 83.47 4.12 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.934 -0.707 . . . . 72.5 109.396 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.41 -62.38 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.318 -0.993 . . . . 70.120000000000005 108.318 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -88.81 -32.78 17.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.813 -1.18 . . . . 72.209999999999994 107.813 -176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.35 160.02 7.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.245 -1.391 . . . . 62.329999999999998 107.245 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.92 113.43 40.47 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.27 -0.641 . . . . 54.520000000000003 109.27 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -86.8 101.0 0.55 Allowed 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 121.801 1.667 . . . . 74.310000000000002 112.112 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -84.09 157.48 21.73 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.246 -0.65 . . . . 65.129999999999995 109.246 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -140.22 148.04 40.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.319 0.581 . . . . 64.340000000000003 112.063 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -105.42 -40.86 5.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.792 -1.929 . . . . 54.439999999999998 105.792 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -139.11 166.28 24.92 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 114.295 -1.32 . . . . 75.439999999999998 110.987 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.94 -33.85 72.45 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 123.774 0.83 . . . . 70.099999999999994 110.951 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -65.18 -21.44 66.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.868 -1.06 . . . . 64.329999999999998 112.293 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.31 0.576 . . . . 60.409999999999997 110.357 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.49 133.72 30.75 Favored Pre-proline 0 N--CA 1.422 -1.857 0 CA-C-N 115.341 -0.845 . . . . 61.039999999999999 111.008 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.42 177.35 8.63 Favored 'Trans proline' 0 C--O 1.257 1.465 0 C-N-CA 122.804 2.336 . . . . 73.219999999999999 112.76 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.99 -130.58 47.82 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 110.127 -1.189 . . . . 62.119999999999997 110.127 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.97 9.57 22.23 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 109.096 -0.705 . . . . 53.509999999999998 109.096 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.64 148.63 50.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.018 -0.537 . . . . 73.540000000000006 111.208 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -116.9 174.72 3.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 108.951 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.76 121.47 31.94 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 108.021 -1.103 . . . . 75.109999999999999 108.021 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -91.4 158.6 16.42 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.611 -0.885 . . . . 72.219999999999999 108.611 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.73 0.28 28.78 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.744 -0.662 . . . . 71.349999999999994 113.666 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -88.5 -19.68 26.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.12 0.486 . . . . 71.420000000000002 109.709 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.32 25.01 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 111.303 -0.719 . . . . 51.340000000000003 111.303 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -118.71 160.65 21.46 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 123.437 0.695 . . . . 71.319999999999993 111.494 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.8 m -80.39 139.61 36.43 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.989 -1.005 . . . . 73.219999999999999 110.336 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.3 157.41 28.3 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.831 -1.308 . . . . 71.25 109.831 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 10.1 tp10 -73.6 158.81 34.09 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.897 -0.779 . . . . 72.510000000000005 108.897 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.93 -39.01 61.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.945 -1.131 . . . . 54.25 107.945 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.502 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 37.6 mm -82.34 140.2 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.247 -1.761 . . . . 65.0 106.247 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.32 -37.89 60.52 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.284 0.564 . . . . 53.43 110.354 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.7 84.65 5.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 110.792 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -80.46 121.08 81.08 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.844 -0.616 . . . . 62.350000000000001 110.213 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 39.1 Cg_exo -57.39 -42.04 66.05 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.655 2.903 . . . . 63.420000000000002 114.674 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -150.68 -47.16 0.12 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.775 -0.454 . . . . 73.450000000000003 109.775 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.64 67.09 2.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.848 0.832 . . . . 64.209999999999994 110.852 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 2' ' ' GLU . 65.9 mtt180 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-N 114.089 -1.414 . . . . 73.430000000000007 109.916 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.268 -1.382 . . . . 63.140000000000001 107.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 15.9 mt-10 -91.4 176.86 6.41 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 112.877 -1.965 . . . . 73.120000000000005 110.174 -169.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -161.61 150.63 15.98 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 106.777 -1.564 . . . . 73.030000000000001 106.777 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.1 -25.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-O 121.094 0.474 . . . . 70.219999999999999 110.128 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -88.84 -44.49 10.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.896 -0.779 . . . . 65.439999999999998 108.896 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -133.18 88.58 2.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.709 -0.678 . . . . 75.329999999999998 110.338 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.49 132.83 60.89 Favored Pre-proline 0 C--N 1.297 -1.677 0 CA-C-N 115.894 -0.594 . . . . 53.240000000000002 110.962 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.7 Cg_exo -67.36 123.27 10.64 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.18 1.92 . . . . 60.229999999999997 109.396 174.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 62.0 pttt -82.26 163.76 21.62 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.065 -0.654 . . . . 63.229999999999997 111.234 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.1 p -150.99 157.39 42.83 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.197 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 2.8 mmp_? -116.68 -33.91 4.69 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.092 -1.077 . . . . 71.140000000000001 108.092 170.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.79 158.81 32.44 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.074 -0.967 . . . . 75.420000000000002 110.137 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -61.47 -30.87 70.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.118 -0.946 . . . . 70.129999999999995 111.533 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -71.78 -10.92 60.49 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.909 0.707 . . . . 60.119999999999997 112.909 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.24 -12.97 61.05 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.391 0.615 . . . . 71.430000000000007 109.581 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.3 m -110.92 126.71 28.18 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.603 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -84.9 168.85 10.61 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.67 2.247 . . . . 55.310000000000002 113.672 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.58 -126.17 40.47 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.273 -0.876 . . . . 73.140000000000001 113.522 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.12 13.3 29.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.068 -0.566 . . . . 60.43 110.881 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.87 151.13 25.29 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.898 -0.778 . . . . 75.299999999999997 108.898 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 44.1 pt -129.26 172.83 14.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.357 -1.349 . . . . 71.530000000000001 107.357 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.0 t -92.04 111.08 22.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.274 -1.38 . . . . 60.219999999999999 107.274 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.3 mmm180 -77.95 164.22 25.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.475 -0.565 . . . . 71.519999999999996 109.475 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.32 1.34 20.07 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 114.129 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.7 p-10 -89.81 -21.38 22.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.084 -0.709 . . . . 74.439999999999998 109.084 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.93 15.17 19.09 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.573 -0.74 . . . . 63.32 111.381 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 92.9 m-85 -131.59 150.16 52.25 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 122.863 0.465 . . . . 71.329999999999998 110.858 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.67 124.17 22.11 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.688 -0.687 . . . . 71.450000000000003 111.248 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.97 163.88 27.62 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.227 -1.149 . . . . 73.239999999999995 110.227 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' ' 32' ' ' ILE . 42.1 tt0 -62.02 152.91 31.14 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.425 0.631 . . . . 73.409999999999997 110.992 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . . . -77.45 -23.35 50.49 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.341 -0.845 . . . . 65.409999999999997 112.397 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 34' ' ' ALA . 39.2 mt -72.98 148.91 8.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.612 -0.722 . . . . 73.430000000000007 109.165 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -88.27 -10.44 49.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.198 0.523 . . . . 71.540000000000006 111.357 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -76.96 -176.94 4.16 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.616 -0.883 . . . . 72.319999999999993 108.616 174.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.17 119.7 51.51 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.682 -0.488 . . . . 71.310000000000002 109.682 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 56.1 Cg_exo -56.14 155.5 23.87 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.467 2.778 . . . . 54.149999999999999 112.909 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.53 -13.38 37.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.878 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' HB2' ' A' ' 2' ' ' GLU . . . 70.13 61.39 0.24 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.332 1.053 . . . . 53.420000000000002 109.439 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 . . . . . 0 CA--C 1.495 -1.15 0 CA-C-N 113.863 -1.517 . . . . 73.129999999999995 111.258 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.7 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -146.76 148.84 32.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.287 -0.635 . . . . 73.319999999999993 109.287 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -168.56 145.75 3.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.671 -1.974 . . . . 65.230000000000004 105.671 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.3 mp -94.4 -30.48 4.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 112.278 0.473 . . . . 73.439999999999998 112.278 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -87.89 -41.22 13.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.617 -0.833 . . . . 74.230000000000004 109.29 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -125.42 83.66 2.19 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 114.969 -1.014 . . . . 53.140000000000001 110.288 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.96 119.36 76.39 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.083 -0.71 . . . . 61.240000000000002 109.083 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.95 104.82 0.87 Allowed 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.908 2.405 . . . . 72.439999999999998 114.275 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -85.06 154.23 22.21 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.191 -0.913 . . . . 62.439999999999998 108.547 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.0 p -127.62 148.91 50.38 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.034 0.445 . . . . 64.030000000000001 111.186 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -112.02 -39.33 4.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.119 -1.808 . . . . 72.319999999999993 106.119 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -127.48 157.04 41.13 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.189 -1.369 . . . . 74.140000000000001 109.422 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.73 -29.12 70.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.394 0.678 . . . . 64.310000000000002 111.728 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.8 p -63.68 -23.05 67.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.239 -0.891 . . . . 73.099999999999994 111.866 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.485 0.66 . . . . 75.140000000000001 110.3 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 34.5 m -105.39 110.46 64.36 Favored Pre-proline 0 N--CA 1.401 -2.892 0 CA-C-N 115.384 -0.826 . . . . 72.129999999999995 109.879 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.84 178.84 6.52 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.517 2.145 . . . . 73.400000000000006 112.733 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.27 -111.87 4.52 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.989 -0.551 . . . . 44.530000000000001 112.997 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.51 16.18 9.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.845 -0.798 . . . . 61.350000000000001 108.845 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.95 144.4 29.19 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.179 -0.919 . . . . 73.310000000000002 109.867 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.2 pt -122.29 174.12 7.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.945 -1.502 . . . . 73.319999999999993 106.945 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.41 108.47 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.777 -1.194 . . . . 53.020000000000003 107.777 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 70.5 mtp180 -82.17 165.92 20.09 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 116.127 -0.488 . . . . 71.209999999999994 111.128 -177.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.85 -4.24 57.9 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 115.77 -0.65 . . . . 72.129999999999995 112.925 -177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 36.7 p-10 -89.05 -14.8 35.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.992 -0.744 . . . . 71.439999999999998 108.992 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 15.47 38.88 Favored Glycine 0 CA--C 1.493 -1.3 0 CA-C-N 115.479 -0.782 . . . . 73.400000000000006 111.183 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -124.14 154.38 40.11 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 123.482 0.713 . . . . 71.120000000000005 111.532 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.31 118.71 22.2 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.796 -1.093 . . . . 63.229999999999997 110.211 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.09 160.43 28.33 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.816 -1.183 . . . . 73.25 111.008 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 41.5 tt0 -63.62 155.51 29.54 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.491 -0.559 . . . . 73.129999999999995 109.491 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.35 26.44 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.189 -0.46 . . . . 72.219999999999999 110.836 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.35 138.01 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 106.685 -1.598 . . . . 73.400000000000006 106.685 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -99.24 82.95 2.77 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 111.446 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.54 -85.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.229 -0.896 . . . . 35.43 108.966 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.79 117.55 68.7 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.564 -0.902 . . . . 71.129999999999995 108.564 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.44 121.07 6.86 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.581 1.521 . . . . 73.420000000000002 111.023 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -112.68 -54.32 2.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.628 -1.249 . . . . 70.150000000000006 107.628 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.3 87.71 0.91 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.925 -1.034 . . . . 63.030000000000001 109.424 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 99.7 mtt180 . . . . . 0 C--N 1.301 -1.527 0 CA-C-N 114.966 -1.016 . . . . 75.349999999999994 111.063 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 18' ' ' GLY . 1.8 p . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 116.055 1.872 . . . . 74.040000000000006 116.055 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 3' ' ' ALA . 38.3 tt0 -91.29 178.72 5.89 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.378 -1.341 . . . . 75.409999999999997 107.378 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' A' ' 2' ' ' GLU . . . -65.86 98.23 0.4 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.559 0.695 . . . . 64.0 109.165 174.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.8 mt -111.69 -66.52 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 114.815 -1.084 . . . . 74.430000000000007 108.795 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -88.38 -37.2 16.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.245 -1.343 . . . . 75.120000000000005 108.636 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -145.79 143.39 29.65 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.054 -1.43 . . . . 62.240000000000002 109.037 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.74 104.86 3.05 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 123.833 0.708 . . . . 65.349999999999994 109.196 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 2.8 Cg_endo -83.78 117.04 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.455 2.103 . . . . 73.519999999999996 110.823 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.73 155.23 26.83 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.676 -0.49 . . . . 73.25 109.676 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 14.6 p -144.52 162.86 35.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.169 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -123.07 -41.06 2.35 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.247 -1.39 . . . . 71.019999999999996 107.247 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -119.48 154.23 34.1 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.234 -1.348 . . . . 74.340000000000003 109.514 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.13 -28.16 67.91 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.978 0.894 . . . . 71.219999999999999 111.14 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 p -68.6 -11.95 60.7 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.464 -1.243 . . . . 71.109999999999999 113.19 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -69.06 -24.8 64.21 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.056 -0.72 . . . . 70.5 109.056 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -95.71 121.5 61.19 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 115.443 -0.799 . . . . 74.400000000000006 109.962 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -85.11 -167.27 0.4 Allowed 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.101 2.534 . . . . 60.32 112.375 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 1' ' ' CYS . . . 64.48 -111.99 4.63 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.237 -0.745 . . . . 64.209999999999994 111.237 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.64 19.43 3.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.584 -1.265 . . . . 64.239999999999995 107.584 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.78 153.62 20.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.952 -1.022 . . . . 75.400000000000006 111.946 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.15 175.13 5.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.214 -0.903 . . . . 71.299999999999997 109.911 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.04 110.71 23.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.853 -0.795 . . . . 50.119999999999997 108.853 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -82.65 169.98 15.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.075 0.464 . . . . 64.340000000000003 111.405 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.62 -1.76 46.89 Favored Glycine 0 N--CA 1.464 0.514 0 CA-C-N 115.734 -0.666 . . . . 42.229999999999997 113.433 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -89.03 -15.19 34.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.786 -0.82 . . . . 74.010000000000005 108.786 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.54 15.54 34.41 Favored Glycine 0 CA--C 1.481 -2.056 0 N-CA-C 111.292 -0.723 . . . . 33.409999999999997 111.292 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.76 156.4 42.5 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.719 -0.741 . . . . 74.420000000000002 110.705 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 72.6 m -79.87 141.18 36.37 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 109.383 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 2' ' ' GLU . . . -155.13 168.55 33.04 Favored Glycine 0 N--CA 1.407 -3.246 0 N-CA-C 109.271 -1.532 . . . . 72.319999999999993 109.271 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 40.8 tt0 -65.32 162.05 18.32 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.627 -0.508 . . . . 71.299999999999997 109.627 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.64 64.89 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.566 0.698 . . . . 53.43 109.784 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.53 140.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 106.559 -1.645 . . . . 54.299999999999997 106.559 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -81.22 -32.15 33.55 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.164 0.506 . . . . 74.519999999999996 110.042 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.1 87.48 2.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.962 -1.125 . . . . 73.439999999999998 107.962 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 126.75 84.19 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.372 -0.831 . . . . 71.140000000000001 112.01 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.25 -36.92 79.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.782 2.988 . . . . 74.010000000000005 112.621 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -135.79 -79.92 0.42 Allowed 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.739 -1.208 . . . . 74.129999999999995 107.739 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 168.29 88.95 0.0 OUTLIER 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.87 1.268 . . . . 60.310000000000002 109.534 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HE ' ' CD ' ' A' ' 30' ' ' GLU . 74.1 mtm180 . . . . . 0 C--N 1.308 -1.231 0 CA-C-O 119.316 -0.373 . . . . 73.099999999999994 110.153 170.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.399 -2.985 0 N-CA-C 103.382 -2.822 . . . . 75.219999999999999 103.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.7 -31.39 19.74 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.65 -0.87 . . . . 73.409999999999997 108.65 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.39 93.41 9.31 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.455 -0.942 . . . . 75.519999999999996 108.455 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.19 -33.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 74.420000000000002 109.032 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -88.83 -43.12 11.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.66 -1.237 . . . . 60.530000000000001 107.66 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.19 35.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.196 -1.365 . . . . 74.319999999999993 108.733 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 153.0 84.83 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.17 -1.377 . . . . 65.510000000000005 110.369 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.47 161.9 31.06 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.921 1.747 . . . . 74.219999999999999 109.856 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -80.7 145.09 31.77 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.83 -0.434 . . . . 73.109999999999999 109.83 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.562 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.4 p -121.35 148.03 44.91 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.828 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 7.2 mpt_? -109.22 -32.46 7.19 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 73.25 107.155 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -144.95 160.02 42.0 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 125.395 1.478 . . . . 74.329999999999998 108.528 172.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -59.23 -37.43 77.51 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.962 0.887 . . . . 74.129999999999995 110.549 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -68.33 -17.39 64.25 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.348 -1.296 . . . . 60.210000000000001 113.75 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 2.2 p30 -91.04 6.25 45.61 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.914 -1.114 . . . . 75.299999999999997 111.734 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.0 m -89.23 145.26 33.81 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 120.719 -0.392 . . . . 70.340000000000003 110.74 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.82 132.56 52.47 Favored 'Trans proline' 0 C--O 1.257 1.453 0 C-N-CA 123.373 2.715 . . . . 71.109999999999999 113.019 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.71 -106.94 1.72 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.801 -1.09 . . . . 33.340000000000003 112.563 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.07 16.9 5.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.545 -0.168 . . . . 35.409999999999997 110.545 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.69 150.34 41.29 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.1 -0.704 . . . . 55.310000000000002 109.1 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 46.0 pt -104.07 170.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.875 -0.416 . . . . 61.149999999999999 109.875 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.3 t -98.24 122.75 41.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.04 -1.096 . . . . 65.329999999999998 108.04 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mtm-85 -88.72 166.67 13.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.916 -0.401 . . . . 74.540000000000006 109.916 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.5 -7.57 41.0 Favored Glycine 0 N--CA 1.467 0.715 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 113.831 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 33.5 p-10 -89.18 -24.84 22.07 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 122.548 -0.383 . . . . 61.43 110.057 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.92 9.71 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.609 -0.805 . . . . 74.430000000000007 111.547 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 70.8 m-85 -125.32 155.91 39.49 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.729 -0.841 . . . . 73.409999999999997 108.729 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.3 m -80.26 153.06 28.74 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.816 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.46 -179.7 33.51 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-O 119.189 -0.784 . . . . 72.120000000000005 111.34 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.07 150.12 30.35 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.268 0.627 . . . . 65.040000000000006 110.125 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.14 32.87 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.369 -0.832 . . . . 64.409999999999997 110.333 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.3 mt -139.59 128.63 28.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.087 -1.82 . . . . 52.030000000000001 106.087 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -87.72 87.22 7.31 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 121.589 0.709 . . . . 73.120000000000005 111.599 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.67 -92.4 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.383 -1.34 . . . . 75.430000000000007 107.383 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.65 60.18 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.392 -1.336 . . . . 74.209999999999994 107.392 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.12 110.83 2.07 Favored 'Trans proline' 0 C--O 1.249 1.052 0 N-CA-C 108.579 -1.354 . . . . 72.450000000000003 108.579 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -109.15 -65.93 1.1 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.324 0.583 . . . . 75.310000000000002 111.592 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.26 38.63 2.16 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.77 -1.196 . . . . 63.0 107.77 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 CA--C 1.489 -1.38 0 C-N-CA 126.562 1.945 . . . . 63.310000000000002 115.481 -169.499 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 101.683 -3.451 . . . . 64.319999999999993 101.683 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -137.87 155.16 49.25 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.605 -0.725 . . . . 61.030000000000001 111.996 -163.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.82 132.54 5.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.874 -2.269 . . . . 71.129999999999995 104.874 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 mm -96.48 -20.44 5.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 120.875 0.369 . . . . 73.340000000000003 111.533 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -88.25 -41.41 12.95 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.576 -0.85 . . . . 73.329999999999998 108.9 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.91 102.82 3.01 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.979 -0.749 . . . . 74.099999999999994 108.979 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 134.42 57.53 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 116.601 -0.272 . . . . 54.240000000000002 110.402 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.12 119.4 6.57 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.796 2.331 . . . . 64.200000000000003 112.277 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.77 157.81 17.79 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.45 -0.945 . . . . 61.310000000000002 108.45 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.8 p -136.88 142.01 42.78 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.398 0.618 . . . . 61.520000000000003 111.478 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.9 -32.52 7.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.645 -1.613 . . . . 72.409999999999997 106.645 171.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -140.02 161.5 37.47 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.705 -1.589 . . . . 71.120000000000005 108.651 174.095 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.54 -29.54 70.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.561 -0.745 . . . . 72.340000000000003 111.864 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -69.54 -15.56 63.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.847 -0.615 . . . . 62.509999999999998 112.57 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.519 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m-20 -68.41 -22.55 64.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.451 0.643 . . . . 55.219999999999999 110.007 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -89.83 123.54 66.03 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-N 115.351 -0.84 . . . . 61.409999999999997 111.513 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.23 -179.81 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.979 2.453 . . . . 73.209999999999994 112.077 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.83 -123.82 34.34 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 112.311 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ALA . . . -113.04 10.44 18.78 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.005 -0.739 . . . . 64.439999999999998 109.005 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 m -71.08 146.68 49.13 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.675 -0.693 . . . . 73.349999999999994 110.614 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 22.9 pt -127.12 171.41 15.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.901 -0.777 . . . . 71.349999999999994 108.901 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.7 115.02 26.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.077 0.465 . . . . 71.200000000000003 109.781 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -86.3 167.76 14.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 109.899 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.42 -2.23 54.13 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 113.403 -174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -89.96 -17.55 27.72 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.761 0.315 . . . . 55.130000000000003 111.024 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.53 27.16 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.717 -0.953 . . . . 72.510000000000005 110.717 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -126.3 154.99 42.67 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 124.452 1.101 . . . . 75.329999999999998 109.988 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 74.4 m -80.19 126.2 30.81 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 72.230000000000004 109.839 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.46 -178.97 15.57 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.139 -1.185 . . . . 73.430000000000007 110.139 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.0 tp10 -66.17 156.19 34.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.873 0.336 . . . . 72.019999999999996 110.271 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . -80.59 -53.39 6.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.37 0.605 . . . . 73.219999999999999 111.482 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 35' ' ' ALA . 50.2 mm -115.66 150.31 17.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.05 -0.977 . . . . 51.109999999999999 109.704 -172.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -82.41 136.76 34.88 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.489 -0.93 . . . . 72.329999999999998 108.489 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 69.82 24.64 5.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.422 1.089 . . . . 64.230000000000004 110.15 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.94 166.49 42.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.444 -0.798 . . . . 60.130000000000003 110.77 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 58.7 Cg_exo -42.09 -50.21 5.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.97 3.113 . . . . 72.209999999999994 115.2 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -96.87 -38.09 9.98 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.131 -0.628 . . . . 74.400000000000006 109.84 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . . . 72.6 14.99 5.06 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 125.113 1.365 . . . . 73.340000000000003 111.488 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-N 114.324 -1.307 . . . . 73.349999999999994 109.871 -176.407 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 122.019 0.914 . . . . 74.319999999999993 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.428 ' CD ' ' HD2' ' A' ' 39' ' ' ARG . 6.0 pt-20 -97.71 161.64 13.66 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.713 -1.13 . . . . 71.120000000000005 110.503 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.0 120.07 30.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 106.422 -1.696 . . . . 73.25 106.422 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.45 -29.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-N 114.734 -1.121 . . . . 62.530000000000001 112.228 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.8 -42.23 12.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.137 -1.06 . . . . 74.430000000000007 108.137 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.26 78.62 1.77 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.982 -1.008 . . . . 73.099999999999994 108.403 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.98 117.2 12.01 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.253 -0.885 . . . . 71.349999999999994 111.758 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 3' ' ' ALA . 34.0 Cg_endo -89.87 108.79 0.4 Allowed 'Trans proline' 0 N--CA 1.429 -2.289 0 C-N-CA 122.458 2.105 . . . . 74.310000000000002 111.806 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.6 pttm -88.7 145.6 25.55 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.572 -0.529 . . . . 75.400000000000006 109.572 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.6 p -127.38 154.55 44.86 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.826 0.822 . . . . 70.019999999999996 111.598 -173.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -115.22 -35.25 4.73 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.089 -1.448 . . . . 71.349999999999994 107.089 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -130.57 158.45 39.95 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.306 -1.315 . . . . 73.530000000000001 110.103 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 6.4 m-20 -62.71 -34.33 76.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.626 0.726 . . . . 70.209999999999994 110.679 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -67.01 -6.41 16.9 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.502 -1.226 . . . . 74.540000000000006 113.212 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.7 -40.46 92.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.285 0.564 . . . . 73.510000000000005 109.523 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 79.2 m -131.71 98.34 18.02 Favored Pre-proline 0 N--CA 1.409 -2.479 0 N-CA-C 107.836 -1.172 . . . . 70.129999999999995 107.836 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.75 -166.21 0.39 Allowed 'Trans proline' 0 C--O 1.261 1.667 0 C-N-CA 122.896 2.397 . . . . 72.049999999999997 115.291 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.74 -111.22 4.0 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 113.933 -1.485 . . . . 34.109999999999999 112.762 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 -14.93 36.79 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.15 -0.525 . . . . 60.140000000000001 111.426 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.91 155.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.316 -0.554 . . . . 73.340000000000003 110.951 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.7 pt -131.9 179.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.401 -0.963 . . . . 65.219999999999999 108.401 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 50.4 t -101.28 126.55 48.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.318 -1.364 . . . . 74.200000000000003 107.318 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 41.4 mtt180 -91.25 165.81 13.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.796 -0.446 . . . . 71.310000000000002 109.796 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -5.92 66.76 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.71 -0.677 . . . . 72.530000000000001 112.491 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.586 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.5 p-10 -88.3 -11.69 45.69 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.908 -0.775 . . . . 61.409999999999997 108.908 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.42 42.49 Favored Glycine 0 CA--C 1.488 -1.601 0 CA-C-N 115.598 -0.728 . . . . 64.519999999999996 111.298 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 60.7 m-85 -125.14 157.03 37.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.496 0.718 . . . . 70.329999999999998 110.285 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.8 m -79.98 166.53 21.5 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.733 0.301 . . . . 62.420000000000002 110.414 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' ' HE ' ' A' ' 23' ' ' ARG . . . 170.55 -176.16 44.18 Favored Glycine 0 CA--C 1.486 -1.762 0 C-N-CA 120.172 -1.013 . . . . 52.450000000000003 112.488 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' HG12 ' A' ' 32' ' ' ILE . 9.8 tp10 -60.75 154.92 20.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.347 0.674 . . . . 74.549999999999997 109.95 176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.92 16.54 1.43 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.961 0.905 . . . . 52.439999999999998 112.356 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' HG3' ' A' ' 30' ' ' GLU . 50.3 mm -93.93 129.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.509 -1.663 . . . . 55.009999999999998 106.509 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -90.64 -21.78 21.51 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 115.62 -0.718 . . . . 74.439999999999998 111.483 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.03 -166.54 1.52 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.128 -1.064 . . . . 73.099999999999994 108.128 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.65 114.76 15.74 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 109.893 -0.41 . . . . 71.5 109.893 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.26 -173.99 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.666 2.244 . . . . 63.25 111.43 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -148.25 -59.93 0.25 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.039 -1.097 . . . . 74.099999999999994 108.039 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.53 78.84 7.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.819 -0.628 . . . . 54.420000000000002 109.943 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.428 ' HD2' ' CD ' ' A' ' 2' ' ' GLU . 80.0 mtm180 . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.927 -0.579 . . . . 72.310000000000002 109.987 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.388 0.613 . . . . 75.109999999999999 109.775 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.06 175.31 7.45 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.779 -1.101 . . . . 72.129999999999995 109.118 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.91 8.67 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.635 -1.246 . . . . 73.450000000000003 107.635 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.66 -26.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.735 -0.666 . . . . 71.129999999999995 110.596 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -88.06 -40.8 13.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.456 0.646 . . . . 63.310000000000002 109.709 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.63 87.85 1.66 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.044 -0.98 . . . . 63.109999999999999 109.62 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.07 135.45 96.32 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.296 -0.865 . . . . 74.530000000000001 111.459 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.12 122.2 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.465 2.11 . . . . 65.140000000000001 111.348 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 50.9 mtpt -76.58 145.98 38.62 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.845 -0.428 . . . . 73.340000000000003 109.845 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.6 p -117.82 146.85 43.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.645 0.259 . . . . 54.409999999999997 110.764 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.38 -45.08 4.16 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.79 -1.559 . . . . 71.340000000000003 106.79 172.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -136.66 155.26 50.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.04 -1.436 . . . . 72.140000000000001 109.309 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.415 ' OD2' ' HB ' ' A' ' 21' ' ' ILE . 2.9 m-20 -58.43 -35.01 71.45 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 123.698 0.799 . . . . 70.420000000000002 111.023 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -67.31 -16.26 64.16 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.29 1.218 . . . . 32.299999999999997 114.29 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -90.25 -4.14 57.37 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.289 -0.964 . . . . 72.109999999999999 111.549 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.93 137.41 28.25 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 115.791 -0.64 . . . . 62.100000000000001 110.012 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.0 122.27 6.03 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 124.18 3.254 . . . . 64.450000000000003 114.525 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.61 -119.25 17.57 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.131 -0.94 . . . . 70.140000000000001 112.914 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.93 10.54 36.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.316 -0.442 . . . . 64.329999999999998 110.866 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.54 146.8 52.96 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.125 -0.694 . . . . 63.340000000000003 109.125 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' OD2' ' A' ' 13' ' ' ASP . 36.0 pt -111.67 167.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.007 0.432 . . . . 73.430000000000007 111.0 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.19 105.1 17.39 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.564 -1.273 . . . . 54.420000000000002 107.564 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.96 165.16 22.89 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.01 0.433 . . . . 72.230000000000004 111.546 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.38 48.2 Favored Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.381 -0.827 . . . . 74.040000000000006 113.743 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -88.18 -15.47 35.92 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.987 -0.746 . . . . 72.319999999999993 108.987 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.39 10.83 37.67 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 111.037 -0.825 . . . . 40.140000000000001 111.037 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 71.4 m-85 -124.69 151.75 44.58 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 121.44 0.638 . . . . 73.049999999999997 110.686 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.7 m -74.19 147.22 42.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.464 -0.789 . . . . 45.32 109.271 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.15 159.68 32.26 Favored Glycine 0 CA--C 1.472 -2.637 0 N-CA-C 110.321 -1.112 . . . . 72.140000000000001 110.321 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -63.69 161.39 15.1 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.196 0.586 . . . . 74.030000000000001 110.007 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.25 42.69 0.27 Allowed 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.5 1.12 . . . . 71.010000000000005 111.398 -176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 34' ' ' ALA . 24.0 mt -93.13 130.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.98 -1.489 . . . . 34.119999999999997 106.98 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -99.68 -6.95 26.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.904 0.859 . . . . 74.040000000000006 110.334 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -98.8 -158.02 0.64 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.487 -1.233 . . . . 74.430000000000007 107.871 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.6 93.14 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.554 -0.165 . . . . 75.109999999999999 110.554 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.97 147.72 51.0 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.48 2.787 . . . . 62.509999999999998 112.808 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -109.59 -7.59 15.1 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.477 0.656 . . . . 71.209999999999994 109.391 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 70.91 70.77 0.19 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.707 1.203 . . . . 65.540000000000006 111.241 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 CA--C 1.476 -1.884 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 174.615 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 113.269 0.841 . . . . 61.200000000000003 113.269 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -99.07 -55.39 2.71 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.27 -0.877 . . . . 71.230000000000004 110.277 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.85 142.92 13.95 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 106.394 -1.706 . . . . 61.32 106.394 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.69 -39.76 4.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 116.579 -0.282 . . . . 73.120000000000005 111.68 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -89.25 -41.19 12.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.178 -1.045 . . . . 74.430000000000007 108.178 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -87.46 136.98 32.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.737 -1.12 . . . . 73.030000000000001 109.463 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 108.66 12.04 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 123.373 0.42 . . . . 73.530000000000001 111.594 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 35.1 Cg_endo -89.4 123.89 1.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.332 2.021 . . . . 42.409999999999997 109.914 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.9 pttt -100.07 145.69 27.64 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.995 -0.682 . . . . 62.43 111.416 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.4 p -124.1 152.07 43.16 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.631 0.253 . . . . 74.519999999999996 110.876 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -110.2 -36.13 5.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.524 -1.658 . . . . 72.129999999999995 106.524 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -132.38 151.89 51.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.36 -1.291 . . . . 74.439999999999998 109.184 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.45 -40.9 88.35 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.951 0.881 . . . . 73.230000000000004 109.343 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 p -63.33 -18.46 63.65 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.649 -1.614 . . . . 55.229999999999997 114.47 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.305 2.6 p30 -78.91 -9.1 59.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 118.668 -1.213 . . . . 75.099999999999994 112.051 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -125.99 106.77 25.36 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 62.399999999999999 109.347 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.06 -168.2 0.49 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 123.412 2.741 . . . . 44.210000000000001 115.792 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.47 -128.32 32.78 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 113.85 -1.523 . . . . 70.120000000000005 112.167 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.65 6.58 46.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.417 -0.392 . . . . 52.420000000000002 110.87 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.5 m -93.72 147.85 22.65 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 111.98 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 pt -138.0 177.06 5.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 114.052 -1.431 . . . . 71.109999999999999 107.97 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -97.9 124.63 42.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.565 -0.902 . . . . 71.319999999999993 108.565 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.01 167.77 10.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 O-C-N 122.193 -0.317 . . . . 72.129999999999995 110.765 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.26 -9.14 56.98 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 114.424 0.53 . . . . 75.439999999999998 114.424 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -88.84 -17.57 29.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.45 0.643 . . . . 71.329999999999998 109.398 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.26 17.83 23.5 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.888 -0.885 . . . . 51.0 110.888 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 70.9 m-85 -121.08 151.98 39.21 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.165 0.507 . . . . 61.32 111.938 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.5 m -79.49 109.76 14.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.169 -0.923 . . . . 71.319999999999993 109.674 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.79 163.63 12.78 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 109.112 -1.595 . . . . 61.049999999999997 109.112 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -80.27 166.36 21.44 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.744 -1.576 . . . . 63.340000000000003 106.744 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.38 74.07 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.864 0.364 . . . . 40.399999999999999 110.259 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.73 -62.01 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-O 121.319 0.58 . . . . 70.439999999999998 110.912 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -87.38 95.62 10.07 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 115.261 -0.882 . . . . 55.32 112.848 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.15 -22.6 18.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.358 -0.837 . . . . 63.219999999999999 110.939 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.95 156.09 84.44 Favored Pre-proline 0 C--O 1.254 1.298 0 CA-C-N 115.651 -0.704 . . . . 64.439999999999998 109.259 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.12 84.56 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.108 1.872 . . . . 71.109999999999999 111.321 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.4 -50.94 0.13 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 108.954 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.12 72.44 1.21 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.67 . . . . 71.510000000000005 112.274 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 28' ' ' CYS . 37.5 mtm180 . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 107.209 -1.404 . . . . 74.540000000000006 107.209 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.251 1.177 0 CA-C-O 121.523 0.678 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.05 135.06 33.59 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 155.59 38.07 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mt -103.97 -40.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 O-C-N 123.672 0.608 . . . . 0.0 110.798 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -89.39 -40.53 12.68 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.406 0.622 . . . . 0.0 110.501 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.47 49.53 1.2 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.389 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.67 122.87 86.4 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.387 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.43 120.32 5.88 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.047 1.831 . . . . 0.0 109.81 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.4 pttt -76.08 158.94 31.27 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.885 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.8 p -120.22 150.49 40.58 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.207 0.527 . . . . 0.0 111.823 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 73.5 mtm180 -110.92 -47.57 3.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 13.5 ptm180 -141.1 159.24 42.63 Favored 'General case' 0 CA--C 1.477 -1.857 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.085 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.63 -36.92 70.04 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.216 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 p -67.04 -27.65 67.57 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.539 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 11' ' ' ARG 0.281 1.7 p30 -86.46 10.31 15.57 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.618 178.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.2 m -93.63 136.68 23.81 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.541 173.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.43 152.7 71.16 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.621 2.881 . . . . 0.0 113.521 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 -114.52 6.93 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.507 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.96 15.27 7.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.04 153.87 20.53 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 pt -113.2 172.18 3.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.9 t -89.68 103.39 16.05 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -74.08 166.21 23.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.256 0.55 . . . . 0.0 111.512 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.94 -2.56 47.06 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.845 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.427 HD21 ' HB2' ' A' ' 27' ' ' TYR . 32.4 p-10 -89.89 -17.05 28.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.79 31.42 Favored Glycine 0 CA--C 1.498 -0.991 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 85.4 m-85 -128.43 160.72 31.37 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.443 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.9 m -80.27 140.88 36.0 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.305 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.01 161.44 35.03 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 39' ' ' ARG . 9.2 tp10 -64.63 162.1 16.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.256 0.528 . . . . 0.0 109.846 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.79 -49.56 17.74 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mm -116.12 122.69 70.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -73.45 -29.97 62.89 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.26 0.552 . . . . 0.0 110.818 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.0 -28.15 65.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.577 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.67 111.16 23.64 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.392 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 5.4 Cg_exo -79.66 99.47 1.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.333 0 C-N-CA 121.077 1.184 . . . . 0.0 110.365 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -134.46 -75.73 0.47 Allowed 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 86.94 2.05 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.334 0.588 . . . . 0.0 110.82 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.549 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 84.1 mtp180 . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.927 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.631 -1.618 . . . . 64.129999999999995 106.631 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.07 139.87 30.35 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 113.72 -1.582 . . . . 74.420000000000002 109.041 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.52 130.18 6.61 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.63 -1.248 . . . . 64.219999999999999 107.63 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.64 -27.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 112.529 0.566 . . . . 70.450000000000003 112.529 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.63 -44.28 10.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.249 -0.907 . . . . 62.009999999999998 109.195 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.7 86.81 2.24 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.481 -0.781 . . . . 64.420000000000002 110.376 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.0 123.94 90.18 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.552 -0.749 . . . . 74.049999999999997 109.407 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.63 110.1 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 112.105 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 20.6 pttp -80.82 153.51 27.67 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 110.772 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 19.2 p -135.8 151.34 49.98 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.265 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -105.97 -36.64 6.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.249 -1.759 . . . . 74.129999999999995 106.249 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -136.5 161.41 35.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.659 -1.61 . . . . 72.540000000000006 109.916 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 4.8 m-20 -63.46 -30.75 71.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.958 0.903 . . . . 65.409999999999997 111.494 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -69.18 -15.08 63.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.335 -0.848 . . . . 74.420000000000002 112.697 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -73.34 -16.0 61.37 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.358 -0.608 . . . . 65.319999999999993 109.358 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.59 123.62 47.33 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 109.015 -0.735 . . . . 70.010000000000005 109.015 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.8 -174.69 0.73 Allowed 'Trans proline' 0 C--O 1.258 1.475 0 C-N-CA 122.692 2.261 . . . . 75.319999999999993 112.716 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.89 -102.21 0.68 Allowed Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.34 -0.845 . . . . 75.310000000000002 112.411 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.74 11.72 2.69 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.242 0.544 . . . . 50.140000000000001 109.692 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.8 m -84.36 151.67 24.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 110.542 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.9 pt -118.09 171.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.219 -1.03 . . . . 72.109999999999999 108.219 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 46.1 t -94.52 107.63 19.61 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.424 -0.954 . . . . 71.319999999999993 108.424 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -73.32 166.44 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.65 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.21 -8.72 45.37 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 114.48 0.552 . . . . 52.219999999999999 114.48 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -89.25 -19.09 25.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.047 0.451 . . . . 63.030000000000001 109.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.77 23.41 10.88 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.078 -0.809 . . . . 63.409999999999997 111.078 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 74.6 m-85 -127.18 151.46 48.64 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 122.841 0.457 . . . . 74.200000000000003 110.768 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.4 m -79.53 128.37 33.29 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.58 -0.737 . . . . 73.209999999999994 111.434 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.25 168.64 35.26 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.598 -1.401 . . . . 60.140000000000001 109.598 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 8.9 tp10 -78.52 167.31 21.47 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.634 -0.876 . . . . 75.030000000000001 108.634 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.908 0.861 . . . . 73.019999999999996 109.166 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.628 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 57.6 mt -96.48 150.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 105.615 -1.994 . . . . 72.439999999999998 105.615 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -59.93 -59.32 5.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 111.32 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 123.05 41.08 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.959 -1.497 . . . . 71.0 106.959 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -73.16 132.39 82.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 109.848 -0.427 . . . . 74.120000000000005 109.848 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 52.7 Cg_exo -55.81 -45.09 41.52 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.419 2.746 . . . . 73.510000000000005 114.355 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -150.05 -50.81 0.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.996 -0.372 . . . . 64.049999999999997 109.996 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.68 70.76 6.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.722 0.772 . . . . 72.230000000000004 109.532 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HG2' ' HB3' ' A' ' 35' ' ' ALA . 66.7 mtp180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-N 114.476 -1.238 . . . . 75.319999999999993 109.518 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.41 -2.474 0 N-CA-C 103.944 -2.613 . . . . 64.430000000000007 103.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -88.08 143.95 26.78 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 120.901 0.381 . . . . 62.109999999999999 109.996 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.59 36.33 3.56 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.404 -0.816 . . . . 74.349999999999994 110.109 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.11 -50.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.612 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.28 -34.82 12.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.798 0.809 . . . . 55.520000000000003 109.079 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.0 104.73 3.72 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.997 -1.456 . . . . 51.229999999999997 109.152 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.2 116.12 56.33 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 110.649 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.47 114.97 2.93 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.637 2.225 . . . . 73.530000000000001 111.859 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -89.68 159.62 17.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.357 -0.979 . . . . 63.219999999999999 108.357 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 18.7 p -152.26 158.78 43.3 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.266 0.555 . . . . 44.350000000000001 111.685 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -119.78 -35.83 3.43 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.311 -1.366 . . . . 73.349999999999994 107.311 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -125.75 156.82 38.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.585 -1.189 . . . . 73.450000000000003 109.287 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -63.16 -32.24 73.58 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.027 0.931 . . . . 74.030000000000001 110.971 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -65.83 -16.31 63.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.655 -1.157 . . . . 62.130000000000003 113.182 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.79 -14.51 59.56 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.137 0.494 . . . . 62.409999999999997 109.831 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.1 m -89.75 130.36 43.26 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.884 -0.598 . . . . 61.450000000000003 112.136 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.92 -179.75 5.5 Favored 'Trans proline' 0 C--O 1.27 2.123 0 C-N-CA 122.503 2.135 . . . . 74.340000000000003 112.112 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 -116.8 9.3 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.098 -0.956 . . . . 34.43 111.501 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.73 19.67 3.55 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.519 -0.919 . . . . 73.409999999999997 108.519 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.8 m -77.59 150.81 34.65 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.09 -0.959 . . . . 64.439999999999998 110.267 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -109.05 174.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.966 -0.753 . . . . 74.129999999999995 108.966 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.16 118.65 30.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.738 -0.838 . . . . 75.400000000000006 108.738 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -87.66 170.5 11.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.737 -0.21 . . . . 73.140000000000001 110.72 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.64 -6.59 50.88 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 114.347 0.499 . . . . 72.030000000000001 114.347 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -89.47 -17.71 28.16 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.935 0.398 . . . . 74.319999999999993 110.541 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 22.86 21.41 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.567 -1.013 . . . . 61.039999999999999 110.567 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.18 147.21 48.16 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 124.571 1.148 . . . . 63.439999999999998 110.746 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.6 m -81.07 139.44 35.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.855 -1.066 . . . . 65.230000000000004 112.167 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.5 147.24 12.37 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.491 -1.044 . . . . 61.119999999999997 110.491 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 7.9 tp10 -72.59 161.78 30.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.745 -0.835 . . . . 70.030000000000001 108.745 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.56 74.19 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.615 0.766 . . . . 65.439999999999998 109.995 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 40.1 mt -118.6 135.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.225 0 N-CA-C 106.965 -1.494 . . . . 74.120000000000005 106.965 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -75.34 -33.78 61.15 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.003 0.43 . . . . 64.319999999999993 110.449 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.96 0.79 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.937 0.717 . . . . 75.209999999999994 112.937 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.47 124.04 87.18 Favored Pre-proline 0 C--O 1.212 -0.894 0 N-CA-C 108.953 -0.758 . . . . 72.420000000000002 108.953 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -50.97 -53.24 7.49 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.429 2.753 . . . . 71.430000000000007 115.138 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -127.42 -26.14 3.09 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 111.866 0.321 . . . . 74.129999999999995 111.866 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.3 26.19 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.411 0.893 . . . . 63.439999999999998 113.411 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-O 121.939 0.876 . . . . 75.25 112.087 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 121.408 0.623 . . . . 74.400000000000006 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -89.95 149.09 22.74 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.269 -0.878 . . . . 74.129999999999995 111.414 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 93.5 8.88 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.05 -0.977 . . . . 72.319999999999993 109.057 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.75 -63.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.659 -1.608 . . . . 75.010000000000005 106.659 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -99.19 -34.05 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -177.11 148.51 0.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.886 -1.506 . . . . 63.409999999999997 108.447 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 140.73 49.66 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.11 -0.7 . . . . 63.509999999999998 109.11 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.45 131.04 40.37 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 110.767 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.91 147.55 26.2 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.857 -0.424 . . . . 74.409999999999997 109.857 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.8 p -126.27 155.35 42.05 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 75.510000000000005 111.93 -175.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -120.45 -34.48 3.62 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.631 -1.248 . . . . 74.239999999999995 107.631 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -132.82 160.19 37.61 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.879 1.272 . . . . 75.400000000000006 108.803 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.59 -32.54 74.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.425 0.631 . . . . 75.109999999999999 110.717 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -68.38 -13.0 61.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.989 -1.005 . . . . 61.310000000000002 113.182 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.55 -28.41 62.82 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.687 -0.857 . . . . 64.099999999999994 108.687 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.2 m -89.82 132.78 35.52 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.827 -1.079 . . . . 71.099999999999994 109.397 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.14 139.9 17.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.302 2.001 . . . . 71.230000000000004 114.405 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.14 -102.68 0.13 Allowed Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 116.087 1.195 . . . . 74.129999999999995 116.087 172.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -91.79 -5.81 52.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.218 0.451 . . . . 62.210000000000001 112.218 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.27 140.18 36.32 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.231 0.538 . . . . 74.209999999999994 110.2 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -120.61 172.14 8.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.335 -1.357 . . . . 62.329999999999998 107.335 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.6 t -89.62 114.36 25.95 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.782 -0.822 . . . . 72.25 108.782 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 76.2 mtp180 -88.83 164.54 15.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.886 -0.413 . . . . 74.329999999999998 109.886 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.5 45.97 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 114.0 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.9 p-10 -89.62 -14.4 35.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.929 -0.767 . . . . 75.219999999999999 108.929 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.24 16.7 34.13 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.353 -0.84 . . . . 33.32 111.043 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -125.51 152.18 45.34 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.25 0.547 . . . . 75.319999999999993 110.31 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.47 134.97 36.04 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.903 -1.044 . . . . 51.329999999999998 110.296 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.02 145.26 11.5 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.65 -0.98 . . . . 72.239999999999995 110.65 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 31' ' ' ALA . 18.8 tt0 -65.37 146.57 54.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.143 -0.688 . . . . 34.149999999999999 109.143 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 30' ' ' GLU . . . -80.7 -86.16 0.09 Allowed 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.579 -0.897 . . . . 52.549999999999997 108.579 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 mt -149.62 93.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 105.593 -2.002 . . . . 65.209999999999994 105.593 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -139.13 -168.71 2.49 Favored 'General case' 0 C--N 1.246 -3.916 0 C-N-CA 123.868 0.867 . . . . 74.530000000000001 108.967 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.3 35.83 4.04 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.185 -0.672 . . . . 73.540000000000006 109.185 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 38' ' ' ALA . . . -71.46 117.75 59.97 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.599 -0.728 . . . . 44.340000000000003 111.988 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 Cg_exo -64.47 -35.86 46.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 113.55 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -129.83 -19.75 3.26 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.697 -0.401 . . . . 73.219999999999999 111.98 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . . . -83.17 33.92 0.46 Allowed 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.939 -0.476 . . . . 70.219999999999999 112.284 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.398 -0.964 . . . . 73.230000000000004 108.398 173.006 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.52 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 30.5 p . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 106.375 -1.713 . . . . 72.439999999999998 106.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.83 152.79 35.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.746 -0.835 . . . . 71.120000000000005 108.746 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.48 58.14 4.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.993 0.901 . . . . 71.5 112.099 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.82 -55.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.239 -1.023 . . . . 75.129999999999995 108.239 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -89.99 -33.75 16.25 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.527 -0.76 . . . . 75.140000000000001 108.962 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.28 119.67 6.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.125 -0.943 . . . . 72.030000000000001 109.3 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 107.91 8.51 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 122.915 0.486 . . . . 34.130000000000003 111.83 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 56.5 Cg_endo -96.67 125.91 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.742 2.295 . . . . 74.219999999999999 111.179 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -97.49 149.87 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.321 -0.622 . . . . 70.219999999999999 109.321 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -130.52 157.07 43.68 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.095 0.474 . . . . 74.099999999999994 111.823 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -117.48 -51.14 2.51 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.193 -2.151 . . . . 74.25 105.193 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -123.05 158.06 31.41 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 113.98 -1.464 . . . . 73.019999999999996 109.564 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.31 -29.85 70.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.174 0.511 . . . . 75.530000000000001 112.134 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.0 p -66.41 -21.27 66.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.327 -0.851 . . . . 74.340000000000003 111.669 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.57 -20.57 63.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.226 0.536 . . . . 63.530000000000001 109.986 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -94.14 119.84 66.23 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 115.303 -0.862 . . . . 71.409999999999997 109.78 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.15 141.2 32.18 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.847 2.365 . . . . 72.239999999999995 115.139 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.95 -108.84 2.61 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 114.446 -1.252 . . . . 41.509999999999998 114.235 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -102.37 -2.23 29.29 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.598 -0.519 . . . . 73.239999999999995 109.598 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.1 m -73.55 139.95 45.98 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.933 -0.766 . . . . 71.030000000000001 108.933 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.27 169.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 108.031 -1.1 . . . . 54.130000000000003 108.031 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.56 115.94 28.45 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.481 -0.563 . . . . 53.350000000000001 109.481 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -88.92 161.46 16.64 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.277 -0.638 . . . . 72.349999999999994 109.277 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.98 -2.56 47.42 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 113.43 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -89.5 -18.9 25.8 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.638 0.256 . . . . 71.400000000000006 110.87 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.34 4.71 32.74 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.515 -0.634 . . . . 71.340000000000003 111.515 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.77 146.55 36.17 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.584 0.754 . . . . 73.400000000000006 110.874 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.0 m -80.98 148.85 29.58 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.353 -0.84 . . . . 64.230000000000004 109.01 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 1' ' ' CYS . . . -176.3 152.01 12.21 Favored Glycine 0 N--CA 1.416 -2.692 0 C-N-CA 118.971 -1.585 . . . . 63.119999999999997 112.772 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.73 140.67 28.92 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.356 1.062 . . . . 71.340000000000003 109.502 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -85.61 0.11 Allowed 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 114.28 -1.327 . . . . 75.349999999999994 109.9 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.3 mt -153.53 102.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 105.678 -1.971 . . . . 72.109999999999999 105.678 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.5 t80 179.86 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.824 0 O-C-N 124.275 0.985 . . . . 60.520000000000003 108.672 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.73 60.15 1.1 Allowed 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.568 -1.196 . . . . 75.340000000000003 109.881 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . . . -72.84 123.3 89.41 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.748 -1.114 . . . . 70.209999999999994 110.522 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -43.15 -49.33 7.27 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 124.634 3.556 . . . . 62.409999999999997 115.568 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -107.21 -16.9 14.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.32 0.581 . . . . 65.150000000000006 111.307 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' H ' ' A' ' 19' ' ' ALA . . . -94.31 17.21 13.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.095 0.776 . . . . 64.439999999999998 113.095 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 . . . . . 0 C--N 1.285 -2.213 0 CA-C-N 115.208 -0.905 . . . . 65.5 110.973 177.544 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.999 0.904 . . . . 74.329999999999998 109.633 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.61 147.99 24.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.702 -1.135 . . . . 71.510000000000005 108.445 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.94 142.9 12.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.39 -0.967 . . . . 61.240000000000002 108.39 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.46 -23.08 4.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.74 -0.664 . . . . 64.510000000000005 110.384 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -89.23 -42.29 11.71 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.477 -0.489 . . . . 74.420000000000002 110.136 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.02 89.04 1.42 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.145 -0.479 . . . . 65.450000000000003 112.032 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -80.39 126.74 78.11 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.869 -0.605 . . . . 51.350000000000001 109.649 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.0 Cg_exo -66.09 119.82 6.9 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.709 2.272 . . . . 74.099999999999994 113.125 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 99.4 mttt -83.89 134.26 34.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.978 -0.749 . . . . 75.340000000000003 108.978 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.5 p -100.07 147.76 25.29 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.986 0.422 . . . . 71.439999999999998 112.033 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -109.2 -31.33 7.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.636 -1.246 . . . . 72.319999999999993 107.636 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -148.52 156.6 42.66 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.302 -1.317 . . . . 55.439999999999998 109.246 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 13.2 m-20 -59.53 -37.73 79.13 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.092 0.949 . . . . 73.109999999999999 110.311 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -71.82 -12.15 61.15 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.078 -1.419 . . . . 60.43 114.018 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.42 0.21 53.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.348 -0.941 . . . . 71.409999999999997 110.905 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 90.0 m -91.13 136.22 27.53 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 109.77 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 179.44 5.95 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.565 2.177 . . . . 63.539999999999999 112.967 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.66 -122.75 31.07 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.359 -0.837 . . . . 72.349999999999994 112.048 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.38 19.47 13.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.704 -0.85 . . . . 44.32 108.704 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.3 m -81.2 145.78 30.81 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.216 -0.902 . . . . 74.510000000000005 112.511 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 13' ' ' ASP . 30.7 pt -119.73 179.15 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.059 -1.46 . . . . 70.510000000000005 107.059 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -90.63 117.93 29.67 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.44 -0.948 . . . . 73.030000000000001 108.44 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -89.02 160.05 17.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.38 -1.12 41.7 Favored Glycine 0 C--N 1.31 -0.892 0 CA-C-N 115.931 -0.577 . . . . 75.239999999999995 113.411 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -89.66 -19.53 24.75 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.694 -0.484 . . . . 73.439999999999998 109.694 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 2.44 34.21 Favored Glycine 0 CA--C 1.499 -0.952 0 N-CA-C 111.486 -0.646 . . . . 74.030000000000001 111.486 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 95.7 m-85 -114.69 161.65 17.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 123.414 0.685 . . . . 72.510000000000005 109.997 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 76.6 m -80.26 142.01 35.0 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.579 -0.526 . . . . 61.32 109.579 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.21 146.84 14.71 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.9 -1.28 . . . . 72.049999999999997 109.9 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.3 tt0 -59.94 148.51 34.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.64 0.733 . . . . 72.239999999999995 110.597 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.39 -151.85 0.09 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.473 -1.239 . . . . 63.539999999999999 107.736 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.5 mm -95.82 136.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 C-N-CA 119.398 -0.921 . . . . 72.25 110.413 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.583 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 22.7 t80 -170.82 154.46 4.32 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 102.731 -3.062 . . . . 73.219999999999999 102.731 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.24 3.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 119.061 0.846 . . . . 63.009999999999998 110.341 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.63 155.06 73.78 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.441 -0.8 . . . . 62.409999999999997 109.078 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.92 125.47 11.57 Favored 'Trans proline' 0 C--O 1.241 0.639 0 N-CA-C 108.23 -1.488 . . . . 71.140000000000001 108.23 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -109.65 -46.34 3.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.006 0.432 . . . . 63.409999999999997 110.43 -173.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.3 78.58 1.02 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.664 -0.698 . . . . 63.409999999999997 109.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 115.368 -0.833 . . . . 74.409999999999997 108.795 178.601 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 122.39 1.091 . . . . 60.549999999999997 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.67 165.94 10.73 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.621 -1.172 . . . . 74.209999999999994 112.188 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.18 126.17 12.04 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.457 -1.683 . . . . 74.420000000000002 106.457 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.9 mt -93.67 -23.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 120.976 0.417 . . . . 62.140000000000001 111.629 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -87.83 -42.53 12.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.008 -0.677 . . . . 63.030000000000001 109.304 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.19 82.68 1.93 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.02 -0.991 . . . . 65.340000000000003 108.849 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -64.87 122.45 79.31 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.284 -0.871 . . . . 62.219999999999999 111.494 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -74.15 127.43 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.492 2.128 . . . . 63.530000000000001 109.923 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.0 pttm -94.49 156.89 16.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.55 -0.167 . . . . 64.120000000000005 110.55 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 15.2 p -142.55 157.68 44.46 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.507 0.194 . . . . 75.129999999999995 110.903 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 11' ' ' ARG . 71.6 mtt180 -111.57 -42.51 3.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.145 -1.428 . . . . 71.510000000000005 107.145 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -127.5 157.52 39.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.758 -1.564 . . . . 71.400000000000006 108.631 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 9.2 m-20 -61.89 -34.93 76.92 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.365 -0.834 . . . . 64.340000000000003 111.248 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -64.66 -21.62 66.77 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.526 -1.216 . . . . 71.439999999999998 112.584 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.19 -29.5 70.32 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.393 -0.595 . . . . 63.340000000000003 109.393 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 44.3 m -89.97 121.2 69.08 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 115.754 -0.657 . . . . 73.120000000000005 109.333 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.83 -177.55 2.59 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.45 2.1 . . . . 74.430000000000007 112.491 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.73 -132.75 51.42 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.575 -0.739 . . . . 63.310000000000002 111.926 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.33 11.08 33.91 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.606 0.241 . . . . 73.129999999999995 110.823 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.4 m -84.7 149.23 25.94 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.882 0.848 . . . . 73.219999999999999 112.63 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.25 175.71 10.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 113.858 -1.519 . . . . 74.439999999999998 107.683 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 37.8 t -97.25 110.85 23.32 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.07 -0.715 . . . . 41.030000000000001 109.07 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -74.15 169.36 17.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 111.649 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.93 -14.53 61.17 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 115.438 -0.801 . . . . 61.119999999999997 112.997 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.32 -16.27 33.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.082 0.468 . . . . 72.209999999999994 111.49 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.46 17.1 32.29 Favored Glycine 0 CA--C 1.485 -1.803 0 C-N-CA 120.233 -0.984 . . . . 40.399999999999999 111.05 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 71.1 m-85 -121.18 147.16 45.98 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.66 -0.77 . . . . 73.420000000000002 109.268 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 71.9 m -70.82 127.92 34.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.065 -0.516 . . . . 53.310000000000002 110.725 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.33 153.82 20.57 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.139 -1.184 . . . . 64.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -79.28 178.11 8.32 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.47 -0.566 . . . . 72.450000000000003 109.47 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.15 -72.69 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.074 0.549 . . . . 62.399999999999999 112.133 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.0 mt -138.78 146.96 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.811 -1.181 . . . . 71.299999999999997 107.811 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.639 -1.245 . . . . 51.119999999999997 107.639 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.56 -81.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.011 -0.737 . . . . 73.319999999999993 109.011 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 36' ' ' PRO 0.27 . . -80.54 -50.89 1.05 Allowed Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 120.471 -0.492 . . . . 75.409999999999997 110.429 170.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 20.9 Cg_exo -64.38 142.57 79.46 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.42 2.08 . . . . 71.040000000000006 107.816 167.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -119.95 25.5 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.204 0.526 . . . . 72.129999999999995 111.989 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.8 39.19 4.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.806 0.843 . . . . 50.030000000000001 110.199 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-N 114.596 -1.184 . . . . 75.510000000000005 111.31 -174.626 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 108.628 -0.879 . . . . 63.439999999999998 108.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.36 170.02 9.8 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.769 -1.105 . . . . 52.109999999999999 109.936 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.78 144.37 4.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.928 -1.508 . . . . 75.510000000000005 106.928 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.4 mt -105.0 -21.48 5.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.093 0.473 . . . . 64.409999999999997 110.367 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -88.23 -43.87 11.28 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.234 -1.024 . . . . 75.310000000000002 108.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.11 77.99 1.36 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.041 -1.096 . . . . 61.200000000000003 108.041 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 116.64 31.82 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 115.289 -0.869 . . . . 54.140000000000001 110.679 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.83 118.36 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.791 2.328 . . . . 64.310000000000002 111.453 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 96.8 mttt -86.15 163.22 17.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.981 -0.554 . . . . 65.450000000000003 110.636 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.1 p -139.21 148.68 43.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.933 -0.576 . . . . 75.510000000000005 109.996 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -115.67 -40.32 3.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.452 -1.685 . . . . 73.010000000000005 106.452 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -132.96 160.98 35.52 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.712 1.605 . . . . 65.349999999999994 108.004 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.08 -30.71 71.68 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.537 0.684 . . . . 31.23 111.47 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -67.41 -17.26 64.65 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.064 -0.971 . . . . 65.409999999999997 112.125 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -67.11 -23.92 65.88 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.159 0.504 . . . . 62.100000000000001 109.646 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.77 137.68 26.81 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-N 115.316 -0.856 . . . . 64.030000000000001 110.055 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -86.18 177.61 4.47 Favored 'Trans proline' 0 C--O 1.253 1.272 0 C-N-CA 122.541 2.16 . . . . 71.010000000000005 112.572 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.02 -124.18 35.89 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.036 -0.984 . . . . 43.049999999999997 112.885 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.66 13.12 21.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.787 0.327 . . . . 53.020000000000003 110.167 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.38 155.22 32.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.305 0.574 . . . . 74.319999999999993 112.01 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.86 174.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.623 -0.88 . . . . 74.230000000000004 108.623 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.03 115.5 28.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.689 -0.856 . . . . 74.510000000000005 108.689 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -84.85 165.72 17.48 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.108 0.48 . . . . 65.540000000000006 111.172 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.15 7.3 37.5 Favored Glycine 0 CA--C 1.51 -0.226 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 112.854 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -95.2 -16.36 22.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.617 -0.512 . . . . 74.299999999999997 109.617 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.01 11.97 41.31 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.729 -0.948 . . . . 74.109999999999999 110.729 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 89.9 m-85 -127.87 160.8 30.71 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.458 -0.871 . . . . 70.319999999999993 110.775 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.3 m -80.0 140.54 36.54 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.602 -0.726 . . . . 73.310000000000002 111.368 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.65 176.6 39.73 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.124 -1.19 . . . . 51.210000000000001 110.124 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 9.3 tp10 -74.68 173.74 10.07 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.821 0.848 . . . . 54.100000000000001 109.414 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.59 -24.64 63.71 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.191 0.996 . . . . 45.25 108.405 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.62 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 53.3 mt -92.57 149.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 105.853 -1.906 . . . . 64.310000000000002 105.853 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -44.75 -47.08 10.78 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.318 1.047 . . . . 71.549999999999997 113.275 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -119.58 135.45 54.79 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.776 -0.824 . . . . 72.540000000000006 108.776 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.74 110.03 15.6 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.599 0.562 . . . . 74.439999999999998 111.933 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 70.7 Cg_endo -83.57 -38.32 0.14 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.522 2.148 . . . . 63.409999999999997 114.071 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -117.15 -51.42 2.54 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.444 0.64 . . . . 73.25 109.882 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 56.71 3.57 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.779 0.799 . . . . 45.140000000000001 108.944 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 . . . . . 0 N--CA 1.426 -1.625 0 CA-C-N 115.352 -0.84 . . . . 62.32 109.237 -179.298 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.296 -1.372 . . . . 54.539999999999999 107.296 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -89.52 123.66 33.82 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.016 0.912 . . . . 73.340000000000003 109.705 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -149.72 100.82 3.01 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 114.165 -1.38 . . . . 55.509999999999998 108.887 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 mm -91.38 -13.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.362 -0.835 . . . . 74.109999999999999 109.878 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.11 -45.41 9.61 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.416 -0.811 . . . . 63.530000000000001 109.754 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.71 96.13 2.08 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.562 -0.745 . . . . 73.349999999999994 109.316 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 3' ' ' ALA . . . -72.57 126.41 90.83 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 115.91 -0.587 . . . . 64.219999999999999 110.166 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.55 116.41 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.539 2.159 . . . . 64.219999999999999 112.788 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -70.77 148.2 48.16 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.289 -1.004 . . . . 44.420000000000002 108.289 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 29.9 p -117.74 150.58 38.87 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 120.981 -0.288 . . . . 52.229999999999997 110.264 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.73 -43.66 2.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.278 -1.379 . . . . 72.219999999999999 107.278 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -132.18 153.1 50.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.64 -1.164 . . . . 53.520000000000003 108.729 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 6.1 m-20 -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.319 -0.855 . . . . 75.019999999999996 110.606 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -68.02 -19.26 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.64 -1.164 . . . . 73.530000000000001 113.284 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.23 -3.71 59.06 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.067 -1.053 . . . . 55.530000000000001 111.004 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -94.22 118.29 67.11 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 109.401 -0.592 . . . . 71.0 109.401 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.89 -175.44 2.68 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.586 2.19 . . . . 71.299999999999997 111.53 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.1 13.98 60.68 Favored Glycine 0 N--CA 1.465 0.599 0 CA-C-N 116.643 -0.253 . . . . 64.409999999999997 112.829 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.66 8.97 5.64 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.655 1.582 . . . . 70.519999999999996 111.129 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.76 149.17 50.28 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.047 -0.524 . . . . 65.140000000000001 109.629 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 44.9 pt -110.92 174.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.772 -0.825 . . . . 73.209999999999994 108.772 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -95.56 107.32 19.49 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.277 -1.008 . . . . 60.299999999999997 108.277 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -84.18 168.55 15.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.397 0.617 . . . . 72.230000000000004 110.857 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.45 2.25 63.14 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.295 -0.866 . . . . 75.340000000000003 112.398 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -88.74 -17.97 28.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.926 . . . . 65.140000000000001 108.501 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.8 6.94 42.7 Favored Glycine 0 CA--C 1.487 -1.673 0 N-CA-C 111.274 -0.731 . . . . 73.219999999999999 111.274 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.69 159.34 28.15 Favored 'General case' 0 N--CA 1.414 -2.255 0 C-N-CA 123.331 0.652 . . . . 71.010000000000005 110.39 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.2 m -80.21 131.94 35.78 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.254 -0.885 . . . . 44.229999999999997 108.633 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.47 170.01 30.38 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.633 -1.387 . . . . 65.549999999999997 109.633 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 42.4 tt0 -69.6 157.74 36.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 117.643 0.722 . . . . 65.239999999999995 110.062 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 -141.83 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.648 -1.242 . . . . 74.209999999999994 107.648 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.2 mt -101.97 130.51 51.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.647 -1.242 . . . . 75.430000000000007 107.647 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 37.1 t80 -165.58 167.89 16.93 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.669 -1.604 . . . . 71.310000000000002 106.669 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.7 -80.26 0.16 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.403 0.547 . . . . 75.019999999999996 112.069 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.5 151.09 71.41 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 109.735 -0.469 . . . . 75.109999999999999 109.735 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -64.77 112.69 2.06 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.706 1.604 . . . . 60.420000000000002 111.271 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -138.17 -39.23 0.54 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.115 0.783 . . . . 71.239999999999995 113.115 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.22 43.49 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.67 -0.863 . . . . 73.120000000000005 108.67 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 26.2 mtp180 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 114.667 -1.152 . . . . 75.439999999999998 111.433 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.469 0 CA-C-O 122.558 1.17 . . . . 63.420000000000002 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.25 -26.67 22.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.365 -1.743 . . . . 72.340000000000003 107.399 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.04 93.59 9.4 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.865 -1.532 . . . . 43.039999999999999 106.865 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.8 mt -89.62 -16.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.834 -1.075 . . . . 54.409999999999997 111.071 -174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -89.34 -27.34 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.872 -1.159 . . . . 72.420000000000002 107.872 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.61 12.02 34.99 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.938 -1.028 . . . . 73.239999999999995 110.407 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.12 166.19 40.22 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 123.756 0.822 . . . . 72.140000000000001 110.722 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.8 164.54 22.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.786 1.657 . . . . 74.120000000000005 110.716 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.19 162.51 26.54 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.743 0.306 . . . . 72.439999999999998 111.63 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.7 p -151.89 154.49 36.24 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.984 -0.553 . . . . 70.200000000000003 110.809 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -114.93 -34.23 5.16 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.221 -1.029 . . . . 75.430000000000007 108.221 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.85 161.71 34.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.512 -1.222 . . . . 74.319999999999993 110.664 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.91 -33.49 68.83 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.802 0.841 . . . . 62.219999999999999 111.57 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -65.03 -25.21 67.74 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.085 -0.961 . . . . 64.409999999999997 112.407 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.72 -26.76 68.8 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.524 0.678 . . . . 64.25 109.261 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -96.79 128.45 35.74 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.13 -0.941 . . . . 31.420000000000002 110.167 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.02 158.6 4.88 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.67 2.246 . . . . 64.099999999999994 114.547 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.36 -111.81 4.34 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.774 -1.103 . . . . 63.039999999999999 114.746 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.569 ' H ' ' HB3' ' A' ' 38' ' ' ALA . . . -105.45 5.54 31.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.437 0.637 . . . . 74.219999999999999 109.844 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.79 136.15 33.36 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.712 -1.218 . . . . 63.210000000000001 107.712 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.73 177.24 4.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.175 -1.046 . . . . 72.230000000000004 108.175 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -89.31 118.82 29.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.233 -0.987 . . . . 52.32 108.368 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -89.56 166.89 13.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.507 -0.553 . . . . 74.129999999999995 109.507 -177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.53 -8.69 52.88 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 114.221 0.448 . . . . 64.510000000000005 114.221 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -89.07 -17.13 29.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.361 0.6 . . . . 74.450000000000003 109.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.82 19.54 24.19 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 111.277 -0.729 . . . . 63.310000000000002 111.277 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.5 154.59 35.07 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.971 0.908 . . . . 75.439999999999998 109.9 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 93.8 m -80.14 101.59 8.88 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 123.14 0.576 . . . . 51.549999999999997 111.87 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.47 16.79 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.538 -0.839 . . . . 61.229999999999997 111.028 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 33' ' ' TYR . 27.3 tt0 -61.94 159.35 14.27 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.088 0.955 . . . . 62.310000000000002 111.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -71.48 0.16 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.386 -1.279 . . . . 71.310000000000002 110.106 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -133.23 -66.09 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.877 -1.157 . . . . 72.319999999999993 107.877 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.47 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 50.2 t80 -163.75 103.2 0.91 Allowed 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.699 -1.591 . . . . 75.329999999999998 107.562 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.8 167.41 10.31 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.709 -0.678 . . . . 64.530000000000001 111.809 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -80.2 169.51 19.56 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 114.802 -1.09 . . . . 73.120000000000005 108.301 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 20.2 Cg_endo -65.11 92.31 0.21 Allowed 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.303 1.335 . . . . 74.120000000000005 112.389 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -143.76 -55.1 0.37 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 105.735 -1.95 . . . . 71.219999999999999 105.735 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.569 ' HB3' ' H ' ' A' ' 19' ' ' ALA . . . -149.89 97.54 2.6 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.311 -1.737 . . . . 55.030000000000001 106.311 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 . . . . . 0 C--N 1.288 -2.092 0 CA-C-O 121.466 0.65 . . . . 64.129999999999995 109.381 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.422 -1.855 0 CA-C-O 122.108 0.956 . . . . 65.329999999999998 111.264 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -89.76 -35.3 15.81 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.883 -1.508 . . . . 73.219999999999999 108.974 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.63 89.18 7.08 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.378 -1.342 . . . . 62.119999999999997 107.378 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.23 -15.24 8.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.74 -0.664 . . . . 55.229999999999997 111.03 -175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.05 -31.98 18.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.275 -1.38 . . . . 71.219999999999999 107.275 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 25.01 11.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.604 -1.18 . . . . 72.319999999999993 110.122 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.2 126.66 88.2 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 75.420000000000002 109.401 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.21 143.46 44.05 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.901 1.734 . . . . 54.210000000000001 111.473 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 14.9 ptmm? -82.28 158.79 23.33 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.948 -0.39 . . . . 74.340000000000003 109.948 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -132.57 151.54 51.9 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.295 0.569 . . . . 62.340000000000003 111.963 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -101.34 -44.96 5.48 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.264 -2.124 . . . . 72.120000000000005 105.264 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 8.5 ptp180 -129.93 163.2 26.91 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.608 -1.633 . . . . 73.129999999999995 110.18 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.08 -32.12 73.57 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.886 -1.052 . . . . 73.540000000000006 110.815 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -72.72 -4.72 33.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.129 -0.941 . . . . 64.109999999999999 112.969 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 69.5 m-20 -77.71 -23.25 49.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.467 0.651 . . . . 70.510000000000005 109.45 172.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 29.2 m -104.96 127.37 28.89 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 108.656 -0.868 . . . . 73.219999999999999 108.656 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 16' ' ' CYS . 73.6 Cg_endo -100.52 -175.65 0.14 Allowed 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.413 2.076 . . . . 70.040000000000006 113.27 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.64 -108.9 2.63 Favored Glycine 0 CA--C 1.489 -1.545 0 CA-C-N 115.025 -0.989 . . . . 72.549999999999997 113.463 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 30' ' ' GLU . . . -115.23 0.24 13.46 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.174 0.512 . . . . 61.549999999999997 109.969 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 72.2 m -91.99 139.87 30.22 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 122.03 0.919 . . . . 71.140000000000001 111.826 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.79 179.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 113.883 -1.508 . . . . 72.239999999999995 107.065 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.8 t -95.51 104.94 16.86 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.198 -1.038 . . . . 51.229999999999997 108.198 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 74.3 mtp180 -79.96 170.16 16.86 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.453 -0.34 . . . . 71.129999999999995 110.893 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.52 -2.31 27.12 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 115.933 -0.576 . . . . 54.149999999999999 114.011 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 27' ' ' TYR . 32.1 p-10 -88.89 -19.19 26.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.826 -0.805 . . . . 71.019999999999996 108.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.07 32.33 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 110.939 -0.864 . . . . 74.540000000000006 110.939 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.532 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 73.9 m-85 -129.31 157.59 41.47 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.085 -0.558 . . . . 61.030000000000001 110.808 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.37 133.86 47.33 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.244 -0.889 . . . . 73.340000000000003 109.827 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.57 135.69 4.61 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.403 -1.079 . . . . 72.329999999999998 110.403 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 41.8 tt0 -51.36 139.0 20.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.263 1.03 . . . . 74.409999999999997 112.112 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.28 -62.43 1.66 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.873 -1.512 . . . . 63.009999999999998 110.549 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -131.04 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.016 -2.216 . . . . 64.319999999999993 105.016 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -59.93 107.79 0.67 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 123.888 0.742 . . . . 74.129999999999995 110.674 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 -166.22 1.21 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.933 0.716 . . . . 45.539999999999999 112.933 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -75.16 147.96 83.63 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-N 115.38 -0.827 . . . . 72.239999999999995 110.122 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 31.4 Cg_exo -65.25 121.32 8.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.151 2.568 . . . . 64.510000000000005 114.534 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -150.31 -63.17 0.2 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.877 -2.268 . . . . 75.099999999999994 104.877 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.35 95.7 2.76 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.674 -1.602 . . . . 63.32 106.674 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 106.14 -1.8 . . . . 60.420000000000002 106.14 177.633 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.41 -2.452 0 N-CA-C 107.859 -1.163 . . . . 73.340000000000003 107.859 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 38.3 mt-10 -141.89 -170.03 3.04 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.644 -2.354 . . . . 64.409999999999997 104.644 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.57 83.47 4.12 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.934 -0.707 . . . . 72.5 109.396 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.41 -62.38 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.318 -0.993 . . . . 70.120000000000005 108.318 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -88.81 -32.78 17.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.813 -1.18 . . . . 72.209999999999994 107.813 -176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.35 160.02 7.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.245 -1.391 . . . . 62.329999999999998 107.245 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.92 113.43 40.47 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.27 -0.641 . . . . 54.520000000000003 109.27 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -86.8 101.0 0.55 Allowed 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 121.801 1.667 . . . . 74.310000000000002 112.112 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -84.09 157.48 21.73 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.246 -0.65 . . . . 65.129999999999995 109.246 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -140.22 148.04 40.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.319 0.581 . . . . 64.340000000000003 112.063 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -105.42 -40.86 5.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.792 -1.929 . . . . 54.439999999999998 105.792 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -139.11 166.28 24.92 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 114.295 -1.32 . . . . 75.439999999999998 110.987 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.94 -33.85 72.45 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 123.774 0.83 . . . . 70.099999999999994 110.951 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -65.18 -21.44 66.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.868 -1.06 . . . . 64.329999999999998 112.293 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.31 0.576 . . . . 60.409999999999997 110.357 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.49 133.72 30.75 Favored Pre-proline 0 N--CA 1.422 -1.857 0 CA-C-N 115.341 -0.845 . . . . 61.039999999999999 111.008 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.42 177.35 8.63 Favored 'Trans proline' 0 C--O 1.257 1.465 0 C-N-CA 122.804 2.336 . . . . 73.219999999999999 112.76 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.99 -130.58 47.82 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 110.127 -1.189 . . . . 62.119999999999997 110.127 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.97 9.57 22.23 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 109.096 -0.705 . . . . 53.509999999999998 109.096 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.64 148.63 50.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.018 -0.537 . . . . 73.540000000000006 111.208 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -116.9 174.72 3.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 108.951 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.76 121.47 31.94 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 108.021 -1.103 . . . . 75.109999999999999 108.021 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -91.4 158.6 16.42 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.611 -0.885 . . . . 72.219999999999999 108.611 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.73 0.28 28.78 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.744 -0.662 . . . . 71.349999999999994 113.666 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -88.5 -19.68 26.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.12 0.486 . . . . 71.420000000000002 109.709 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.32 25.01 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 111.303 -0.719 . . . . 51.340000000000003 111.303 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -118.71 160.65 21.46 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 123.437 0.695 . . . . 71.319999999999993 111.494 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.8 m -80.39 139.61 36.43 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.989 -1.005 . . . . 73.219999999999999 110.336 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.3 157.41 28.3 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.831 -1.308 . . . . 71.25 109.831 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 10.1 tp10 -73.6 158.81 34.09 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.897 -0.779 . . . . 72.510000000000005 108.897 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.93 -39.01 61.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.945 -1.131 . . . . 54.25 107.945 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.502 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 37.6 mm -82.34 140.2 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.247 -1.761 . . . . 65.0 106.247 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.32 -37.89 60.52 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.284 0.564 . . . . 53.43 110.354 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.7 84.65 5.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 110.792 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -80.46 121.08 81.08 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.844 -0.616 . . . . 62.350000000000001 110.213 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 39.1 Cg_exo -57.39 -42.04 66.05 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.655 2.903 . . . . 63.420000000000002 114.674 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -150.68 -47.16 0.12 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.775 -0.454 . . . . 73.450000000000003 109.775 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.64 67.09 2.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.848 0.832 . . . . 64.209999999999994 110.852 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 2' ' ' GLU . 65.9 mtt180 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-N 114.089 -1.414 . . . . 73.430000000000007 109.916 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.268 -1.382 . . . . 63.140000000000001 107.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 15.9 mt-10 -91.4 176.86 6.41 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 112.877 -1.965 . . . . 73.120000000000005 110.174 -169.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -161.61 150.63 15.98 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 106.777 -1.564 . . . . 73.030000000000001 106.777 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.1 -25.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-O 121.094 0.474 . . . . 70.219999999999999 110.128 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -88.84 -44.49 10.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.896 -0.779 . . . . 65.439999999999998 108.896 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -133.18 88.58 2.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.709 -0.678 . . . . 75.329999999999998 110.338 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.49 132.83 60.89 Favored Pre-proline 0 C--N 1.297 -1.677 0 CA-C-N 115.894 -0.594 . . . . 53.240000000000002 110.962 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.7 Cg_exo -67.36 123.27 10.64 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.18 1.92 . . . . 60.229999999999997 109.396 174.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 62.0 pttt -82.26 163.76 21.62 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.065 -0.654 . . . . 63.229999999999997 111.234 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.1 p -150.99 157.39 42.83 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.197 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 2.8 mmp_? -116.68 -33.91 4.69 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.092 -1.077 . . . . 71.140000000000001 108.092 170.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.79 158.81 32.44 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.074 -0.967 . . . . 75.420000000000002 110.137 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -61.47 -30.87 70.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.118 -0.946 . . . . 70.129999999999995 111.533 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -71.78 -10.92 60.49 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.909 0.707 . . . . 60.119999999999997 112.909 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.24 -12.97 61.05 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.391 0.615 . . . . 71.430000000000007 109.581 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.3 m -110.92 126.71 28.18 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.603 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -84.9 168.85 10.61 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.67 2.247 . . . . 55.310000000000002 113.672 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.58 -126.17 40.47 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.273 -0.876 . . . . 73.140000000000001 113.522 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.12 13.3 29.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.068 -0.566 . . . . 60.43 110.881 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.87 151.13 25.29 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.898 -0.778 . . . . 75.299999999999997 108.898 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 44.1 pt -129.26 172.83 14.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.357 -1.349 . . . . 71.530000000000001 107.357 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.0 t -92.04 111.08 22.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.274 -1.38 . . . . 60.219999999999999 107.274 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.3 mmm180 -77.95 164.22 25.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.475 -0.565 . . . . 71.519999999999996 109.475 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.32 1.34 20.07 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 114.129 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.7 p-10 -89.81 -21.38 22.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.084 -0.709 . . . . 74.439999999999998 109.084 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.93 15.17 19.09 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.573 -0.74 . . . . 63.32 111.381 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 92.9 m-85 -131.59 150.16 52.25 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 122.863 0.465 . . . . 71.329999999999998 110.858 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.67 124.17 22.11 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.688 -0.687 . . . . 71.450000000000003 111.248 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.97 163.88 27.62 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.227 -1.149 . . . . 73.239999999999995 110.227 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' ' 32' ' ' ILE . 42.1 tt0 -62.02 152.91 31.14 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.425 0.631 . . . . 73.409999999999997 110.992 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . . . -77.45 -23.35 50.49 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.341 -0.845 . . . . 65.409999999999997 112.397 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 34' ' ' ALA . 39.2 mt -72.98 148.91 8.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.612 -0.722 . . . . 73.430000000000007 109.165 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -88.27 -10.44 49.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.198 0.523 . . . . 71.540000000000006 111.357 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -76.96 -176.94 4.16 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.616 -0.883 . . . . 72.319999999999993 108.616 174.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.17 119.7 51.51 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.682 -0.488 . . . . 71.310000000000002 109.682 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 56.1 Cg_exo -56.14 155.5 23.87 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.467 2.778 . . . . 54.149999999999999 112.909 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.53 -13.38 37.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.878 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' HB2' ' A' ' 2' ' ' GLU . . . 70.13 61.39 0.24 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.332 1.053 . . . . 53.420000000000002 109.439 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 . . . . . 0 CA--C 1.495 -1.15 0 CA-C-N 113.863 -1.517 . . . . 73.129999999999995 111.258 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.7 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -146.76 148.84 32.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.287 -0.635 . . . . 73.319999999999993 109.287 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -168.56 145.75 3.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.671 -1.974 . . . . 65.230000000000004 105.671 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.3 mp -94.4 -30.48 4.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 112.278 0.473 . . . . 73.439999999999998 112.278 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -87.89 -41.22 13.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.617 -0.833 . . . . 74.230000000000004 109.29 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -125.42 83.66 2.19 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 114.969 -1.014 . . . . 53.140000000000001 110.288 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.96 119.36 76.39 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.083 -0.71 . . . . 61.240000000000002 109.083 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.95 104.82 0.87 Allowed 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.908 2.405 . . . . 72.439999999999998 114.275 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -85.06 154.23 22.21 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.191 -0.913 . . . . 62.439999999999998 108.547 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.0 p -127.62 148.91 50.38 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.034 0.445 . . . . 64.030000000000001 111.186 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -112.02 -39.33 4.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.119 -1.808 . . . . 72.319999999999993 106.119 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -127.48 157.04 41.13 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.189 -1.369 . . . . 74.140000000000001 109.422 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.73 -29.12 70.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.394 0.678 . . . . 64.310000000000002 111.728 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.8 p -63.68 -23.05 67.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.239 -0.891 . . . . 73.099999999999994 111.866 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.485 0.66 . . . . 75.140000000000001 110.3 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 34.5 m -105.39 110.46 64.36 Favored Pre-proline 0 N--CA 1.401 -2.892 0 CA-C-N 115.384 -0.826 . . . . 72.129999999999995 109.879 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.84 178.84 6.52 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.517 2.145 . . . . 73.400000000000006 112.733 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.27 -111.87 4.52 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.989 -0.551 . . . . 44.530000000000001 112.997 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.51 16.18 9.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.845 -0.798 . . . . 61.350000000000001 108.845 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.95 144.4 29.19 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.179 -0.919 . . . . 73.310000000000002 109.867 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.2 pt -122.29 174.12 7.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.945 -1.502 . . . . 73.319999999999993 106.945 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.41 108.47 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.777 -1.194 . . . . 53.020000000000003 107.777 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 70.5 mtp180 -82.17 165.92 20.09 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 116.127 -0.488 . . . . 71.209999999999994 111.128 -177.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.85 -4.24 57.9 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 115.77 -0.65 . . . . 72.129999999999995 112.925 -177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 36.7 p-10 -89.05 -14.8 35.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.992 -0.744 . . . . 71.439999999999998 108.992 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 15.47 38.88 Favored Glycine 0 CA--C 1.493 -1.3 0 CA-C-N 115.479 -0.782 . . . . 73.400000000000006 111.183 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -124.14 154.38 40.11 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 123.482 0.713 . . . . 71.120000000000005 111.532 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.31 118.71 22.2 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.796 -1.093 . . . . 63.229999999999997 110.211 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.09 160.43 28.33 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.816 -1.183 . . . . 73.25 111.008 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 41.5 tt0 -63.62 155.51 29.54 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.491 -0.559 . . . . 73.129999999999995 109.491 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.35 26.44 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.189 -0.46 . . . . 72.219999999999999 110.836 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.35 138.01 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 106.685 -1.598 . . . . 73.400000000000006 106.685 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -99.24 82.95 2.77 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 111.446 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.54 -85.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.229 -0.896 . . . . 35.43 108.966 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.79 117.55 68.7 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.564 -0.902 . . . . 71.129999999999995 108.564 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.44 121.07 6.86 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.581 1.521 . . . . 73.420000000000002 111.023 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -112.68 -54.32 2.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.628 -1.249 . . . . 70.150000000000006 107.628 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.3 87.71 0.91 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.925 -1.034 . . . . 63.030000000000001 109.424 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 99.7 mtt180 . . . . . 0 C--N 1.301 -1.527 0 CA-C-N 114.966 -1.016 . . . . 75.349999999999994 111.063 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 18' ' ' GLY . 1.8 p . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 116.055 1.872 . . . . 74.040000000000006 116.055 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 3' ' ' ALA . 38.3 tt0 -91.29 178.72 5.89 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.378 -1.341 . . . . 75.409999999999997 107.378 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' A' ' 2' ' ' GLU . . . -65.86 98.23 0.4 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.559 0.695 . . . . 64.0 109.165 174.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.8 mt -111.69 -66.52 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 114.815 -1.084 . . . . 74.430000000000007 108.795 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -88.38 -37.2 16.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.245 -1.343 . . . . 75.120000000000005 108.636 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -145.79 143.39 29.65 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.054 -1.43 . . . . 62.240000000000002 109.037 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.74 104.86 3.05 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 123.833 0.708 . . . . 65.349999999999994 109.196 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 2.8 Cg_endo -83.78 117.04 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.455 2.103 . . . . 73.519999999999996 110.823 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.73 155.23 26.83 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.676 -0.49 . . . . 73.25 109.676 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 14.6 p -144.52 162.86 35.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.169 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -123.07 -41.06 2.35 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.247 -1.39 . . . . 71.019999999999996 107.247 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -119.48 154.23 34.1 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.234 -1.348 . . . . 74.340000000000003 109.514 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.13 -28.16 67.91 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.978 0.894 . . . . 71.219999999999999 111.14 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 p -68.6 -11.95 60.7 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.464 -1.243 . . . . 71.109999999999999 113.19 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -69.06 -24.8 64.21 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.056 -0.72 . . . . 70.5 109.056 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -95.71 121.5 61.19 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 115.443 -0.799 . . . . 74.400000000000006 109.962 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -85.11 -167.27 0.4 Allowed 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.101 2.534 . . . . 60.32 112.375 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 1' ' ' CYS . . . 64.48 -111.99 4.63 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.237 -0.745 . . . . 64.209999999999994 111.237 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.64 19.43 3.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.584 -1.265 . . . . 64.239999999999995 107.584 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.78 153.62 20.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.952 -1.022 . . . . 75.400000000000006 111.946 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.15 175.13 5.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.214 -0.903 . . . . 71.299999999999997 109.911 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.04 110.71 23.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.853 -0.795 . . . . 50.119999999999997 108.853 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -82.65 169.98 15.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.075 0.464 . . . . 64.340000000000003 111.405 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.62 -1.76 46.89 Favored Glycine 0 N--CA 1.464 0.514 0 CA-C-N 115.734 -0.666 . . . . 42.229999999999997 113.433 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -89.03 -15.19 34.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.786 -0.82 . . . . 74.010000000000005 108.786 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.54 15.54 34.41 Favored Glycine 0 CA--C 1.481 -2.056 0 N-CA-C 111.292 -0.723 . . . . 33.409999999999997 111.292 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.76 156.4 42.5 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.719 -0.741 . . . . 74.420000000000002 110.705 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 72.6 m -79.87 141.18 36.37 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 109.383 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 2' ' ' GLU . . . -155.13 168.55 33.04 Favored Glycine 0 N--CA 1.407 -3.246 0 N-CA-C 109.271 -1.532 . . . . 72.319999999999993 109.271 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 40.8 tt0 -65.32 162.05 18.32 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.627 -0.508 . . . . 71.299999999999997 109.627 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.64 64.89 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.566 0.698 . . . . 53.43 109.784 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.53 140.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 106.559 -1.645 . . . . 54.299999999999997 106.559 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -81.22 -32.15 33.55 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.164 0.506 . . . . 74.519999999999996 110.042 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.1 87.48 2.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.962 -1.125 . . . . 73.439999999999998 107.962 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 126.75 84.19 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.372 -0.831 . . . . 71.140000000000001 112.01 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.25 -36.92 79.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.782 2.988 . . . . 74.010000000000005 112.621 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -135.79 -79.92 0.42 Allowed 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.739 -1.208 . . . . 74.129999999999995 107.739 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 168.29 88.95 0.0 OUTLIER 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.87 1.268 . . . . 60.310000000000002 109.534 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HE ' ' CD ' ' A' ' 30' ' ' GLU . 74.1 mtm180 . . . . . 0 C--N 1.308 -1.231 0 CA-C-O 119.316 -0.373 . . . . 73.099999999999994 110.153 170.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.399 -2.985 0 N-CA-C 103.382 -2.822 . . . . 75.219999999999999 103.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.7 -31.39 19.74 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.65 -0.87 . . . . 73.409999999999997 108.65 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.39 93.41 9.31 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.455 -0.942 . . . . 75.519999999999996 108.455 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.19 -33.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 74.420000000000002 109.032 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -88.83 -43.12 11.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.66 -1.237 . . . . 60.530000000000001 107.66 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.19 35.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.196 -1.365 . . . . 74.319999999999993 108.733 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 153.0 84.83 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.17 -1.377 . . . . 65.510000000000005 110.369 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.47 161.9 31.06 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.921 1.747 . . . . 74.219999999999999 109.856 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -80.7 145.09 31.77 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.83 -0.434 . . . . 73.109999999999999 109.83 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.562 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.4 p -121.35 148.03 44.91 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.828 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 7.2 mpt_? -109.22 -32.46 7.19 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 73.25 107.155 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -144.95 160.02 42.0 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 125.395 1.478 . . . . 74.329999999999998 108.528 172.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -59.23 -37.43 77.51 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.962 0.887 . . . . 74.129999999999995 110.549 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -68.33 -17.39 64.25 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.348 -1.296 . . . . 60.210000000000001 113.75 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 2.2 p30 -91.04 6.25 45.61 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.914 -1.114 . . . . 75.299999999999997 111.734 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.0 m -89.23 145.26 33.81 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 120.719 -0.392 . . . . 70.340000000000003 110.74 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.82 132.56 52.47 Favored 'Trans proline' 0 C--O 1.257 1.453 0 C-N-CA 123.373 2.715 . . . . 71.109999999999999 113.019 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.71 -106.94 1.72 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.801 -1.09 . . . . 33.340000000000003 112.563 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.07 16.9 5.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.545 -0.168 . . . . 35.409999999999997 110.545 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.69 150.34 41.29 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.1 -0.704 . . . . 55.310000000000002 109.1 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 46.0 pt -104.07 170.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.875 -0.416 . . . . 61.149999999999999 109.875 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.3 t -98.24 122.75 41.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.04 -1.096 . . . . 65.329999999999998 108.04 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mtm-85 -88.72 166.67 13.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.916 -0.401 . . . . 74.540000000000006 109.916 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.5 -7.57 41.0 Favored Glycine 0 N--CA 1.467 0.715 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 113.831 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 33.5 p-10 -89.18 -24.84 22.07 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 122.548 -0.383 . . . . 61.43 110.057 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.92 9.71 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.609 -0.805 . . . . 74.430000000000007 111.547 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 70.8 m-85 -125.32 155.91 39.49 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.729 -0.841 . . . . 73.409999999999997 108.729 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.3 m -80.26 153.06 28.74 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.816 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.46 -179.7 33.51 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-O 119.189 -0.784 . . . . 72.120000000000005 111.34 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.07 150.12 30.35 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.268 0.627 . . . . 65.040000000000006 110.125 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.14 32.87 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.369 -0.832 . . . . 64.409999999999997 110.333 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.3 mt -139.59 128.63 28.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.087 -1.82 . . . . 52.030000000000001 106.087 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -87.72 87.22 7.31 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 121.589 0.709 . . . . 73.120000000000005 111.599 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.67 -92.4 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.383 -1.34 . . . . 75.430000000000007 107.383 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.65 60.18 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.392 -1.336 . . . . 74.209999999999994 107.392 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.12 110.83 2.07 Favored 'Trans proline' 0 C--O 1.249 1.052 0 N-CA-C 108.579 -1.354 . . . . 72.450000000000003 108.579 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -109.15 -65.93 1.1 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.324 0.583 . . . . 75.310000000000002 111.592 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.26 38.63 2.16 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.77 -1.196 . . . . 63.0 107.77 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 CA--C 1.489 -1.38 0 C-N-CA 126.562 1.945 . . . . 63.310000000000002 115.481 -169.499 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 101.683 -3.451 . . . . 64.319999999999993 101.683 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -137.87 155.16 49.25 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.605 -0.725 . . . . 61.030000000000001 111.996 -163.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.82 132.54 5.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.874 -2.269 . . . . 71.129999999999995 104.874 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 mm -96.48 -20.44 5.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 120.875 0.369 . . . . 73.340000000000003 111.533 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -88.25 -41.41 12.95 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.576 -0.85 . . . . 73.329999999999998 108.9 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.91 102.82 3.01 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.979 -0.749 . . . . 74.099999999999994 108.979 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 134.42 57.53 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 116.601 -0.272 . . . . 54.240000000000002 110.402 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.12 119.4 6.57 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.796 2.331 . . . . 64.200000000000003 112.277 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.77 157.81 17.79 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.45 -0.945 . . . . 61.310000000000002 108.45 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.8 p -136.88 142.01 42.78 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.398 0.618 . . . . 61.520000000000003 111.478 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.9 -32.52 7.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.645 -1.613 . . . . 72.409999999999997 106.645 171.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -140.02 161.5 37.47 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.705 -1.589 . . . . 71.120000000000005 108.651 174.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.54 -29.54 70.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.561 -0.745 . . . . 72.340000000000003 111.864 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -69.54 -15.56 63.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.847 -0.615 . . . . 62.509999999999998 112.57 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.519 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m-20 -68.41 -22.55 64.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.451 0.643 . . . . 55.219999999999999 110.007 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -89.83 123.54 66.03 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-N 115.351 -0.84 . . . . 61.409999999999997 111.513 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.23 -179.81 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.979 2.453 . . . . 73.209999999999994 112.077 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.83 -123.82 34.34 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 112.311 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ALA . . . -113.04 10.44 18.78 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.005 -0.739 . . . . 64.439999999999998 109.005 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 m -71.08 146.68 49.13 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.675 -0.693 . . . . 73.349999999999994 110.614 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 22.9 pt -127.12 171.41 15.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.901 -0.777 . . . . 71.349999999999994 108.901 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.7 115.02 26.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.077 0.465 . . . . 71.200000000000003 109.781 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -86.3 167.76 14.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 109.899 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.42 -2.23 54.13 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 113.403 -174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -89.96 -17.55 27.72 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.761 0.315 . . . . 55.130000000000003 111.024 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.53 27.16 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.717 -0.953 . . . . 72.510000000000005 110.717 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -126.3 154.99 42.67 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 124.452 1.101 . . . . 75.329999999999998 109.988 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 74.4 m -80.19 126.2 30.81 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 72.230000000000004 109.839 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.46 -178.97 15.57 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.139 -1.185 . . . . 73.430000000000007 110.139 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.0 tp10 -66.17 156.19 34.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.873 0.336 . . . . 72.019999999999996 110.271 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . -80.59 -53.39 6.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.37 0.605 . . . . 73.219999999999999 111.482 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 35' ' ' ALA . 50.2 mm -115.66 150.31 17.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.05 -0.977 . . . . 51.109999999999999 109.704 -172.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -82.41 136.76 34.88 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.489 -0.93 . . . . 72.329999999999998 108.489 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 69.82 24.64 5.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.422 1.089 . . . . 64.230000000000004 110.15 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.94 166.49 42.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.444 -0.798 . . . . 60.130000000000003 110.77 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 58.7 Cg_exo -42.09 -50.21 5.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.97 3.113 . . . . 72.209999999999994 115.2 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -96.87 -38.09 9.98 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.131 -0.628 . . . . 74.400000000000006 109.84 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . . . 72.6 14.99 5.06 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 125.113 1.365 . . . . 73.340000000000003 111.488 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-N 114.324 -1.307 . . . . 73.349999999999994 109.871 -176.407 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 122.019 0.914 . . . . 74.319999999999993 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' CD ' ' HD2' ' A' ' 39' ' ' ARG . 6.0 pt-20 -97.71 161.64 13.66 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.713 -1.13 . . . . 71.120000000000005 110.503 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.0 120.07 30.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 106.422 -1.696 . . . . 73.25 106.422 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.45 -29.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-N 114.734 -1.121 . . . . 62.530000000000001 112.228 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.8 -42.23 12.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.137 -1.06 . . . . 74.430000000000007 108.137 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.26 78.62 1.77 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.982 -1.008 . . . . 73.099999999999994 108.403 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.98 117.2 12.01 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.253 -0.885 . . . . 71.349999999999994 111.758 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 3' ' ' ALA . 34.0 Cg_endo -89.87 108.79 0.4 Allowed 'Trans proline' 0 N--CA 1.429 -2.289 0 C-N-CA 122.458 2.105 . . . . 74.310000000000002 111.806 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.6 pttm -88.7 145.6 25.55 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.572 -0.529 . . . . 75.400000000000006 109.572 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.6 p -127.38 154.55 44.86 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.826 0.822 . . . . 70.019999999999996 111.598 -173.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -115.22 -35.25 4.73 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.089 -1.448 . . . . 71.349999999999994 107.089 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -130.57 158.45 39.95 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.306 -1.315 . . . . 73.530000000000001 110.103 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 6.4 m-20 -62.71 -34.33 76.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.626 0.726 . . . . 70.209999999999994 110.679 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -67.01 -6.41 16.9 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.502 -1.226 . . . . 74.540000000000006 113.212 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.7 -40.46 92.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.285 0.564 . . . . 73.510000000000005 109.523 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 79.2 m -131.71 98.34 18.02 Favored Pre-proline 0 N--CA 1.409 -2.479 0 N-CA-C 107.836 -1.172 . . . . 70.129999999999995 107.836 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.75 -166.21 0.39 Allowed 'Trans proline' 0 C--O 1.261 1.667 0 C-N-CA 122.896 2.397 . . . . 72.049999999999997 115.291 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.74 -111.22 4.0 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 113.933 -1.485 . . . . 34.109999999999999 112.762 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 -14.93 36.79 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.15 -0.525 . . . . 60.140000000000001 111.426 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.91 155.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.316 -0.554 . . . . 73.340000000000003 110.951 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.7 pt -131.9 179.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.401 -0.963 . . . . 65.219999999999999 108.401 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 50.4 t -101.28 126.55 48.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.318 -1.364 . . . . 74.200000000000003 107.318 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 41.4 mtt180 -91.25 165.81 13.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.796 -0.446 . . . . 71.310000000000002 109.796 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -5.92 66.76 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.71 -0.677 . . . . 72.530000000000001 112.491 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.586 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.5 p-10 -88.3 -11.69 45.69 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.908 -0.775 . . . . 61.409999999999997 108.908 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.42 42.49 Favored Glycine 0 CA--C 1.488 -1.601 0 CA-C-N 115.598 -0.728 . . . . 64.519999999999996 111.298 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 60.7 m-85 -125.14 157.03 37.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.496 0.718 . . . . 70.329999999999998 110.285 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.8 m -79.98 166.53 21.5 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.733 0.301 . . . . 62.420000000000002 110.414 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' ' HE ' ' A' ' 23' ' ' ARG . . . 170.55 -176.16 44.18 Favored Glycine 0 CA--C 1.486 -1.762 0 C-N-CA 120.172 -1.013 . . . . 52.450000000000003 112.488 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' HG12 ' A' ' 32' ' ' ILE . 9.8 tp10 -60.75 154.92 20.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.347 0.674 . . . . 74.549999999999997 109.95 176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.92 16.54 1.43 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.961 0.905 . . . . 52.439999999999998 112.356 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' HG3' ' A' ' 30' ' ' GLU . 50.3 mm -93.93 129.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.509 -1.663 . . . . 55.009999999999998 106.509 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -90.64 -21.78 21.51 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 115.62 -0.718 . . . . 74.439999999999998 111.483 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.03 -166.54 1.52 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.128 -1.064 . . . . 73.099999999999994 108.128 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.65 114.76 15.74 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 109.893 -0.41 . . . . 71.5 109.893 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.26 -173.99 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.666 2.244 . . . . 63.25 111.43 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -148.25 -59.93 0.25 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.039 -1.097 . . . . 74.099999999999994 108.039 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.53 78.84 7.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.819 -0.628 . . . . 54.420000000000002 109.943 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.428 ' HD2' ' CD ' ' A' ' 2' ' ' GLU . 80.0 mtm180 . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.927 -0.579 . . . . 72.310000000000002 109.987 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.388 0.613 . . . . 75.109999999999999 109.775 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.06 175.31 7.45 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.779 -1.101 . . . . 72.129999999999995 109.118 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.91 8.67 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.635 -1.246 . . . . 73.450000000000003 107.635 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.66 -26.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.735 -0.666 . . . . 71.129999999999995 110.596 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -88.06 -40.8 13.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.456 0.646 . . . . 63.310000000000002 109.709 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.63 87.85 1.66 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.044 -0.98 . . . . 63.109999999999999 109.62 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.07 135.45 96.32 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.296 -0.865 . . . . 74.530000000000001 111.459 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.12 122.2 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.465 2.11 . . . . 65.140000000000001 111.348 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 50.9 mtpt -76.58 145.98 38.62 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.845 -0.428 . . . . 73.340000000000003 109.845 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.6 p -117.82 146.85 43.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.645 0.259 . . . . 54.409999999999997 110.764 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.38 -45.08 4.16 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.79 -1.559 . . . . 71.340000000000003 106.79 172.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -136.66 155.26 50.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.04 -1.436 . . . . 72.140000000000001 109.309 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.415 ' OD2' ' HB ' ' A' ' 21' ' ' ILE . 2.9 m-20 -58.43 -35.01 71.45 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 123.698 0.799 . . . . 70.420000000000002 111.023 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -67.31 -16.26 64.16 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.29 1.218 . . . . 32.299999999999997 114.29 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -90.25 -4.14 57.37 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.289 -0.964 . . . . 72.109999999999999 111.549 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.93 137.41 28.25 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 115.791 -0.64 . . . . 62.100000000000001 110.012 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.0 122.27 6.03 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 124.18 3.254 . . . . 64.450000000000003 114.525 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.61 -119.25 17.57 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.131 -0.94 . . . . 70.140000000000001 112.914 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.93 10.54 36.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.316 -0.442 . . . . 64.329999999999998 110.866 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.54 146.8 52.96 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.125 -0.694 . . . . 63.340000000000003 109.125 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' OD2' ' A' ' 13' ' ' ASP . 36.0 pt -111.67 167.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.007 0.432 . . . . 73.430000000000007 111.0 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.19 105.1 17.39 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.564 -1.273 . . . . 54.420000000000002 107.564 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.96 165.16 22.89 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.01 0.433 . . . . 72.230000000000004 111.546 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.38 48.2 Favored Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.381 -0.827 . . . . 74.040000000000006 113.743 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -88.18 -15.47 35.92 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.987 -0.746 . . . . 72.319999999999993 108.987 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.39 10.83 37.67 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 111.037 -0.825 . . . . 40.140000000000001 111.037 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 71.4 m-85 -124.69 151.75 44.58 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 121.44 0.638 . . . . 73.049999999999997 110.686 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.7 m -74.19 147.22 42.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.464 -0.789 . . . . 45.32 109.271 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.15 159.68 32.26 Favored Glycine 0 CA--C 1.472 -2.637 0 N-CA-C 110.321 -1.112 . . . . 72.140000000000001 110.321 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -63.69 161.39 15.1 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.196 0.586 . . . . 74.030000000000001 110.007 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.25 42.69 0.27 Allowed 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.5 1.12 . . . . 71.010000000000005 111.398 -176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 34' ' ' ALA . 24.0 mt -93.13 130.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.98 -1.489 . . . . 34.119999999999997 106.98 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -99.68 -6.95 26.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.904 0.859 . . . . 74.040000000000006 110.334 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -98.8 -158.02 0.64 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.487 -1.233 . . . . 74.430000000000007 107.871 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.6 93.14 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.554 -0.165 . . . . 75.109999999999999 110.554 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.97 147.72 51.0 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.48 2.787 . . . . 62.509999999999998 112.808 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -109.59 -7.59 15.1 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.477 0.656 . . . . 71.209999999999994 109.391 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 70.91 70.77 0.19 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.707 1.203 . . . . 65.540000000000006 111.241 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 CA--C 1.476 -1.884 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 174.615 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 113.269 0.841 . . . . 61.200000000000003 113.269 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -99.07 -55.39 2.71 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.27 -0.877 . . . . 71.230000000000004 110.277 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.85 142.92 13.95 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 106.394 -1.706 . . . . 61.32 106.394 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.69 -39.76 4.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 116.579 -0.282 . . . . 73.120000000000005 111.68 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -89.25 -41.19 12.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.178 -1.045 . . . . 74.430000000000007 108.178 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -87.46 136.98 32.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.737 -1.12 . . . . 73.030000000000001 109.463 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 108.66 12.04 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 123.373 0.42 . . . . 73.530000000000001 111.594 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 35.1 Cg_endo -89.4 123.89 1.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.332 2.021 . . . . 42.409999999999997 109.914 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.9 pttt -100.07 145.69 27.64 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.995 -0.682 . . . . 62.43 111.416 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.4 p -124.1 152.07 43.16 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.631 0.253 . . . . 74.519999999999996 110.876 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -110.2 -36.13 5.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.524 -1.658 . . . . 72.129999999999995 106.524 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -132.38 151.89 51.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.36 -1.291 . . . . 74.439999999999998 109.184 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.45 -40.9 88.35 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.951 0.881 . . . . 73.230000000000004 109.343 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 p -63.33 -18.46 63.65 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.649 -1.614 . . . . 55.229999999999997 114.47 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.305 2.6 p30 -78.91 -9.1 59.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 118.668 -1.213 . . . . 75.099999999999994 112.051 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -125.99 106.77 25.36 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 62.399999999999999 109.347 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.06 -168.2 0.49 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 123.412 2.741 . . . . 44.210000000000001 115.792 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.47 -128.32 32.78 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 113.85 -1.523 . . . . 70.120000000000005 112.167 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.65 6.58 46.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.417 -0.392 . . . . 52.420000000000002 110.87 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.5 m -93.72 147.85 22.65 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 111.98 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 pt -138.0 177.06 5.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 114.052 -1.431 . . . . 71.109999999999999 107.97 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -97.9 124.63 42.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.565 -0.902 . . . . 71.319999999999993 108.565 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.01 167.77 10.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 O-C-N 122.193 -0.317 . . . . 72.129999999999995 110.765 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.26 -9.14 56.98 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 114.424 0.53 . . . . 75.439999999999998 114.424 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -88.84 -17.57 29.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.45 0.643 . . . . 71.329999999999998 109.398 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.26 17.83 23.5 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.888 -0.885 . . . . 51.0 110.888 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 70.9 m-85 -121.08 151.98 39.21 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.165 0.507 . . . . 61.32 111.938 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.5 m -79.49 109.76 14.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.169 -0.923 . . . . 71.319999999999993 109.674 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.79 163.63 12.78 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 109.112 -1.595 . . . . 61.049999999999997 109.112 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -80.27 166.36 21.44 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.744 -1.576 . . . . 63.340000000000003 106.744 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.38 74.07 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.864 0.364 . . . . 40.399999999999999 110.259 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.73 -62.01 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-O 121.319 0.58 . . . . 70.439999999999998 110.912 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -87.38 95.62 10.07 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 115.261 -0.882 . . . . 55.32 112.848 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.15 -22.6 18.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.358 -0.837 . . . . 63.219999999999999 110.939 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.95 156.09 84.44 Favored Pre-proline 0 C--O 1.254 1.298 0 CA-C-N 115.651 -0.704 . . . . 64.439999999999998 109.259 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.12 84.56 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.108 1.872 . . . . 71.109999999999999 111.321 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.4 -50.94 0.13 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 108.954 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.12 72.44 1.21 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.67 . . . . 71.510000000000005 112.274 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 28' ' ' CYS . 37.5 mtm180 . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 107.209 -1.404 . . . . 74.540000000000006 107.209 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.251 1.177 0 CA-C-O 121.523 0.678 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.05 135.06 33.59 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 155.59 38.07 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mt -103.97 -40.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 O-C-N 123.672 0.608 . . . . 0.0 110.798 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -89.39 -40.53 12.68 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.406 0.622 . . . . 0.0 110.501 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.47 49.53 1.2 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.389 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.67 122.87 86.4 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.387 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.43 120.32 5.88 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.047 1.831 . . . . 0.0 109.81 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.4 pttt -76.08 158.94 31.27 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.885 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.8 p -120.22 150.49 40.58 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.207 0.527 . . . . 0.0 111.823 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 73.5 mtm180 -110.92 -47.57 3.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 13.5 ptm180 -141.1 159.24 42.63 Favored 'General case' 0 CA--C 1.477 -1.857 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.085 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.63 -36.92 70.04 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.216 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 p -67.04 -27.65 67.57 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.539 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 11' ' ' ARG 0.281 1.7 p30 -86.46 10.31 15.57 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.618 178.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.2 m -93.63 136.68 23.81 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.541 173.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.43 152.7 71.16 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.621 2.881 . . . . 0.0 113.521 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 -114.52 6.93 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.507 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.96 15.27 7.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.04 153.87 20.53 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 pt -113.2 172.18 3.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.9 t -89.68 103.39 16.05 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -74.08 166.21 23.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.256 0.55 . . . . 0.0 111.512 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.94 -2.56 47.06 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.845 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.427 HD21 ' HB2' ' A' ' 27' ' ' TYR . 32.4 p-10 -89.89 -17.05 28.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.79 31.42 Favored Glycine 0 CA--C 1.498 -0.991 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 85.4 m-85 -128.43 160.72 31.37 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.443 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.9 m -80.27 140.88 36.0 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.305 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.01 161.44 35.03 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 39' ' ' ARG . 9.2 tp10 -64.63 162.1 16.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.256 0.528 . . . . 0.0 109.846 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.79 -49.56 17.74 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mm -116.12 122.69 70.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -73.45 -29.97 62.89 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.26 0.552 . . . . 0.0 110.818 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.0 -28.15 65.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.577 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.67 111.16 23.64 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.392 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 5.4 Cg_exo -79.66 99.47 1.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.333 0 C-N-CA 121.077 1.184 . . . . 0.0 110.365 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -134.46 -75.73 0.47 Allowed 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 86.94 2.05 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.334 0.588 . . . . 0.0 110.82 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.549 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 84.1 mtp180 . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.927 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.631 -1.618 . . . . 64.129999999999995 106.631 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.07 139.87 30.35 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 113.72 -1.582 . . . . 74.420000000000002 109.041 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.52 130.18 6.61 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.63 -1.248 . . . . 64.219999999999999 107.63 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.64 -27.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 112.529 0.566 . . . . 70.450000000000003 112.529 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.63 -44.28 10.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.249 -0.907 . . . . 62.009999999999998 109.195 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.7 86.81 2.24 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.481 -0.781 . . . . 64.420000000000002 110.376 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.0 123.94 90.18 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.552 -0.749 . . . . 74.049999999999997 109.407 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.63 110.1 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 112.105 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 20.6 pttp -80.82 153.51 27.67 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 110.772 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 19.2 p -135.8 151.34 49.98 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.265 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -105.97 -36.64 6.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.249 -1.759 . . . . 74.129999999999995 106.249 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -136.5 161.41 35.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.659 -1.61 . . . . 72.540000000000006 109.916 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 4.8 m-20 -63.46 -30.75 71.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.958 0.903 . . . . 65.409999999999997 111.494 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -69.18 -15.08 63.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.335 -0.848 . . . . 74.420000000000002 112.697 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -73.34 -16.0 61.37 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.358 -0.608 . . . . 65.319999999999993 109.358 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.59 123.62 47.33 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 109.015 -0.735 . . . . 70.010000000000005 109.015 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.8 -174.69 0.73 Allowed 'Trans proline' 0 C--O 1.258 1.475 0 C-N-CA 122.692 2.261 . . . . 75.319999999999993 112.716 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.89 -102.21 0.68 Allowed Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.34 -0.845 . . . . 75.310000000000002 112.411 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.74 11.72 2.69 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.242 0.544 . . . . 50.140000000000001 109.692 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.8 m -84.36 151.67 24.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 110.542 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.9 pt -118.09 171.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.219 -1.03 . . . . 72.109999999999999 108.219 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 46.1 t -94.52 107.63 19.61 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.424 -0.954 . . . . 71.319999999999993 108.424 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -73.32 166.44 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.65 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.21 -8.72 45.37 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 114.48 0.552 . . . . 52.219999999999999 114.48 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -89.25 -19.09 25.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.047 0.451 . . . . 63.030000000000001 109.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.77 23.41 10.88 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.078 -0.809 . . . . 63.409999999999997 111.078 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 74.6 m-85 -127.18 151.46 48.64 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 122.841 0.457 . . . . 74.200000000000003 110.768 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.4 m -79.53 128.37 33.29 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.58 -0.737 . . . . 73.209999999999994 111.434 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.25 168.64 35.26 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.598 -1.401 . . . . 60.140000000000001 109.598 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 8.9 tp10 -78.52 167.31 21.47 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.634 -0.876 . . . . 75.030000000000001 108.634 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.908 0.861 . . . . 73.019999999999996 109.166 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.628 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 57.6 mt -96.48 150.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 105.615 -1.994 . . . . 72.439999999999998 105.615 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -59.93 -59.32 5.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 111.32 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 123.05 41.08 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.959 -1.497 . . . . 71.0 106.959 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -73.16 132.39 82.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 109.848 -0.427 . . . . 74.120000000000005 109.848 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 52.7 Cg_exo -55.81 -45.09 41.52 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.419 2.746 . . . . 73.510000000000005 114.355 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -150.05 -50.81 0.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.996 -0.372 . . . . 64.049999999999997 109.996 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.68 70.76 6.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.722 0.772 . . . . 72.230000000000004 109.532 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HG2' ' HB3' ' A' ' 35' ' ' ALA . 66.7 mtp180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-N 114.476 -1.238 . . . . 75.319999999999993 109.518 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.41 -2.474 0 N-CA-C 103.944 -2.613 . . . . 64.430000000000007 103.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -88.08 143.95 26.78 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 120.901 0.381 . . . . 62.109999999999999 109.996 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.59 36.33 3.56 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.404 -0.816 . . . . 74.349999999999994 110.109 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.11 -50.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.612 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.28 -34.82 12.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.798 0.809 . . . . 55.520000000000003 109.079 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.0 104.73 3.72 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.997 -1.456 . . . . 51.229999999999997 109.152 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.2 116.12 56.33 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 110.649 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.47 114.97 2.93 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.637 2.225 . . . . 73.530000000000001 111.859 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -89.68 159.62 17.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.357 -0.979 . . . . 63.219999999999999 108.357 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 18.7 p -152.26 158.78 43.3 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.266 0.555 . . . . 44.350000000000001 111.685 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -119.78 -35.83 3.43 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.311 -1.366 . . . . 73.349999999999994 107.311 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -125.75 156.82 38.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.585 -1.189 . . . . 73.450000000000003 109.287 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -63.16 -32.24 73.58 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.027 0.931 . . . . 74.030000000000001 110.971 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -65.83 -16.31 63.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.655 -1.157 . . . . 62.130000000000003 113.182 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.79 -14.51 59.56 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.137 0.494 . . . . 62.409999999999997 109.831 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.1 m -89.75 130.36 43.26 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.884 -0.598 . . . . 61.450000000000003 112.136 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.92 -179.75 5.5 Favored 'Trans proline' 0 C--O 1.27 2.123 0 C-N-CA 122.503 2.135 . . . . 74.340000000000003 112.112 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 -116.8 9.3 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.098 -0.956 . . . . 34.43 111.501 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.73 19.67 3.55 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.519 -0.919 . . . . 73.409999999999997 108.519 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.8 m -77.59 150.81 34.65 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.09 -0.959 . . . . 64.439999999999998 110.267 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -109.05 174.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.966 -0.753 . . . . 74.129999999999995 108.966 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.16 118.65 30.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.738 -0.838 . . . . 75.400000000000006 108.738 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -87.66 170.5 11.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.737 -0.21 . . . . 73.140000000000001 110.72 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.64 -6.59 50.88 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 114.347 0.499 . . . . 72.030000000000001 114.347 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -89.47 -17.71 28.16 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.935 0.398 . . . . 74.319999999999993 110.541 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 22.86 21.41 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.567 -1.013 . . . . 61.039999999999999 110.567 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.18 147.21 48.16 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 124.571 1.148 . . . . 63.439999999999998 110.746 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.6 m -81.07 139.44 35.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.855 -1.066 . . . . 65.230000000000004 112.167 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.5 147.24 12.37 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.491 -1.044 . . . . 61.119999999999997 110.491 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 7.9 tp10 -72.59 161.78 30.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.745 -0.835 . . . . 70.030000000000001 108.745 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.56 74.19 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.615 0.766 . . . . 65.439999999999998 109.995 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 40.1 mt -118.6 135.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.225 0 N-CA-C 106.965 -1.494 . . . . 74.120000000000005 106.965 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -75.34 -33.78 61.15 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.003 0.43 . . . . 64.319999999999993 110.449 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.96 0.79 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.937 0.717 . . . . 75.209999999999994 112.937 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.47 124.04 87.18 Favored Pre-proline 0 C--O 1.212 -0.894 0 N-CA-C 108.953 -0.758 . . . . 72.420000000000002 108.953 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -50.97 -53.24 7.49 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.429 2.753 . . . . 71.430000000000007 115.138 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -127.42 -26.14 3.09 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 111.866 0.321 . . . . 74.129999999999995 111.866 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.3 26.19 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.411 0.893 . . . . 63.439999999999998 113.411 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-O 121.939 0.876 . . . . 75.25 112.087 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 121.408 0.623 . . . . 74.400000000000006 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -89.95 149.09 22.74 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.269 -0.878 . . . . 74.129999999999995 111.414 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 93.5 8.88 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.05 -0.977 . . . . 72.319999999999993 109.057 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.75 -63.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.659 -1.608 . . . . 75.010000000000005 106.659 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -99.19 -34.05 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -177.11 148.51 0.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.886 -1.506 . . . . 63.409999999999997 108.447 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 140.73 49.66 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.11 -0.7 . . . . 63.509999999999998 109.11 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.45 131.04 40.37 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 110.767 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.91 147.55 26.2 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.857 -0.424 . . . . 74.409999999999997 109.857 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.8 p -126.27 155.35 42.05 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 75.510000000000005 111.93 -175.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -120.45 -34.48 3.62 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.631 -1.248 . . . . 74.239999999999995 107.631 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -132.82 160.19 37.61 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.879 1.272 . . . . 75.400000000000006 108.803 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.59 -32.54 74.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.425 0.631 . . . . 75.109999999999999 110.717 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -68.38 -13.0 61.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.989 -1.005 . . . . 61.310000000000002 113.182 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.55 -28.41 62.82 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.687 -0.857 . . . . 64.099999999999994 108.687 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.2 m -89.82 132.78 35.52 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.827 -1.079 . . . . 71.099999999999994 109.397 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.14 139.9 17.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.302 2.001 . . . . 71.230000000000004 114.405 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.14 -102.68 0.13 Allowed Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 116.087 1.195 . . . . 74.129999999999995 116.087 172.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -91.79 -5.81 52.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.218 0.451 . . . . 62.210000000000001 112.218 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.27 140.18 36.32 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.231 0.538 . . . . 74.209999999999994 110.2 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -120.61 172.14 8.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.335 -1.357 . . . . 62.329999999999998 107.335 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.6 t -89.62 114.36 25.95 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.782 -0.822 . . . . 72.25 108.782 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 76.2 mtp180 -88.83 164.54 15.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.886 -0.413 . . . . 74.329999999999998 109.886 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.5 45.97 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 114.0 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.9 p-10 -89.62 -14.4 35.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.929 -0.767 . . . . 75.219999999999999 108.929 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.24 16.7 34.13 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.353 -0.84 . . . . 33.32 111.043 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -125.51 152.18 45.34 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.25 0.547 . . . . 75.319999999999993 110.31 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.47 134.97 36.04 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.903 -1.044 . . . . 51.329999999999998 110.296 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.02 145.26 11.5 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.65 -0.98 . . . . 72.239999999999995 110.65 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 31' ' ' ALA . 18.8 tt0 -65.37 146.57 54.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.143 -0.688 . . . . 34.149999999999999 109.143 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 30' ' ' GLU . . . -80.7 -86.16 0.09 Allowed 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.579 -0.897 . . . . 52.549999999999997 108.579 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 mt -149.62 93.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 105.593 -2.002 . . . . 65.209999999999994 105.593 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -139.13 -168.71 2.49 Favored 'General case' 0 C--N 1.246 -3.916 0 C-N-CA 123.868 0.867 . . . . 74.530000000000001 108.967 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.3 35.83 4.04 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.185 -0.672 . . . . 73.540000000000006 109.185 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 38' ' ' ALA . . . -71.46 117.75 59.97 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.599 -0.728 . . . . 44.340000000000003 111.988 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 Cg_exo -64.47 -35.86 46.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 113.55 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -129.83 -19.75 3.26 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.697 -0.401 . . . . 73.219999999999999 111.98 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . . . -83.17 33.92 0.46 Allowed 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.939 -0.476 . . . . 70.219999999999999 112.284 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.398 -0.964 . . . . 73.230000000000004 108.398 173.006 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.52 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 30.5 p . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 106.375 -1.713 . . . . 72.439999999999998 106.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.83 152.79 35.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.746 -0.835 . . . . 71.120000000000005 108.746 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.48 58.14 4.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.993 0.901 . . . . 71.5 112.099 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.82 -55.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.239 -1.023 . . . . 75.129999999999995 108.239 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -89.99 -33.75 16.25 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.527 -0.76 . . . . 75.140000000000001 108.962 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.28 119.67 6.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.125 -0.943 . . . . 72.030000000000001 109.3 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 107.91 8.51 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 122.915 0.486 . . . . 34.130000000000003 111.83 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 56.5 Cg_endo -96.67 125.91 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.742 2.295 . . . . 74.219999999999999 111.179 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -97.49 149.87 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.321 -0.622 . . . . 70.219999999999999 109.321 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -130.52 157.07 43.68 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.095 0.474 . . . . 74.099999999999994 111.823 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -117.48 -51.14 2.51 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.193 -2.151 . . . . 74.25 105.193 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -123.05 158.06 31.41 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 113.98 -1.464 . . . . 73.019999999999996 109.564 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.31 -29.85 70.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.174 0.511 . . . . 75.530000000000001 112.134 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.0 p -66.41 -21.27 66.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.327 -0.851 . . . . 74.340000000000003 111.669 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.57 -20.57 63.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.226 0.536 . . . . 63.530000000000001 109.986 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -94.14 119.84 66.23 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 115.303 -0.862 . . . . 71.409999999999997 109.78 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.15 141.2 32.18 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.847 2.365 . . . . 72.239999999999995 115.139 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.95 -108.84 2.61 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 114.446 -1.252 . . . . 41.509999999999998 114.235 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -102.37 -2.23 29.29 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.598 -0.519 . . . . 73.239999999999995 109.598 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.1 m -73.55 139.95 45.98 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.933 -0.766 . . . . 71.030000000000001 108.933 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.27 169.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 108.031 -1.1 . . . . 54.130000000000003 108.031 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.56 115.94 28.45 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.481 -0.563 . . . . 53.350000000000001 109.481 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -88.92 161.46 16.64 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.277 -0.638 . . . . 72.349999999999994 109.277 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.98 -2.56 47.42 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 113.43 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -89.5 -18.9 25.8 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.638 0.256 . . . . 71.400000000000006 110.87 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.34 4.71 32.74 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.515 -0.634 . . . . 71.340000000000003 111.515 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.77 146.55 36.17 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.584 0.754 . . . . 73.400000000000006 110.874 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.0 m -80.98 148.85 29.58 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.353 -0.84 . . . . 64.230000000000004 109.01 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 1' ' ' CYS . . . -176.3 152.01 12.21 Favored Glycine 0 N--CA 1.416 -2.692 0 C-N-CA 118.971 -1.585 . . . . 63.119999999999997 112.772 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.73 140.67 28.92 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.356 1.062 . . . . 71.340000000000003 109.502 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -85.61 0.11 Allowed 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 114.28 -1.327 . . . . 75.349999999999994 109.9 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.3 mt -153.53 102.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 105.678 -1.971 . . . . 72.109999999999999 105.678 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.5 t80 179.86 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.824 0 O-C-N 124.275 0.985 . . . . 60.520000000000003 108.672 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.73 60.15 1.1 Allowed 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.568 -1.196 . . . . 75.340000000000003 109.881 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . . . -72.84 123.3 89.41 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.748 -1.114 . . . . 70.209999999999994 110.522 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -43.15 -49.33 7.27 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 124.634 3.556 . . . . 62.409999999999997 115.568 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -107.21 -16.9 14.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.32 0.581 . . . . 65.150000000000006 111.307 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' H ' ' A' ' 19' ' ' ALA . . . -94.31 17.21 13.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.095 0.776 . . . . 64.439999999999998 113.095 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 . . . . . 0 C--N 1.285 -2.213 0 CA-C-N 115.208 -0.905 . . . . 65.5 110.973 177.544 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.999 0.904 . . . . 74.329999999999998 109.633 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.61 147.99 24.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.702 -1.135 . . . . 71.510000000000005 108.445 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.94 142.9 12.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.39 -0.967 . . . . 61.240000000000002 108.39 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.46 -23.08 4.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.74 -0.664 . . . . 64.510000000000005 110.384 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -89.23 -42.29 11.71 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.477 -0.489 . . . . 74.420000000000002 110.136 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.02 89.04 1.42 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.145 -0.479 . . . . 65.450000000000003 112.032 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -80.39 126.74 78.11 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.869 -0.605 . . . . 51.350000000000001 109.649 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.0 Cg_exo -66.09 119.82 6.9 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.709 2.272 . . . . 74.099999999999994 113.125 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 99.4 mttt -83.89 134.26 34.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.978 -0.749 . . . . 75.340000000000003 108.978 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.5 p -100.07 147.76 25.29 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.986 0.422 . . . . 71.439999999999998 112.033 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -109.2 -31.33 7.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.636 -1.246 . . . . 72.319999999999993 107.636 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -148.52 156.6 42.66 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.302 -1.317 . . . . 55.439999999999998 109.246 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 13.2 m-20 -59.53 -37.73 79.13 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.092 0.949 . . . . 73.109999999999999 110.311 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -71.82 -12.15 61.15 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.078 -1.419 . . . . 60.43 114.018 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.42 0.21 53.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.348 -0.941 . . . . 71.409999999999997 110.905 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 90.0 m -91.13 136.22 27.53 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 109.77 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 179.44 5.95 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.565 2.177 . . . . 63.539999999999999 112.967 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.66 -122.75 31.07 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.359 -0.837 . . . . 72.349999999999994 112.048 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.38 19.47 13.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.704 -0.85 . . . . 44.32 108.704 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.3 m -81.2 145.78 30.81 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.216 -0.902 . . . . 74.510000000000005 112.511 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 13' ' ' ASP . 30.7 pt -119.73 179.15 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.059 -1.46 . . . . 70.510000000000005 107.059 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -90.63 117.93 29.67 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.44 -0.948 . . . . 73.030000000000001 108.44 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -89.02 160.05 17.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.38 -1.12 41.7 Favored Glycine 0 C--N 1.31 -0.892 0 CA-C-N 115.931 -0.577 . . . . 75.239999999999995 113.411 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -89.66 -19.53 24.75 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.694 -0.484 . . . . 73.439999999999998 109.694 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 2.44 34.21 Favored Glycine 0 CA--C 1.499 -0.952 0 N-CA-C 111.486 -0.646 . . . . 74.030000000000001 111.486 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 95.7 m-85 -114.69 161.65 17.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 123.414 0.685 . . . . 72.510000000000005 109.997 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 76.6 m -80.26 142.01 35.0 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.579 -0.526 . . . . 61.32 109.579 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.21 146.84 14.71 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.9 -1.28 . . . . 72.049999999999997 109.9 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.3 tt0 -59.94 148.51 34.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.64 0.733 . . . . 72.239999999999995 110.597 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.39 -151.85 0.09 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.473 -1.239 . . . . 63.539999999999999 107.736 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.5 mm -95.82 136.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 C-N-CA 119.398 -0.921 . . . . 72.25 110.413 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.583 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 22.7 t80 -170.82 154.46 4.32 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 102.731 -3.062 . . . . 73.219999999999999 102.731 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.24 3.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 119.061 0.846 . . . . 63.009999999999998 110.341 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.63 155.06 73.78 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.441 -0.8 . . . . 62.409999999999997 109.078 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.92 125.47 11.57 Favored 'Trans proline' 0 C--O 1.241 0.639 0 N-CA-C 108.23 -1.488 . . . . 71.140000000000001 108.23 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -109.65 -46.34 3.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.006 0.432 . . . . 63.409999999999997 110.43 -173.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.3 78.58 1.02 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.664 -0.698 . . . . 63.409999999999997 109.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 115.368 -0.833 . . . . 74.409999999999997 108.795 178.601 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 122.39 1.091 . . . . 60.549999999999997 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.67 165.94 10.73 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.621 -1.172 . . . . 74.209999999999994 112.188 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.18 126.17 12.04 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.457 -1.683 . . . . 74.420000000000002 106.457 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.9 mt -93.67 -23.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 120.976 0.417 . . . . 62.140000000000001 111.629 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -87.83 -42.53 12.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.008 -0.677 . . . . 63.030000000000001 109.304 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.19 82.68 1.93 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.02 -0.991 . . . . 65.340000000000003 108.849 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -64.87 122.45 79.31 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.284 -0.871 . . . . 62.219999999999999 111.494 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -74.15 127.43 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.492 2.128 . . . . 63.530000000000001 109.923 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.0 pttm -94.49 156.89 16.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.55 -0.167 . . . . 64.120000000000005 110.55 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 15.2 p -142.55 157.68 44.46 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.507 0.194 . . . . 75.129999999999995 110.903 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 11' ' ' ARG . 71.6 mtt180 -111.57 -42.51 3.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.145 -1.428 . . . . 71.510000000000005 107.145 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -127.5 157.52 39.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.758 -1.564 . . . . 71.400000000000006 108.631 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 9.2 m-20 -61.89 -34.93 76.92 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.365 -0.834 . . . . 64.340000000000003 111.248 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -64.66 -21.62 66.77 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.526 -1.216 . . . . 71.439999999999998 112.584 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.19 -29.5 70.32 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.393 -0.595 . . . . 63.340000000000003 109.393 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 44.3 m -89.97 121.2 69.08 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 115.754 -0.657 . . . . 73.120000000000005 109.333 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.83 -177.55 2.59 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.45 2.1 . . . . 74.430000000000007 112.491 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.73 -132.75 51.42 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.575 -0.739 . . . . 63.310000000000002 111.926 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.33 11.08 33.91 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.606 0.241 . . . . 73.129999999999995 110.823 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.4 m -84.7 149.23 25.94 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.882 0.848 . . . . 73.219999999999999 112.63 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.25 175.71 10.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 113.858 -1.519 . . . . 74.439999999999998 107.683 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 37.8 t -97.25 110.85 23.32 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.07 -0.715 . . . . 41.030000000000001 109.07 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -74.15 169.36 17.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 111.649 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.93 -14.53 61.17 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 115.438 -0.801 . . . . 61.119999999999997 112.997 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.32 -16.27 33.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.082 0.468 . . . . 72.209999999999994 111.49 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.46 17.1 32.29 Favored Glycine 0 CA--C 1.485 -1.803 0 C-N-CA 120.233 -0.984 . . . . 40.399999999999999 111.05 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 71.1 m-85 -121.18 147.16 45.98 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.66 -0.77 . . . . 73.420000000000002 109.268 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 71.9 m -70.82 127.92 34.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.065 -0.516 . . . . 53.310000000000002 110.725 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.33 153.82 20.57 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.139 -1.184 . . . . 64.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -79.28 178.11 8.32 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.47 -0.566 . . . . 72.450000000000003 109.47 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.15 -72.69 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.074 0.549 . . . . 62.399999999999999 112.133 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.0 mt -138.78 146.96 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.811 -1.181 . . . . 71.299999999999997 107.811 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.639 -1.245 . . . . 51.119999999999997 107.639 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.56 -81.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.011 -0.737 . . . . 73.319999999999993 109.011 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 36' ' ' PRO 0.27 . . -80.54 -50.89 1.05 Allowed Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 120.471 -0.492 . . . . 75.409999999999997 110.429 170.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 20.9 Cg_exo -64.38 142.57 79.46 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.42 2.08 . . . . 71.040000000000006 107.816 167.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -119.95 25.5 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.204 0.526 . . . . 72.129999999999995 111.989 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.8 39.19 4.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.806 0.843 . . . . 50.030000000000001 110.199 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-N 114.596 -1.184 . . . . 75.510000000000005 111.31 -174.626 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 108.628 -0.879 . . . . 63.439999999999998 108.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.36 170.02 9.8 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.769 -1.105 . . . . 52.109999999999999 109.936 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.78 144.37 4.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.928 -1.508 . . . . 75.510000000000005 106.928 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.4 mt -105.0 -21.48 5.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.093 0.473 . . . . 64.409999999999997 110.367 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -88.23 -43.87 11.28 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.234 -1.024 . . . . 75.310000000000002 108.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.11 77.99 1.36 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.041 -1.096 . . . . 61.200000000000003 108.041 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 116.64 31.82 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 115.289 -0.869 . . . . 54.140000000000001 110.679 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.83 118.36 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.791 2.328 . . . . 64.310000000000002 111.453 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 96.8 mttt -86.15 163.22 17.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.981 -0.554 . . . . 65.450000000000003 110.636 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.1 p -139.21 148.68 43.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.933 -0.576 . . . . 75.510000000000005 109.996 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -115.67 -40.32 3.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.452 -1.685 . . . . 73.010000000000005 106.452 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -132.96 160.98 35.52 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.712 1.605 . . . . 65.349999999999994 108.004 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.08 -30.71 71.68 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.537 0.684 . . . . 31.23 111.47 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -67.41 -17.26 64.65 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.064 -0.971 . . . . 65.409999999999997 112.125 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -67.11 -23.92 65.88 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.159 0.504 . . . . 62.100000000000001 109.646 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.77 137.68 26.81 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-N 115.316 -0.856 . . . . 64.030000000000001 110.055 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -86.18 177.61 4.47 Favored 'Trans proline' 0 C--O 1.253 1.272 0 C-N-CA 122.541 2.16 . . . . 71.010000000000005 112.572 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.02 -124.18 35.89 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.036 -0.984 . . . . 43.049999999999997 112.885 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.66 13.12 21.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.787 0.327 . . . . 53.020000000000003 110.167 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.38 155.22 32.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.305 0.574 . . . . 74.319999999999993 112.01 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.86 174.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.623 -0.88 . . . . 74.230000000000004 108.623 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.03 115.5 28.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.689 -0.856 . . . . 74.510000000000005 108.689 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -84.85 165.72 17.48 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.108 0.48 . . . . 65.540000000000006 111.172 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.15 7.3 37.5 Favored Glycine 0 CA--C 1.51 -0.226 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 112.854 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -95.2 -16.36 22.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.617 -0.512 . . . . 74.299999999999997 109.617 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.01 11.97 41.31 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.729 -0.948 . . . . 74.109999999999999 110.729 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 89.9 m-85 -127.87 160.8 30.71 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.458 -0.871 . . . . 70.319999999999993 110.775 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.3 m -80.0 140.54 36.54 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.602 -0.726 . . . . 73.310000000000002 111.368 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.65 176.6 39.73 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.124 -1.19 . . . . 51.210000000000001 110.124 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 9.3 tp10 -74.68 173.74 10.07 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.821 0.848 . . . . 54.100000000000001 109.414 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.59 -24.64 63.71 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.191 0.996 . . . . 45.25 108.405 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.62 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 53.3 mt -92.57 149.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 105.853 -1.906 . . . . 64.310000000000002 105.853 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -44.75 -47.08 10.78 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.318 1.047 . . . . 71.549999999999997 113.275 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -119.58 135.45 54.79 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.776 -0.824 . . . . 72.540000000000006 108.776 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.74 110.03 15.6 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.599 0.562 . . . . 74.439999999999998 111.933 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 70.7 Cg_endo -83.57 -38.32 0.14 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.522 2.148 . . . . 63.409999999999997 114.071 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -117.15 -51.42 2.54 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.444 0.64 . . . . 73.25 109.882 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 56.71 3.57 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.779 0.799 . . . . 45.140000000000001 108.944 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 . . . . . 0 N--CA 1.426 -1.625 0 CA-C-N 115.352 -0.84 . . . . 62.32 109.237 -179.298 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.296 -1.372 . . . . 54.539999999999999 107.296 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -89.52 123.66 33.82 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.016 0.912 . . . . 73.340000000000003 109.705 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -149.72 100.82 3.01 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 114.165 -1.38 . . . . 55.509999999999998 108.887 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 mm -91.38 -13.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.362 -0.835 . . . . 74.109999999999999 109.878 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.11 -45.41 9.61 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.416 -0.811 . . . . 63.530000000000001 109.754 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.71 96.13 2.08 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.562 -0.745 . . . . 73.349999999999994 109.316 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 3' ' ' ALA . . . -72.57 126.41 90.83 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 115.91 -0.587 . . . . 64.219999999999999 110.166 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.55 116.41 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.539 2.159 . . . . 64.219999999999999 112.788 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -70.77 148.2 48.16 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.289 -1.004 . . . . 44.420000000000002 108.289 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 29.9 p -117.74 150.58 38.87 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 120.981 -0.288 . . . . 52.229999999999997 110.264 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.73 -43.66 2.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.278 -1.379 . . . . 72.219999999999999 107.278 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -132.18 153.1 50.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.64 -1.164 . . . . 53.520000000000003 108.729 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 6.1 m-20 -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.319 -0.855 . . . . 75.019999999999996 110.606 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -68.02 -19.26 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.64 -1.164 . . . . 73.530000000000001 113.284 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.23 -3.71 59.06 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.067 -1.053 . . . . 55.530000000000001 111.004 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -94.22 118.29 67.11 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 109.401 -0.592 . . . . 71.0 109.401 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.89 -175.44 2.68 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.586 2.19 . . . . 71.299999999999997 111.53 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.1 13.98 60.68 Favored Glycine 0 N--CA 1.465 0.599 0 CA-C-N 116.643 -0.253 . . . . 64.409999999999997 112.829 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.66 8.97 5.64 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.655 1.582 . . . . 70.519999999999996 111.129 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.76 149.17 50.28 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.047 -0.524 . . . . 65.140000000000001 109.629 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 44.9 pt -110.92 174.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.772 -0.825 . . . . 73.209999999999994 108.772 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -95.56 107.32 19.49 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.277 -1.008 . . . . 60.299999999999997 108.277 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -84.18 168.55 15.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.397 0.617 . . . . 72.230000000000004 110.857 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.45 2.25 63.14 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.295 -0.866 . . . . 75.340000000000003 112.398 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -88.74 -17.97 28.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.926 . . . . 65.140000000000001 108.501 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.8 6.94 42.7 Favored Glycine 0 CA--C 1.487 -1.673 0 N-CA-C 111.274 -0.731 . . . . 73.219999999999999 111.274 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.69 159.34 28.15 Favored 'General case' 0 N--CA 1.414 -2.255 0 C-N-CA 123.331 0.652 . . . . 71.010000000000005 110.39 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.2 m -80.21 131.94 35.78 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.254 -0.885 . . . . 44.229999999999997 108.633 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.47 170.01 30.38 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.633 -1.387 . . . . 65.549999999999997 109.633 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 42.4 tt0 -69.6 157.74 36.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 117.643 0.722 . . . . 65.239999999999995 110.062 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 -141.83 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.648 -1.242 . . . . 74.209999999999994 107.648 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.2 mt -101.97 130.51 51.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.647 -1.242 . . . . 75.430000000000007 107.647 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 37.1 t80 -165.58 167.89 16.93 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.669 -1.604 . . . . 71.310000000000002 106.669 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.7 -80.26 0.16 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.403 0.547 . . . . 75.019999999999996 112.069 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.5 151.09 71.41 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 109.735 -0.469 . . . . 75.109999999999999 109.735 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -64.77 112.69 2.06 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.706 1.604 . . . . 60.420000000000002 111.271 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -138.17 -39.23 0.54 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.115 0.783 . . . . 71.239999999999995 113.115 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.22 43.49 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.67 -0.863 . . . . 73.120000000000005 108.67 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 26.2 mtp180 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 114.667 -1.152 . . . . 75.439999999999998 111.433 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.469 0 CA-C-O 122.558 1.17 . . . . 63.420000000000002 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.25 -26.67 22.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.365 -1.743 . . . . 72.340000000000003 107.399 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.04 93.59 9.4 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.865 -1.532 . . . . 43.039999999999999 106.865 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.8 mt -89.62 -16.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.834 -1.075 . . . . 54.409999999999997 111.071 -174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -89.34 -27.34 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.872 -1.159 . . . . 72.420000000000002 107.872 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.61 12.02 34.99 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.938 -1.028 . . . . 73.239999999999995 110.407 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.12 166.19 40.22 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 123.756 0.822 . . . . 72.140000000000001 110.722 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.8 164.54 22.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.786 1.657 . . . . 74.120000000000005 110.716 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.19 162.51 26.54 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.743 0.306 . . . . 72.439999999999998 111.63 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.7 p -151.89 154.49 36.24 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.984 -0.553 . . . . 70.200000000000003 110.809 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -114.93 -34.23 5.16 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.221 -1.029 . . . . 75.430000000000007 108.221 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.85 161.71 34.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.512 -1.222 . . . . 74.319999999999993 110.664 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.91 -33.49 68.83 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.802 0.841 . . . . 62.219999999999999 111.57 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -65.03 -25.21 67.74 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.085 -0.961 . . . . 64.409999999999997 112.407 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.72 -26.76 68.8 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.524 0.678 . . . . 64.25 109.261 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -96.79 128.45 35.74 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.13 -0.941 . . . . 31.420000000000002 110.167 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.02 158.6 4.88 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.67 2.246 . . . . 64.099999999999994 114.547 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.36 -111.81 4.34 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.774 -1.103 . . . . 63.039999999999999 114.746 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.569 ' H ' ' HB3' ' A' ' 38' ' ' ALA . . . -105.45 5.54 31.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.437 0.637 . . . . 74.219999999999999 109.844 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.79 136.15 33.36 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.712 -1.218 . . . . 63.210000000000001 107.712 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.73 177.24 4.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.175 -1.046 . . . . 72.230000000000004 108.175 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -89.31 118.82 29.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.233 -0.987 . . . . 52.32 108.368 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -89.56 166.89 13.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.507 -0.553 . . . . 74.129999999999995 109.507 -177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.53 -8.69 52.88 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 114.221 0.448 . . . . 64.510000000000005 114.221 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -89.07 -17.13 29.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.361 0.6 . . . . 74.450000000000003 109.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.82 19.54 24.19 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 111.277 -0.729 . . . . 63.310000000000002 111.277 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.5 154.59 35.07 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.971 0.908 . . . . 75.439999999999998 109.9 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 93.8 m -80.14 101.59 8.88 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 123.14 0.576 . . . . 51.549999999999997 111.87 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.47 16.79 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.538 -0.839 . . . . 61.229999999999997 111.028 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 33' ' ' TYR . 27.3 tt0 -61.94 159.35 14.27 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.088 0.955 . . . . 62.310000000000002 111.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -71.48 0.16 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.386 -1.279 . . . . 71.310000000000002 110.106 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -133.23 -66.09 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.877 -1.157 . . . . 72.319999999999993 107.877 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.47 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 50.2 t80 -163.75 103.2 0.91 Allowed 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.699 -1.591 . . . . 75.329999999999998 107.562 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.8 167.41 10.31 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.709 -0.678 . . . . 64.530000000000001 111.809 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -80.2 169.51 19.56 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 114.802 -1.09 . . . . 73.120000000000005 108.301 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 20.2 Cg_endo -65.11 92.31 0.21 Allowed 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.303 1.335 . . . . 74.120000000000005 112.389 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -143.76 -55.1 0.37 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 105.735 -1.95 . . . . 71.219999999999999 105.735 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.569 ' HB3' ' H ' ' A' ' 19' ' ' ALA . . . -149.89 97.54 2.6 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.311 -1.737 . . . . 55.030000000000001 106.311 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 . . . . . 0 C--N 1.288 -2.092 0 CA-C-O 121.466 0.65 . . . . 64.129999999999995 109.381 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.422 -1.855 0 CA-C-O 122.108 0.956 . . . . 65.329999999999998 111.264 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -89.76 -35.3 15.81 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.883 -1.508 . . . . 73.219999999999999 108.974 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.63 89.18 7.08 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.378 -1.342 . . . . 62.119999999999997 107.378 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.23 -15.24 8.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.74 -0.664 . . . . 55.229999999999997 111.03 -175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.05 -31.98 18.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.275 -1.38 . . . . 71.219999999999999 107.275 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 25.01 11.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.604 -1.18 . . . . 72.319999999999993 110.122 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.2 126.66 88.2 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 75.420000000000002 109.401 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.21 143.46 44.05 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.901 1.734 . . . . 54.210000000000001 111.473 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 14.9 ptmm? -82.28 158.79 23.33 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.948 -0.39 . . . . 74.340000000000003 109.948 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -132.57 151.54 51.9 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.295 0.569 . . . . 62.340000000000003 111.963 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -101.34 -44.96 5.48 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.264 -2.124 . . . . 72.120000000000005 105.264 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 8.5 ptp180 -129.93 163.2 26.91 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.608 -1.633 . . . . 73.129999999999995 110.18 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.08 -32.12 73.57 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.886 -1.052 . . . . 73.540000000000006 110.815 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -72.72 -4.72 33.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.129 -0.941 . . . . 64.109999999999999 112.969 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 69.5 m-20 -77.71 -23.25 49.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.467 0.651 . . . . 70.510000000000005 109.45 172.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 29.2 m -104.96 127.37 28.89 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 108.656 -0.868 . . . . 73.219999999999999 108.656 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 16' ' ' CYS . 73.6 Cg_endo -100.52 -175.65 0.14 Allowed 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.413 2.076 . . . . 70.040000000000006 113.27 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.64 -108.9 2.63 Favored Glycine 0 CA--C 1.489 -1.545 0 CA-C-N 115.025 -0.989 . . . . 72.549999999999997 113.463 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 30' ' ' GLU . . . -115.23 0.24 13.46 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.174 0.512 . . . . 61.549999999999997 109.969 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 72.2 m -91.99 139.87 30.22 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 122.03 0.919 . . . . 71.140000000000001 111.826 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.79 179.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 113.883 -1.508 . . . . 72.239999999999995 107.065 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.8 t -95.51 104.94 16.86 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.198 -1.038 . . . . 51.229999999999997 108.198 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 74.3 mtp180 -79.96 170.16 16.86 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.453 -0.34 . . . . 71.129999999999995 110.893 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.52 -2.31 27.12 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 115.933 -0.576 . . . . 54.149999999999999 114.011 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 27' ' ' TYR . 32.1 p-10 -88.89 -19.19 26.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.826 -0.805 . . . . 71.019999999999996 108.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.07 32.33 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 110.939 -0.864 . . . . 74.540000000000006 110.939 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.532 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 73.9 m-85 -129.31 157.59 41.47 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.085 -0.558 . . . . 61.030000000000001 110.808 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.37 133.86 47.33 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.244 -0.889 . . . . 73.340000000000003 109.827 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.57 135.69 4.61 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.403 -1.079 . . . . 72.329999999999998 110.403 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 41.8 tt0 -51.36 139.0 20.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.263 1.03 . . . . 74.409999999999997 112.112 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.28 -62.43 1.66 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.873 -1.512 . . . . 63.009999999999998 110.549 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -131.04 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.016 -2.216 . . . . 64.319999999999993 105.016 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -59.93 107.79 0.67 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 123.888 0.742 . . . . 74.129999999999995 110.674 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 -166.22 1.21 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.933 0.716 . . . . 45.539999999999999 112.933 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -75.16 147.96 83.63 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-N 115.38 -0.827 . . . . 72.239999999999995 110.122 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 31.4 Cg_exo -65.25 121.32 8.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.151 2.568 . . . . 64.510000000000005 114.534 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -150.31 -63.17 0.2 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.877 -2.268 . . . . 75.099999999999994 104.877 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.35 95.7 2.76 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.674 -1.602 . . . . 63.32 106.674 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 106.14 -1.8 . . . . 60.420000000000002 106.14 177.633 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.41 -2.452 0 N-CA-C 107.859 -1.163 . . . . 73.340000000000003 107.859 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 38.3 mt-10 -141.89 -170.03 3.04 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.644 -2.354 . . . . 64.409999999999997 104.644 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.57 83.47 4.12 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.934 -0.707 . . . . 72.5 109.396 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.41 -62.38 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.318 -0.993 . . . . 70.120000000000005 108.318 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -88.81 -32.78 17.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.813 -1.18 . . . . 72.209999999999994 107.813 -176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.35 160.02 7.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.245 -1.391 . . . . 62.329999999999998 107.245 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.92 113.43 40.47 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.27 -0.641 . . . . 54.520000000000003 109.27 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -86.8 101.0 0.55 Allowed 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 121.801 1.667 . . . . 74.310000000000002 112.112 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -84.09 157.48 21.73 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.246 -0.65 . . . . 65.129999999999995 109.246 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -140.22 148.04 40.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.319 0.581 . . . . 64.340000000000003 112.063 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -105.42 -40.86 5.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.792 -1.929 . . . . 54.439999999999998 105.792 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -139.11 166.28 24.92 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 114.295 -1.32 . . . . 75.439999999999998 110.987 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.94 -33.85 72.45 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 123.774 0.83 . . . . 70.099999999999994 110.951 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -65.18 -21.44 66.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.868 -1.06 . . . . 64.329999999999998 112.293 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.31 0.576 . . . . 60.409999999999997 110.357 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.49 133.72 30.75 Favored Pre-proline 0 N--CA 1.422 -1.857 0 CA-C-N 115.341 -0.845 . . . . 61.039999999999999 111.008 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.42 177.35 8.63 Favored 'Trans proline' 0 C--O 1.257 1.465 0 C-N-CA 122.804 2.336 . . . . 73.219999999999999 112.76 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.99 -130.58 47.82 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 110.127 -1.189 . . . . 62.119999999999997 110.127 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.97 9.57 22.23 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 109.096 -0.705 . . . . 53.509999999999998 109.096 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.64 148.63 50.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.018 -0.537 . . . . 73.540000000000006 111.208 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -116.9 174.72 3.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 108.951 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.76 121.47 31.94 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 108.021 -1.103 . . . . 75.109999999999999 108.021 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -91.4 158.6 16.42 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.611 -0.885 . . . . 72.219999999999999 108.611 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.73 0.28 28.78 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.744 -0.662 . . . . 71.349999999999994 113.666 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -88.5 -19.68 26.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.12 0.486 . . . . 71.420000000000002 109.709 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.32 25.01 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 111.303 -0.719 . . . . 51.340000000000003 111.303 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -118.71 160.65 21.46 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 123.437 0.695 . . . . 71.319999999999993 111.494 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.8 m -80.39 139.61 36.43 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.989 -1.005 . . . . 73.219999999999999 110.336 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.3 157.41 28.3 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.831 -1.308 . . . . 71.25 109.831 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 10.1 tp10 -73.6 158.81 34.09 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.897 -0.779 . . . . 72.510000000000005 108.897 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.93 -39.01 61.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.945 -1.131 . . . . 54.25 107.945 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.502 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 37.6 mm -82.34 140.2 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.247 -1.761 . . . . 65.0 106.247 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.32 -37.89 60.52 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.284 0.564 . . . . 53.43 110.354 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.7 84.65 5.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 110.792 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -80.46 121.08 81.08 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.844 -0.616 . . . . 62.350000000000001 110.213 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 39.1 Cg_exo -57.39 -42.04 66.05 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.655 2.903 . . . . 63.420000000000002 114.674 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -150.68 -47.16 0.12 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.775 -0.454 . . . . 73.450000000000003 109.775 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.64 67.09 2.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.848 0.832 . . . . 64.209999999999994 110.852 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 2' ' ' GLU . 65.9 mtt180 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-N 114.089 -1.414 . . . . 73.430000000000007 109.916 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.268 -1.382 . . . . 63.140000000000001 107.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 15.9 mt-10 -91.4 176.86 6.41 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 112.877 -1.965 . . . . 73.120000000000005 110.174 -169.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -161.61 150.63 15.98 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 106.777 -1.564 . . . . 73.030000000000001 106.777 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.1 -25.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-O 121.094 0.474 . . . . 70.219999999999999 110.128 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -88.84 -44.49 10.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.896 -0.779 . . . . 65.439999999999998 108.896 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -133.18 88.58 2.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.709 -0.678 . . . . 75.329999999999998 110.338 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.49 132.83 60.89 Favored Pre-proline 0 C--N 1.297 -1.677 0 CA-C-N 115.894 -0.594 . . . . 53.240000000000002 110.962 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.7 Cg_exo -67.36 123.27 10.64 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.18 1.92 . . . . 60.229999999999997 109.396 174.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 62.0 pttt -82.26 163.76 21.62 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.065 -0.654 . . . . 63.229999999999997 111.234 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.1 p -150.99 157.39 42.83 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.197 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 2.8 mmp_? -116.68 -33.91 4.69 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.092 -1.077 . . . . 71.140000000000001 108.092 170.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.79 158.81 32.44 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.074 -0.967 . . . . 75.420000000000002 110.137 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -61.47 -30.87 70.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.118 -0.946 . . . . 70.129999999999995 111.533 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -71.78 -10.92 60.49 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.909 0.707 . . . . 60.119999999999997 112.909 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.24 -12.97 61.05 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.391 0.615 . . . . 71.430000000000007 109.581 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.3 m -110.92 126.71 28.18 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.603 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -84.9 168.85 10.61 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.67 2.247 . . . . 55.310000000000002 113.672 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.58 -126.17 40.47 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.273 -0.876 . . . . 73.140000000000001 113.522 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.12 13.3 29.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.068 -0.566 . . . . 60.43 110.881 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.87 151.13 25.29 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.898 -0.778 . . . . 75.299999999999997 108.898 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 44.1 pt -129.26 172.83 14.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.357 -1.349 . . . . 71.530000000000001 107.357 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.0 t -92.04 111.08 22.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.274 -1.38 . . . . 60.219999999999999 107.274 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.3 mmm180 -77.95 164.22 25.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.475 -0.565 . . . . 71.519999999999996 109.475 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.32 1.34 20.07 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 114.129 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.7 p-10 -89.81 -21.38 22.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.084 -0.709 . . . . 74.439999999999998 109.084 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.93 15.17 19.09 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.573 -0.74 . . . . 63.32 111.381 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 92.9 m-85 -131.59 150.16 52.25 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 122.863 0.465 . . . . 71.329999999999998 110.858 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.67 124.17 22.11 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.688 -0.687 . . . . 71.450000000000003 111.248 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.97 163.88 27.62 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.227 -1.149 . . . . 73.239999999999995 110.227 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' ' 32' ' ' ILE . 42.1 tt0 -62.02 152.91 31.14 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.425 0.631 . . . . 73.409999999999997 110.992 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . . . -77.45 -23.35 50.49 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.341 -0.845 . . . . 65.409999999999997 112.397 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 34' ' ' ALA . 39.2 mt -72.98 148.91 8.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.612 -0.722 . . . . 73.430000000000007 109.165 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -88.27 -10.44 49.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.198 0.523 . . . . 71.540000000000006 111.357 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -76.96 -176.94 4.16 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.616 -0.883 . . . . 72.319999999999993 108.616 174.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.17 119.7 51.51 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.682 -0.488 . . . . 71.310000000000002 109.682 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 56.1 Cg_exo -56.14 155.5 23.87 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.467 2.778 . . . . 54.149999999999999 112.909 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.53 -13.38 37.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.878 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' HB2' ' A' ' 2' ' ' GLU . . . 70.13 61.39 0.24 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.332 1.053 . . . . 53.420000000000002 109.439 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 . . . . . 0 CA--C 1.495 -1.15 0 CA-C-N 113.863 -1.517 . . . . 73.129999999999995 111.258 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.7 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -146.76 148.84 32.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.287 -0.635 . . . . 73.319999999999993 109.287 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -168.56 145.75 3.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.671 -1.974 . . . . 65.230000000000004 105.671 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.3 mp -94.4 -30.48 4.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 112.278 0.473 . . . . 73.439999999999998 112.278 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -87.89 -41.22 13.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.617 -0.833 . . . . 74.230000000000004 109.29 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -125.42 83.66 2.19 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 114.969 -1.014 . . . . 53.140000000000001 110.288 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.96 119.36 76.39 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.083 -0.71 . . . . 61.240000000000002 109.083 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.95 104.82 0.87 Allowed 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.908 2.405 . . . . 72.439999999999998 114.275 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -85.06 154.23 22.21 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.191 -0.913 . . . . 62.439999999999998 108.547 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.0 p -127.62 148.91 50.38 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.034 0.445 . . . . 64.030000000000001 111.186 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -112.02 -39.33 4.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.119 -1.808 . . . . 72.319999999999993 106.119 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -127.48 157.04 41.13 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.189 -1.369 . . . . 74.140000000000001 109.422 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.73 -29.12 70.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.394 0.678 . . . . 64.310000000000002 111.728 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.8 p -63.68 -23.05 67.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.239 -0.891 . . . . 73.099999999999994 111.866 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.485 0.66 . . . . 75.140000000000001 110.3 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 34.5 m -105.39 110.46 64.36 Favored Pre-proline 0 N--CA 1.401 -2.892 0 CA-C-N 115.384 -0.826 . . . . 72.129999999999995 109.879 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.84 178.84 6.52 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.517 2.145 . . . . 73.400000000000006 112.733 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.27 -111.87 4.52 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.989 -0.551 . . . . 44.530000000000001 112.997 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.51 16.18 9.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.845 -0.798 . . . . 61.350000000000001 108.845 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.95 144.4 29.19 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.179 -0.919 . . . . 73.310000000000002 109.867 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.2 pt -122.29 174.12 7.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.945 -1.502 . . . . 73.319999999999993 106.945 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.41 108.47 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.777 -1.194 . . . . 53.020000000000003 107.777 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 70.5 mtp180 -82.17 165.92 20.09 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 116.127 -0.488 . . . . 71.209999999999994 111.128 -177.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.85 -4.24 57.9 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 115.77 -0.65 . . . . 72.129999999999995 112.925 -177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 36.7 p-10 -89.05 -14.8 35.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.992 -0.744 . . . . 71.439999999999998 108.992 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 15.47 38.88 Favored Glycine 0 CA--C 1.493 -1.3 0 CA-C-N 115.479 -0.782 . . . . 73.400000000000006 111.183 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -124.14 154.38 40.11 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 123.482 0.713 . . . . 71.120000000000005 111.532 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.31 118.71 22.2 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.796 -1.093 . . . . 63.229999999999997 110.211 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.09 160.43 28.33 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.816 -1.183 . . . . 73.25 111.008 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 41.5 tt0 -63.62 155.51 29.54 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.491 -0.559 . . . . 73.129999999999995 109.491 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.35 26.44 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.189 -0.46 . . . . 72.219999999999999 110.836 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.35 138.01 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 106.685 -1.598 . . . . 73.400000000000006 106.685 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -99.24 82.95 2.77 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 111.446 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.54 -85.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.229 -0.896 . . . . 35.43 108.966 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.79 117.55 68.7 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.564 -0.902 . . . . 71.129999999999995 108.564 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.44 121.07 6.86 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.581 1.521 . . . . 73.420000000000002 111.023 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -112.68 -54.32 2.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.628 -1.249 . . . . 70.150000000000006 107.628 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.3 87.71 0.91 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.925 -1.034 . . . . 63.030000000000001 109.424 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 99.7 mtt180 . . . . . 0 C--N 1.301 -1.527 0 CA-C-N 114.966 -1.016 . . . . 75.349999999999994 111.063 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 18' ' ' GLY . 1.8 p . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 116.055 1.872 . . . . 74.040000000000006 116.055 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 3' ' ' ALA . 38.3 tt0 -91.29 178.72 5.89 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.378 -1.341 . . . . 75.409999999999997 107.378 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' A' ' 2' ' ' GLU . . . -65.86 98.23 0.4 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.559 0.695 . . . . 64.0 109.165 174.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.8 mt -111.69 -66.52 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 114.815 -1.084 . . . . 74.430000000000007 108.795 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -88.38 -37.2 16.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.245 -1.343 . . . . 75.120000000000005 108.636 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -145.79 143.39 29.65 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.054 -1.43 . . . . 62.240000000000002 109.037 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.74 104.86 3.05 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 123.833 0.708 . . . . 65.349999999999994 109.196 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 2.8 Cg_endo -83.78 117.04 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.455 2.103 . . . . 73.519999999999996 110.823 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.73 155.23 26.83 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.676 -0.49 . . . . 73.25 109.676 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 14.6 p -144.52 162.86 35.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.169 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -123.07 -41.06 2.35 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.247 -1.39 . . . . 71.019999999999996 107.247 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -119.48 154.23 34.1 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.234 -1.348 . . . . 74.340000000000003 109.514 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.13 -28.16 67.91 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.978 0.894 . . . . 71.219999999999999 111.14 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 p -68.6 -11.95 60.7 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.464 -1.243 . . . . 71.109999999999999 113.19 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -69.06 -24.8 64.21 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.056 -0.72 . . . . 70.5 109.056 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -95.71 121.5 61.19 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 115.443 -0.799 . . . . 74.400000000000006 109.962 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -85.11 -167.27 0.4 Allowed 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.101 2.534 . . . . 60.32 112.375 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 1' ' ' CYS . . . 64.48 -111.99 4.63 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.237 -0.745 . . . . 64.209999999999994 111.237 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.64 19.43 3.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.584 -1.265 . . . . 64.239999999999995 107.584 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.78 153.62 20.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.952 -1.022 . . . . 75.400000000000006 111.946 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.15 175.13 5.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.214 -0.903 . . . . 71.299999999999997 109.911 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.04 110.71 23.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.853 -0.795 . . . . 50.119999999999997 108.853 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -82.65 169.98 15.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.075 0.464 . . . . 64.340000000000003 111.405 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.62 -1.76 46.89 Favored Glycine 0 N--CA 1.464 0.514 0 CA-C-N 115.734 -0.666 . . . . 42.229999999999997 113.433 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -89.03 -15.19 34.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.786 -0.82 . . . . 74.010000000000005 108.786 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.54 15.54 34.41 Favored Glycine 0 CA--C 1.481 -2.056 0 N-CA-C 111.292 -0.723 . . . . 33.409999999999997 111.292 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.76 156.4 42.5 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.719 -0.741 . . . . 74.420000000000002 110.705 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 72.6 m -79.87 141.18 36.37 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 109.383 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 2' ' ' GLU . . . -155.13 168.55 33.04 Favored Glycine 0 N--CA 1.407 -3.246 0 N-CA-C 109.271 -1.532 . . . . 72.319999999999993 109.271 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 40.8 tt0 -65.32 162.05 18.32 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.627 -0.508 . . . . 71.299999999999997 109.627 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.64 64.89 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.566 0.698 . . . . 53.43 109.784 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.53 140.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 106.559 -1.645 . . . . 54.299999999999997 106.559 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -81.22 -32.15 33.55 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.164 0.506 . . . . 74.519999999999996 110.042 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.1 87.48 2.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.962 -1.125 . . . . 73.439999999999998 107.962 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 126.75 84.19 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.372 -0.831 . . . . 71.140000000000001 112.01 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.25 -36.92 79.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.782 2.988 . . . . 74.010000000000005 112.621 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -135.79 -79.92 0.42 Allowed 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.739 -1.208 . . . . 74.129999999999995 107.739 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 168.29 88.95 0.0 OUTLIER 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.87 1.268 . . . . 60.310000000000002 109.534 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HE ' ' CD ' ' A' ' 30' ' ' GLU . 74.1 mtm180 . . . . . 0 C--N 1.308 -1.231 0 CA-C-O 119.316 -0.373 . . . . 73.099999999999994 110.153 170.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.399 -2.985 0 N-CA-C 103.382 -2.822 . . . . 75.219999999999999 103.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.7 -31.39 19.74 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.65 -0.87 . . . . 73.409999999999997 108.65 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.39 93.41 9.31 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.455 -0.942 . . . . 75.519999999999996 108.455 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.19 -33.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 74.420000000000002 109.032 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -88.83 -43.12 11.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.66 -1.237 . . . . 60.530000000000001 107.66 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.19 35.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.196 -1.365 . . . . 74.319999999999993 108.733 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 153.0 84.83 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.17 -1.377 . . . . 65.510000000000005 110.369 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.47 161.9 31.06 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.921 1.747 . . . . 74.219999999999999 109.856 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -80.7 145.09 31.77 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.83 -0.434 . . . . 73.109999999999999 109.83 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.562 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.4 p -121.35 148.03 44.91 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.828 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 7.2 mpt_? -109.22 -32.46 7.19 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 73.25 107.155 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -144.95 160.02 42.0 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 125.395 1.478 . . . . 74.329999999999998 108.528 172.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -59.23 -37.43 77.51 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.962 0.887 . . . . 74.129999999999995 110.549 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -68.33 -17.39 64.25 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.348 -1.296 . . . . 60.210000000000001 113.75 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 2.2 p30 -91.04 6.25 45.61 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.914 -1.114 . . . . 75.299999999999997 111.734 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.0 m -89.23 145.26 33.81 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 120.719 -0.392 . . . . 70.340000000000003 110.74 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.82 132.56 52.47 Favored 'Trans proline' 0 C--O 1.257 1.453 0 C-N-CA 123.373 2.715 . . . . 71.109999999999999 113.019 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.71 -106.94 1.72 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.801 -1.09 . . . . 33.340000000000003 112.563 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.07 16.9 5.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.545 -0.168 . . . . 35.409999999999997 110.545 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.69 150.34 41.29 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.1 -0.704 . . . . 55.310000000000002 109.1 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 46.0 pt -104.07 170.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.875 -0.416 . . . . 61.149999999999999 109.875 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.3 t -98.24 122.75 41.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.04 -1.096 . . . . 65.329999999999998 108.04 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mtm-85 -88.72 166.67 13.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.916 -0.401 . . . . 74.540000000000006 109.916 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.5 -7.57 41.0 Favored Glycine 0 N--CA 1.467 0.715 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 113.831 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 33.5 p-10 -89.18 -24.84 22.07 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 122.548 -0.383 . . . . 61.43 110.057 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.92 9.71 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.609 -0.805 . . . . 74.430000000000007 111.547 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 70.8 m-85 -125.32 155.91 39.49 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.729 -0.841 . . . . 73.409999999999997 108.729 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.3 m -80.26 153.06 28.74 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.816 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.46 -179.7 33.51 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-O 119.189 -0.784 . . . . 72.120000000000005 111.34 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.07 150.12 30.35 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.268 0.627 . . . . 65.040000000000006 110.125 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.14 32.87 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.369 -0.832 . . . . 64.409999999999997 110.333 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.3 mt -139.59 128.63 28.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.087 -1.82 . . . . 52.030000000000001 106.087 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -87.72 87.22 7.31 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 121.589 0.709 . . . . 73.120000000000005 111.599 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.67 -92.4 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.383 -1.34 . . . . 75.430000000000007 107.383 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.65 60.18 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.392 -1.336 . . . . 74.209999999999994 107.392 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.12 110.83 2.07 Favored 'Trans proline' 0 C--O 1.249 1.052 0 N-CA-C 108.579 -1.354 . . . . 72.450000000000003 108.579 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -109.15 -65.93 1.1 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.324 0.583 . . . . 75.310000000000002 111.592 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.26 38.63 2.16 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.77 -1.196 . . . . 63.0 107.77 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 CA--C 1.489 -1.38 0 C-N-CA 126.562 1.945 . . . . 63.310000000000002 115.481 -169.499 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 101.683 -3.451 . . . . 64.319999999999993 101.683 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -137.87 155.16 49.25 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.605 -0.725 . . . . 61.030000000000001 111.996 -163.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.82 132.54 5.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.874 -2.269 . . . . 71.129999999999995 104.874 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 mm -96.48 -20.44 5.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 120.875 0.369 . . . . 73.340000000000003 111.533 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -88.25 -41.41 12.95 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.576 -0.85 . . . . 73.329999999999998 108.9 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.91 102.82 3.01 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.979 -0.749 . . . . 74.099999999999994 108.979 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 134.42 57.53 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 116.601 -0.272 . . . . 54.240000000000002 110.402 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.12 119.4 6.57 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.796 2.331 . . . . 64.200000000000003 112.277 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.77 157.81 17.79 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.45 -0.945 . . . . 61.310000000000002 108.45 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.8 p -136.88 142.01 42.78 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.398 0.618 . . . . 61.520000000000003 111.478 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.9 -32.52 7.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.645 -1.613 . . . . 72.409999999999997 106.645 171.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -140.02 161.5 37.47 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.705 -1.589 . . . . 71.120000000000005 108.651 174.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.54 -29.54 70.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.561 -0.745 . . . . 72.340000000000003 111.864 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -69.54 -15.56 63.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.847 -0.615 . . . . 62.509999999999998 112.57 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.519 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m-20 -68.41 -22.55 64.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.451 0.643 . . . . 55.219999999999999 110.007 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -89.83 123.54 66.03 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-N 115.351 -0.84 . . . . 61.409999999999997 111.513 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.23 -179.81 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.979 2.453 . . . . 73.209999999999994 112.077 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.83 -123.82 34.34 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 112.311 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ALA . . . -113.04 10.44 18.78 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.005 -0.739 . . . . 64.439999999999998 109.005 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 m -71.08 146.68 49.13 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.675 -0.693 . . . . 73.349999999999994 110.614 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 22.9 pt -127.12 171.41 15.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.901 -0.777 . . . . 71.349999999999994 108.901 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.7 115.02 26.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.077 0.465 . . . . 71.200000000000003 109.781 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -86.3 167.76 14.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 109.899 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.42 -2.23 54.13 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 113.403 -174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -89.96 -17.55 27.72 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.761 0.315 . . . . 55.130000000000003 111.024 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.53 27.16 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.717 -0.953 . . . . 72.510000000000005 110.717 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -126.3 154.99 42.67 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 124.452 1.101 . . . . 75.329999999999998 109.988 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 74.4 m -80.19 126.2 30.81 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 72.230000000000004 109.839 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.46 -178.97 15.57 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.139 -1.185 . . . . 73.430000000000007 110.139 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.0 tp10 -66.17 156.19 34.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.873 0.336 . . . . 72.019999999999996 110.271 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . -80.59 -53.39 6.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.37 0.605 . . . . 73.219999999999999 111.482 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 35' ' ' ALA . 50.2 mm -115.66 150.31 17.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.05 -0.977 . . . . 51.109999999999999 109.704 -172.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -82.41 136.76 34.88 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.489 -0.93 . . . . 72.329999999999998 108.489 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 69.82 24.64 5.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.422 1.089 . . . . 64.230000000000004 110.15 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.94 166.49 42.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.444 -0.798 . . . . 60.130000000000003 110.77 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 58.7 Cg_exo -42.09 -50.21 5.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.97 3.113 . . . . 72.209999999999994 115.2 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -96.87 -38.09 9.98 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.131 -0.628 . . . . 74.400000000000006 109.84 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . . . 72.6 14.99 5.06 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 125.113 1.365 . . . . 73.340000000000003 111.488 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-N 114.324 -1.307 . . . . 73.349999999999994 109.871 -176.407 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 122.019 0.914 . . . . 74.319999999999993 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.428 ' CD ' ' HD2' ' A' ' 39' ' ' ARG . 6.0 pt-20 -97.71 161.64 13.66 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.713 -1.13 . . . . 71.120000000000005 110.503 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.0 120.07 30.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 106.422 -1.696 . . . . 73.25 106.422 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.45 -29.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-N 114.734 -1.121 . . . . 62.530000000000001 112.228 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.8 -42.23 12.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.137 -1.06 . . . . 74.430000000000007 108.137 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.26 78.62 1.77 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.982 -1.008 . . . . 73.099999999999994 108.403 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.98 117.2 12.01 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.253 -0.885 . . . . 71.349999999999994 111.758 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 3' ' ' ALA . 34.0 Cg_endo -89.87 108.79 0.4 Allowed 'Trans proline' 0 N--CA 1.429 -2.289 0 C-N-CA 122.458 2.105 . . . . 74.310000000000002 111.806 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.6 pttm -88.7 145.6 25.55 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.572 -0.529 . . . . 75.400000000000006 109.572 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.6 p -127.38 154.55 44.86 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.826 0.822 . . . . 70.019999999999996 111.598 -173.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -115.22 -35.25 4.73 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.089 -1.448 . . . . 71.349999999999994 107.089 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -130.57 158.45 39.95 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.306 -1.315 . . . . 73.530000000000001 110.103 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 6.4 m-20 -62.71 -34.33 76.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.626 0.726 . . . . 70.209999999999994 110.679 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -67.01 -6.41 16.9 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.502 -1.226 . . . . 74.540000000000006 113.212 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.7 -40.46 92.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.285 0.564 . . . . 73.510000000000005 109.523 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 79.2 m -131.71 98.34 18.02 Favored Pre-proline 0 N--CA 1.409 -2.479 0 N-CA-C 107.836 -1.172 . . . . 70.129999999999995 107.836 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.75 -166.21 0.39 Allowed 'Trans proline' 0 C--O 1.261 1.667 0 C-N-CA 122.896 2.397 . . . . 72.049999999999997 115.291 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.74 -111.22 4.0 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 113.933 -1.485 . . . . 34.109999999999999 112.762 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 -14.93 36.79 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.15 -0.525 . . . . 60.140000000000001 111.426 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.91 155.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.316 -0.554 . . . . 73.340000000000003 110.951 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.7 pt -131.9 179.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.401 -0.963 . . . . 65.219999999999999 108.401 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 50.4 t -101.28 126.55 48.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.318 -1.364 . . . . 74.200000000000003 107.318 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 41.4 mtt180 -91.25 165.81 13.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.796 -0.446 . . . . 71.310000000000002 109.796 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -5.92 66.76 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.71 -0.677 . . . . 72.530000000000001 112.491 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.586 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.5 p-10 -88.3 -11.69 45.69 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.908 -0.775 . . . . 61.409999999999997 108.908 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.42 42.49 Favored Glycine 0 CA--C 1.488 -1.601 0 CA-C-N 115.598 -0.728 . . . . 64.519999999999996 111.298 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 60.7 m-85 -125.14 157.03 37.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.496 0.718 . . . . 70.329999999999998 110.285 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.8 m -79.98 166.53 21.5 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.733 0.301 . . . . 62.420000000000002 110.414 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' ' HE ' ' A' ' 23' ' ' ARG . . . 170.55 -176.16 44.18 Favored Glycine 0 CA--C 1.486 -1.762 0 C-N-CA 120.172 -1.013 . . . . 52.450000000000003 112.488 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' HG12 ' A' ' 32' ' ' ILE . 9.8 tp10 -60.75 154.92 20.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.347 0.674 . . . . 74.549999999999997 109.95 176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.92 16.54 1.43 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.961 0.905 . . . . 52.439999999999998 112.356 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' HG3' ' A' ' 30' ' ' GLU . 50.3 mm -93.93 129.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.509 -1.663 . . . . 55.009999999999998 106.509 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -90.64 -21.78 21.51 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 115.62 -0.718 . . . . 74.439999999999998 111.483 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.03 -166.54 1.52 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.128 -1.064 . . . . 73.099999999999994 108.128 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.65 114.76 15.74 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 109.893 -0.41 . . . . 71.5 109.893 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.26 -173.99 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.666 2.244 . . . . 63.25 111.43 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -148.25 -59.93 0.25 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.039 -1.097 . . . . 74.099999999999994 108.039 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.53 78.84 7.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.819 -0.628 . . . . 54.420000000000002 109.943 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.428 ' HD2' ' CD ' ' A' ' 2' ' ' GLU . 80.0 mtm180 . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.927 -0.579 . . . . 72.310000000000002 109.987 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.388 0.613 . . . . 75.109999999999999 109.775 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.06 175.31 7.45 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.779 -1.101 . . . . 72.129999999999995 109.118 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.91 8.67 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.635 -1.246 . . . . 73.450000000000003 107.635 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.66 -26.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.735 -0.666 . . . . 71.129999999999995 110.596 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -88.06 -40.8 13.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.456 0.646 . . . . 63.310000000000002 109.709 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.63 87.85 1.66 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.044 -0.98 . . . . 63.109999999999999 109.62 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.07 135.45 96.32 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.296 -0.865 . . . . 74.530000000000001 111.459 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.12 122.2 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.465 2.11 . . . . 65.140000000000001 111.348 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 50.9 mtpt -76.58 145.98 38.62 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.845 -0.428 . . . . 73.340000000000003 109.845 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.6 p -117.82 146.85 43.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.645 0.259 . . . . 54.409999999999997 110.764 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.38 -45.08 4.16 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.79 -1.559 . . . . 71.340000000000003 106.79 172.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -136.66 155.26 50.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.04 -1.436 . . . . 72.140000000000001 109.309 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.415 ' OD2' ' HB ' ' A' ' 21' ' ' ILE . 2.9 m-20 -58.43 -35.01 71.45 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 123.698 0.799 . . . . 70.420000000000002 111.023 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -67.31 -16.26 64.16 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.29 1.218 . . . . 32.299999999999997 114.29 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -90.25 -4.14 57.37 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.289 -0.964 . . . . 72.109999999999999 111.549 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.93 137.41 28.25 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 115.791 -0.64 . . . . 62.100000000000001 110.012 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.0 122.27 6.03 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 124.18 3.254 . . . . 64.450000000000003 114.525 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.61 -119.25 17.57 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.131 -0.94 . . . . 70.140000000000001 112.914 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.93 10.54 36.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.316 -0.442 . . . . 64.329999999999998 110.866 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.54 146.8 52.96 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.125 -0.694 . . . . 63.340000000000003 109.125 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' OD2' ' A' ' 13' ' ' ASP . 36.0 pt -111.67 167.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.007 0.432 . . . . 73.430000000000007 111.0 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.19 105.1 17.39 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.564 -1.273 . . . . 54.420000000000002 107.564 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.96 165.16 22.89 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.01 0.433 . . . . 72.230000000000004 111.546 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.38 48.2 Favored Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.381 -0.827 . . . . 74.040000000000006 113.743 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -88.18 -15.47 35.92 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.987 -0.746 . . . . 72.319999999999993 108.987 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.39 10.83 37.67 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 111.037 -0.825 . . . . 40.140000000000001 111.037 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 71.4 m-85 -124.69 151.75 44.58 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 121.44 0.638 . . . . 73.049999999999997 110.686 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.7 m -74.19 147.22 42.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.464 -0.789 . . . . 45.32 109.271 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.15 159.68 32.26 Favored Glycine 0 CA--C 1.472 -2.637 0 N-CA-C 110.321 -1.112 . . . . 72.140000000000001 110.321 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -63.69 161.39 15.1 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.196 0.586 . . . . 74.030000000000001 110.007 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.25 42.69 0.27 Allowed 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.5 1.12 . . . . 71.010000000000005 111.398 -176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 34' ' ' ALA . 24.0 mt -93.13 130.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.98 -1.489 . . . . 34.119999999999997 106.98 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -99.68 -6.95 26.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.904 0.859 . . . . 74.040000000000006 110.334 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -98.8 -158.02 0.64 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.487 -1.233 . . . . 74.430000000000007 107.871 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.6 93.14 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.554 -0.165 . . . . 75.109999999999999 110.554 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.97 147.72 51.0 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.48 2.787 . . . . 62.509999999999998 112.808 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -109.59 -7.59 15.1 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.477 0.656 . . . . 71.209999999999994 109.391 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 70.91 70.77 0.19 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.707 1.203 . . . . 65.540000000000006 111.241 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 CA--C 1.476 -1.884 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 174.615 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 113.269 0.841 . . . . 61.200000000000003 113.269 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -99.07 -55.39 2.71 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.27 -0.877 . . . . 71.230000000000004 110.277 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.85 142.92 13.95 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 106.394 -1.706 . . . . 61.32 106.394 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.69 -39.76 4.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 116.579 -0.282 . . . . 73.120000000000005 111.68 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -89.25 -41.19 12.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.178 -1.045 . . . . 74.430000000000007 108.178 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -87.46 136.98 32.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.737 -1.12 . . . . 73.030000000000001 109.463 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 108.66 12.04 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 123.373 0.42 . . . . 73.530000000000001 111.594 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 35.1 Cg_endo -89.4 123.89 1.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.332 2.021 . . . . 42.409999999999997 109.914 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.9 pttt -100.07 145.69 27.64 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.995 -0.682 . . . . 62.43 111.416 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.4 p -124.1 152.07 43.16 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.631 0.253 . . . . 74.519999999999996 110.876 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -110.2 -36.13 5.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.524 -1.658 . . . . 72.129999999999995 106.524 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -132.38 151.89 51.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.36 -1.291 . . . . 74.439999999999998 109.184 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.45 -40.9 88.35 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.951 0.881 . . . . 73.230000000000004 109.343 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 p -63.33 -18.46 63.65 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.649 -1.614 . . . . 55.229999999999997 114.47 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.305 2.6 p30 -78.91 -9.1 59.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 118.668 -1.213 . . . . 75.099999999999994 112.051 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -125.99 106.77 25.36 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 62.399999999999999 109.347 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.06 -168.2 0.49 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 123.412 2.741 . . . . 44.210000000000001 115.792 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.47 -128.32 32.78 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 113.85 -1.523 . . . . 70.120000000000005 112.167 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.65 6.58 46.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.417 -0.392 . . . . 52.420000000000002 110.87 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.5 m -93.72 147.85 22.65 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 111.98 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 pt -138.0 177.06 5.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 114.052 -1.431 . . . . 71.109999999999999 107.97 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -97.9 124.63 42.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.565 -0.902 . . . . 71.319999999999993 108.565 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.01 167.77 10.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 O-C-N 122.193 -0.317 . . . . 72.129999999999995 110.765 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.26 -9.14 56.98 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 114.424 0.53 . . . . 75.439999999999998 114.424 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -88.84 -17.57 29.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.45 0.643 . . . . 71.329999999999998 109.398 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.26 17.83 23.5 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.888 -0.885 . . . . 51.0 110.888 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 70.9 m-85 -121.08 151.98 39.21 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.165 0.507 . . . . 61.32 111.938 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.5 m -79.49 109.76 14.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.169 -0.923 . . . . 71.319999999999993 109.674 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.79 163.63 12.78 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 109.112 -1.595 . . . . 61.049999999999997 109.112 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -80.27 166.36 21.44 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.744 -1.576 . . . . 63.340000000000003 106.744 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.38 74.07 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.864 0.364 . . . . 40.399999999999999 110.259 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.73 -62.01 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-O 121.319 0.58 . . . . 70.439999999999998 110.912 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -87.38 95.62 10.07 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 115.261 -0.882 . . . . 55.32 112.848 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.15 -22.6 18.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.358 -0.837 . . . . 63.219999999999999 110.939 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.95 156.09 84.44 Favored Pre-proline 0 C--O 1.254 1.298 0 CA-C-N 115.651 -0.704 . . . . 64.439999999999998 109.259 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.12 84.56 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.108 1.872 . . . . 71.109999999999999 111.321 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.4 -50.94 0.13 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 108.954 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.12 72.44 1.21 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.67 . . . . 71.510000000000005 112.274 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 28' ' ' CYS . 37.5 mtm180 . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 107.209 -1.404 . . . . 74.540000000000006 107.209 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.251 1.177 0 CA-C-O 121.523 0.678 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.05 135.06 33.59 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.22 155.59 38.07 Favored 'General case' 0 N--CA 1.405 -2.72 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.1 mt -103.97 -40.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.664 0 O-C-N 123.672 0.608 . . . . 0.0 110.798 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -89.39 -40.53 12.68 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.406 0.622 . . . . 0.0 110.501 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.47 49.53 1.2 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.389 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.67 122.87 86.4 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.387 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.43 120.32 5.88 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.047 1.831 . . . . 0.0 109.81 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.4 pttt -76.08 158.94 31.27 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.885 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.8 p -120.22 150.49 40.58 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.207 0.527 . . . . 0.0 111.823 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 73.5 mtm180 -110.92 -47.57 3.21 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 169.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 13.5 ptm180 -141.1 159.24 42.63 Favored 'General case' 0 CA--C 1.477 -1.857 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.085 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.63 -36.92 70.04 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.216 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 p -67.04 -27.65 67.57 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.539 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 11' ' ' ARG 0.281 1.7 p30 -86.46 10.31 15.57 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.618 178.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.2 m -93.63 136.68 23.81 Favored Pre-proline 0 N--CA 1.421 -1.917 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.541 173.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.43 152.7 71.16 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.621 2.881 . . . . 0.0 113.521 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 -114.52 6.93 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.507 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.96 15.27 7.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 88.9 m -60.04 153.87 20.53 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 pt -113.2 172.18 3.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.9 t -89.68 103.39 16.05 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -74.08 166.21 23.79 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.256 0.55 . . . . 0.0 111.512 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.94 -2.56 47.06 Favored Glycine 0 C--O 1.227 -0.316 0 CA-C-N 115.312 -0.858 . . . . 0.0 113.845 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.427 HD21 ' HB2' ' A' ' 27' ' ' TYR . 32.4 p-10 -89.89 -17.05 28.75 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.79 31.42 Favored Glycine 0 CA--C 1.498 -0.991 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 85.4 m-85 -128.43 160.72 31.37 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.443 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.9 m -80.27 140.88 36.0 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.305 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.01 161.44 35.03 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 39' ' ' ARG . 9.2 tp10 -64.63 162.1 16.32 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 117.256 0.528 . . . . 0.0 109.846 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.79 -49.56 17.74 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mm -116.12 122.69 70.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -73.45 -29.97 62.89 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.26 0.552 . . . . 0.0 110.818 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.0 -28.15 65.28 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.577 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.67 111.16 23.64 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.392 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 5.4 Cg_exo -79.66 99.47 1.22 Allowed 'Trans proline' 0 N--CA 1.428 -2.333 0 C-N-CA 121.077 1.184 . . . . 0.0 110.365 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -134.46 -75.73 0.47 Allowed 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 86.94 2.05 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.334 0.588 . . . . 0.0 110.82 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.549 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 84.1 mtp180 . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.927 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 106.631 -1.618 . . . . 64.129999999999995 106.631 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -91.07 139.87 30.35 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 113.72 -1.582 . . . . 74.420000000000002 109.041 -177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.52 130.18 6.61 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.63 -1.248 . . . . 64.219999999999999 107.63 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.64 -27.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 112.529 0.566 . . . . 70.450000000000003 112.529 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.63 -44.28 10.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.249 -0.907 . . . . 62.009999999999998 109.195 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.7 86.81 2.24 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.481 -0.781 . . . . 64.420000000000002 110.376 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.0 123.94 90.18 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 115.552 -0.749 . . . . 74.049999999999997 109.407 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.63 110.1 1.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.629 2.219 . . . . 75.129999999999995 112.105 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 20.6 pttp -80.82 153.51 27.67 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 110.772 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 19.2 p -135.8 151.34 49.98 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.265 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -105.97 -36.64 6.91 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.249 -1.759 . . . . 74.129999999999995 106.249 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -136.5 161.41 35.94 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 113.659 -1.61 . . . . 72.540000000000006 109.916 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 4.8 m-20 -63.46 -30.75 71.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.958 0.903 . . . . 65.409999999999997 111.494 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -69.18 -15.08 63.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.335 -0.848 . . . . 74.420000000000002 112.697 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -73.34 -16.0 61.37 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.358 -0.608 . . . . 65.319999999999993 109.358 174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.59 123.62 47.33 Favored Pre-proline 0 N--CA 1.412 -2.338 0 N-CA-C 109.015 -0.735 . . . . 70.010000000000005 109.015 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -90.8 -174.69 0.73 Allowed 'Trans proline' 0 C--O 1.258 1.475 0 C-N-CA 122.692 2.261 . . . . 75.319999999999993 112.716 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.89 -102.21 0.68 Allowed Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.34 -0.845 . . . . 75.310000000000002 112.411 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.74 11.72 2.69 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.242 0.544 . . . . 50.140000000000001 109.692 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.8 m -84.36 151.67 24.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 110.542 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.9 pt -118.09 171.99 5.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.219 -1.03 . . . . 72.109999999999999 108.219 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 46.1 t -94.52 107.63 19.61 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.424 -0.954 . . . . 71.319999999999993 108.424 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -73.32 166.44 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.166 -0.47 . . . . 62.32 110.65 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.21 -8.72 45.37 Favored Glycine 0 N--CA 1.473 1.125 0 N-CA-C 114.48 0.552 . . . . 52.219999999999999 114.48 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -89.25 -19.09 25.81 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.047 0.451 . . . . 63.030000000000001 109.97 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.77 23.41 10.88 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.078 -0.809 . . . . 63.409999999999997 111.078 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 74.6 m-85 -127.18 151.46 48.64 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 122.841 0.457 . . . . 74.200000000000003 110.768 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.4 m -79.53 128.37 33.29 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.58 -0.737 . . . . 73.209999999999994 111.434 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.25 168.64 35.26 Favored Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 109.598 -1.401 . . . . 60.140000000000001 109.598 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 8.9 tp10 -78.52 167.31 21.47 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 108.634 -0.876 . . . . 75.030000000000001 108.634 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.21 -16.6 61.95 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.908 0.861 . . . . 73.019999999999996 109.166 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.628 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 57.6 mt -96.48 150.19 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 105.615 -1.994 . . . . 72.439999999999998 105.615 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -59.93 -59.32 5.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.907 0.384 . . . . 74.140000000000001 111.32 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 123.05 41.08 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.959 -1.497 . . . . 71.0 106.959 173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -73.16 132.39 82.35 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 109.848 -0.427 . . . . 74.120000000000005 109.848 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 52.7 Cg_exo -55.81 -45.09 41.52 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.419 2.746 . . . . 73.510000000000005 114.355 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -150.05 -50.81 0.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.996 -0.372 . . . . 64.049999999999997 109.996 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.68 70.76 6.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.722 0.772 . . . . 72.230000000000004 109.532 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.609 ' HG2' ' HB3' ' A' ' 35' ' ' ALA . 66.7 mtp180 . . . . . 0 N--CA 1.422 -1.846 0 CA-C-N 114.476 -1.238 . . . . 75.319999999999993 109.518 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.7 m . . . . . 0 N--CA 1.41 -2.474 0 N-CA-C 103.944 -2.613 . . . . 64.430000000000007 103.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -88.08 143.95 26.78 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-O 120.901 0.381 . . . . 62.109999999999999 109.996 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.59 36.33 3.56 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.404 -0.816 . . . . 74.349999999999994 110.109 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.11 -50.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.612 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.28 -34.82 12.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.798 0.809 . . . . 55.520000000000003 109.079 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.0 104.73 3.72 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.997 -1.456 . . . . 51.229999999999997 109.152 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.2 116.12 56.33 Favored Pre-proline 0 C--N 1.298 -1.662 0 CA-C-N 115.589 -0.732 . . . . 74.230000000000004 110.649 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -64.47 114.97 2.93 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.637 2.225 . . . . 73.530000000000001 111.859 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -89.68 159.62 17.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.357 -0.979 . . . . 63.219999999999999 108.357 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 18.7 p -152.26 158.78 43.3 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.266 0.555 . . . . 44.350000000000001 111.685 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -119.78 -35.83 3.43 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.311 -1.366 . . . . 73.349999999999994 107.311 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -125.75 156.82 38.82 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.585 -1.189 . . . . 73.450000000000003 109.287 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -63.16 -32.24 73.58 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 124.027 0.931 . . . . 74.030000000000001 110.971 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -65.83 -16.31 63.7 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.655 -1.157 . . . . 62.130000000000003 113.182 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.79 -14.51 59.56 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.137 0.494 . . . . 62.409999999999997 109.831 176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.1 m -89.75 130.36 43.26 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.884 -0.598 . . . . 61.450000000000003 112.136 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.92 -179.75 5.5 Favored 'Trans proline' 0 C--O 1.27 2.123 0 C-N-CA 122.503 2.135 . . . . 74.340000000000003 112.112 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 -116.8 9.3 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.098 -0.956 . . . . 34.43 111.501 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.73 19.67 3.55 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.519 -0.919 . . . . 73.409999999999997 108.519 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.8 m -77.59 150.81 34.65 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.09 -0.959 . . . . 64.439999999999998 110.267 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.9 pt -109.05 174.11 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.966 -0.753 . . . . 74.129999999999995 108.966 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.16 118.65 30.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.738 -0.838 . . . . 75.400000000000006 108.738 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -87.66 170.5 11.21 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.737 -0.21 . . . . 73.140000000000001 110.72 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.64 -6.59 50.88 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 114.347 0.499 . . . . 72.030000000000001 114.347 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -89.47 -17.71 28.16 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.935 0.398 . . . . 74.319999999999993 110.541 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.19 22.86 21.41 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.567 -1.013 . . . . 61.039999999999999 110.567 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.18 147.21 48.16 Favored 'General case' 0 N--CA 1.421 -1.877 0 C-N-CA 124.571 1.148 . . . . 63.439999999999998 110.746 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.6 m -81.07 139.44 35.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.855 -1.066 . . . . 65.230000000000004 112.167 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.5 147.24 12.37 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 110.491 -1.044 . . . . 61.119999999999997 110.491 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 7.9 tp10 -72.59 161.78 30.33 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.745 -0.835 . . . . 70.030000000000001 108.745 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.56 74.19 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.615 0.766 . . . . 65.439999999999998 109.995 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 40.1 mt -118.6 135.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.225 0 N-CA-C 106.965 -1.494 . . . . 74.120000000000005 106.965 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -75.34 -33.78 61.15 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.003 0.43 . . . . 64.319999999999993 110.449 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.96 0.79 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.937 0.717 . . . . 75.209999999999994 112.937 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.47 124.04 87.18 Favored Pre-proline 0 C--O 1.212 -0.894 0 N-CA-C 108.953 -0.758 . . . . 72.420000000000002 108.953 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -50.97 -53.24 7.49 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.429 2.753 . . . . 71.430000000000007 115.138 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -127.42 -26.14 3.09 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 111.866 0.321 . . . . 74.129999999999995 111.866 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.3 26.19 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.411 0.893 . . . . 63.439999999999998 113.411 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-O 121.939 0.876 . . . . 75.25 112.087 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.421 -1.901 0 CA-C-O 121.408 0.623 . . . . 74.400000000000006 109.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -89.95 149.09 22.74 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 115.269 -0.878 . . . . 74.129999999999995 111.414 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.74 93.5 8.88 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.05 -0.977 . . . . 72.319999999999993 109.057 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.75 -63.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.659 -1.608 . . . . 75.010000000000005 106.659 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -99.19 -34.05 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 106.978 -1.49 . . . . 74.209999999999994 106.978 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -177.11 148.51 0.63 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.886 -1.506 . . . . 63.409999999999997 108.447 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 140.73 49.66 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 109.11 -0.7 . . . . 63.509999999999998 109.11 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.45 131.04 40.37 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 110.767 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.91 147.55 26.2 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.857 -0.424 . . . . 74.409999999999997 109.857 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.648 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.8 p -126.27 155.35 42.05 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.433 0.635 . . . . 75.510000000000005 111.93 -175.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -120.45 -34.48 3.62 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.631 -1.248 . . . . 74.239999999999995 107.631 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -132.82 160.19 37.61 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 124.879 1.272 . . . . 75.400000000000006 108.803 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.59 -32.54 74.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.425 0.631 . . . . 75.109999999999999 110.717 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -68.38 -13.0 61.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.989 -1.005 . . . . 61.310000000000002 113.182 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -72.55 -28.41 62.82 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.687 -0.857 . . . . 64.099999999999994 108.687 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.2 m -89.82 132.78 35.52 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 114.827 -1.079 . . . . 71.099999999999994 109.397 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.14 139.9 17.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.302 2.001 . . . . 71.230000000000004 114.405 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.14 -102.68 0.13 Allowed Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 116.087 1.195 . . . . 74.129999999999995 116.087 172.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -91.79 -5.81 52.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.218 0.451 . . . . 62.210000000000001 112.218 -173.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.27 140.18 36.32 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-O 121.231 0.538 . . . . 74.209999999999994 110.2 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -120.61 172.14 8.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.335 -1.357 . . . . 62.329999999999998 107.335 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.6 t -89.62 114.36 25.95 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.782 -0.822 . . . . 72.25 108.782 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 76.2 mtp180 -88.83 164.54 15.16 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.886 -0.413 . . . . 74.329999999999998 109.886 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.5 45.97 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 114.0 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.9 p-10 -89.62 -14.4 35.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.929 -0.767 . . . . 75.219999999999999 108.929 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.24 16.7 34.13 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.353 -0.84 . . . . 33.32 111.043 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -125.51 152.18 45.34 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-O 121.25 0.547 . . . . 75.319999999999993 110.31 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.47 134.97 36.04 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.903 -1.044 . . . . 51.329999999999998 110.296 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.02 145.26 11.5 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.65 -0.98 . . . . 72.239999999999995 110.65 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 31' ' ' ALA . 18.8 tt0 -65.37 146.57 54.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.143 -0.688 . . . . 34.149999999999999 109.143 174.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 30' ' ' GLU . . . -80.7 -86.16 0.09 Allowed 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.579 -0.897 . . . . 52.549999999999997 108.579 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 mt -149.62 93.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 105.593 -2.002 . . . . 65.209999999999994 105.593 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -139.13 -168.71 2.49 Favored 'General case' 0 C--N 1.246 -3.916 0 C-N-CA 123.868 0.867 . . . . 74.530000000000001 108.967 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.3 35.83 4.04 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.185 -0.672 . . . . 73.540000000000006 109.185 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 38' ' ' ALA . . . -71.46 117.75 59.97 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.599 -0.728 . . . . 44.340000000000003 111.988 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 26.9 Cg_exo -64.47 -35.86 46.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 113.55 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -129.83 -19.75 3.26 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.697 -0.401 . . . . 73.219999999999999 111.98 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . . . -83.17 33.92 0.46 Allowed 'General case' 0 C--N 1.319 -0.734 0 O-C-N 121.939 -0.476 . . . . 70.219999999999999 112.284 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.398 -0.964 . . . . 73.230000000000004 108.398 173.006 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.52 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 30.5 p . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 106.375 -1.713 . . . . 72.439999999999998 106.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.83 152.79 35.59 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.746 -0.835 . . . . 71.120000000000005 108.746 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.48 58.14 4.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.993 0.901 . . . . 71.5 112.099 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -119.82 -55.16 3.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.239 -1.023 . . . . 75.129999999999995 108.239 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -89.99 -33.75 16.25 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.527 -0.76 . . . . 75.140000000000001 108.962 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.28 119.67 6.88 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.125 -0.943 . . . . 72.030000000000001 109.3 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 107.91 8.51 Favored Pre-proline 0 C--N 1.309 -1.175 0 C-N-CA 122.915 0.486 . . . . 34.130000000000003 111.83 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 56.5 Cg_endo -96.67 125.91 0.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.742 2.295 . . . . 74.219999999999999 111.179 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -97.49 149.87 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.321 -0.622 . . . . 70.219999999999999 109.321 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -130.52 157.07 43.68 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.095 0.474 . . . . 74.099999999999994 111.823 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -117.48 -51.14 2.51 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 105.193 -2.151 . . . . 74.25 105.193 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -123.05 158.06 31.41 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 113.98 -1.464 . . . . 73.019999999999996 109.564 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.31 -29.85 70.13 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.174 0.511 . . . . 75.530000000000001 112.134 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.0 p -66.41 -21.27 66.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.327 -0.851 . . . . 74.340000000000003 111.669 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.57 -20.57 63.65 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.226 0.536 . . . . 63.530000000000001 109.986 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -94.14 119.84 66.23 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 115.303 -0.862 . . . . 71.409999999999997 109.78 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.15 141.2 32.18 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.847 2.365 . . . . 72.239999999999995 115.139 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.95 -108.84 2.61 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 114.446 -1.252 . . . . 41.509999999999998 114.235 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' H ' ' HB1' ' A' ' 38' ' ' ALA . . . -102.37 -2.23 29.29 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.598 -0.519 . . . . 73.239999999999995 109.598 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 70.1 m -73.55 139.95 45.98 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.933 -0.766 . . . . 71.030000000000001 108.933 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.7 pt -124.27 169.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 108.031 -1.1 . . . . 54.130000000000003 108.031 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.56 115.94 28.45 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.481 -0.563 . . . . 53.350000000000001 109.481 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -88.92 161.46 16.64 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.277 -0.638 . . . . 72.349999999999994 109.277 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.98 -2.56 47.42 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 113.43 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -89.5 -18.9 25.8 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.638 0.256 . . . . 71.400000000000006 110.87 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.34 4.71 32.74 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 111.515 -0.634 . . . . 71.340000000000003 111.515 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.77 146.55 36.17 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 123.584 0.754 . . . . 73.400000000000006 110.874 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 91.0 m -80.98 148.85 29.58 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.353 -0.84 . . . . 64.230000000000004 109.01 172.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 1' ' ' CYS . . . -176.3 152.01 12.21 Favored Glycine 0 N--CA 1.416 -2.692 0 C-N-CA 118.971 -1.585 . . . . 63.119999999999997 112.772 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.73 140.67 28.92 Favored 'General case' 0 C--O 1.249 1.048 0 C-N-CA 124.356 1.062 . . . . 71.340000000000003 109.502 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -85.61 0.11 Allowed 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 114.28 -1.327 . . . . 75.349999999999994 109.9 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.3 mt -153.53 102.64 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 N-CA-C 105.678 -1.971 . . . . 72.109999999999999 105.678 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.5 t80 179.86 -46.88 0.01 OUTLIER 'General case' 0 C--N 1.271 -2.824 0 O-C-N 124.275 0.985 . . . . 60.520000000000003 108.672 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.73 60.15 1.1 Allowed 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.568 -1.196 . . . . 75.340000000000003 109.881 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . . . -72.84 123.3 89.41 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.748 -1.114 . . . . 70.209999999999994 110.522 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -43.15 -49.33 7.27 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 124.634 3.556 . . . . 62.409999999999997 115.568 -176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -107.21 -16.9 14.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.32 0.581 . . . . 65.150000000000006 111.307 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.603 ' HB1' ' H ' ' A' ' 19' ' ' ALA . . . -94.31 17.21 13.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.095 0.776 . . . . 64.439999999999998 113.095 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 . . . . . 0 C--N 1.285 -2.213 0 CA-C-N 115.208 -0.905 . . . . 65.5 110.973 177.544 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.999 0.904 . . . . 74.329999999999998 109.633 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -88.61 147.99 24.28 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.702 -1.135 . . . . 71.510000000000005 108.445 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.94 142.9 12.26 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.39 -0.967 . . . . 61.240000000000002 108.39 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.46 -23.08 4.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.74 -0.664 . . . . 64.510000000000005 110.384 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -89.23 -42.29 11.71 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.477 -0.489 . . . . 74.420000000000002 110.136 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.02 89.04 1.42 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.145 -0.479 . . . . 65.450000000000003 112.032 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -80.39 126.74 78.11 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.869 -0.605 . . . . 51.350000000000001 109.649 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.0 Cg_exo -66.09 119.82 6.9 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.709 2.272 . . . . 74.099999999999994 113.125 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 99.4 mttt -83.89 134.26 34.69 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.978 -0.749 . . . . 75.340000000000003 108.978 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.5 p -100.07 147.76 25.29 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 120.986 0.422 . . . . 71.439999999999998 112.033 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -109.2 -31.33 7.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.636 -1.246 . . . . 72.319999999999993 107.636 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -148.52 156.6 42.66 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.302 -1.317 . . . . 55.439999999999998 109.246 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 13.2 m-20 -59.53 -37.73 79.13 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.092 0.949 . . . . 73.109999999999999 110.311 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -71.82 -12.15 61.15 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.078 -1.419 . . . . 60.43 114.018 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.42 0.21 53.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 119.348 -0.941 . . . . 71.409999999999997 110.905 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 90.0 m -91.13 136.22 27.53 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 109.77 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.07 179.44 5.95 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.565 2.177 . . . . 63.539999999999999 112.967 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.66 -122.75 31.07 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 115.359 -0.837 . . . . 72.349999999999994 112.048 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.38 19.47 13.38 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.704 -0.85 . . . . 44.32 108.704 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.3 m -81.2 145.78 30.81 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.216 -0.902 . . . . 74.510000000000005 112.511 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 13' ' ' ASP . 30.7 pt -119.73 179.15 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 107.059 -1.46 . . . . 70.510000000000005 107.059 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -90.63 117.93 29.67 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.44 -0.948 . . . . 73.030000000000001 108.44 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -89.02 160.05 17.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.38 -1.12 41.7 Favored Glycine 0 C--N 1.31 -0.892 0 CA-C-N 115.931 -0.577 . . . . 75.239999999999995 113.411 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -89.66 -19.53 24.75 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.694 -0.484 . . . . 73.439999999999998 109.694 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.93 2.44 34.21 Favored Glycine 0 CA--C 1.499 -0.952 0 N-CA-C 111.486 -0.646 . . . . 74.030000000000001 111.486 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 95.7 m-85 -114.69 161.65 17.85 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 123.414 0.685 . . . . 72.510000000000005 109.997 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 76.6 m -80.26 142.01 35.0 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.579 -0.526 . . . . 61.32 109.579 175.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.21 146.84 14.71 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.9 -1.28 . . . . 72.049999999999997 109.9 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.3 tt0 -59.94 148.51 34.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.64 0.733 . . . . 72.239999999999995 110.597 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.39 -151.85 0.09 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.473 -1.239 . . . . 63.539999999999999 107.736 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.5 mm -95.82 136.93 25.22 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 C-N-CA 119.398 -0.921 . . . . 72.25 110.413 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.583 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 22.7 t80 -170.82 154.46 4.32 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 102.731 -3.062 . . . . 73.219999999999999 102.731 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.94 -58.24 3.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 119.061 0.846 . . . . 63.009999999999998 110.341 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.63 155.06 73.78 Favored Pre-proline 0 C--N 1.305 -1.347 0 CA-C-N 115.441 -0.8 . . . . 62.409999999999997 109.078 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.92 125.47 11.57 Favored 'Trans proline' 0 C--O 1.241 0.639 0 N-CA-C 108.23 -1.488 . . . . 71.140000000000001 108.23 172.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -109.65 -46.34 3.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.006 0.432 . . . . 63.409999999999997 110.43 -173.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.3 78.58 1.02 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.664 -0.698 . . . . 63.409999999999997 109.478 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 115.368 -0.833 . . . . 74.409999999999997 108.795 178.601 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 122.39 1.091 . . . . 60.549999999999997 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.67 165.94 10.73 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 114.621 -1.172 . . . . 74.209999999999994 112.188 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.18 126.17 12.04 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 106.457 -1.683 . . . . 74.420000000000002 106.457 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.9 mt -93.67 -23.83 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 120.976 0.417 . . . . 62.140000000000001 111.629 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -87.83 -42.53 12.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.008 -0.677 . . . . 63.030000000000001 109.304 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.19 82.68 1.93 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.02 -0.991 . . . . 65.340000000000003 108.849 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -64.87 122.45 79.31 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.284 -0.871 . . . . 62.219999999999999 111.494 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -74.15 127.43 11.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.492 2.128 . . . . 63.530000000000001 109.923 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.0 pttm -94.49 156.89 16.25 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 110.55 -0.167 . . . . 64.120000000000005 110.55 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 15.2 p -142.55 157.68 44.46 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 120.507 0.194 . . . . 75.129999999999995 110.903 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 11' ' ' ARG . 71.6 mtt180 -111.57 -42.51 3.84 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.145 -1.428 . . . . 71.510000000000005 107.145 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -127.5 157.52 39.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.758 -1.564 . . . . 71.400000000000006 108.631 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 9.2 m-20 -61.89 -34.93 76.92 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.365 -0.834 . . . . 64.340000000000003 111.248 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -64.66 -21.62 66.77 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.526 -1.216 . . . . 71.439999999999998 112.584 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -65.19 -29.5 70.32 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.393 -0.595 . . . . 63.340000000000003 109.393 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 44.3 m -89.97 121.2 69.08 Favored Pre-proline 0 N--CA 1.425 -1.724 0 CA-C-N 115.754 -0.657 . . . . 73.120000000000005 109.333 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.83 -177.55 2.59 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.45 2.1 . . . . 74.430000000000007 112.491 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.73 -132.75 51.42 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.575 -0.739 . . . . 63.310000000000002 111.926 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.33 11.08 33.91 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.606 0.241 . . . . 73.129999999999995 110.823 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 87.4 m -84.7 149.23 25.94 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 121.882 0.848 . . . . 73.219999999999999 112.63 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.25 175.71 10.27 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 113.858 -1.519 . . . . 74.439999999999998 107.683 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 37.8 t -97.25 110.85 23.32 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.07 -0.715 . . . . 41.030000000000001 109.07 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -74.15 169.36 17.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 111.649 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.93 -14.53 61.17 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-N 115.438 -0.801 . . . . 61.119999999999997 112.997 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.32 -16.27 33.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.082 0.468 . . . . 72.209999999999994 111.49 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.46 17.1 32.29 Favored Glycine 0 CA--C 1.485 -1.803 0 C-N-CA 120.233 -0.984 . . . . 40.399999999999999 111.05 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 71.1 m-85 -121.18 147.16 45.98 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.66 -0.77 . . . . 73.420000000000002 109.268 178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 71.9 m -70.82 127.92 34.28 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.065 -0.516 . . . . 53.310000000000002 110.725 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.33 153.82 20.57 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.139 -1.184 . . . . 64.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -79.28 178.11 8.32 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 109.47 -0.566 . . . . 72.450000000000003 109.47 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.15 -72.69 0.16 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.074 0.549 . . . . 62.399999999999999 112.133 -172.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 58.0 mt -138.78 146.96 25.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.811 -1.181 . . . . 71.299999999999997 107.811 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.639 -1.245 . . . . 51.119999999999997 107.639 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.56 -81.13 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.011 -0.737 . . . . 73.319999999999993 109.011 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 36' ' ' PRO 0.27 . . -80.54 -50.89 1.05 Allowed Pre-proline 0 C--N 1.317 -0.839 0 C-N-CA 120.471 -0.492 . . . . 75.409999999999997 110.429 170.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 20.9 Cg_exo -64.38 142.57 79.46 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.42 2.08 . . . . 71.040000000000006 107.816 167.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -119.95 25.5 9.89 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.204 0.526 . . . . 72.129999999999995 111.989 -170.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.8 39.19 4.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.806 0.843 . . . . 50.030000000000001 110.199 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-N 114.596 -1.184 . . . . 75.510000000000005 111.31 -174.626 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 108.628 -0.879 . . . . 63.439999999999998 108.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.36 170.02 9.8 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.769 -1.105 . . . . 52.109999999999999 109.936 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.78 144.37 4.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.928 -1.508 . . . . 75.510000000000005 106.928 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.4 mt -105.0 -21.48 5.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.093 0.473 . . . . 64.409999999999997 110.367 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -88.23 -43.87 11.28 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.234 -1.024 . . . . 75.310000000000002 108.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.11 77.99 1.36 Allowed 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.041 -1.096 . . . . 61.200000000000003 108.041 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 116.64 31.82 Favored Pre-proline 0 N--CA 1.437 -1.097 0 CA-C-N 115.289 -0.869 . . . . 54.140000000000001 110.679 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -76.83 118.36 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.791 2.328 . . . . 64.310000000000002 111.453 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 96.8 mttt -86.15 163.22 17.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.981 -0.554 . . . . 65.450000000000003 110.636 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 28.1 p -139.21 148.68 43.43 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.933 -0.576 . . . . 75.510000000000005 109.996 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -115.67 -40.32 3.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.452 -1.685 . . . . 73.010000000000005 106.452 173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -132.96 160.98 35.52 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.712 1.605 . . . . 65.349999999999994 108.004 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.08 -30.71 71.68 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.537 0.684 . . . . 31.23 111.47 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 p -67.41 -17.26 64.65 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.064 -0.971 . . . . 65.409999999999997 112.125 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -67.11 -23.92 65.88 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.159 0.504 . . . . 62.100000000000001 109.646 175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.77 137.68 26.81 Favored Pre-proline 0 N--CA 1.418 -2.048 0 CA-C-N 115.316 -0.856 . . . . 64.030000000000001 110.055 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -86.18 177.61 4.47 Favored 'Trans proline' 0 C--O 1.253 1.272 0 C-N-CA 122.541 2.16 . . . . 71.010000000000005 112.572 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.02 -124.18 35.89 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.036 -0.984 . . . . 43.049999999999997 112.885 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.66 13.12 21.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.787 0.327 . . . . 53.020000000000003 110.167 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.38 155.22 32.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.305 0.574 . . . . 74.319999999999993 112.01 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.86 174.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.623 -0.88 . . . . 74.230000000000004 108.623 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 t -91.03 115.5 28.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.689 -0.856 . . . . 74.510000000000005 108.689 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -84.85 165.72 17.48 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.108 0.48 . . . . 65.540000000000006 111.172 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.15 7.3 37.5 Favored Glycine 0 CA--C 1.51 -0.226 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 112.854 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -95.2 -16.36 22.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.617 -0.512 . . . . 74.299999999999997 109.617 174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.01 11.97 41.31 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.729 -0.948 . . . . 74.109999999999999 110.729 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 89.9 m-85 -127.87 160.8 30.71 Favored 'General case' 0 N--CA 1.414 -2.244 0 CA-C-N 114.458 -0.871 . . . . 70.319999999999993 110.775 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 89.3 m -80.0 140.54 36.54 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.602 -0.726 . . . . 73.310000000000002 111.368 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -163.65 176.6 39.73 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.124 -1.19 . . . . 51.210000000000001 110.124 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.62 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 9.3 tp10 -74.68 173.74 10.07 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 123.821 0.848 . . . . 54.100000000000001 109.414 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.59 -24.64 63.71 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.191 0.996 . . . . 45.25 108.405 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.62 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 53.3 mt -92.57 149.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 N-CA-C 105.853 -1.906 . . . . 64.310000000000002 105.853 174.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -44.75 -47.08 10.78 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.318 1.047 . . . . 71.549999999999997 113.275 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 36' ' ' PRO . . . -119.58 135.45 54.79 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.776 -0.824 . . . . 72.540000000000006 108.776 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.74 110.03 15.6 Favored Pre-proline 0 C--N 1.321 -0.65 0 O-C-N 123.599 0.562 . . . . 74.439999999999998 111.933 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 34' ' ' ALA . 70.7 Cg_endo -83.57 -38.32 0.14 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.522 2.148 . . . . 63.409999999999997 114.071 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -117.15 -51.42 2.54 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.444 0.64 . . . . 73.25 109.882 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 56.71 3.57 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.779 0.799 . . . . 45.140000000000001 108.944 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 . . . . . 0 N--CA 1.426 -1.625 0 CA-C-N 115.352 -0.84 . . . . 62.32 109.237 -179.298 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.296 -1.372 . . . . 54.539999999999999 107.296 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -89.52 123.66 33.82 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.016 0.912 . . . . 73.340000000000003 109.705 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 7' ' ' ALA . . . -149.72 100.82 3.01 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 114.165 -1.38 . . . . 55.509999999999998 108.887 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 mm -91.38 -13.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 115.362 -0.835 . . . . 74.109999999999999 109.878 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.11 -45.41 9.61 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.416 -0.811 . . . . 63.530000000000001 109.754 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.71 96.13 2.08 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.562 -0.745 . . . . 73.349999999999994 109.316 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 3' ' ' ALA . . . -72.57 126.41 90.83 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 115.91 -0.587 . . . . 64.219999999999999 110.166 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.55 116.41 3.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.539 2.159 . . . . 64.219999999999999 112.788 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -70.77 148.2 48.16 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.289 -1.004 . . . . 44.420000000000002 108.289 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 29.9 p -117.74 150.58 38.87 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 120.981 -0.288 . . . . 52.229999999999997 110.264 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -117.73 -43.66 2.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.278 -1.379 . . . . 72.219999999999999 107.278 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -132.18 153.1 50.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.64 -1.164 . . . . 53.520000000000003 108.729 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 6.1 m-20 -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.319 -0.855 . . . . 75.019999999999996 110.606 -176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -68.02 -19.26 64.89 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.64 -1.164 . . . . 73.530000000000001 113.284 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.23 -3.71 59.06 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.067 -1.053 . . . . 55.530000000000001 111.004 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -94.22 118.29 67.11 Favored Pre-proline 0 N--CA 1.429 -1.482 0 N-CA-C 109.401 -0.592 . . . . 71.0 109.401 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.89 -175.44 2.68 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 122.586 2.19 . . . . 71.299999999999997 111.53 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.1 13.98 60.68 Favored Glycine 0 N--CA 1.465 0.599 0 CA-C-N 116.643 -0.253 . . . . 64.409999999999997 112.829 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.66 8.97 5.64 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.655 1.582 . . . . 70.519999999999996 111.129 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.1 m -67.76 149.17 50.28 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 116.047 -0.524 . . . . 65.140000000000001 109.629 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 44.9 pt -110.92 174.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.772 -0.825 . . . . 73.209999999999994 108.772 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -95.56 107.32 19.49 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.277 -1.008 . . . . 60.299999999999997 108.277 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -84.18 168.55 15.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.397 0.617 . . . . 72.230000000000004 110.857 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.45 2.25 63.14 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 115.295 -0.866 . . . . 75.340000000000003 112.398 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -88.74 -17.97 28.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.501 -0.926 . . . . 65.140000000000001 108.501 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.8 6.94 42.7 Favored Glycine 0 CA--C 1.487 -1.673 0 N-CA-C 111.274 -0.731 . . . . 73.219999999999999 111.274 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.69 159.34 28.15 Favored 'General case' 0 N--CA 1.414 -2.255 0 C-N-CA 123.331 0.652 . . . . 71.010000000000005 110.39 -175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 64.2 m -80.21 131.94 35.78 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.254 -0.885 . . . . 44.229999999999997 108.633 174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.47 170.01 30.38 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.633 -1.387 . . . . 65.549999999999997 109.633 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 42.4 tt0 -69.6 157.74 36.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 117.643 0.722 . . . . 65.239999999999995 110.062 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.32 -141.83 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.648 -1.242 . . . . 74.209999999999994 107.648 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.2 mt -101.97 130.51 51.59 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.647 -1.242 . . . . 75.430000000000007 107.647 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' A' ' 35' ' ' ALA . 37.1 t80 -165.58 167.89 16.93 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 106.669 -1.604 . . . . 71.310000000000002 106.669 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.7 -80.26 0.16 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 118.403 0.547 . . . . 75.019999999999996 112.069 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 33' ' ' TYR . . . -80.5 151.09 71.41 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 109.735 -0.469 . . . . 75.109999999999999 109.735 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -64.77 112.69 2.06 Favored 'Trans proline' 0 C--O 1.242 0.686 0 C-N-CA 121.706 1.604 . . . . 60.420000000000002 111.271 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -138.17 -39.23 0.54 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.115 0.783 . . . . 71.239999999999995 113.115 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.22 43.49 1.86 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.67 -0.863 . . . . 73.120000000000005 108.67 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 26.2 mtp180 . . . . . 0 N--CA 1.435 -1.213 0 CA-C-N 114.667 -1.152 . . . . 75.439999999999998 111.433 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.469 0 CA-C-O 122.558 1.17 . . . . 63.420000000000002 109.436 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -88.25 -26.67 22.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.365 -1.743 . . . . 72.340000000000003 107.399 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.04 93.59 9.4 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.865 -1.532 . . . . 43.039999999999999 106.865 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.8 mt -89.62 -16.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.834 -1.075 . . . . 54.409999999999997 111.071 -174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -89.34 -27.34 20.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.872 -1.159 . . . . 72.420000000000002 107.872 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.61 12.02 34.99 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.938 -1.028 . . . . 73.239999999999995 110.407 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.12 166.19 40.22 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 123.756 0.822 . . . . 72.140000000000001 110.722 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.8 164.54 22.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.786 1.657 . . . . 74.120000000000005 110.716 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.19 162.51 26.54 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.743 0.306 . . . . 72.439999999999998 111.63 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.527 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.7 p -151.89 154.49 36.24 Favored 'General case' 0 C--O 1.248 1.014 0 CA-C-N 115.984 -0.553 . . . . 70.200000000000003 110.809 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -114.93 -34.23 5.16 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.221 -1.029 . . . . 75.430000000000007 108.221 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -135.85 161.71 34.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.512 -1.222 . . . . 74.319999999999993 110.664 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -57.91 -33.49 68.83 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 123.802 0.841 . . . . 62.219999999999999 111.57 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -65.03 -25.21 67.74 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.085 -0.961 . . . . 64.409999999999997 112.407 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.72 -26.76 68.8 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.524 0.678 . . . . 64.25 109.261 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -96.79 128.45 35.74 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.13 -0.941 . . . . 31.420000000000002 110.167 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.02 158.6 4.88 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.67 2.246 . . . . 64.099999999999994 114.547 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.36 -111.81 4.34 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.774 -1.103 . . . . 63.039999999999999 114.746 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.569 ' H ' ' HB3' ' A' ' 38' ' ' ALA . . . -105.45 5.54 31.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.437 0.637 . . . . 74.219999999999999 109.844 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.79 136.15 33.36 Favored 'General case' 0 N--CA 1.411 -2.382 0 N-CA-C 107.712 -1.218 . . . . 63.210000000000001 107.712 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.73 177.24 4.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.175 -1.046 . . . . 72.230000000000004 108.175 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.6 t -89.31 118.82 29.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.233 -0.987 . . . . 52.32 108.368 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -89.56 166.89 13.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.507 -0.553 . . . . 74.129999999999995 109.507 -177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.53 -8.69 52.88 Favored Glycine 0 N--CA 1.463 0.455 0 N-CA-C 114.221 0.448 . . . . 64.510000000000005 114.221 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -89.07 -17.13 29.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.361 0.6 . . . . 74.450000000000003 109.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.82 19.54 24.19 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 111.277 -0.729 . . . . 63.310000000000002 111.277 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.5 154.59 35.07 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.971 0.908 . . . . 75.439999999999998 109.9 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 93.8 m -80.14 101.59 8.88 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 123.14 0.576 . . . . 51.549999999999997 111.87 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.47 16.79 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.538 -0.839 . . . . 61.229999999999997 111.028 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 33' ' ' TYR . 27.3 tt0 -61.94 159.35 14.27 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 124.088 0.955 . . . . 62.310000000000002 111.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -71.48 0.16 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.386 -1.279 . . . . 71.310000000000002 110.106 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.2 mt -133.23 -66.09 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.877 -1.157 . . . . 72.319999999999993 107.877 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.47 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 50.2 t80 -163.75 103.2 0.91 Allowed 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 113.699 -1.591 . . . . 75.329999999999998 107.562 176.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.8 167.41 10.31 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.709 -0.678 . . . . 64.530000000000001 111.809 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -80.2 169.51 19.56 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 114.802 -1.09 . . . . 73.120000000000005 108.301 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 20.2 Cg_endo -65.11 92.31 0.21 Allowed 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.303 1.335 . . . . 74.120000000000005 112.389 176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -143.76 -55.1 0.37 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 105.735 -1.95 . . . . 71.219999999999999 105.735 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.569 ' HB3' ' H ' ' A' ' 19' ' ' ALA . . . -149.89 97.54 2.6 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.311 -1.737 . . . . 55.030000000000001 106.311 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 . . . . . 0 C--N 1.288 -2.092 0 CA-C-O 121.466 0.65 . . . . 64.129999999999995 109.381 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.2 m . . . . . 0 N--CA 1.422 -1.855 0 CA-C-O 122.108 0.956 . . . . 65.329999999999998 111.264 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -89.76 -35.3 15.81 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.883 -1.508 . . . . 73.219999999999999 108.974 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.63 89.18 7.08 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.378 -1.342 . . . . 62.119999999999997 107.378 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 57.6 mt -89.23 -15.24 8.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.74 -0.664 . . . . 55.229999999999997 111.03 -175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.05 -31.98 18.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.275 -1.38 . . . . 71.219999999999999 107.275 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.79 25.01 11.8 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.604 -1.18 . . . . 72.319999999999993 110.122 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.2 126.66 88.2 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 75.420000000000002 109.401 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.21 143.46 44.05 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.901 1.734 . . . . 54.210000000000001 111.473 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 14.9 ptmm? -82.28 158.79 23.33 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.948 -0.39 . . . . 74.340000000000003 109.948 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -132.57 151.54 51.9 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.295 0.569 . . . . 62.340000000000003 111.963 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -101.34 -44.96 5.48 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.264 -2.124 . . . . 72.120000000000005 105.264 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HG2' ' OD2' ' A' ' 15' ' ' ASP . 8.5 ptp180 -129.93 163.2 26.91 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 113.608 -1.633 . . . . 73.129999999999995 110.18 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.08 -32.12 73.57 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.886 -1.052 . . . . 73.540000000000006 110.815 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -72.72 -4.72 33.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.129 -0.941 . . . . 64.109999999999999 112.969 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' OD2' ' HG2' ' A' ' 12' ' ' ARG . 69.5 m-20 -77.71 -23.25 49.51 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.467 0.651 . . . . 70.510000000000005 109.45 172.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 29.2 m -104.96 127.37 28.89 Favored Pre-proline 0 N--CA 1.419 -1.988 0 N-CA-C 108.656 -0.868 . . . . 73.219999999999999 108.656 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 16' ' ' CYS . 73.6 Cg_endo -100.52 -175.65 0.14 Allowed 'Trans proline' 0 C--O 1.255 1.336 0 C-N-CA 122.413 2.076 . . . . 70.040000000000006 113.27 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.64 -108.9 2.63 Favored Glycine 0 CA--C 1.489 -1.545 0 CA-C-N 115.025 -0.989 . . . . 72.549999999999997 113.463 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 30' ' ' GLU . . . -115.23 0.24 13.46 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.174 0.512 . . . . 61.549999999999997 109.969 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 72.2 m -91.99 139.87 30.22 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-O 122.03 0.919 . . . . 71.140000000000001 111.826 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.9 pt -123.79 179.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 113.883 -1.508 . . . . 72.239999999999995 107.065 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.8 t -95.51 104.94 16.86 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.198 -1.038 . . . . 51.229999999999997 108.198 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 74.3 mtp180 -79.96 170.16 16.86 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.453 -0.34 . . . . 71.129999999999995 110.893 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.52 -2.31 27.12 Favored Glycine 0 N--CA 1.464 0.512 0 CA-C-N 115.933 -0.576 . . . . 54.149999999999999 114.011 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 27' ' ' TYR . 32.1 p-10 -88.89 -19.19 26.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.826 -0.805 . . . . 71.019999999999996 108.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.07 32.33 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 110.939 -0.864 . . . . 74.540000000000006 110.939 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.532 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . 73.9 m-85 -129.31 157.59 41.47 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.085 -0.558 . . . . 61.030000000000001 110.808 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.37 133.86 47.33 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 115.244 -0.889 . . . . 73.340000000000003 109.827 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.57 135.69 4.61 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.403 -1.079 . . . . 72.329999999999998 110.403 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 41.8 tt0 -51.36 139.0 20.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.263 1.03 . . . . 74.409999999999997 112.112 175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.28 -62.43 1.66 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.873 -1.512 . . . . 63.009999999999998 110.549 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.2 mt -131.04 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.016 -2.216 . . . . 64.319999999999993 105.016 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -59.93 107.79 0.67 Allowed 'General case' 0 C--N 1.312 -1.054 0 O-C-N 123.888 0.742 . . . . 74.129999999999995 110.674 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.76 -166.22 1.21 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.933 0.716 . . . . 45.539999999999999 112.933 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -75.16 147.96 83.63 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-N 115.38 -0.827 . . . . 72.239999999999995 110.122 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 31.4 Cg_exo -65.25 121.32 8.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.151 2.568 . . . . 64.510000000000005 114.534 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -150.31 -63.17 0.2 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.877 -2.268 . . . . 75.099999999999994 104.877 171.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.35 95.7 2.76 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 106.674 -1.602 . . . . 63.32 106.674 171.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 . . . . . 0 N--CA 1.403 -2.82 0 N-CA-C 106.14 -1.8 . . . . 60.420000000000002 106.14 177.633 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.41 -2.452 0 N-CA-C 107.859 -1.163 . . . . 73.340000000000003 107.859 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 38.3 mt-10 -141.89 -170.03 3.04 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 104.644 -2.354 . . . . 64.409999999999997 104.644 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.57 83.47 4.12 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.934 -0.707 . . . . 72.5 109.396 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.41 -62.38 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 N-CA-C 108.318 -0.993 . . . . 70.120000000000005 108.318 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -88.81 -32.78 17.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.813 -1.18 . . . . 72.209999999999994 107.813 -176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.35 160.02 7.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.245 -1.391 . . . . 62.329999999999998 107.245 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.92 113.43 40.47 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 109.27 -0.641 . . . . 54.520000000000003 109.27 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -86.8 101.0 0.55 Allowed 'Trans proline' 0 N--CA 1.432 -2.106 0 C-N-CA 121.801 1.667 . . . . 74.310000000000002 112.112 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -84.09 157.48 21.73 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.246 -0.65 . . . . 65.129999999999995 109.246 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.4 p -140.22 148.04 40.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.319 0.581 . . . . 64.340000000000003 112.063 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -105.42 -40.86 5.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 105.792 -1.929 . . . . 54.439999999999998 105.792 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -139.11 166.28 24.92 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 114.295 -1.32 . . . . 75.439999999999998 110.987 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.94 -33.85 72.45 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 123.774 0.83 . . . . 70.099999999999994 110.951 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.0 p -65.18 -21.44 66.77 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.868 -1.06 . . . . 64.329999999999998 112.293 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -68.12 -23.72 64.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.31 0.576 . . . . 60.409999999999997 110.357 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.49 133.72 30.75 Favored Pre-proline 0 N--CA 1.422 -1.857 0 CA-C-N 115.341 -0.845 . . . . 61.039999999999999 111.008 -175.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.42 177.35 8.63 Favored 'Trans proline' 0 C--O 1.257 1.465 0 C-N-CA 122.804 2.336 . . . . 73.219999999999999 112.76 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.99 -130.58 47.82 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 110.127 -1.189 . . . . 62.119999999999997 110.127 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.97 9.57 22.23 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 109.096 -0.705 . . . . 53.509999999999998 109.096 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.5 m -64.64 148.63 50.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 116.018 -0.537 . . . . 73.540000000000006 111.208 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 pt -116.9 174.72 3.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 108.951 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.76 121.47 31.94 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 108.021 -1.103 . . . . 75.109999999999999 108.021 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -91.4 158.6 16.42 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.611 -0.885 . . . . 72.219999999999999 108.611 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.73 0.28 28.78 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.744 -0.662 . . . . 71.349999999999994 113.666 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -88.5 -19.68 26.12 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.12 0.486 . . . . 71.420000000000002 109.709 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.32 25.01 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 111.303 -0.719 . . . . 51.340000000000003 111.303 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -118.71 160.65 21.46 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 123.437 0.695 . . . . 71.319999999999993 111.494 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.8 m -80.39 139.61 36.43 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.989 -1.005 . . . . 73.219999999999999 110.336 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.3 157.41 28.3 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 109.831 -1.308 . . . . 71.25 109.831 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 32' ' ' ILE . 10.1 tp10 -73.6 158.81 34.09 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.897 -0.779 . . . . 72.510000000000005 108.897 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.93 -39.01 61.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.945 -1.131 . . . . 54.25 107.945 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.502 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 37.6 mm -82.34 140.2 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 106.247 -1.761 . . . . 65.0 106.247 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.32 -37.89 60.52 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.284 0.564 . . . . 53.43 110.354 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.7 84.65 5.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 110.792 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . . . -80.46 121.08 81.08 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.844 -0.616 . . . . 62.350000000000001 110.213 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 39.1 Cg_exo -57.39 -42.04 66.05 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.655 2.903 . . . . 63.420000000000002 114.674 -176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -150.68 -47.16 0.12 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.775 -0.454 . . . . 73.450000000000003 109.775 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.64 67.09 2.71 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.848 0.832 . . . . 64.209999999999994 110.852 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 2' ' ' GLU . 65.9 mtt180 . . . . . 0 N--CA 1.426 -1.659 0 CA-C-N 114.089 -1.414 . . . . 73.430000000000007 109.916 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.268 -1.382 . . . . 63.140000000000001 107.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.646 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 15.9 mt-10 -91.4 176.86 6.41 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 112.877 -1.965 . . . . 73.120000000000005 110.174 -169.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -161.61 150.63 15.98 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 106.777 -1.564 . . . . 73.030000000000001 106.777 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.1 -25.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-O 121.094 0.474 . . . . 70.219999999999999 110.128 -177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -88.84 -44.49 10.45 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.896 -0.779 . . . . 65.439999999999998 108.896 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -133.18 88.58 2.51 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.709 -0.678 . . . . 75.329999999999998 110.338 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.49 132.83 60.89 Favored Pre-proline 0 C--N 1.297 -1.677 0 CA-C-N 115.894 -0.594 . . . . 53.240000000000002 110.962 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 22.7 Cg_exo -67.36 123.27 10.64 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.18 1.92 . . . . 60.229999999999997 109.396 174.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 62.0 pttt -82.26 163.76 21.62 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.065 -0.654 . . . . 63.229999999999997 111.234 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.1 p -150.99 157.39 42.83 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 116.225 -0.443 . . . . 71.109999999999999 110.197 -177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 2.8 mmp_? -116.68 -33.91 4.69 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.092 -1.077 . . . . 71.140000000000001 108.092 170.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -124.79 158.81 32.44 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.074 -0.967 . . . . 75.420000000000002 110.137 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -61.47 -30.87 70.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.118 -0.946 . . . . 70.129999999999995 111.533 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -71.78 -10.92 60.49 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.909 0.707 . . . . 60.119999999999997 112.909 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.24 -12.97 61.05 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.391 0.615 . . . . 71.430000000000007 109.581 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.3 m -110.92 126.71 28.18 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.603 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -84.9 168.85 10.61 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.67 2.247 . . . . 55.310000000000002 113.672 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.58 -126.17 40.47 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.273 -0.876 . . . . 73.140000000000001 113.522 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.12 13.3 29.68 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.068 -0.566 . . . . 60.43 110.881 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.87 151.13 25.29 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.898 -0.778 . . . . 75.299999999999997 108.898 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 44.1 pt -129.26 172.83 14.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.357 -1.349 . . . . 71.530000000000001 107.357 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.0 t -92.04 111.08 22.49 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 107.274 -1.38 . . . . 60.219999999999999 107.274 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.3 mmm180 -77.95 164.22 25.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.475 -0.565 . . . . 71.519999999999996 109.475 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.32 1.34 20.07 Favored Glycine 0 N--CA 1.468 0.788 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 114.129 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.7 p-10 -89.81 -21.38 22.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.084 -0.709 . . . . 74.439999999999998 109.084 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.93 15.17 19.09 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.573 -0.74 . . . . 63.32 111.381 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 92.9 m-85 -131.59 150.16 52.25 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 122.863 0.465 . . . . 71.329999999999998 110.858 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -66.67 124.17 22.11 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.688 -0.687 . . . . 71.450000000000003 111.248 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.97 163.88 27.62 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.227 -1.149 . . . . 73.239999999999995 110.227 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' ' 32' ' ' ILE . 42.1 tt0 -62.02 152.91 31.14 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.425 0.631 . . . . 73.409999999999997 110.992 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . . . -77.45 -23.35 50.49 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.341 -0.845 . . . . 65.409999999999997 112.397 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 34' ' ' ALA . 39.2 mt -72.98 148.91 8.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.612 -0.722 . . . . 73.430000000000007 109.165 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -88.27 -10.44 49.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.198 0.523 . . . . 71.540000000000006 111.357 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -76.96 -176.94 4.16 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.616 -0.883 . . . . 72.319999999999993 108.616 174.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.17 119.7 51.51 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.682 -0.488 . . . . 71.310000000000002 109.682 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 56.1 Cg_exo -56.14 155.5 23.87 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 123.467 2.778 . . . . 54.149999999999999 112.909 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.53 -13.38 37.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.878 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' HB2' ' A' ' 2' ' ' GLU . . . 70.13 61.39 0.24 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 124.332 1.053 . . . . 53.420000000000002 109.439 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 . . . . . 0 CA--C 1.495 -1.15 0 CA-C-N 113.863 -1.517 . . . . 73.129999999999995 111.258 -173.336 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.7 m . . . . . 0 N--CA 1.426 -1.656 0 N-CA-C 109.263 -0.643 . . . . 72.209999999999994 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -146.76 148.84 32.36 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.287 -0.635 . . . . 73.319999999999993 109.287 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 6' ' ' ALA . . . -168.56 145.75 3.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.671 -1.974 . . . . 65.230000000000004 105.671 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.3 mp -94.4 -30.48 4.24 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 112.278 0.473 . . . . 73.439999999999998 112.278 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -87.89 -41.22 13.35 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.617 -0.833 . . . . 74.230000000000004 109.29 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -125.42 83.66 2.19 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 114.969 -1.014 . . . . 53.140000000000001 110.288 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.96 119.36 76.39 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 109.083 -0.71 . . . . 61.240000000000002 109.083 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.95 104.82 0.87 Allowed 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.908 2.405 . . . . 72.439999999999998 114.275 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -85.06 154.23 22.21 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.191 -0.913 . . . . 62.439999999999998 108.547 175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.0 p -127.62 148.91 50.38 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.034 0.445 . . . . 64.030000000000001 111.186 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -112.02 -39.33 4.53 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.119 -1.808 . . . . 72.319999999999993 106.119 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -127.48 157.04 41.13 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.189 -1.369 . . . . 74.140000000000001 109.422 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.73 -29.12 70.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.394 0.678 . . . . 64.310000000000002 111.728 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.8 p -63.68 -23.05 67.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.239 -0.891 . . . . 73.099999999999994 111.866 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.485 0.66 . . . . 75.140000000000001 110.3 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 34.5 m -105.39 110.46 64.36 Favored Pre-proline 0 N--CA 1.401 -2.892 0 CA-C-N 115.384 -0.826 . . . . 72.129999999999995 109.879 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.84 178.84 6.52 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.517 2.145 . . . . 73.400000000000006 112.733 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.27 -111.87 4.52 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.989 -0.551 . . . . 44.530000000000001 112.997 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.51 16.18 9.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.845 -0.798 . . . . 61.350000000000001 108.845 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.1 m -83.95 144.4 29.19 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 115.179 -0.919 . . . . 73.310000000000002 109.867 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 49.2 pt -122.29 174.12 7.11 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.945 -1.502 . . . . 73.319999999999993 106.945 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.41 108.47 19.66 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.777 -1.194 . . . . 53.020000000000003 107.777 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 70.5 mtp180 -82.17 165.92 20.09 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 116.127 -0.488 . . . . 71.209999999999994 111.128 -177.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.85 -4.24 57.9 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 115.77 -0.65 . . . . 72.129999999999995 112.925 -177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 36.7 p-10 -89.05 -14.8 35.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.992 -0.744 . . . . 71.439999999999998 108.992 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 15.47 38.88 Favored Glycine 0 CA--C 1.493 -1.3 0 CA-C-N 115.479 -0.782 . . . . 73.400000000000006 111.183 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -124.14 154.38 40.11 Favored 'General case' 0 N--CA 1.42 -1.953 0 C-N-CA 123.482 0.713 . . . . 71.120000000000005 111.532 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 98.4 m -80.31 118.71 22.2 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.796 -1.093 . . . . 63.229999999999997 110.211 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -148.09 160.43 28.33 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.816 -1.183 . . . . 73.25 111.008 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 41.5 tt0 -63.62 155.51 29.54 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.491 -0.559 . . . . 73.129999999999995 109.491 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.35 26.44 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.189 -0.46 . . . . 72.219999999999999 110.836 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.0 mt -123.35 138.01 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 106.685 -1.598 . . . . 73.400000000000006 106.685 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -99.24 82.95 2.77 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 111.446 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.54 -85.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.229 -0.896 . . . . 35.43 108.966 174.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.79 117.55 68.7 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 108.564 -0.902 . . . . 71.129999999999995 108.564 174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -73.44 121.07 6.86 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.581 1.521 . . . . 73.420000000000002 111.023 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -112.68 -54.32 2.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.628 -1.249 . . . . 70.150000000000006 107.628 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.3 87.71 0.91 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.925 -1.034 . . . . 63.030000000000001 109.424 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 99.7 mtt180 . . . . . 0 C--N 1.301 -1.527 0 CA-C-N 114.966 -1.016 . . . . 75.349999999999994 111.063 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 18' ' ' GLY . 1.8 p . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 116.055 1.872 . . . . 74.040000000000006 116.055 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 3' ' ' ALA . 38.3 tt0 -91.29 178.72 5.89 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.378 -1.341 . . . . 75.409999999999997 107.378 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' A' ' 2' ' ' GLU . . . -65.86 98.23 0.4 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.559 0.695 . . . . 64.0 109.165 174.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.8 mt -111.69 -66.52 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 CA-C-N 114.815 -1.084 . . . . 74.430000000000007 108.795 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -88.38 -37.2 16.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.245 -1.343 . . . . 75.120000000000005 108.636 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -145.79 143.39 29.65 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.054 -1.43 . . . . 62.240000000000002 109.037 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.74 104.86 3.05 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 123.833 0.708 . . . . 65.349999999999994 109.196 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 2.8 Cg_endo -83.78 117.04 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.455 2.103 . . . . 73.519999999999996 110.823 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -80.73 155.23 26.83 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.676 -0.49 . . . . 73.25 109.676 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 14.6 p -144.52 162.86 35.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.73 0.3 . . . . 74.340000000000003 111.169 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -123.07 -41.06 2.35 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.247 -1.39 . . . . 71.019999999999996 107.247 171.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -119.48 154.23 34.1 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.234 -1.348 . . . . 74.340000000000003 109.514 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.13 -28.16 67.91 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.978 0.894 . . . . 71.219999999999999 111.14 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 p -68.6 -11.95 60.7 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.464 -1.243 . . . . 71.109999999999999 113.19 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -69.06 -24.8 64.21 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.056 -0.72 . . . . 70.5 109.056 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.4 m -95.71 121.5 61.19 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 115.443 -0.799 . . . . 74.400000000000006 109.962 -175.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -85.11 -167.27 0.4 Allowed 'Trans proline' 0 C--O 1.248 1.008 0 C-N-CA 123.101 2.534 . . . . 60.32 112.375 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 1' ' ' CYS . . . 64.48 -111.99 4.63 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.237 -0.745 . . . . 64.209999999999994 111.237 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.64 19.43 3.09 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.584 -1.265 . . . . 64.239999999999995 107.584 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 71.7 m -90.78 153.62 20.12 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.952 -1.022 . . . . 75.400000000000006 111.946 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.8 pt -121.15 175.13 5.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 CA-C-N 115.214 -0.903 . . . . 71.299999999999997 109.911 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.04 110.71 23.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.853 -0.795 . . . . 50.119999999999997 108.853 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -82.65 169.98 15.63 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.075 0.464 . . . . 64.340000000000003 111.405 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.62 -1.76 46.89 Favored Glycine 0 N--CA 1.464 0.514 0 CA-C-N 115.734 -0.666 . . . . 42.229999999999997 113.433 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -89.03 -15.19 34.7 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.786 -0.82 . . . . 74.010000000000005 108.786 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.54 15.54 34.41 Favored Glycine 0 CA--C 1.481 -2.056 0 N-CA-C 111.292 -0.723 . . . . 33.409999999999997 111.292 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.76 156.4 42.5 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 114.719 -0.741 . . . . 74.420000000000002 110.705 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 72.6 m -79.87 141.18 36.37 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 109.383 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 2' ' ' GLU . . . -155.13 168.55 33.04 Favored Glycine 0 N--CA 1.407 -3.246 0 N-CA-C 109.271 -1.532 . . . . 72.319999999999993 109.271 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 40.8 tt0 -65.32 162.05 18.32 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.627 -0.508 . . . . 71.299999999999997 109.627 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.64 64.89 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.566 0.698 . . . . 53.43 109.784 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.53 140.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 N-CA-C 106.559 -1.645 . . . . 54.299999999999997 106.559 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -81.22 -32.15 33.55 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.164 0.506 . . . . 74.519999999999996 110.042 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.1 87.48 2.51 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.962 -1.125 . . . . 73.439999999999998 107.962 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 126.75 84.19 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.372 -0.831 . . . . 71.140000000000001 112.01 -175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.25 -36.92 79.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.782 2.988 . . . . 74.010000000000005 112.621 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -135.79 -79.92 0.42 Allowed 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.739 -1.208 . . . . 74.129999999999995 107.739 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 168.29 88.95 0.0 OUTLIER 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.87 1.268 . . . . 60.310000000000002 109.534 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HE ' ' CD ' ' A' ' 30' ' ' GLU . 74.1 mtm180 . . . . . 0 C--N 1.308 -1.231 0 CA-C-O 119.316 -0.373 . . . . 73.099999999999994 110.153 170.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.399 -2.985 0 N-CA-C 103.382 -2.822 . . . . 75.219999999999999 103.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.7 -31.39 19.74 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.65 -0.87 . . . . 73.409999999999997 108.65 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.39 93.41 9.31 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.455 -0.942 . . . . 75.519999999999996 108.455 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.0 mt -103.19 -33.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.032 -0.729 . . . . 74.420000000000002 109.032 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -88.83 -43.12 11.46 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.66 -1.237 . . . . 60.530000000000001 107.66 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.19 35.59 1.57 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.196 -1.365 . . . . 74.319999999999993 108.733 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.92 153.0 84.83 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.17 -1.377 . . . . 65.510000000000005 110.369 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.47 161.9 31.06 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.921 1.747 . . . . 74.219999999999999 109.856 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -80.7 145.09 31.77 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.83 -0.434 . . . . 73.109999999999999 109.83 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.562 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 24.4 p -121.35 148.03 44.91 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.669 -0.696 . . . . 71.519999999999996 109.828 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 7.2 mpt_? -109.22 -32.46 7.19 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 73.25 107.155 174.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -144.95 160.02 42.0 Favored 'General case' 0 CA--C 1.491 -1.3 0 C-N-CA 125.395 1.478 . . . . 74.329999999999998 108.528 172.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -59.23 -37.43 77.51 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.962 0.887 . . . . 74.129999999999995 110.549 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.8 p -68.33 -17.39 64.25 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.348 -1.296 . . . . 60.210000000000001 113.75 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 2.2 p30 -91.04 6.25 45.61 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 118.914 -1.114 . . . . 75.299999999999997 111.734 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 73.0 m -89.23 145.26 33.81 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 120.719 -0.392 . . . . 70.340000000000003 110.74 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.82 132.56 52.47 Favored 'Trans proline' 0 C--O 1.257 1.453 0 C-N-CA 123.373 2.715 . . . . 71.109999999999999 113.019 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.71 -106.94 1.72 Allowed Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 114.801 -1.09 . . . . 33.340000000000003 112.563 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.07 16.9 5.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.545 -0.168 . . . . 35.409999999999997 110.545 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.69 150.34 41.29 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 109.1 -0.704 . . . . 55.310000000000002 109.1 176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 46.0 pt -104.07 170.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.875 -0.416 . . . . 61.149999999999999 109.875 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.3 t -98.24 122.75 41.78 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.04 -1.096 . . . . 65.329999999999998 108.04 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mtm-85 -88.72 166.67 13.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.916 -0.401 . . . . 74.540000000000006 109.916 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.5 -7.57 41.0 Favored Glycine 0 N--CA 1.467 0.715 0 CA-C-N 116.271 -0.422 . . . . 72.319999999999993 113.831 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 33.5 p-10 -89.18 -24.84 22.07 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 122.548 -0.383 . . . . 61.43 110.057 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.08 19.92 9.71 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.609 -0.805 . . . . 74.430000000000007 111.547 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 70.8 m-85 -125.32 155.91 39.49 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.729 -0.841 . . . . 73.409999999999997 108.729 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.3 m -80.26 153.06 28.74 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.816 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.46 -179.7 33.51 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-O 119.189 -0.784 . . . . 72.120000000000005 111.34 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.07 150.12 30.35 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.268 0.627 . . . . 65.040000000000006 110.125 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.14 32.87 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.369 -0.832 . . . . 64.409999999999997 110.333 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.3 mt -139.59 128.63 28.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 106.087 -1.82 . . . . 52.030000000000001 106.087 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -87.72 87.22 7.31 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 121.589 0.709 . . . . 73.120000000000005 111.599 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.67 -92.4 0.05 OUTLIER 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.383 -1.34 . . . . 75.430000000000007 107.383 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.65 60.18 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.392 -1.336 . . . . 74.209999999999994 107.392 171.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.12 110.83 2.07 Favored 'Trans proline' 0 C--O 1.249 1.052 0 N-CA-C 108.579 -1.354 . . . . 72.450000000000003 108.579 173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -109.15 -65.93 1.1 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.324 0.583 . . . . 75.310000000000002 111.592 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.26 38.63 2.16 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.77 -1.196 . . . . 63.0 107.77 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 CA--C 1.489 -1.38 0 C-N-CA 126.562 1.945 . . . . 63.310000000000002 115.481 -169.499 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.427 -1.576 0 N-CA-C 101.683 -3.451 . . . . 64.319999999999993 101.683 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -137.87 155.16 49.25 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.605 -0.725 . . . . 61.030000000000001 111.996 -163.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.82 132.54 5.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.874 -2.269 . . . . 71.129999999999995 104.874 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.7 mm -96.48 -20.44 5.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 120.875 0.369 . . . . 73.340000000000003 111.533 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -88.25 -41.41 12.95 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.576 -0.85 . . . . 73.329999999999998 108.9 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.91 102.82 3.01 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.979 -0.749 . . . . 74.099999999999994 108.979 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.69 134.42 57.53 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 116.601 -0.272 . . . . 54.240000000000002 110.402 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.12 119.4 6.57 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.796 2.331 . . . . 64.200000000000003 112.277 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -89.77 157.81 17.79 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.45 -0.945 . . . . 61.310000000000002 108.45 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.8 p -136.88 142.01 42.78 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.398 0.618 . . . . 61.520000000000003 111.478 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.9 -32.52 7.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.645 -1.613 . . . . 72.409999999999997 106.645 171.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.519 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -140.02 161.5 37.47 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 113.705 -1.589 . . . . 71.120000000000005 108.651 174.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.54 -29.54 70.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.561 -0.745 . . . . 72.340000000000003 111.864 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 p -69.54 -15.56 63.26 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.847 -0.615 . . . . 62.509999999999998 112.57 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.519 ' OD2' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m-20 -68.41 -22.55 64.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.451 0.643 . . . . 55.219999999999999 110.007 173.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -89.83 123.54 66.03 Favored Pre-proline 0 N--CA 1.42 -1.973 0 CA-C-N 115.351 -0.84 . . . . 61.409999999999997 111.513 -174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.23 -179.81 4.6 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.979 2.453 . . . . 73.209999999999994 112.077 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.83 -123.82 34.34 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 112.311 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' ALA . . . -113.04 10.44 18.78 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.005 -0.739 . . . . 64.439999999999998 109.005 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 m -71.08 146.68 49.13 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.675 -0.693 . . . . 73.349999999999994 110.614 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 31' ' ' ALA . 22.9 pt -127.12 171.41 15.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.901 -0.777 . . . . 71.349999999999994 108.901 177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.7 115.02 26.75 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.077 0.465 . . . . 71.200000000000003 109.781 -176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -86.3 167.76 14.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 109.899 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.42 -2.23 54.13 Favored Glycine 0 N--CA 1.469 0.834 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 113.403 -174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -89.96 -17.55 27.72 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 120.761 0.315 . . . . 55.130000000000003 111.024 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.53 27.16 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.717 -0.953 . . . . 72.510000000000005 110.717 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -126.3 154.99 42.67 Favored 'General case' 0 N--CA 1.419 -2.012 0 C-N-CA 124.452 1.101 . . . . 75.329999999999998 109.988 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 74.4 m -80.19 126.2 30.81 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.491 -0.777 . . . . 72.230000000000004 109.839 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.46 -178.97 15.57 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.139 -1.185 . . . . 73.430000000000007 110.139 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 38' ' ' ALA . 9.0 tp10 -66.17 156.19 34.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.873 0.336 . . . . 72.019999999999996 110.271 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 19' ' ' ALA . . . -80.59 -53.39 6.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.37 0.605 . . . . 73.219999999999999 111.482 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 35' ' ' ALA . 50.2 mm -115.66 150.31 17.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.05 -0.977 . . . . 51.109999999999999 109.704 -172.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -82.41 136.76 34.88 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.489 -0.93 . . . . 72.329999999999998 108.489 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 69.82 24.64 5.25 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.422 1.089 . . . . 64.230000000000004 110.15 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.94 166.49 42.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.444 -0.798 . . . . 60.130000000000003 110.77 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 58.7 Cg_exo -42.09 -50.21 5.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.97 3.113 . . . . 72.209999999999994 115.2 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -96.87 -38.09 9.98 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.131 -0.628 . . . . 74.400000000000006 109.84 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . . . 72.6 14.99 5.06 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 125.113 1.365 . . . . 73.340000000000003 111.488 174.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 N--CA 1.417 -2.124 0 CA-C-N 114.324 -1.307 . . . . 73.349999999999994 109.871 -176.407 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 122.019 0.914 . . . . 74.319999999999993 109.646 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' CD ' ' HD2' ' A' ' 39' ' ' ARG . 6.0 pt-20 -97.71 161.64 13.66 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.713 -1.13 . . . . 71.120000000000005 110.503 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -89.0 120.07 30.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 106.422 -1.696 . . . . 73.25 106.422 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.45 -29.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-N 114.734 -1.121 . . . . 62.530000000000001 112.228 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -88.8 -42.23 12.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.137 -1.06 . . . . 74.430000000000007 108.137 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.26 78.62 1.77 Allowed 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.982 -1.008 . . . . 73.099999999999994 108.403 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.98 117.2 12.01 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.253 -0.885 . . . . 71.349999999999994 111.758 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 3' ' ' ALA . 34.0 Cg_endo -89.87 108.79 0.4 Allowed 'Trans proline' 0 N--CA 1.429 -2.289 0 C-N-CA 122.458 2.105 . . . . 74.310000000000002 111.806 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 23.6 pttm -88.7 145.6 25.55 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 109.572 -0.529 . . . . 75.400000000000006 109.572 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 27.6 p -127.38 154.55 44.86 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 121.826 0.822 . . . . 70.019999999999996 111.598 -173.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -115.22 -35.25 4.73 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.089 -1.448 . . . . 71.349999999999994 107.089 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -130.57 158.45 39.95 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.306 -1.315 . . . . 73.530000000000001 110.103 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 6.4 m-20 -62.71 -34.33 76.94 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.626 0.726 . . . . 70.209999999999994 110.679 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -67.01 -6.41 16.9 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.502 -1.226 . . . . 74.540000000000006 113.212 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.7 -40.46 92.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.285 0.564 . . . . 73.510000000000005 109.523 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 79.2 m -131.71 98.34 18.02 Favored Pre-proline 0 N--CA 1.409 -2.479 0 N-CA-C 107.836 -1.172 . . . . 70.129999999999995 107.836 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.75 -166.21 0.39 Allowed 'Trans proline' 0 C--O 1.261 1.667 0 C-N-CA 122.896 2.397 . . . . 72.049999999999997 115.291 -171.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.74 -111.22 4.0 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 113.933 -1.485 . . . . 34.109999999999999 112.762 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 -14.93 36.79 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.15 -0.525 . . . . 60.140000000000001 111.426 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.91 155.46 18.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.316 -0.554 . . . . 73.340000000000003 110.951 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.7 pt -131.9 179.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.401 -0.963 . . . . 65.219999999999999 108.401 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 13' ' ' ASP . 50.4 t -101.28 126.55 48.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.318 -1.364 . . . . 74.200000000000003 107.318 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 41.4 mtt180 -91.25 165.81 13.26 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.796 -0.446 . . . . 71.310000000000002 109.796 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -5.92 66.76 Favored Glycine 0 C--N 1.317 -0.503 0 CA-C-N 115.71 -0.677 . . . . 72.530000000000001 112.491 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.586 ' OD1' ' HB2' ' A' ' 23' ' ' ARG . 32.5 p-10 -88.3 -11.69 45.69 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.908 -0.775 . . . . 61.409999999999997 108.908 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.42 42.49 Favored Glycine 0 CA--C 1.488 -1.601 0 CA-C-N 115.598 -0.728 . . . . 64.519999999999996 111.298 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 60.7 m-85 -125.14 157.03 37.39 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.496 0.718 . . . . 70.329999999999998 110.285 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 63.8 m -79.98 166.53 21.5 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.733 0.301 . . . . 62.420000000000002 110.414 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA3' ' HE ' ' A' ' 23' ' ' ARG . . . 170.55 -176.16 44.18 Favored Glycine 0 CA--C 1.486 -1.762 0 C-N-CA 120.172 -1.013 . . . . 52.450000000000003 112.488 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' HG12 ' A' ' 32' ' ' ILE . 9.8 tp10 -60.75 154.92 20.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 124.347 0.674 . . . . 74.549999999999997 109.95 176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.92 16.54 1.43 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 123.961 0.905 . . . . 52.439999999999998 112.356 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' HG3' ' A' ' 30' ' ' GLU . 50.3 mm -93.93 129.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.509 -1.663 . . . . 55.009999999999998 106.509 174.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -90.64 -21.78 21.51 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 115.62 -0.718 . . . . 74.439999999999998 111.483 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.03 -166.54 1.52 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.128 -1.064 . . . . 73.099999999999994 108.128 174.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.65 114.76 15.74 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 109.893 -0.41 . . . . 71.5 109.893 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.26 -173.99 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.666 2.244 . . . . 63.25 111.43 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -148.25 -59.93 0.25 Allowed 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.039 -1.097 . . . . 74.099999999999994 108.039 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.53 78.84 7.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.819 -0.628 . . . . 54.420000000000002 109.943 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.428 ' HD2' ' CD ' ' A' ' 2' ' ' GLU . 80.0 mtm180 . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.927 -0.579 . . . . 72.310000000000002 109.987 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.247 0.927 0 CA-C-O 121.388 0.613 . . . . 75.109999999999999 109.775 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.06 175.31 7.45 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.779 -1.101 . . . . 72.129999999999995 109.118 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.24 131.91 8.67 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.635 -1.246 . . . . 73.450000000000003 107.635 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.66 -26.82 5.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.735 -0.666 . . . . 71.129999999999995 110.596 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -88.06 -40.8 13.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.456 0.646 . . . . 63.310000000000002 109.709 -176.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.63 87.85 1.66 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.044 -0.98 . . . . 63.109999999999999 109.62 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.07 135.45 96.32 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.296 -0.865 . . . . 74.530000000000001 111.459 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.12 122.2 8.2 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.465 2.11 . . . . 65.140000000000001 111.348 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 50.9 mtpt -76.58 145.98 38.62 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.845 -0.428 . . . . 73.340000000000003 109.845 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 26.6 p -117.82 146.85 43.57 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.645 0.259 . . . . 54.409999999999997 110.764 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.38 -45.08 4.16 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.79 -1.559 . . . . 71.340000000000003 106.79 172.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -136.66 155.26 50.13 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.04 -1.436 . . . . 72.140000000000001 109.309 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.415 ' OD2' ' HB ' ' A' ' 21' ' ' ILE . 2.9 m-20 -58.43 -35.01 71.45 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 123.698 0.799 . . . . 70.420000000000002 111.023 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.9 p -67.31 -16.26 64.16 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.29 1.218 . . . . 32.299999999999997 114.29 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -90.25 -4.14 57.37 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.289 -0.964 . . . . 72.109999999999999 111.549 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.9 m -89.93 137.41 28.25 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 115.791 -0.64 . . . . 62.100000000000001 110.012 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.0 122.27 6.03 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 124.18 3.254 . . . . 64.450000000000003 114.525 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.61 -119.25 17.57 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.131 -0.94 . . . . 70.140000000000001 112.914 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.93 10.54 36.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.316 -0.442 . . . . 64.329999999999998 110.866 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.54 146.8 52.96 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.125 -0.694 . . . . 63.340000000000003 109.125 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' OD2' ' A' ' 13' ' ' ASP . 36.0 pt -111.67 167.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.007 0.432 . . . . 73.430000000000007 111.0 -173.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.1 t -92.19 105.1 17.39 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.564 -1.273 . . . . 54.420000000000002 107.564 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -79.96 165.16 22.89 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-O 121.01 0.433 . . . . 72.230000000000004 111.546 -175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.43 -6.38 48.2 Favored Glycine 0 C--N 1.314 -0.694 0 CA-C-N 115.381 -0.827 . . . . 74.040000000000006 113.743 -175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -88.18 -15.47 35.92 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.987 -0.746 . . . . 72.319999999999993 108.987 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.39 10.83 37.67 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 111.037 -0.825 . . . . 40.140000000000001 111.037 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 9' ' ' LYS . 71.4 m-85 -124.69 151.75 44.58 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-O 121.44 0.638 . . . . 73.049999999999997 110.686 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.7 m -74.19 147.22 42.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.464 -0.789 . . . . 45.32 109.271 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.15 159.68 32.26 Favored Glycine 0 CA--C 1.472 -2.637 0 N-CA-C 110.321 -1.112 . . . . 72.140000000000001 110.321 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -63.69 161.39 15.1 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 124.196 0.586 . . . . 74.030000000000001 110.007 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.25 42.69 0.27 Allowed 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.5 1.12 . . . . 71.010000000000005 111.398 -176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.485 HG22 ' H ' ' A' ' 34' ' ' ALA . 24.0 mt -93.13 130.9 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.98 -1.489 . . . . 34.119999999999997 106.98 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -99.68 -6.95 26.31 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 121.904 0.859 . . . . 74.040000000000006 110.334 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -98.8 -158.02 0.64 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.487 -1.233 . . . . 74.430000000000007 107.871 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.6 93.14 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 110.554 -0.165 . . . . 75.109999999999999 110.554 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -54.97 147.72 51.0 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.48 2.787 . . . . 62.509999999999998 112.808 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -109.59 -7.59 15.1 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.477 0.656 . . . . 71.209999999999994 109.391 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 70.91 70.77 0.19 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.707 1.203 . . . . 65.540000000000006 111.241 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 . . . . . 0 CA--C 1.476 -1.884 0 N-CA-C 106.719 -1.586 . . . . 72.319999999999993 106.719 174.615 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.5 p . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 113.269 0.841 . . . . 61.200000000000003 113.269 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -99.07 -55.39 2.71 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.27 -0.877 . . . . 71.230000000000004 110.277 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.85 142.92 13.95 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 106.394 -1.706 . . . . 61.32 106.394 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -106.69 -39.76 4.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 116.579 -0.282 . . . . 73.120000000000005 111.68 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -89.25 -41.19 12.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.178 -1.045 . . . . 74.430000000000007 108.178 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 8' ' ' PRO . . . -87.46 136.98 32.72 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.737 -1.12 . . . . 73.030000000000001 109.463 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.99 108.66 12.04 Favored Pre-proline 0 C--N 1.31 -1.142 0 O-C-N 123.373 0.42 . . . . 73.530000000000001 111.594 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 6' ' ' ALA . 35.1 Cg_endo -89.4 123.89 1.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.332 2.021 . . . . 42.409999999999997 109.914 177.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 63.9 pttt -100.07 145.69 27.64 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.995 -0.682 . . . . 62.43 111.416 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.747 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . 25.4 p -124.1 152.07 43.16 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 120.631 0.253 . . . . 74.519999999999996 110.876 -176.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -110.2 -36.13 5.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.524 -1.658 . . . . 72.129999999999995 106.524 169.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -132.38 151.89 51.68 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.36 -1.291 . . . . 74.439999999999998 109.184 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.45 -40.9 88.35 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.951 0.881 . . . . 73.230000000000004 109.343 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.3 p -63.33 -18.46 63.65 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.649 -1.614 . . . . 55.229999999999997 114.47 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . 0.305 2.6 p30 -78.91 -9.1 59.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 118.668 -1.213 . . . . 75.099999999999994 112.051 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 m -125.99 106.77 25.36 Favored Pre-proline 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 62.399999999999999 109.347 173.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.06 -168.2 0.49 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 123.412 2.741 . . . . 44.210000000000001 115.792 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.47 -128.32 32.78 Favored Glycine 0 N--CA 1.422 -2.243 0 CA-C-N 113.85 -1.523 . . . . 70.120000000000005 112.167 176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.65 6.58 46.86 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.417 -0.392 . . . . 52.420000000000002 110.87 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.5 m -93.72 147.85 22.65 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.672 0.748 . . . . 74.120000000000005 111.98 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 pt -138.0 177.06 5.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 114.052 -1.431 . . . . 71.109999999999999 107.97 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -97.9 124.63 42.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.565 -0.902 . . . . 71.319999999999993 108.565 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -98.01 167.77 10.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 O-C-N 122.193 -0.317 . . . . 72.129999999999995 110.765 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.26 -9.14 56.98 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 114.424 0.53 . . . . 75.439999999999998 114.424 -174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -88.84 -17.57 29.43 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.45 0.643 . . . . 71.329999999999998 109.398 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.26 17.83 23.5 Favored Glycine 0 N--CA 1.436 -1.355 0 N-CA-C 110.888 -0.885 . . . . 51.0 110.888 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 70.9 m-85 -121.08 151.98 39.21 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.165 0.507 . . . . 61.32 111.938 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 39.5 m -79.49 109.76 14.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.169 -0.923 . . . . 71.319999999999993 109.674 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.79 163.63 12.78 Favored Glycine 0 CA--C 1.477 -2.312 0 N-CA-C 109.112 -1.595 . . . . 61.049999999999997 109.112 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -80.27 166.36 21.44 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.744 -1.576 . . . . 63.340000000000003 106.744 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.38 74.07 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.864 0.364 . . . . 40.399999999999999 110.259 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.73 -62.01 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-O 121.319 0.58 . . . . 70.439999999999998 110.912 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -87.38 95.62 10.07 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 115.261 -0.882 . . . . 55.32 112.848 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.15 -22.6 18.36 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.358 -0.837 . . . . 63.219999999999999 110.939 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.95 156.09 84.44 Favored Pre-proline 0 C--O 1.254 1.298 0 CA-C-N 115.651 -0.704 . . . . 64.439999999999998 109.259 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.12 84.56 0.71 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.108 1.872 . . . . 71.109999999999999 111.321 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.4 -50.94 0.13 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 108.954 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.12 72.44 1.21 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.727 -0.67 . . . . 71.510000000000005 112.274 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 28' ' ' CYS . 37.5 mtm180 . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 107.209 -1.404 . . . . 74.540000000000006 107.209 176.321 . . . . . . . . 1 1 . 1 stop_ save_